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Diverticulosis
Diverticulosis is defined as the presence of diverticula in the colonic wall. These diverticula 
are protrusions of the colonic wall and mostly occur between the antimesenteric 
and mesenteric taeniae, where blood vessels penetrate the colonic wall. Strictly, these 
diverticula should be considered as ‘false’ or ‘pseudo’ diverticula, as not all bowel wall 
layers are involved, but only mucosa and submucosa (1-4).
In the Western world, diverticulosis is common and its prevalence increases with 
age. Investigating prevalence rates of diverticulosis is challenging as the majority of 
individuals remain asymptomatic. Nevertheless, diverticulosis is estimated to be present 
in approximately 5% of people at the age of 40, which increases up to 60% in people 
at the age of 70 or older (5-7). In Western individuals, diverticula are most commonly 
present in the left colon and particularly in the sigmoid colon (8). Contrarily, in Asian 
individuals, diverticula are typically present in the right colon and might have a different 
origin (9).
Although the etiology of diverticulosis is not yet fully understood, it is thought to be 
multifactorial and involves several factors, such as genetic, lifestyle, and environmental 
factors (10). Changes in the colonic wall, alterations in gut motility, and increased 
intracolonic pressure are thought to be the main contributors to the development of 
diverticula (4, 11). Western dietary habits have been identified to contribute to the 
development of diverticula. In particular, a low-fiber diet has been associated with 
diverticulosis, because of its effect on stool transit and intracolonic pressure (11). 
Consequences of ageing on the colon have been studied and include changes such as 
collagen cross-linking, elastin depositions, and decreased smooth muscle function (12-
14).
Diverticulitis
An estimated 4-7.3% of individuals with diverticulosis will have diverticulitis, which 
occurs when one or more diverticula get inflamed or infected (15). In the Netherlands, 
the incidence and prevalence of diverticulosis and diverticulitis are 0.7 and 1.8 per 
1000 patients per year and an approximate number of 22,000 patients are referred to 
secondary care for diverticulitis, annually (16, 17). Recent data from Italy suggest an 
annual increase of 3% of acute diverticulitis-related hospital admissions between 2008 
and 2015, with an increase from 39 to 48 hospitalizations per 100,000 inhabitants (18). 
Its burden on healthcare is well illustrated by the fact that diverticular disease is the third 
most common gastrointestinal discharge diagnosis in the United States (19). Moreover, 
certainly in the light of its increasing incidence, it is an important condition in terms 
of healthcare costs, which have been estimated to lead up to 2.1 billion U.S. dollars per 
year (19).
The pathogenesis of diverticulitis is a complex interplay between multiple factors and 
has not been completely elucidated. At first, it was thought that impaction of diverticula 
resulted in diverticulitis through increased intradiverticular pressure, with mucosal 
ulceration, bacterial proliferation, as well as local ischemia and microperforation as a 
consequence (20, 21). However, in recent years, new evidence has pointed more towards 
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the role of alterations in gut microbiome composition and function, with subsequent 
low-grade mucosal inflammation (20).
Several controllable and uncontrollable factors have been identified that put patients 
at higher risk of the progression of diverticulosis to diverticulitis. Again, it seems that a 
low-fiber diet plays a role and puts individuals at risk of diverticulitis (22). Moreover, 
obesity is an important risk factor, whereas physical activity seems to be a protective 
factor (23). Also, various drugs have been reported to add to the risk of diverticulitis, 
such as non-steroidal anti-inflammatory drugs, corticosteroids, and opiate analgesics 
(20, 24).
Acute diverticulitis can either be uncomplicated or complicated. In case of the latter, 
the inflammatory process leads to complications such as intra-abdominal abscess 
formation or perforation with purulent or fecal peritonitis. Approximately 10-20% of 
patients with diverticulitis present with complicated disease (25, 26), which requires 
more rigorous treatment, because, evidently, it is associated with worse outcomes (e.g 
peritonitis, colonic stenosis, fistula) than uncomplicated disease. Hence, it is important 
to distinguish between these types of acute diverticulitis. Generally, clinical findings 
alone are not enough to accurately assess disease severity and imaging is required to 
confirm the diagnosis (27). In the setting of acute diverticulitis, both ultrasound (US) and 
computed tomography scan (CT) have been investigated and both methods have been 
demonstrated to have a sensitivity and specificity of over 90% (28, 29). Nevertheless, in 
case of suspected complicated diverticulitis and in critically ill patients, it is agreed upon 
that CT is the imaging method of choice (27). 
Once complicated diverticulitis is diagnosed, it is further divided into different disease 
stages for which several classifications have been introduced through the years. Originally, 
Hinchey et al. (30) proposed their classification for acute diverticulitis in 1978, which 
was based on clinical and surgical findings. However, with the addition of CT imaging 
in the diagnostic process of acute diverticulitis, several adaptations of the Hinchey 
classification, as well as novel classifications were introduced (31). Nowadays, one of the 
most widely used classifications is the modified Hinchey classification as proposed by 
Wasvary et al. (32). This classification describes mild diverticulitis (grade 0), diverticulitis 
with confined pericolic inflammation or phlegmon (grade Ia), pericolic or mesocolic 
abscess formation (grade Ib), pelvic, distant intra-abdominal, or retroperitoneal abscess 
formation (grade II), as well as perforated diverticulitis with purulent (grade III) or fecal 
(grade IV) peritonitis. 
In this thesis, the main focus is put on these different stages of complicated diverticulitis 
and their non-resectional or resectional management.
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Diverticulitis with abscess formation
Of the patients with acute complicated diverticulitis, approximately 15-20% of cases 
will be complicated by abscess formation (Hinchey Ib and II diverticulitis) (33-35). 
Over the course of past decades, the treatment of diverticular abscesses has changed 
significantly. Traditionally, diverticular abscesses were managed surgically. However, 
facilitated by improvements in disease imaging, interventional radiology and antibiotic 
treatment, treatment gradually became more conservative (36, 37). Nowadays, non-
surgical treatment by means of antibiotics with or without image-guided percutaneous 
drainage has become standard practice for most cases (36). Importantly, the choice of 
treatment remains dependent on the patient’s clinical presentation, but also on factors 
affecting the amenability for drainage, such as the location and size of the abscess(es). 
In efforts to standardize treatment, several guidelines on diverticular disease have stated 
cut-off values for abscess size on which the choice for percutaneous drainage could 
partly be based (27). Although mostly based on low-quality evidence, sizes ranging from 
3-5 centimeters or larger were used to define large abscesses that require drainage in 
addition to antibiotic treatment (38, 39). In addition to initial treatment outcomes, it 
is also important to consider the rate of long-term adverse outcomes, such as recurrent 
diverticular disease, surgery, or recurrence-related mortality. Recurrence and long-term 
surgery rates have been reported to be as high as 25% and 18.2%, respectively, although 
most studies were small, observational and of retrospective design (40). Hence, this 
emphasizes the need for strong evidence to support accurate patient selection and to 
help guide adequate treatment choices.
Perforated diverticulitis with purulent or fecal peritonitis
The first scientific report on the surgical treatment of diverticulitis dates back to 1907 
(41). Ever since, the optimal surgical management of perforated diverticulitis has been 
a frequently debated topic and, consequently, standards have changed several times. 
Whereas at first a three-stage procedure was advocated, during the course of the second 
half of the 20th century, a two-staged approach became increasingly popular (42). This 
approach was named after the French surgeon Henri Hartmann, who already introduced 
it in 1923, although not for complicated diverticulitis but for rectum carcinoma (43). 
It involves resection of the diseased segment, construction of a colostomy, closure of the 
rectal stump, and – during a second procedure – restoration of intestinal continuity (42). 
Later on, during the past three decades, this ‘gold standard’ for perforated diverticulitis 
became challenged by novel one-stage approaches, such as laparoscopic peritoneal lavage 
and sigmoidectomy with primary anastomosis.
Results of the non-resectional treatment of perforated diverticulitis with purulent 
peritonitis by means of laparoscopic peritoneal lavage were first published in 1996 
(44). As the laparoscopic lavage procedure was considered less invasive and avoided 
the need for stoma construction, it gained increased interest soon after early results 
seemed positive (45). Lavage was deemed suitable for Hinchey III diverticulitis of 
which the idea is that it results from a perforated abscess while the original diverticular 
perforation is sealed off. Obviously, lavage was not deemed suitable in those cases in 
which an overt connection between the bowel and abdominal cavity is present (Hinchey 
IV) or in cases of peritonitis caused by misdiagnosed perforated cancer. Subsequently, 
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randomized controlled trials comparing laparoscopic lavage to sigmoid resection in 
Hinchey III patients were initiated and conducted (46-48). Conclusions based on the 
results of these trials differed and, interestingly, conclusions of the several meta-analyses 
that synthesized evidence from these trials were also conflictive. In general, a higher 
short-term failure risk after lavage needs to be weighed against the benefits such as a 
lower percentage of stomas and secondary procedures (e.g. stoma reversal) during the 
later stages of follow-up. Recently, research has focused more on long-term outcomes, as 
well as on the identification of risk factors for treatment failure to aid the identification 
of patients who might benefit most from laparoscopic lavage and who are at low risk for 
short-term failure.
With regard to sigmoidectomy with primary anastomosis, an important aspect to 
withhold surgeons from performing this one-stage procedure was the fear of anastomotic 
leakage in the setting of peritonitis. Nevertheless, some factors, such as the improvement 
in the management of sepsis, have helped gain increased interest for this approach. 
Despite its inherent risk of anastomotic leakage, the procedure was thought to have 
some significant advantages over the Hartmann’s procedure. In the vast majority of 
cases, a defunctioning ileostomy is constructed during the primary anastomosis 
procedure. In contrast to the Hartmann’s reversal, ileostomy reversal is technically less 
challenging with a lower risk of leakage and, therefore, was hypothesized to lead to 
higher stoma reversal rates and less complications after the reversal procedure. Several 
pro- and retrospective observational cohort studies were published that confirmed these 
advantages. These studies demonstrated that patients undergoing primary anastomosis 
had similar or less morbidity and mortality as compared to the Hartmann’s procedure, 
as well as higher stoma reversal rates with less reversal-related morbidity (35, 49-51). 
However, importantly, most of these studies were at risk for confounding by indication, 
leading (relatively) healthier patients to be selected to undergo sigmoidectomy with 
primary anastomosis. To overcome this risk of bias, randomized controlled trials were 
initiated with the goal to compare both procedures for Hinchey III and IV diverticulitis. 
Stoma-related complications
As mentioned before, in the vast majority of patients undergoing emergency surgery for 
perforated diverticulitis a stoma is constructed. However, a number of other indications 
exists for which the construction of a definite or temporary stoma is required, such as 
surgery for colorectal cancer, inflammatory bowel disease, or urological indications. Next 
to having a significant impact on factors such as body image and social functioning (52), 
the presence of a stoma also puts patients at risk for the development of a parastomal 
hernia.
Often defined as an incisional hernia related to an abdominal wall stoma, parastomal hernia 
is a common complication and incidence rates depend on the type of stoma, diagnostic 
methods, as well as the length of follow-up (53). In case of end colostomies, incidence 
rates range from 4.0 to 48.1%, whereas rates for loop ileostomies range from 0.0 to 6.2% 
(54). Parastomal hernias can lead to several problems, such as pain, problems with stoma 
appliance handling, leakage, bowel obstruction, and incarceration (53). There are several 
surgical options for the management of parastomal hernia (55). However, it remains 
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debated if in some patients ‘watchful waiting’ might also be appropriate, an approach that 
is also seen in incisional and inguinal hernia management (56, 57).
Importantly, the incision site of the stoma also remains vulnerable for herniation after 
patients undergo stoma reversal, which puts these patients at risk for the development 
of a stoma site incisional hernia. Similar to a parastomal hernia, a stoma site incisional 
hernia can lead to pain, discomfort, and incarceration. In recent years, the incidence, 
risk factors, and potential methods for prevention have gained increased attention, 
which will also be touched upon in this thesis.
Postoperative ileus
As opposed to the more long-term problem of abdominal wall hernia after surgery, 
postoperative ileus is a problem that arises shortly after the procedure. Postoperative 
ileus is generally defined as prolonged inhibition of gastrointestinal motility after 
surgery, although there is a wide variety in reported definitions throughout the literature 
(58, 59). Due to the different definitions reported, the true incidence of (prolonged) 
postoperative ileus is difficult to estimate, but seems to range between 10 to 30% of 
patients undergoing abdominal surgery (60, 61). Symptoms might include nausea, 
vomiting, intolerance of oral intake, abdominal distension, and lack of defecation, 
which results in lengthened hospital stay, a higher risk of hospital-acquired infections, as 
well as an increase in costs (59, 62). 
The pathophysiology of postoperative ileus is complex and involves both neurogenic 
and inflammatory factors that are triggered by surgery and its inherent gut manipulation 
(63). Next to the development of enhanced recovery protocols, numerous other 
strategies for the prevention and treatment of postoperative ileus have been assessed, 
such as chewing gum, prokinetic agents (e.g. magnesium oxide, metoclopramide), and 
peripheral μ-opioid receptor antagonists (e.g. Alvimopan) (59). In recent years, the role 
of the vagus nerve and cholinergic anti-inflammatory pathway have been investigated 
as potential mechanism to help prevent postoperative ileus, for example, by means of 
vagus nerve stimulation (63). Hence, it was hypothesized that nicotine chewing gum 
might be an inexpensive and widely available option to prevent postoperative ileus, both 
by activation of the cephalic-vagal reflex through chewing, as well as by activation of the 
cholinergic anti-inflammatory pathway due to nicotine administration (64).
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Aims and outline of  this thesis
The aim of this thesis is to investigate and help improve the management of complicated 
diverticulitis by focusing on both its non-resectional, as well as its resectional treatment. 
Moreover, stoma-related complications and the prevention of postoperative ileus will be 
addressed.
Part I of this thesis focuses on the non-resectional treatment of complicated diverticulitis. 
Chapter 2 describes a retrospective, multicenter cohort study of patients with Hinchey 
Ib and II diverticulitis, in which short- and long-term outcomes of non-surgical 
treatment by means of antibiotics with or without percutaneous drainage are assessed. 
Chapter 3 is a follow-up study of a cohort of patients who underwent laparoscopic 
peritoneal lavage for perforated diverticulitis, which describes long-term outcomes, such 
as recurrent diverticulitis, reoperations, and readmissions.
In Chapter 4, the role of laparoscopic lavage for the treatment of perforated diverticulitis 
is further discussed, providing a comprehensive overview of the currently available 
evidence.
In Part II strategies for the resectional treatment of complicated diverticulitis are 
addressed.
Chapter 5 describes the clinical and patient-reported outcomes of the DIVA arm of the 
international, multicenter, randomized Ladies trial, comparing Hartmann’s procedure 
to sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent 
or fecal peritonitis.
In Chapter 6, the cost-effectiveness analysis of this study is described. 
Chapter 7 is a systematic review and meta-analysis of observational and experimental 
studies comparing both these surgical procedures for the same indication of perforated 
diverticulitis with peritonitis.
In Part III the existing evidence on the treatment of diverticulitis is appraised.
Chapter 8 is a narrative review and addresses several important topics in the 
multidisciplinary management of complicated diverticulitis. 
In Chapter 9 all the available evidence on a broad range of topics, including the 
epidemiology, classification, diagnostics, and management of both uncomplicated and 
complicated diverticulitis, is appraised and presented as a result of the efforts of the 
European Society of Coloproctology guideline committee.
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Part IV focuses on stoma-related complications.
Chapter 10 describes a multicenter, retrospective cohort study in which a comparison 
is made between a non-operative (‘watchful waiting’) strategy and surgical treatment, in 
terms of choice of treatment reasons, cross-over rates, and complications. 
Chapter 11 describes a systematic review assessing the comparability of the different 
diagnostic modalities reported throughout the literature, as there is a large variance in 
reported rates of parastomal hernia. 
Chapter 12 is a systematic review and meta-analysis with the aim to assess the incidence, 
risk factors and prevention of stoma site incisional hernia.
In Part V focus is put on the prevention of postoperative ileus. 
Chapter 13 describes a double-blind, randomized pilot study in which the effects of 
nicotine chewing gum are compared to regular chewing gum in terms of their effect on 
gastrointestinal motility after elective oncological colorectal surgery.
In Chapter 14 results from all chapters will be discussed and future perspectives will be 
described. Lastly, Chapter 15 and Chapter 16 summarize the results presented in this 
thesis in English and Dutch.
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Abstract
Background
Treatment strategies for diverticulitis with abscess formation have shifted from 
(emergency) surgical treatment to non-surgical management (antibiotics with or 
without percutaneous drainage (PCD)). The aim was to assess outcomes of non-surgical 
treatment and to identify risk factors for adverse outcomes.
Methods
Patients with a first episode of CT-diagnosed diverticular abscess (modified Hinchey Ib 
or II) between January 2008 and January 2015 were included retrospectively, if initially 
treated non-surgically. Baseline characteristics, short-term (within 30 days) and long-
term treatment outcomes were recorded. Treatment failure was a composite outcome 
of complications (perforation, colonic obstruction and fistula formation), readmissions, 
persistent diverticulitis, emergency surgery, death, or need for PCD in the no-PCD 
group. Regression analyses were used to analyse risk factors for treatment failure, 
recurrences and surgery.
Results
Overall, 447 patients from ten hospitals were included (Hinchey Ib 215; Hinchey II 
232), with a median follow-up of 72 (i.q.r. 55–93) months. Most patients were treated 
without PCD (332 of 447, 74.3 per cent). Univariable analyses, stratified by Hinchey 
grade, showed no differences between no PCD and PCD in short-term treatment failure 
(Hinchey I: 22.3 versus 33 per cent, P= 0.359; Hinchey II: 25.9 versus 36 per cent, P= 
0.149) or emergency surgery (Hinchey I: 5.1 versus 6 per cent, P= 0.693; Hinchey II: 
10.4 versus 15 per cent, P= 0.117), but significantly more complications were found in 
patients with Hinchey II disease undergoing PCD (12 versus 3.7 per cent; P= 0.032). 
Multivariable analyses showed that treatment strategy (PCD versus no PCD) was not 
independently associated with short-term treatment failure (odds ratio (OR) 1.47, 95 
per cent c.i. 0.81 to 2.68), emergency surgery (OR 1.29, 0.56 to 2.99) or long-term 
surgery (hazard ratio 1.08, 95 per cent c.i. 0.69 to 1.69). Abscesses of at least 3 cm in 
diameter were associated with short-term treatment failure (OR 2.05, 1.09 to 3.86), and 
abscesses of 5 cm or larger with the need for surgery during short-term follow-up (OR 
2.96, 1.03 to 8.13).
Conclusion
The choice between PCD with antibiotics or antibiotics alone as initial non-surgical 
treatment of Hinchey Ib and II diverticulitis does not seem to influence outcomes.
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Introduction
Diverticulosis is common in the Western world and is estimated to affect more than half 
of the population over the age of 65 years(1). Diverticulosis might lead to diverticulitis 
in approximately 4.3-7% of cases(2, 3), of which 25 per cent present with acute 
complicated diverticulitis; this can consist of severe complications, such as abscess, 
perforation, stenosis or fistula(4). Abscess formation occurs in approximately 15 per 
cent of patients with acute complicated diverticulitis(5-7). It can be classified according 
to the modified Hinchey classification as type Ib (confined pericolic abscess smaller than 
5 cm) or Hinchey II (pelvic, distant intra-abdominal or retroperitoneal abscess at least 
5 cm in size)(8, 9).
Over the years, treatment strategies for diverticulitis with abscess formation have 
gradually shifted from (emergency) surgical treatment to non-surgical management 
comprising antibiotics with or without percutaneous drainage (PCD)(10). Currently, 
guidelines(11-13) advise that small pericolic abscesses can be treated with antibiotics, 
whereas distant (pelvic) or larger abscesses, usually defined as those with a diameter of 
3-5 cm or larger, should be treated with PCD, if possible. As patients undergoing non-
surgical treatment are at risk of adverse outcomes such as emergency surgery, disease 
recurrence, readmission and even death (both in the short and long term)(10, 14), 
adequate patient selection for the optimal choice of treatment has come to play an 
important role in the management of these patients. 
However, the clinical course of complicated diverticulitis with abscess formation after 
non-surgical treatment, as well as the risk factors for adverse outcomes, have not been 
analysed adequately(10, 12). Most of the existing studies(15-22) addressing these topics 
are limited by a short follow-up, small and single institutional study populations and a 
lack of time-to-event analysis.
Therefore, the primary aim of this multicentre retrospective study was to assess both 
the short- and long-term outcomes of initial non-surgical treatment strategies for acute 
complicated diverticulitis with abscess formation (Hinchey Ib and II) in a large number 
of patients. The second aim was to identify risk factors associated with adverse outcomes, 
to help facilitate adequate patient selection and assess the optimal treatment strategy.
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Methods
This multicentre retrospective study was conducted in two academic and eight teaching 
hospitals in the Netherlands. The study was approved by the institutional review boards 
of all participating hospitals. This article was written in accordance with the STROBE 
statement and checklist(23). All patients aged 18 years and older, who had a first 
episode of CT-diagnosed complicated diverticulitis with abscess formation (modified 
Hinchey Ib or II(8)), and who had initial non-surgical treatment, being either antibiotic 
treatment (no PCD) or antibiotic treatment with PCD, were eligible for inclusion in 
the cohort. Patients with perforated diverticulitis with peritonitis (Hinchey III or IV) 
and those with signs of sepsis or concurrent fistula formation were excluded. Potentially 
eligible patients who presented between 1 January 2008 and 31 January 2015 were 
sought by using a diagnosis-specific code (Diagnose Behandeling Combinatie or 
Diagnosis Related Group), ICD-9 or ICD-10 codes in all hospital databases. In Gelre 
Hospital, patients could only be identified between 1 January 2012 and 31 January 
2015. Subsequently, patients’ medical records were screened for inclusion and exclusion 
criteria before definitive inclusion in the study cohort.
Data collection
All medical records were reviewed retrospectively. Baseline patient characteristics were 
collected, such as age, BMI, co-morbidities, medical and surgical history, previous 
episodes of uncomplicated diverticulitis, medication, smoking, alcohol consumption 
and ASA fitness grades. Radiological details of the number, location and size of 
abscesses were recorded, as well as clinical signs and symptoms (nausea, vomiting, bowel 
complaints, rectal blood loss), and laboratory parameters (C-reactive protein (CRP) and 
white blood cell count (WBC)). The largest reported size of the abscess was used as the 
measure of abscess size. Details of treatment were recorded, including type and duration 
of antibiotic treatment, PCD (approach, type of drain and duration of drainage) and 
surgical procedures (for example, elective or emergency resection or stoma reversal 
surgery).
Outcomes
Short-term outcomes were: treatment failure, complications (colonic obstruction, 
perforation and fistula formation), clinical deterioration/progression of disease, 
emergency surgery (all unscheduled operations), readmissions, persistent diverticulitis 
(complaints lasting more than 30 days) and death. Long-term outcomes were: recurrent 
(un)complicated diverticulitis episodes, sigmoid resection and death. Short term was 
defined as the first 30 days after diagnosis of abscess, or during the primary admission if 
a patient was still in hospital after 30 days, whereas long term was defined as the period 
thereafter. Treatment failure was defined as the composite outcome of complications, 
readmissions, persistent diverticulitis, emergency surgery, death or need for PCD in the 
no-PCD group. Recurrent diverticulitis was registered as complicated in the presence of 
a phlegmon, abscess, fistula, stenosis or perforation, whereas uncomplicated diverticulitis 
was registered if it was mentioned in the medical record as recurrent disease, in the 
absence of the abovementioned complications.
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Statistical analysis
Multiple imputation techniques were used to impute missing data to avoid selection 
bias. Data were assumed to be missing at random. All reported results are based on 
the imputed data, where the estimates of interests at the final computational step were 
combined across the imputed data sets using Rubin’s rules(24). Continuous variables 
are presented as mean (s.d.) or median (i.q.r.), depending on the normality of data 
distribution, and compared using the independent t test or Mann–Whitney U test, as 
appropriate. Categorical variables are presented as numbers with percentages, and were 
analysed using Pearson’s χ2 test and Fisher’s exact test. Differences in patient and disease 
characteristics between patients with and without treatment failure and emergency 
surgery were assessed to identify risk factors for these outcomes. Univariable logistic 
regression analyses were used to calculate crude odds ratios (ORs) with 95 per cent 
confidence intervals. Inclusion of relevant diagnostic items in the multivariable model, 
to identify independent predictors, was based on clinical knowledge and P values (P 
<0.200 or P <0.050, depending on the event rate). Recurrence and sigmoid resection in 
the long term were assessed by means of Kaplan–Meier estimates, stratified by Hinchey 
classification and treatment (no PCD versus PCD), with censoring at the end of study 
follow-up or death. The effect of Hinchey classification and treatment on the outcome 
was assessed by means of the Mantel–Cox log rank test. Cox proportional hazards 
regression was used to analyse risk factors for recurrence and sigmoid resection in the 
long term. Hazard ratios (HRs) with 95 per cent confidence intervals are presented for 
co-variables associated with recurrence or sigmoid resection during long-term follow-
up. Differences between hospitals could have an effect on treatment outcomes; to test 
for this bias by clustering of data, the short and long-term analyses were also adjusted 
for hospital. Short-term outcomes were adjusted by fitting a generalized linear mixed 
model for each outcome, using a logistic regression mixed model. Hinchey classification 
and PCD were entered separately as fixed effects and hospital as a random effect. For 
the short-term multivariable logistic regression analyses, hospital was entered as a co-
variable in each multivariable model. Long-term Cox regression analyses were adjusted 
by entering hospital as a co-variable in each multivariable model. Finally, sensitivity 
analyses of the non-imputed data set were undertaken to test whether the imputation 
technique had any influence on the outcomes of interest. All analyses were done using 
SPSS® version 24.0 (IBM, Armonk, New York, USA).
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Results
Patient and disease characteristics are shown in Table 1. A total of 447 patients with 
CT-proven Hinchey type Ib (215 patients) or II (232) diverticulitis were included. 
The Academic Medical Centre contributed 20 patients (4.5 per cent), Erasmus 
University Medical Centre 11 (2.5 per cent), Meander Medical Centre 69 (15.4 per 
cent), Havenziekenhuis 4 (0.9 per cent), IJsselland Hospital 24 (5.4 per cent), Amphia 
Hospital 84 (18.8 per cent), Reinier de Graaf Gasthuis 32 (7.2 per cent), Onze Lieve 
Vrouwe Gasthuis 99 (22.1 per cent), Gelre Hospital 51 (11.4 per cent) and Catharina 
Hospital 53 (11.9 per cent). The mean(s.d.) age of the patients was 61(13) years and 
40.7 per cent were men. The mean BMI of the total cohort was 27.8(5.7) kg/m2. Some 
271 patients (60.6 per cent) had co-morbidities and 123 (27.5 per cent) had an ASA 
fitness grade above II. The mean CRP level was 168(106) mg/l for the total cohort and 
mean WBC was 14.8(5.2) × 109/l. 
Most patients were treated with amoxicillin–clavulanic acid (90 of 289, 31.1 per cent), 
cefuroxime and metronidazole (88 of 289, 30.4 per cent), ceftriaxone and metronidazole 
(41 of 289, 14.2 per cent), or other antibiotics (70 of 289, 24.2 per cent) such as 
clindamycin, co-trimoxazole or piperacillin tazobactam; median duration of antibiotic 
treatment was 7 (i.q.r. 5–12) days. Information on route of antibiotic administration 
was available for 174 of 332 patients in the no-PCD group and 67 of 115 in the 
PCD group; 36 (20.6 per cent) and six (9 per cent) patients respectively received oral 
antibiotics. Most patients (332, 74.3 per cent) were initially treated without PCD; the 
remaining 115 patients (26.7 per cent) underwent PCD for a median of 6 (3–16) days. 
The PCD approach was mainly transabdominal (86 of 115, 74.8 per cent), guided 
by either ultrasound imaging (49 of 115, 42.6 per cent) or CT (63 of 115, 54.8 per 
cent). Median duration of hospital stay was 7 (5–13) days and median follow-up was 
72 (55–93) months.
Levels of inflammatory parameters were higher in the PCD group, with a mean CRP 
concentration of 222(114) mg/l compared with 149(96) mg/l in the no-PCD group, 
and mean WBC of 16.3(5.6) versus 14.3(4.9) × 109/l respectively. A larger proportion of 
patients in the PCD group were classified as having Hinchey II disease (84.3 versus 40.7 
per cent), and with multiple abscesses (20.0 versus 12.0 per cent). Of 63 patients with 
multiple abscesses, four were known to use corticosteroids, one to use mycophenolic acid, 
and one patient had undergone renal transplantation, whereas none of these patients 
received chemotherapy around the time of presentation. Median abscess diameter was 
6.4 (5.0–8.5) cm in the PCD group compared with 3.6 (2.5–5.1) cm in the group 
treated without PCD. Median duration of hospital stay was longer in the PCD group: 
10 (7–18) versus 7 (4–10) days.
Missing data
All candidate predictors had missing data, except age, sex and ASA classification. Most 
variables had between 1 and 20 per cent missing data. Three variables had a large amount 
of missing data: BMI (47.9 per cent), smoking (60.6 per cent) and alcohol consumption 
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(64.2 per cent). For abscess size, 31.5 per cent of data were missing. In total, 2140 data 
items (14.9 per cent) were imputed.
Short- and long-term outcomes
Short-and long-term outcomes are summarized in Table 2. Of the total cohort, 120 
patients (26.8 per cent) experienced treatment failure and 40 (8.9 per cent) required 
emergency surgery within 30 days after first presentation. One patient had operative 
drainage and a stoma was constructed in three patients, two of whom also underwent 
sigmoid resection in a second stage. Seventy-one patients (15.9 per cent) were readmitted 
to hospital within 30 days after first presentation and 63 (14.1 per cent) had persistent 
diverticulitis. Overall, 16 patients in the no-PCD group (4.8 per cent) underwent PCD 
during short-term follow-up and two in the PCD group (1.7 per cent) had a second 
PCD procedure. Five patients (1.1 per cent) died from severe sepsis caused by perforated 
diverticulitis. Three of these patients died after undergoing emergency surgery, whereas 
two did not have surgery or receive further treatment owing to co-morbidity. In all, 122 
patients (27.3 per cent) experienced one or more episodes of recurrent diverticulitis. 
In total, 166 episodes of recurrent diverticulitis were recorded, of which 94 (56.6 per 
cent) were uncomplicated and 72 (43.4 per cent) were complicated. Median time to 
recurrence was 8 (3–24) months. Eighteen patients (14.8 per cent) had a first recurrence 
within 1 month after the end of short-term follow-up.
During long-term follow-up, 13 patients (2.9 per cent) underwent PCD, seven in the 
no-PCD and six in the PCD group. A total of 124 patients (27.7 per cent) required 
sigmoid resection, 14 in an emergency setting. Median time to operation was 5 (3–13) 
months. Twenty-eight patients died (6.3 per cent) during long-term follow-up, two 
from diverticulitis-related causes. One of these patients died from severe sepsis caused 
by anastomotic leakage after Hartmann reversal surgery, and one from severe sepsis 
owing to intestinal ischaemia after sigmoid resection for diverticular stenosis. Overall, 
data on colonic evaluation was available for 394 patients, of whom 239 (PCD 58, no 
PCD 181) underwent colonoscopy during follow-up after a median of 10.9 (7.0–21.6) 
weeks. A malignancy was found in 12 of these patients, including nine in the no-PCD 
group (P= 1.000).
During short-term follow-up, patients in the PCD group had significantly more 
emergency resections (13.9 versus 7.2 per cent; P= 0.030), as well as complications, 
treatment failure and clinical deterioration/disease progression. In analyses stratified 
by Hinchey grade, among patients with Hinchey II disease, significantly more 
complications were found in the PCD group (12 versus 3.7 per cent; P= 0.032). Figs 
1 and 2 show the time-to-event analyses of recurrence and surgery during long-term 
follow-up; there were no significant differences in recurrence (P= 0.544) or surgery (P= 
0.088). Overall, patients in the PCD group had significantly more complications during 
long-term follow-up (24.3 versus 13.9 per cent; P= 0.009), which was also evident in the 
Hinchey Ib subgroup (39 versus 12.7 per cent; P= 0.016). The mortality rate was higher 
in the PCD group (10.4 versus 4.8 per cent; P= 0.048). In the subgroup with Hinchey 
II disease, there were more sigmoid resections among patients who underwent PCD (32 
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versus 22.2 per cent; P= 0.046). No other differences between treatment groups were 
found in short- and long-term outcomes.
Risk factors for treatment failure and emergency surgery during short-term follow-up
Univariable analyses of all possible predictors for treatment failure and emergency 
surgery are shown in Table S1 (supporting information). Different cut-off sizes for 
abscess diameter were reviewed univariably to analyse which could best predict outcome. 
A cut-off size of 3 cm seemed to be the best predictor of treatment failure (univariable 
OR 2.33, 95 per cent c.i. 1.32 to 4.11), and a cut-off size of 5 cm the best predictor 
of emergency surgery (univariable OR2.97, 1.28 to 6.85).The results of multivariable 
analysis are shown in Table 3. A higher BMI slightly decreased the risk of treatment 
failure (OR 0.94, 0.89 to 0.997), whereas an abscess size of at least 3 cm increased the 
risk (OR 2.05, 1.09 to 3.86). With regard to emergency surgery, history of abdominal 
surgery increased the risk (OR 2.05, 1.04 to 4.05), as did an abscess size of 5 cm or 
larger (OR 2.96, 1.08 to 8.13). No other variable had an effect on the risk of treatment 
failure or emergency surgery. Two separate subgroup analyses were performed to assess 
the effect of PCD on the outcome for different abscess sizes (at least 3 cm and at least 5 
cm). The first included only the 324 patients with an abscess of 3 cm or larger. In this 
subgroup, there were no differences in rate of treatment failure between patients treated 
with (109) or without (215) PCD (35.7 versus 28.4 per cent respectively; P= 0.200), or 
in rate of emergency surgery (14.3 versus 9.3 per cent; P= 0.198). The second subgroup 
analysis included only the 185 patients with an abscess size of at least 5 cm. In this 
subgroup, there were also no differences in rate of treatment failure between patients 
treated with (94) and without (91) PCD (35 versus 28 per cent respectively; P= 0.409), 
or in rate of emergency surgery (16 versus 12 per cent; P= 0.416).
Risk factors for recurrence and sigmoid resection during long-term follow-up
Univariable analyses of all possible predictors for treatment failure and emergency 
surgery during long-term follow-up are shown in Table S2 (supporting information) 
and results of the subsequent multivariable analysis in Table 4. A history of diverticulitis 
increased the risk of recurrence (HR 1.71, 95 per cent c.i. 1.17 to 2.48). A history of 
abdominal surgery (HR 0.63, 0.42 to 0.98) and sigmoid resection (HR 0.15, 0.05 to 
0.48) decreased the risk of recurrence. Older patients seemed to be at slightly higher 
risk of sigmoid resection during long-term follow-up (HR 1.02, 1.001 to 1.03) and 
the symptoms vomiting (HR 1.82, 1.13 to 2.93) and nausea (HR 1.72, 1.03 to 2.85) 
also increased this risk. No other variable had an effect on the occurrence of sigmoid 
resection during long-term follow-up.
Sensitivity analyses
Overall, sensitivity analyses of the non-imputed data set showed similar results for 
short- and long-term outcomes, and short-term complications and emergency resection 
were not significantly different in hospital-adjusted analyses (Table S3, supporting 
information). Stratified analyses by Hinchey grade showed significant differences in the 
non-imputed data for short-term readmission and persistent diverticulitis (Table S4, 
supporting information). In addition, sensitivity analyses of the non-imputed data set 
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and hospital-adjusted analyses were undertaken for multivariable logistic regression and 
Cox regression analyses (Tables S5 and S6, supporting information).
Discussion
In the present study, multivariable analysis showed that initial non-surgical treatment of 
Hinchey Ib and II diverticular abscesses (antibiotics alone versus PCD in combination 
with antibiotics) had no independent effect on short- and long-term outcomes. 
Abscess size of at least 3 cm was identified as an independent risk factor for short-
term treatment failure, and 5 cm or more as an independent risk factor for short-term 
emergency surgery. Previous studies of treatment outcomes of diverticular abscesses have 
been limited by factors such as small and single-institution study populations, a lack of 
time-to-event analysis and short follow-up(10, 12). The cohort study of 3148 patients 
with Hinchey stage Ib and II disease investigated by Gregersen and colleagues(25, 
26) remains the largest reporting on both short- and long-term treatment outcomes. 
However, an important limitation of that study was the absence of data on the clinical 
condition of the patients, as well as data on abscess size and location. This complicates 
comparison of treatment modalities because, owing to the introduction of selection 
bias and confounding, differences in outcomes may primarily reflect disease and clinical 
severity. The present study, with a total of 447 patients, took these patient and disease 
characteristics into account, and also assessed long-term outcomes. The comparison of 
PCD and no PCD in this cohort showed that patients who underwent PCD seemed 
to have worse outcomes, in terms of a greater likelihood of short-term emergency 
resections, complications, disease progression and treatment failure, as well as more 
long-term complications. However, confounding by indication cannot be excluded from 
this analysis and differences may primarily reflect disease and clinical severity. Indeed, 
patients undergoing PCD had more advanced disease than those in the no-PCD group, 
with the majority of patients having Hinchey stage II disease (84.3 versus 40.7 per 
cent; P <0.001). Patients in the PCD group had larger abscesses, as well as significantly 
more distant abscesses or multiple abscesses. Hence, when the patients were stratified 
by Hinchey grade, most short- and long-term outcomes did not differ between the 
PCD and no-PCD groups, with the exception of short-term complications and long-
term resections among patients with Hinchey II disease, and long-term complications 
in those with Hinchey Ib diverticulitis. More importantly, in the multivariable analyses, 
the initial treatment strategy did not seem to be a predictor with regard to treatment 
failure, emergency surgery, or sigmoid resection in long-term follow-up, strengthening 
the conclusion that treatment strategy has no effect on the outcome.
The short-term mortality rate in the present study ranged between 0 and 2 per cent 
across the groups analysed, which is comparable to pooled average mortality rates 
derived from previous studies of treatment with antibiotics (0.6 per cent) and PCD 
(1.6 per cent)(14). Short-term emergency surgery rates ranged from 5.1 to 15 per 
cent, which is also largely in accordance with the pooled average of 12.1 per cent (14). 
Reported rates of diverticulitis recurrence vary from 3 to 68 per cent, with an average of 
28 per cent; recurrent disease consists mostly of uncomplicated or locally complicated 
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diverticulitis(10). Although rates may vary between studies because of differences in 
median follow-up or in definitions, the recurrence rates reported in the present study 
seem to be in line with earlier reports (27, 28). In light of the long-term surgery and 
recurrence rates in the present study, which were relatively low (and the recurrences 
mostly uncomplicated), it can be questioned whether elective surgery is indicated in 
conservatively managed patients, as surgery comes with an inherent risk of complication 
and most patients seem to fare well with conservative management alone.
The rates of adverse and unwanted outcomes in patients with diverticular abscess remain 
high and present a major burden to the patient, as well the healthcare system. Therefore, 
an aim of the present study was to identify potential risk factors related to these adverse 
outcomes in order to help improve individual patient management. Abscess size was 
shown to be an independent predictor of adverse outcome; an abscess diameter of at 
least 3 cm increased the risk of short-term treatment failure, whereas an abscess of 5 cm 
or larger increased the risk of emergency surgery. These results indicate that, for abscesses 
larger than 3 cm, and particularly those larger than 5 cm, it can still be debated which 
treatment strategy is most appropriate, as the results show no definite advantage of one 
strategy over the other in short-term outcomes. Treatment should not be based solely 
on abscess size, but other patient and disease characteristics should also be considered. 
However, no other significant predictors were found in the multivariable analyses for 
treatment failure or emergency surgery, making it difficult to select a subpopulation of 
patients who would benefit from PCD. The findings do seem to acknowledge that a 
cut-off value of 3 cm is appropriate for differentiating between small and large abscesses 
(11, 13, 17, 29, 30). 
An important limitation of this study is its retrospective design, which introduces 
the potential for selection bias and confounding by indication. However, registration 
of a wide range of baseline patient and disease characteristics allowed correction for 
potential known confounders in multivariable logistic and Cox regression analyses. 
Another inevitable consequence of retrospective observational research is the potential 
risk of missing data, as the availability of baseline and outcome data is largely dependent 
on the completeness of medical records. It was hypothesized that re-evaluation of CT 
images by one or more radiologists could have led to the introduction of (hindsight) 
bias, as a result of the radiologists’ foreknowledge of the reasons for and outcomes of 
reviewing the images. To prevent selection bias introduced by missing data, multiple 
imputation methods were used to handle the missing data. Sensitivity analyses of the 
non-imputed data set did not significantly change the results. With regard to outcome 
data, it is possible that patients might have received care at a general practitioner or 
in other hospitals during follow-up, creating the potential for an underestimation of 
disease recurrences and readmissions. Finally, the multicentre setting of this study could 
have introduced heterogeneity through between-hospital differences in treatment, such 
as reasons for choosing PCD or criteria for drain removal. However, these differences 
were considered small, because all hospitals base their practice on the national guideline 
for treatment of acute diverticulitis and hospital-adjusted analyses showed comparable 
outcomes. In addition, the multicentre setting had beneficial effects by increasing both 
the study’s generalizability and sample size. This study of a large cohort of patients with 
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Hinchey stage Ib and II abscesses has provided evidence that patients with abscesses of at 
least 3 or 5 cm are at a higher risk of short-term treatment failure or emergency surgery 
respectively, regardless of the choice of non-surgical treatment strategy. As no clear 
difference between the two treatment strategies was found, it remains debatable how to 
treat these patients appropriately. Nevertheless, these data help facilitate informed and 
shared decision-making, as well as providing valuable information for future prospective 
studies regarding PCD treatment in patients with abscess formation.
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Tables
Table 1 Baseline characteristics
Total cohort
(n = 447)
No PCD
(n = 332)
PCD
(n = 115) P§
Patient demographics
Age (years)* 61(13) 60(13) 63(13) 0.140¶
Sex ratio (M : F) 182 : 265 139 : 193 43 : 72 0.400
BMI (kg/m2)* 27.8(5.7) 27.6(5.5) 28.4(6.3) 0.404¶
Smoking 227 (51.0) 167 (50.3) 61 (53.0) 0.603
Alcohol consumption 232 (51.9) 178 (53.6) 54 (47.0) 0.274
Co-morbidities
ASA fitness grade >II 123 (27.5) 84 (25.3) 39 (33.9) 0.075
Patients with registered co-morbidity 270 (60.6) 201 (60.5) 70 (60.9) 0.952
Medical history
History of diverticulitis 137 (30.6) 93 (28.0) 44 (38.3) 0.035
History of abdominal surgery 151 (33.8) 119 (35.8) 32 (27.8) 0.130
Medication
NSAIDs 182 (40.7) 133 (40.1) 49 (42.6) 0.573
Steroids 43 (9.4) 35 (10.5) 8 (7.0) 0.239
Clinical symptoms
Duration of symptoms (days)† 7 (3–14) 7 (3–12) 8 (4–14) 0.062#
Nausea 236 (52.8) 163 (49.1) 73 (63.5) 0.018
Vomiting 108 (24.2) 65 (19.6) 43 (37.4) 0.001
Diffuse abdominal pain 61 (13.6) 44 (13.3) 16 (13.9) 0.704**
Change in bowel habit 294 (65.8) 221 (66.6) 73 (63.5) 0.548
Rectal blood loss 70 (15.7) 44 (13.3) 26 (22.6) 0.044
Clinical signs
Rebound tenderness 141 (31.5) 104 (31.3) 37 (32.1) 0.602
Local muscular guarding/resistance 115 (25.7) 81 (24.4) 34 (29.6) 0.259
Diffuse muscular guarding 50 (11.2) 32 (9.6) 18 (15.7) 0.255**
Temperature (°C)* 37.7(0.9) 37.7(0.9) 37.8(1.0) 0.319¶
Laboratory parameters*
C-reactive protein (mg/l) 168(106) 149(96) 222(114)  < 0.001¶
White blood cell count (× 109/l) 14.8(5.2) 14.3(4.9) 16.3(5.6) 0.001¶
Radiological parameters
Hinchey II‡ 232 (51.9) 135 (40.7) 97 (84.3)  < 0.001
Largest abscess diameter (cm)† 4.2 (2.7–6.1) 3.6 (2.5–5.1) 6.4 (5.0–8.5)  < 0.001#
Distant location of abscess 106 (23.7) 71 (21.4) 35 (30.4) 0.046
No. of patients with multiple abscesses 63 (14.1) 40 (12.0) 23 (20.0) 0.035
Free peridiverticular air 143 (32.0) 106 (31.9) 37 (32.2) 0.925
Free air in abdomen 56 (12.5) 36 (10.8) 20 (17.4) 0.252
Free fluid 90 (20.1) 61 (18.4) 29 (25.2) 0.187
Duration of hospital stay (days)† 7 (5–13) 7 (4–10) 10 (7–18)  < 0.001#
Values in parentheses are percentages, unless indicated otherwise; values are *mean (s.d.) and †median (i.q.r.). ‡ Abscess 5 
cm or larger in diameter and/or distant abscess. PCD, percutaneous drainage; NSAID, non-steroidal anti-inflammatory 
drug; §Pearson c2 test, except ¶independent t test, #Mann–Whitney U test and **Fisher’s exact test. 
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Table 3 Multivariable logistic regression analysis of risk factors for short-term treatment failure and emergency surgery
Odds ratio P
Treatment failure
Age (per year) 1.001 (0.98, 1.02) 0.955
BMI (per kg/m2) 0.94 (0.89, 0.997) 0.041
Alcohol consumption 0.63 (0.36, 1.10) 0.099
Co-morbidity 1.40 (0.85, 2.29) 0.183
NSAID prescription 0.58 (0.21, 1.57) 0.242
Nausea 1.32 (0.83, 2.12) 0.245
C-reactive protein (mg/l) 1.001 (0.998, 1.003) 0.656
Abscess ≥ 3 cm 2.05 (1.09, 3.86) 0.027
Percutaneous drainage 1.47 (0.81, 2.68) 0.185
Emergency surgery
History of abdominal surgery 2.05 (1.04, 4.05) 0.038
Rebound tenderness 2.03 (0.98, 4.21) 0.058
Abscess ≥ 5 cm 2.96 (1.08, 8.13) 0.036
Percutaneous drainage 1.29 (0.56, 2.99) 0.554
Values in parentheses are 95 per cent confidence intervals. NSAID, non-steroidal anti-inflammatory drug.
Table 4 Multivariable Cox regression analysis of risk factors for recurrence and surgery during long-term follow-up
Hazard ratio P
Recurrence
Age (per year) 0.995 (0.98, 1.01) 0.481
History of diverticulitis 1.71 (1.17, 2.48) 0.005
History of abdominal surgery 0.63 (0.42, 0.98) 0.040
Rebound tenderness 0.72 (0.46, 1.13) 0.152
Sigmoid resection during short-term follow-up 0.15 (0.05, 0.48) 0.001
Surgery
Age (per year) 1.02 (1.001, 1.03) 0.042
Alcohol consumption 0.64 (0.29, 1.39) 0.218
Co-morbidity 1.49 (0.96, 2.31) 0.078
History of diverticulitis 1.30 (0.88, 1.93) 0.190
Duration of symptoms (per day) 1.01 (0.996, 1.03) 0.136
Nausea 1.72 (1.03, 2.85) 0.037
Vomiting 1.82 (1.13, 2.93) 0.014
Diffuse abdominal pain 0.60 (0.29, 1.25) 0.161
Distant abscess 0.72 (0.42, 1.23) 0.221
Free peridiverticular air 1.39 (0.91, 2.12) 0.129
Percutaneous drainage 1.08 (0.69, 1.69) 0.736
Values in parentheses are 95 per cent confidence intervals.
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Figures
Figure 1 Kaplan–Meier analysis of recurrence-free survival according to whether the patient underwent percutaneous 
abscess drainage. PCD, percutaneous drainage. P =0.544 (log rank test).
Figure 2 Kaplan–Meier analysis of resection-free survival according to whether the patient underwent percutaneous 
abscess drainage. PCD, percutaneous drainage. P =0.088 (log rank test).
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Abstract
Aim
Laparoscopic peritoneal lavage has increasingly been investigated as a promising 
alternative to sigmoidectomy for perforated diverticulitis with purulent peritonitis. 
Most studies only reported outcomes up to 12 months. Therefore, the objective of this 
study was to evaluate long-term outcomes of patients treated with laparoscopic lavage.
Methods 
Between 2008 and 2010, 38 patients treated with laparoscopic lavage for perforated 
diverticulitis in 10 Dutch teaching hospitals were included. Long-term follow-up data 
on patient outcomes, e.g. diverticulitis recurrence, reoperations and readmissions, were 
collected retrospectively. The characteristics of patients with recurrent diverticulitis or 
complications requiring surgery or leading to death, categorized as ‘overall complicated 
outcome’, were compared with patients who developed no complications or complications 
not requiring surgery.
Results 
The median follow-up was 46 months (interquartile range: 7-77), during which 17 
episodes of recurrent diverticulitis (seven complicated) in 12 patients (32%) occurred. 
Twelve patients (32%) required additional surgery with a total of 29 procedures. Fifteen 
patients (39%) had a total of 50 readmissions. Of initially successfully treated patients 
(n=31), twelve (31%) had recurrent diverticulitis or other complications. At 90 days, 32 
(84%) patients were alive without undergoing a sigmoidectomy. However, seven (22%) 
of these patients eventually had a sigmoidectomy after 90 days. Diverticulitis-related 
events occurred up to six years after the index procedure.
Conclusion
Long-term diverticulitis recurrence, reintervention and readmission rates after 
laparoscopic lavage were high. A complicated outcome was also seen in patients who 
had initially been treated successfully with laparoscopic lavage with relevant events 
occurring up to 6 years after initial surgery.
What does this paper add to the literature?
Laparoscopic lavage for perforated diverticulitis has increasingly been investigated, but 
long-term data were scarce. With a median follow-up of 46 months, this paper reports 
on long-term outcomes after laparoscopic lavage and shows long-term diverticulitis 
recurrence, reintervention and readmission rates after laparoscopic lavage to be high. 
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Introduction
Diverticular disease is a common problem in developed countries, resulting in an 
estimated annual rate of up to 786,000 hospital admissions in Europe (1). Of patients 
with acute diverticulitis 8%-35% present with abscess formation or peritonitis (modified 
Hinchey grade Ib-IV), resulting in an estimated 60,000 perforated diverticulitis cases 
per year in Europe (1-5). Perforated diverticulitis with generalized peritonitis requires 
surgical treatment in most cases. Nevertheless, both the Hartmann’s procedure (HP) and 
sigmoidectomy with primary anastomosis (PA) have been associated with significant 
morbidity and mortality rates (6-8). Therefore, after its introduction in 1996, laparoscopic 
peritoneal lavage (LL) has increasingly been investigated as a promising alternative to 
sigmoidectomy (9-17). Despite initial promising results, recent randomized controlled 
trials showed increased rates of severe postoperative complications and reoperations 
compared with sigmoidectomy (18-23).
Current studies on LL predominantly report on outcomes up to 12 months after surgery 
(13, 14, 16, 17, 24-26). Reports on the long-term consequences of LL as therapy for 
perforated diverticulitis are scarce (27-29). Therefore, further exploration of long-term 
outcomes is of importance, since leaving the diseased colonic segment in situ after LL 
potentially puts patients at increased risk for both uncomplicated and complicated 
diverticulitis recurrence, which might necessitate surgery (3, 19, 23). Additionally, long-
term outcomes of patients treated with LL potentially could provide relevant insights 
into which patients might benefit most from this treatment (26).
Therefore, the aim of this study was to assess the long-term outcomes of a previously 
published cohort study of patients treated with LL for perforated diverticulitis, with 
regard to diverticulitis recurrence, subsequent related complications, and surgical 
interventions (25).
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Methods 
A multicentre, retrospective cohort study was performed. The study was approved by 
the institutional review boards of all participating hospitals. Due to the retrospective 
design, informed consent was waived for participation in this study. The Strengthening 
the Reporting of Observational studies in Epidemiology (STROBE) recommendations 
for reporting of observational studies were followed (30). Detailed methods of the short-
term follow-up of this study were published previously by Swank et al. (25).
Patient inclusion 
Patients treated with LL for perforated diverticulitis in 10 Dutch teaching hospitals 
between 1 January 2008 and 31 December 2010 were included (25). Patient records 
were screened for the diagnosis ‘diverticulitis’ or ‘acute abdomen’ and subsequently 
operation type was recorded. Patients who underwent LL as primary treatment for 
complicated diverticulitis with either free air and/or purulent peritonitis were included.
Data collection: short-term follow-up
Baseline patient demographics, such as co-morbidities, American Society of 
Anesthesiologists (ASA) score, preoperative white blood cell (WBC) count, C-reactive 
protein (CRP) and the results of preoperative X-ray or computed tomography (CT) 
scan were recorded previously. Furthermore, operative records were screened, and short-
term recurrent diverticulitis, numbers and types of complications, diagnostic measures, 
re-interventions and readmissions were recorded.
Data collection: long-term follow-up
In the present study, additional long-term data collection was performed through 
retrospective review of patient records. All events are reported jointly in this study. 
Short-term follow-up was defined as the first 90 days after index surgery; long-term 
follow-up consisted of the period thereafter. During long-term follow-up, patient 
records were screened for survival status, readmissions, re-interventions, complicated 
or uncomplicated diverticulitis recurrence, development of fistulas, intra-abdominal 
abscesses, colonic stenosis, or other potentially related complications, as well as 
colonoscopies and abdominal CT scans, diagnosis of colorectal malignancies (e.g. 
rectosigmoid) and midline incisional or parastomal hernias.
Outcome parameters
Primary treatment failure of LL was defined as ongoing abdominal sepsis. Long-term 
outcomes of patients without a sigmoidectomy at 90 days of follow-up after the index 
procedure were assessed. The modified Hinchey classification was used to categorize 
patients according to the intra-operative findings (5). The Mannheim Peritonitis Index 
was used as predictor of the mortality risk (31). Recurrent diverticulitis episodes were 
classified as either uncomplicated or complicated based on the information available 
from patient records. Diverticulitis episodes were classified as complicated when 
associated with perforation, abscess formation, fistulas, stenosis or diverticular bleeding 
(32). Clinical follow-up was calculated as the time between the index admission and the 
last recorded hospital visit and, additionally, total study follow-up was calculated as the 
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time between the index admission and the time of data extraction by the researcher (D.S. 
or D.L.). ‘Overall complicated outcome’ was defined as postoperative complications or 
recurrent diverticulitis requiring surgery or resulting in mortality. To identify potential 
risk factors for an overall complicated outcome during follow-up, patients with and 
without a complicated outcome were compared.
Statistical analysis
Statistical analysis was performed using IBM SPSS statistics (Version 24, IBM, Armonk, 
NY, USA). Continuous variables were presented as medians with interquartile range 
(IQR) or means with standard deviation (±SD), depending on normality of data. 
Discrete variables were presented as numbers (n) with percentages (%). Depending on 
the data distribution a Student’s t-test or Mann-Whitney U test, as appropriate, was 
used for comparison of continuous variables. Fisher’s exact test was used for comparing 
discrete variables with two categories and a Chi-squared test for discrete variables with 
three or more categories. A  P value of < 0.05 was considered statistically significant.
Results 
Baseline characteristics 
Medical records were screened for potentially eligible patients in 34 Dutch hospitals. 
Eventually, from 10 of these hospitals, 38 patients were included who were treated 
for Hinchey grade II or III diverticulitis by means of LL. Baseline characteristics are 
summarized in Table 1 and were previously described by Swank et al. (25). One or 
more co-morbidities were present in 18 patients, consisting of cardiovascular disease 
(n=8), previously diagnosed malignant disease (n=5), hypertension (n=3) and chronic 
obstructive pulmonary disease (COPD) (n=2). None of the included patients had a 
previous episode of diverticulitis, two patients had previous abdominal surgery not 
related to diverticular disease, and one patient suffered from respiratory insufficiency 
before the LL procedure.
Overall outcomes 
Short-term (<90 days) and long-term follow-up are summarized in Table 2-4 and Fig. 
1. The number of recurrent diverticulitis episodes and surgical reinterventions for 1-, 
3- and 5-year intervals as well as until the end of follow-up are presented in Table 5. 
Patient records were examined after a median of 90 months (84-96). Median clinical 
follow-up, as defined earlier, was 46 months (7-77). During the entire follow-up period, 
27 (71%) patients had at least one adverse event. In 12 patients (32%), 17 recurrent 
episodes of diverticulitis (seven complicated and 10 uncomplicated) were reported. The 
median time between LL and first recurrence of diverticulitis was 341 days (range 61-
2119, IQR 115-795). Recurrence-free survival is presented in Fig. 2. The median time 
to sigmoidectomy was 240 days (range 2-1406); resection-free survival is shown in Fig. 
3. Twenty-nine subsequent surgical procedures among 12 patients (32%) were reported, 
of whom seven had emergency surgery at least once. In total, four patients (11%) died 
due to causes related to or as a direct consequence of their diverticular disease, including 
multiple organ failure (n=2), persisting ileus (n=1), and aspiration pneumonia (n=1). 
Chapter 3
56
Four patients died due to unrelated causes: breast cancer (n=1), retroperitoneal bleeding 
(n=1), brain tumour (n=1), and cardiovascular disease (n=1). At least one follow-up 
colonoscopy or sigmoidoscopy (n=25) or CT scan (n=23) was performed in 31 patients. 
Extensive diverticulosis was reported in 19 (61%) of these patients. One patient was 
diagnosed with rectal cancer during follow-up.
Follow-up in patients with initially controlled abdominal sepsis 
LL succeeded in controlling the abdominal sepsis in 31 patients. During short-term 
follow-up, one patient had emergency surgery for repair of a fascial dehiscence. Although 
abdominal sepsis was controlled, one patient died due to a persisting obstructive ileus 
27 days after the index procedure. This patient was diagnosed with terminal lung cancer 
and it therefore was decided not to perform further surgery.
At long-term follow-up, 30 out of 31 patients successfully treated with LL were alive. 
Eleven of these patients (36.7%) developed either a recurrent episode of diverticulitis 
or other complications and six patients (20%) required additional surgery. These 
patients were diagnosed with recurrent complicated diverticulitis (n=5), recurrent 
uncomplicated diverticulitis (n=4), obstructive ileus (n=3), intra-abdominal abscesses 
(n=6), fistula formation (n=3), midline incisional hernia (n=2), parastomal hernia (after 
sigmoidectomy) (n=2) and wound infection (n=1). Additional surgical interventions 
for these patients consisted of sigmoidectomy (n=5), low anterior resection (n=1), 
end colostomy construction (n=1), obstructive ileus relief (n=2), fistulotomy with 
simultaneous abscess drainage (n=1), parastomal hernia repair (n=1) and stoma reversal 
(n=4).
Follow-up in patients with initial failure of  laparoscopic lavage 
LL did not succeed in controlling abdominal sepsis in seven patients. All these patients 
developed complications requiring surgery or died from related causes. During short-
term follow-up, five patients underwent one or more surgical procedures: sigmoidectomy 
(n=3), loop ileostomy construction (n=1), repair of a perforated sigmoid (n=1), 2 surgical 
abscess drainages (n=1), and repair of fascial dehiscence (n=1). Two patients required, 
but could not undergo, emergency laparotomy due to their deteriorating condition. 
Both patients died after the index procedure due to multiple organ failure after 5 and 
37 days, respectively. 
At long-term follow-up five out of seven patients, who initially were unsuccessfully 
treated with LL, were alive. Four of these patients developed either a recurrent episode 
of diverticulitis or other complications and were subsequently operated upon - recurrent 
complicated diverticulitis (n=1), recurrent uncomplicated diverticulitis (n=1), fistula 
formation (n=2), or obstructive ileus (n=1). Additional surgical interventions consisted 
of incisional hernia repair (n=2), surgical excision of an ileosigmoid fistula (n=1), and 
stoma reversal (n=3). One patient died due to aspiration pneumonia following ileostomy 
reversal.
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Follow-up in patients without sigmoidectomy at 90 days
At 90 days after the index procedure, 32 (84%) patients were still alive and did not have 
an initial sigmoidectomy. A total of 15 recurrent episodes of diverticulitis were reported 
among ten (31%) of these patients, of which 5 patients had a complicated recurrence. 
Of these, 7 (22%) underwent further surgery, 6 patients underwent a sigmoidectomy 
and 1 patient received a wedge excision of the sigmoid colon. Indications for surgery 
were recurrent diverticulitis (n=5), obstructive ileus (n=1), and sigmoid perforation 
(n=1). Other procedures in these 7 patients were relief of obstructive ileus (n=2), repair 
of parastomal hernia (n=1) and stoma reversal (n=5). A stoma was constructed in six of 
these patients (three loop ileostomies and three end colostomies). 
Univariate analysis 
Results of the univariate analysis are given in Table 6. Baseline characteristics of patients 
with an overall complicated follow-up were compared with patients that developed 
no complications or complications not requiring surgery. Primary treatment failure 
(OR 3.9, 95% CI 2.13-7.04, P=0.001) was associated with a complicated outcome. 
Additionally, multiple (≥ 2) preoperative co-morbidities (OR 5.43, 95% CI 1.24-23.90; 
P=0.033) and ASA ≥3 (OR 7.2, 95%CI 1.67-31.03, P=0.008) were correlated with a 
complicated outcome. Median CRP appeared to be higher in those patients with an 
overall complicated outcome. However, no statistically significant difference was found 
(172 mmol/L [IQR: 50-275] vs 242 mmol/L [IQR: 128.5-323], p=0.068).
Discussion 
The present retrospective cohort study evaluated the long-term outcomes of 38 patients 
treated with LL for perforated diverticulitis in 10 centres in the Netherlands. Although 
the initial results in this patient cohort were promising, during long-term follow-up 
a significant number of patients had subsequent recurrent diverticulitis or developed 
other related complications with relevant events occurring up to 6 years after initial 
surgery. In patients with an initially successful outcome, complications and subsequent 
surgery frequently occurred.
In our study, nine patients (24%) underwent sigmoidectomy during follow-up. In 
previous reports on long-term outcomes after LL, sigmoidectomy rates of 44.7% and 
21% were reported (28, 29). In the cohort presented by White et al. (28),44.7% of 
patients underwent sigmoidectomy. However, eight LL patients received a planned 
sigmoidectomy before severe symptoms of recurrence were present. These eight patients 
potentially resulted in an overestimate of the sigmoidectomy rate. In our cohort there 
was no intention to treat patients by elective sigmoidectomy unless otherwise indicated 
during follow-up. The sigmoidectomy rate reported at two-year follow-up in the 
DILALA-trial was 21% (n=43) (14, 29). In the recently published LLO Study, the 
overall reoperation rate was 26% (56/212 patients) (33). Furthermore, the recurrence 
rate was 27% (47/172 patients) in patients without re-interventions during admission 
and the first 60 postoperative days. Both studies present results comparable to the 
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present cohort; however, follow-up in these studies was shorter, and therefore reported 
event rates may still increase. 
A potential major advantage of LL for the treatment of perforated diverticulitis is the 
avoidance of HP with construction of an end colostomy or PA with a loop ileostomy, 
especially, since after HP colostomies may be reversed in only 50-60% of patients (34, 
35). In our cohort, 32 (84%) patients were alive without undergoing a sigmoidectomy 
at 90 days. Overall, a stoma could be avoided in the majority (76%) of patients and 
most patients who did receive an end colostomy or loop ileostomy eventually had their 
stoma reversed (78%). 
Leaving the diseased colonic segment in situ puts patients potentially at increased risk 
for both uncomplicated and complicated diverticulitis, which might necessitate surgery 
(19, 23). A complicated outcome was present in 26% of patients who initially had been 
successfully treated with LL. Seven out of 32 had recurrent complaints necessitating 
six sigmoidectomies and one wedge incision (22%) at long-term follow-up. Therefore, 
controlling the abdominal sepsis after LL does not guarantee favourable long-term 
outcomes.  In addition, as shown in the present study, ongoing abdominal sepsis after 
LL is predictive of an overall complicated outcome during both short-term and long-
term follow-up. In those cases, early sigmoidectomy may be necessary. Although the 
present study does not provide enough evidence to draw a definitive conclusion, it raises 
the question as to whether planned sigmoidectomies to avoid long-term sequelae should 
be considered during the follow-up of patients fit for surgery.
Considering the additional events during long-term follow-up, both high ASA scores 
(≥3) and the presence of two or more comorbidities, regardless of their nature or 
treatment, were associated with an unfavourable prognosis. This is largely in accordance 
with two previous studies identifying risk factors for the failure of LL (26, 33). Due to 
the relatively small sample size, multivariate analysis was not performed in this study. 
High preoperative CRP values have previously been associated with negative outcomes 
and increased histologic damage to the colon in patients with diverticulitis (36, 37). 
Therefore, it is conceivable that high preoperative CRP levels might have some predictive 
value for overall unfavourable outcomes after LL. Although median CRP appeared to be 
higher in those patients with an overall complicated outcome, this association was not 
confirmed in the current study.
This study has several limitations of which most are inherent to its retrospective 
observational design. The study cohort is at risk for selection bias, as the decision to 
treat patients with LL was made clinically. At the time of patient inclusion, patients 
with a more favourable prognosis might have been selected more often to undergo this 
treatment. Furthermore, no control patients undergoing primary resection were included 
in this cohort to compare long-term results of both treatment strategies. Additionally, 
the retrospective study design might have led to heterogenic and potentially incomplete 
follow-up, which could underestimate the number of adverse events. Nevertheless, 
despite this, the event rate was still considerable. Finally, given the small sample size of 
this study, the results should be interpreted with caution.
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To date, three randomized studies and several subsequent meta-analyses comparing 
laparoscopic peritoneal lavage to primary resection have been published (16, 17, 19-24, 
38). However, three of these meta-analyses are criticized as having methodological errors 
and provide discrepant conclusions (39). Therefore, effectiveness of LL remains a topic 
for debate. Two meta-analyses reported increased re-operation and morbidity rates in 
LL patients at 3 months, whereas, at 12 months the reoperation rate was reported to be 
higher in the primary resection patients (20, 21). The recently published two-year results 
of the DILALA trial showed significantly less surgical interventions in patients treated 
with LL as compared to HP (14, 29). However, these results have to be interpreted 
with caution, as the increased re-operation rates in the patients who had HP is largely 
attributed to stoma reversal procedures. Additionally, during the second follow-up year, 
eight patients in the LL group developed recurrent diverticulitis compared with only 
two in the HP group. As shown in the present study, recurrence rates may occur well 
after 2 years. Due to the limited follow-up of most previous trials, complication and 
recurrence rates after LL are probably underestimated. Based on 12-month outcomes, 
LL was reported to be cost-effective in two studies (40, 41). However, considering that 
related interventions and readmissions could potentially occur after 12 months, the 
actual related costs of LL may be higher. Nevertheless, LL may result in the avoidance of a 
stoma and an uncomplicated follow-up in selected patients. Interestingly, in our cohort, 
42% of patients had an ASA score of ≥3, which correlated with a complicated outcome. 
Evidently, the present report is preliminary and should be interpreted with caution. 
Nevertheless, it appears that laparoscopic lavage predominantly results in morbidity and 
mortality in frail patients (e.g. those with high ASA-scores or multiple comorbidities). 
LL may be viable as the primary treatment option in a selected population. Therefore, 
accurate selection of patients that might benefit from this treatment is of importance to 
obtain satisfactory results, e.g. by taking age, immunosuppression, severe comorbidities 
(ASA ≥ 3), MPI and history of acute diverticulitis into consideration (26, 33). Long-
term follow-up of other randomized controlled trials comparing LL to sigmoidectomy 
will provide more data on the efficacy and cost-effectiveness, as well as other studies 
assessing potential risk factors of treatment failure, and might help to improve accurate 
patient selection for LL.
Conclusion
In this retrospective cohort of 38 patients treated with LL for perforated diverticulitis, 
long-term recurrence, re-intervention, and readmission rates were high. Moreover, 
a complicated outcome was also present in patients who had initially been treated 
successfully with LL with relevant events occurring up to 6 years after initial surgery. 
Potentially, multiple comorbidities, high ASA scores, and short-term treatment failure 
of LL are of predictive value for an overall complicated outcome.
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Tables
Table 1 Baseline characteristics
No. of patients 38
Sex ratio (M:F) 24:14
Age (years)* 59 (45.5-68.3)
ASA score
1-2 23
3-4 15
Co-morbidities
 None 20
1 6
2 6
> 2 6
Mannheim Peritonitis Index † 13.3 ± 5
Preoperative CRP (mmol/L) † 203 ± 143
Preoperative WBC count (× 103/mm3) † 15.4 ± 5.3
Preoperative hospital stay (days) †
0 28
1 5
2 2
≥ 2 3
Free air
No imaging 3
None 3
Pericolic 4
Distant 28
Operative findings
Pelvic abscess, diffuse free air on CT (Hinchey II) 5
Localized cloudy or purulent exudate (Hinchey III) 29
Generalized cloudy or purulent exudate (Hinchey III) 4
Overt perforation
Yes 2
No 36
ASA, American Society of Anesthesiologists; CRP, C-reactive protein; WBC, white blood cell; CT, computed tomography. 
Continuous values are *median (IQR) and †mean ± SD; discrete variables are absolute numbers.
Table 2 Overall outcomes
Overall outcomes
No. of patients 38
Clinical follow-up (months)* 46 (7-77)
Study follow-up (months)* 90 (84-96)
Overall mortality 8 (21)
Total index admission time (days)* 14 (12-23)
ICU admission 6 (16)
Continuous variables are *median (IQR); discrete variables are absolute numbers (%).
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Table 3 Recurrent diverticulitis, morbidity and surgical re-interventions
< 90 days ≥ 90 days Combined Total events
Recurrent diverticulitis
Sepsis not controlled/ongoing diverticulitis 7 (18) 0 7 (18) 7
Overall recurrence 1 (3) 11 (29) 12 (32) 17
1 1 8 9 9
≥ 2 0 3 3 8
Uncomplicated diverticulitis 1 (3) 5 (13) 6 (18) 10
Complicated diverticulitis 0 6 (16) 6 (18) 7
1 0 5 5 5
≥ 2 0 1 1 2
Time until first episode (days) 341 (115-795) -
Morbidity
Ileus 5 (13) 4 (11) 9 (24) 12
After laparoscopic lavage 5 1 6 6
After subsequent surgery 0 3 3 6
Intra-abdominal abscess 4 (11) 5 (13) 8 (23) 11
Enterocutaneus/ enterovaginal/ 
enterovesical/ ileosigmoid fistula
3 (8) 4 (11) 6 (18) 7
Midline incisional hernia 2 (5) 2 (5) 4 (11) 4
Burst abdomen 2 (5) 0 2 (5) 2
Parastomal hernia 0 2 (5) 2 (5) 2
Wound infection 2 (5) 1 (3) 3 (8) 3
Pneumonia 2 (5) 0 2 (5) 2
Pulmonary embolism 1 (3) 0 1 (3) 1
Atrial fibrillation 1 (3) 0 1 (3) 1
Surgical re-interventions
Overall 6 (18) 10 (26) 12 (32) 29
1 4 4 2 2
≥ 2 2 6 10 10
 ≥ 1 emergency procedures 6 (100) 2 (20) 7 (58) 11
Sigmoid/anterior resection 3 (8) 6 (16) 9 (24) 9
Wedge excision sigmoid 0 1 (3) 1(3) 1
Suture repair of perforated sigmoid 1 (3) 0 1 (3) 1
Stoma construction 3 (8) 6 (16) 9 (24) 9*
End colostomy 2 4 6 6
Loop Ileostomy 1 2 3 3
Stoma reversal 0 7 7 7
(Parastomal) hernia repair 0 3 (8) 3 (8) 3†
Relief of obstructive ileus 0 2 (5) 2 (5) 2
Abscess drainage (surgical) 1 (3) 0 1 (3) 2
Fistulotomy and abscess drainage 0 1 (3) 1 (3) 1
Repair of fascia dehiscence 2 (5) 0 2 (5) 2
Continuous variables are median (IQR); discrete variables are absolute numbers (%). Events that occurred multiple times 
are counted as one event per patient; the total events column depicts the cumulative number of events.
*One ileostomy and one colostomy were constructed in a separate procedure.
†One hernia repair procedure was performed simultaneously with a colostomy reversal.
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Table 4 Readmissions
Readmissions Overall outcomes Total events
Any Readmission 15 (39) 50
1 4 4
≥ 2 11 46
Total readmission time (days) 11 (4-29) 346
Continuous variables are median (IQR); discrete variables are absolute numbers (%).
Table 5 Recurrence of diverticulitis and surgical re-interventions by time period 
Time interval 0-1year 0-3 years 0-5 years End of follow-up
Recurrence of diverticulitis 8 13 16 17
Sigmoid/anterior resection 7 8 9 9
Reoperations 19 24 27 29
Table 6 Univariate analysis of baseline characteristics
Variable Uncomplicated 
Follow-up 
Complicated 
Follow-up 
P value
N 23 15
Sex ratio (M : F) 15:8 9:6 1.00
Age 58 (44-68) 60 (46-70) 1.00*
ASA score 0.008
1-2 18 5
3-4 5 10
Co-morbidities 0.033
0 or 1 19 7
≥ 2 4 8
Mannheim Peritonitis Index* 11 (10-16) 15 (11-16) 0.184*
Preoperative CRP (mmol/L)* 172 (50-275) 242 (128.5-323) 0.068*
Preoperative white blood cell count (×103/mm3)* 16 (13.6-19.6) 13.4 (10.2-19.3) 0.374*
Preoperative hospital stay (days) 0.630
0 or 1 19 14
≥ 2 4 1
Free air 0.545
No 1 2
Pericolic 3 1
Distant 16 12
Per operative diagnosis 0.504
Pelvic abscess, diffuse free air on CT (Hinchey II) 2 3
Localized cloudy or purulent exudate (Hinchey III) 19 10
Generalized cloudy or purulent exudate (Hinchey III) 2 2
Overt perforation 1 1 1.00
Primary treatment failure 0 7 0.001
Continuous values are median (IQR); discrete variables are absolute numbers. ASA, American Society of Anesthesiologists; 
CRP, C-reactive protein; CT, computed tomography.
*Mann–Whitney U test.
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Figure 2 Recurrence-free survival
Figure 3 Resection-free survival
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Summary
Background
Previous studies have suggested that sigmoidectomy with primary anastomosis is superior 
to Hartmann’s procedure. The likelihood of stoma reversal after primary anastomosis 
has been reported to be higher and reversal seems to be associated with lower morbidity 
and mortality. Although promising, results from these previous studies remain uncertain 
because of potential selection bias. Therefore, this study aimed to assess outcomes after 
Hartmann’s procedure versus sigmoidectomy with primary anastomosis, with or without 
defunctioning ileostomy, for perforated diverticulitis with purulent or faecal peritonitis 
(Hinchey III or IV disease) in a randomised trial.
Methods
A multicentre, randomised, open-label, superiority trial was done in eight academic 
hospitals and 34 teaching hospitals in Belgium, Italy, and the Netherlands. Patients 
aged between 18 and 85 years who presented with clinical signs of general peritonitis 
and suspected perforated diverticulitis were eligible for inclusion if plain abdominal 
radiography or CT scan showed diffuse free air or fluid. Patients with Hinchey I or II 
diverticulitis were not eligible for inclusion. Patients were allocated (1:1) to Hartmann’s 
procedure or sigmoidectomy with primary anastomosis, with or without defunctioning 
ileostomy. Patients were enrolled by the surgeon or surgical resident involved, and secure 
online randomisation software was used in the operating room or by the trial coordinator 
on the phone. Random and concealed block sizes of two, four, or six were used, and 
randomisation was stratified by age (<60 and ≥60 years). The primary endpoint was 
12-month stoma-free survival. Patients were analysed according to a modified intention-
to-treat principle. The trial is registered with the Netherlands Trial Register, number 
NTR2037, and ClinicalTrials.gov, number NCT01317485.
Findings
Between July 1, 2010, and Feb 22, 2013, and June 9, 2013, and trial termination 
on June 3, 2016, 133 patients (93 with Hinchey III disease and 40 with Hinchey IV 
disease) were randomly assigned to Hartmann’s procedure (68 patients) or primary 
anastomosis (65 patients). Two patients in the Hartmann’s group were excluded, as 
was one in the primary anastomosis group; the modified intention-to-treat population 
therefore consisted of 66 patients in the Hartmann’s procedure group (46 with Hinchey 
III disease, 20 with Hinchey IV disease) and 64 in the primary anastomosis group (46 
with Hinchey III disease, 18 with Hinchey IV disease). In 17 (27%) of 64 patients 
assigned to primary anastomosis, no stoma was constructed. 12-month stoma-free 
survival was significantly better for patients undergoing primary anastomosis compared 
with Hartmann’s procedure (94.6% [95% CI 88.7–100] vs 71.7% [95% CI 60.1–
83.3], hazard ratio 2.79 [95% CI 1.86–4.18]; log-rank p<0.0001). There were no 
significant differences in short-term morbidity and mortality after the index procedure 
for Hartmann’s procedure compared with primary anastomosis (morbidity: 29 [44%] 
of 66 patients vs 25 [39%] of 64, p=0.60; mortality: two [3%] vs four [6%], p=0.44).
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Interpretation
In haemodynamically stable, immunocompetent patients younger than 85 years, 
primary anastomosis is preferable to Hartmann’s procedure as a treatment for perforated 
diverticulitis (Hinchey III or Hinchey IV disease).
Funding
Netherlands Organisation for Health Research and Development.
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Introduction
Diverticular disease is the third most costly gastrointestinal disorder in developed 
countries, making it an important condition in terms of health-care utilisation (1). An 
estimated 8–35% of patients with acute diverticulitis present with complicated disease, 
including abscess formation (Hinchey classification Ib and II) or perforation with 
purulent or faecal peritonitis (Hinchey III or IV) (2, 3).
In cases of perforated diverticulitis with purulent or faecal peritonitis, emergency 
operative treatment is standard practice (4-7). Hartmann’s procedure - resection with 
end colostomy construction - remains the favoured option for most surgeons and avoids 
the risk of anastomotic leakage (3, 8). However, several studies have suggested that 
sigmoidectomy with primary anastomosis is equal to Hartmann’s procedure in terms of 
post-operative mortality and morbidity (5, 7, 9). Additionally, the likelihood of reversal 
of end colostomies after Hartmann’s procedure has been reported to be lower (50–60%) 
than that of closure of defunctioning ileostomies after sigmoidectomy with primary 
anastomosis (85%), thereby increasing associated health-care costs and negatively 
affecting quality of life (10-12). Moreover, Hartmann’s procedure reversal is associated 
with high mortality and morbidity (13, 14), whereas primary anastomosis allows for a 
safer, less challenging closure procedure (12, 13, 15). In selected cases of sigmoidectomy 
with primary anastomosis, a defunctioning ileostomy might even be avoided (8, 16).
Despite increased interest in sigmoidectomy with primary anastomosis and its potential 
advantages, high-quality evidence from randomised studies comparing this procedure 
with Hartmann’s procedure is scarce, particularly with regard to stoma-free survival, 
which, as a single outcome measure, reflects both the risk of mortality and the likelihood 
of stoma reversal. Therefore, the aim of the DIVA arm of the international, multicentre, 
randomised controlled LADIES trial (17), was to compare Hartmann’s procedure 
with primary anastomosis (with or without defunctioning ileostomy) to determine the 
optimal strategy for perforated diverticulitis with purulent or faecal peritonitis.
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Methods
Study design and participants
The LADIES trial (18) was a multicentre, randomised, open-label, superiority trial 
done at 34 teaching hospitals and eight academic hospitals in Belgium, Italy, and the 
Netherlands. Initially, the trial had a combined design to compare laparoscopic peritoneal 
lavage with sigmoidectomy for purulent perforated diverticulitis (LOLA arm) and 
Hartmann’s procedure with sigmoidectomy with primary anastomosis in both purulent 
and faecal perforated diverticulitis (DIVA arm) (18). After preliminary termination of 
the LOLA arm, patients with purulent peritonitis were no longer randomly assigned to 
laparoscopic lavage and enrolment of patients with both purulent or faecal peritonitis 
continued in the DIVA arm (19).
Patients aged between 18 and 85 years, who presented with clinical signs of general 
peritonitis and suspected perforated diverticulitis were eligible for inclusion if plain 
abdominal radiography or CT scan showed diffuse free air or fluid. Patients with Hinchey 
I and II diverticulitis were not eligible for inclusion. Details of the Hinchey classification 
are provided in the appendix (Table 1)(20). Exclusion criteria were dementia, previous 
sigmoidectomy, previous pelvic radiotherapy, chronic steroid treatment (≥20 mg daily), 
and preoperative shock requiring inotropic support. Before the study procedure, written 
informed consent was obtained from patients by the surgeon or surgical resident 
involved.
The study was designed in accordance with Good Clinical Practice guidelines and the 
Declaration of Helsinki, and received ethics approval from the institutional review board 
(IRB) of the University Medical Centre Amsterdam and local approval was provided in 
the participating hospitals.
Randomisation and masking
Patients underwent diagnostic laparoscopy to confirm their diagnosis, exclude other 
causes of peritonitis, and distinguish between types of peritonitis. After confirmation 
of diagnosis, patients with purulent peritonitis (Hinchey III) were randomly assigned 
(2:1:1) within the LOLA arm between laparoscopic lavage, Hartmann’s procedure, or 
sigmoidectomy with primary anastomosis with or without defunctioning ileostomy. 
Patients with faecal peritonitis or an overt perforation (Hinchey IV) were randomly 
assigned within the DIVA arm. In the DIVA arm, patients were allocated (1:1) to 
Hartmann’s procedure or primary anastomosis, with or without defunctioning ileostomy. 
After termination of the LOLA arm, random assignment to Hartmann’s procedure and 
sigmoidectomy with primary anastomosis (1:1) continued to allow further comparison 
between these strategies. Patients with purulent peritonitis who underwent Hartmann’s 
procedure or sigmoidectomy with primary anastomosis in the LOLA arm before its 
termination were included in the present analyses.
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Patients were enrolled by the surgeon or surgical resident involved. Secure online 
randomisation software (ALEA version 2.2) was used in the operating room or by the 
trial coordinator on the phone. Random concealed block sizes of two, four, or six were 
generated by the randomisation software and used for randomisation. Randomisation 
was stratified by age (<60 years vs ≥60 years). Patients, physicians, and researchers 
were not masked to the allocated treatment during the complete study period after 
randomisation.
Procedures
The surgical procedures have previously been described in detail (18). When allocated to 
Hartmann’s procedure, resection of the diseased segment was done without the explicit 
requirement of the distal transection line to be on the proximal rectum. Construction of 
an end colostomy and closure of the rectal stump were done according to the preference 
of the operating surgeon. For sigmoidectomy with primary anastomosis, the distal 
transection margin was on the proximal rectum and the proximal margin was determined 
by the absence of wall thickening due to diverticulitis. Anastomotic construction and 
configuration were done according to the surgeon’s preference. Decisions on type of 
anastomosis, minimally invasive surgery, construction of defunctioning ileostomy, and 
drain placement were left at the surgeon’s discretion. Stoma reversal was offered to 
patients if they were willing to undergo surgery and if they were considered operable by 
the surgeon and anaesthesiologist.
After the index procedure, patients were followed up at least once in an outpatient 
setting and follow-up after stoma reversal was done according to local protocols. Patients 
who were not in active follow-up at 12 months were contacted to verify remaining 
follow-up.
We measured health-related quality of life with EuroQol-5D-3-level, Short Form-36 v2, 
and gastrointestinal quality-of-life index (21), at weeks 2 and 4, and months 3, 6, and 
12 of follow-up.
An electronic case report form was used to collect data on patient demographics, 
including sex, age, body-mass index, medical history, medication, American Society 
of Anesthesiologists (ASA) score, physiological and operative severity score for the 
enumeration of mortality and morbidity (POSSUM), acute physiology and chronic 
health evaluation (APACHE) II score, Mannheim peritonitis index (MPI), and operative 
and postoperative characteristics, such as surgical approach, type of anastomosis, 
operating time, intra-operative blood loss, and duration of hospital stay. Moreover, 
during 12-month follow-up, outcomes such as major and minor morbidity, mortality, 
surgical reinterventions, readmissions to hospital, stoma reversal procedures, incisional 
hernia occurrence, and the number of days alive and outside of hospital were recorded. 
Questionnaires were sent by mail and the trial coordinator contacted patients who did 
not return or fill out questionnaires. During the study period until July 31, 2014, a chart 
review was done in 28 Dutch participating centres that included at least one patient in 
the trial to assess baseline characteristics of eligible non-included patients (19).
Hartmann’s procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis (LADIES)
103
Ch
ap
te
r 5
Outcomes
The primary endpoint was 12-month stoma-free survival. Secondary endpoints were short-
term mortality and morbidity, regarded as separate endpoints, after index and reversal 
procedures, operative (presence of gastrointestinal surgeon, laparoscopic procedure, 
operating time, drain placement, and anastomotic construction and configuration) and 
postoperative (type of postoperative admission, length of postoperative stay, intensive 
care unit stay, and days until normal intake) care characteristics, and health-related 
quality of life. We defined short-term as within 30 days after surgery or until discharge, 
if the patient remained in hospital at that time. Predefined major morbidity included 
any of the following events or conditions: surgical reintervention, percutaneous 
abscess drainage, fascial dehiscence, urosepsis, myocardial infarction, renal failure, 
and respiratory insufficiency. Other prespecified secondary outcomes were duration of 
hospital stay, incisional hernia occurrence, and the number of days alive and outside of 
the hospital.
Separately, complications were scored according to the Clavien-Dindo classification (22) 
over a 90-day period. Elective stoma reversal was not defined as morbidity or 
reintervention in either treatment group. Although prespecified as a secondary endpoint, 
an economic evaluation of health-care use and associated costs was not included in the 
present study, but will be reported separately.
Statistical analysis
We suspected postoperative mortality to be 15% for both treatment strategies (7). 
Around 60% of patients in the Hartmann’s procedure group and 85% of patients in 
the sigmoidectomy with primary anastomosis group were estimated to undergo stoma 
reversal (13, 14). When corrected for expected mortality, reversal rates were calculated 
to be 50% and 72%, respectively. Before termination of the LOLA arm, a sample 
size of 264 was needed, which was based on an expected difference of 15% (10% vs 
25%) in combined mortality and major morbidity between laparoscopic lavage and 
sigmoidectomy, respectively (90% power; 5% two-sided α). After termination of the 
LOLA arm, a sample size calculation was done based on the primary endpoint of the 
DIVA arm. We calculated a sample size of 212 patients would be needed to show a 
significant difference in 12-month stoma-free survival with log-rank statistics with 90% 
power and a two-sided α of 5%, based on an estimated difference of 22% (50% vs 72% 
for Hartmann’s procedure and primary anastomosis, respectively). When corrected for 
potential loss to follow-up (10%), the sample size was 236 patients.
Patients were analysed according to a modified intention-to-treat principle, as three 
patients were excluded shortly after randomisation because of the following alternate 
diagnoses: wedge excision of giant diverticulum in the absence of other diverticula 
(one patient in the primary anastomosis group with Hinchey IV disease), subtotal 
colectomy with end ileostomy for colonic metastases of a previously unknown 
pancreatic carcinoma (one patient in the Hartmann’s procedure group with Hinchey 
III disease), and rectosigmoid cancer in the absence of diverticula (one patient in the 
Hartmann’s procedure group with Hinchey IV disease). We estimated 12-month stoma-
free survival with the Kaplan-Meier method and analysed differences in survival with 
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the Mantel-Cox log-rank test, without adjustment for other covariates. We used a post-
hoc Cox regression analysis, with treatment and age stratification groups as covariates, 
to adjust for age stratification. We compared categorical data with Fisher’s exact test and 
reported the results as numbers with percentages. Depending on normality, we tested 
continuous variables with Student’s t test or Mann-Whitney U test and presented the 
results as means with SD or medians with IQR. We analysed questionnaires according 
to the relevant guidelines and presented results as subscales and summarised scores. For 
questionnaires, we imputed missing data with a regression model with predictive mean 
matching, creating ten imputed data sets by taking treatment group, Hinchey grade, 
and questionnaire values of other time points into account. We calculated pooled means 
if at least one questionnaire was returned and corrected p values for multiple testing 
with the Benjamini-Hochberg method.
A data safety monitoring board, comprising independent clinical, epidemiological, and 
statistical experts, was established to assess trial progress and safety. The IRB approved 
a formal charter, allowing the data safety monitoring board to stop the study for safety 
reasons or early treatment superiority outside any prespecified definitions. After inclusion 
of every 25 patients, safety variables were supplied to the data safety monitoring board 
by the trial coordinator. In cases of patients with study-related severe morbidity or 
mortality, the data safety monitoring board was granted access to these individual data.
Statistical analyses were done with SPSS version 24.0 and R version 3.4.1. The trial is 
registered with the Netherlands Trial Register, number NTR2037, and ClinicalTrials.
gov, number NCT01317485.
Role of  the funding source
The LADIES trial was investigator-initiated and supported by a grant from the 
Netherlands Organisation for Health Research and Development. The funder of 
the study critically reviewed and adjusted the study design, but had no role in data 
collection, data analysis, data interpretation, writing of the report, or the submission 
process. The corresponding author had full access to all the data in the study and had 
final responsibility for the decision to submit for publication.
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Results
Between July 1, 2010, and Feb 22, 2013, 90 patients (47 assigned to laparoscopic 
lavage and 43 to sigmoidectomy) were recruited and enrolled in the trial, after which 
recruitment was temporarily stopped, as advised by the data safety monitoring board, 
because of safety concerns in the LOLA arm at the third interim analysis. After IRB 
approval, randomisation (1:1) between Hartmann’s procedure and sigmoidectomy with 
primary anastomosis continued in the DIVA arm, as safety concerns were limited to the 
laparoscopic lavage group (19). Continuation of the study commenced on June 9, 2013, 
and lasted until June 3, 2016, after which the DIVA arm was prematurely terminated 
because of slow patient accrual, leading to substantial delays in trial progression. After 
both the data safety monitoring board and IRB approved early termination, 12-month 
follow-up was continued and finished for all 130 included patients. Included patients 
were from one Belgian hospital, two Italian hospitals, and 25 Dutch hospitals (19 
teaching and six academic hospitals).
133 patients (93 with Hinchey III disease and 40 with Hinchey IV disease) were 
randomly assigned to Hartmann’s procedure or sigmoidectomy with primary 
anastomosis (Hinchey III: 47 patients to Hartmann’s procedure and 46 patients to 
primary anastomosis; Hinchey IV: 21 patients to Hartmann’s procedure and 19 patients 
to primary anastomosis; Figure 1). Of the patients with Hinchey III disease, one patient 
in the primary anastomosis group crossed over to laparoscopic lavage and five patients 
crossed over to Hartmann’s procedure. One patient assigned to Hartmann’s procedure 
was excluded because of sigmoid carcinoma (metastases of previously undiagnosed 
pancreatic carcinoma; this patient underwent subtotal colectomy with end ileostomy 
for colonic metastases) and one patient crossed over to primary anastomosis. Of the 
patients with Hinchey IV disease, one patient assigned to Hartmann’s procedure was 
excluded because of rectosigmoid carcinoma (Figure 1). Two patients assigned to primary 
anastomosis crossed over to Hartmann’s procedure and one was excluded because of a 
giant sigmoid diverticulum requiring wedge excision. Reasons for crossover are listed in 
the appendix (Table 2).
Thus, 130 patients were included in the modified intention-to-treat population: 66 
patients in the Hartmann’s procedure group and 64 in the primary anastomosis group; 92 
patients had Hinchey III disease and 38 had Hinchey IV disease (Figure 1). 82 patients 
were included in the analysis of stoma reversal, and in the remaining patients no stoma 
was constructed (18 patients) or no reversal was done during follow-up (29 patients). 
One patient was lost to follow-up after short-term follow-up and could therefore only 
be included in analyses of short-term outcomes after the index procedure. The number 
of patients included per centre is provided in the appendix (Table 3).
We observed no major differences between randomised groups in terms of baseline 
characteristics in the modified intention-to-treat population (Table 1). In the Hartmann’s 
procedure group, 20 (30%) of 66 patients had Hinchey grade IV diverticulitis and 
in the primary anastomosis group, 18 (28%) of 64 patients had Hinchey grade IV 
diverticulitis. A gastrointestinal surgeon was present during the procedure for 57 (86%) 
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of 66 patients in the Hartmann’s procedure group and 58 (91%) of 64 patients in the 
primary anastomosis group. Procedures were done laparoscopically in 20 (30%) of 66 
patients in the Hartmann’s procedure group and 17 (27%) of 64 patients in the primary 
anastomosis group. None of these surgeries were converted to an open procedure. A 
comparison between baseline characteristics of patients with Hinchey III and Hinchey 
IV disease and data for separate Hinchey grades are provided in the appendix (Tables 
4-5). We also compared baseline patient and perioperative characteristics and outcomes 
between eligible non-included patients (235 patients) and included patients (appendix 
Table 6). We observed significantly lower preoperative disease severity scores in non-
included patients compared with included patients (eg, median Portsmouth-POSSUM 
predicted mortality 4.4% [IQR 2.8–11.6] vs 6.1% [4.3–11.3]; p=0.011; and median 
POSSUM predicted morbidity scores 64.8% [IQR 52.5–82.4] vs 71.7% [61.2–82.3]; 
p=0.0028), whereas ASA, APACHE II, and MPI scores were not significantly different 
between non-included and included patients. 20 (9%) of 235 eligible non-included 
patients died, compared with six (5%) of 130 patients in the study population (p=0.21). 
In the non-included patients, the presence of a gastrointestinal surgeon was significantly 
less likely compared with the included patients (68.7% vs 88.5%; p<0.0001).
Patients in the primary anastomosis group had significantly better 12-month stoma-free 
survival compared with patients in the Hartmann’s procedure group (94.6% [95% CI 
88.7–100] vs 71.7% [95% CI 60.1–83.3], hazard ratio [HR] 2.79 [95% CI 1.86–4.18]; 
log-rank p<0.0001; Figure 2). Median time to being stoma-free was 101.0 days (95% 
CI 71.5–130.5) for patients in the primary anastomosis group and 186.0 days (138.0–
234.0) for patients in the Hartmann’s procedure group. A post-hoc subgroup analysis 
found a HR for stoma-free survival of 2.35 (95% CI 1.33–4.15; log-rank p=0.0032) 
for patients younger than 60 years versus 3.41 (1.88–6.20; log-rank p<0.0001) for 
patients aged 60 years and older. Moreover, when adjusted for age (<60 years or ≥60 
years), the HR for stoma-free survival was 2.72 (95% CI 1.81–4.08). Survival curves 
for the primary outcome in both separate Hinchey groups are given in the appendix 
(Figures 2-3). In both Hinchey groups, patients in the primary anastomosis group had 
significantly better 12-month stoma-free survival (Hinchey III: primary anastomosis 
95.3% [95% CI 89.7–100.0] vs Hartmann’s procedure 79.8% [67.5–92.2], HR 2.35 
[95% CI 1.49–3.71]; log-rank p=0.00025; Hinchey IV: primary anastomosis 92.2% 
[CI 77.7–100] vs Hartmann’s procedure 51.9% [28.2–75.6], HR 4.15 [1.71–10.1]; 
log-rank p=0.0016).
We found no significant differences in short-term postoperative outcomes of the index 
procedures (Table 2, Table 3). 29 (44%) of 66 patients in the Hartmann’s procedure 
group and 25 (39%) of 64 patients in the primary anastomosis group had major or minor 
morbidity; major morbidity was noted in eight (12%) of 66 patients in the Hartmann’s 
procedure group and nine (14%) of 64 patients in the primary anastomosis group 
(Table 2). In the Hartmann’s procedure group, two (3%) patients with Hinchey IV disease 
died from ongoing sepsis with multiorgan failure. In the primary anastomosis group, 
four (6%) patients died: three patients with Hinchey IV disease because of ongoing sepsis 
and one patient with Hinchey III disease, with known cardiovascular comorbidities, of 
sepsis further complicated by an occlusion of the right common iliac artery. One of 
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these four patients assigned to primary anastomosis crossed over to the Hartmann’s 
procedure group. Mortality was not significantly different between patients assigned to 
Hartmann’s procedure versus primary anastomosis (p=0.44). Surgical reinterventions in 
the Hartmann’s procedure group consisted of revision of necrotic stoma (two patients), 
closure after open abdomen treatment (one patient), and relaparotomy for ongoing 
sepsis (one patient). In the primary anastomosis group, surgical reinterventions were 
repair of fascial dehiscence (one patient), surgical abscess drainage (one patient), and 
relaparotomy for ongoing sepsis (two patients). One of the patients who underwent 
relaparotomy for ongoing sepsis required a second relaparotomy.
90-day Clavien-Dindo scores showed no significant differences between the groups, 
with grade IIIb or worse complications in 12 (18%) of 66 patients in the Hartmann’s 
procedure group and nine (14%) of 63 patients in the primary anastomosis group 
(appendix Table 7). Overall morbidity was not significantly different for Hartmann’s 
procedure and primary anastomosis in patients with Hinchey III (17 [37%] of 46 
patients in the Hartmann’s procedure group vs 17 [37%] of 46 patients in the primary 
anastomosis group, p=1.0) and Hinchey IV (12 [60%] of 20 patients in the Hartmann’s 
procedure vs eight [44%] of 18 patients in the primary anastomosis group; p=0.52) 
disease (appendix Table 8).
In the Hartmann’s procedure group, a stoma was constructed in 65 (98%) of 66 patients, 
whereas only 46 (73%) of 64 patients in the primary anastomosis group had a stoma 
constructed (Table 4). In the patients in the primary anastomosis group without a stoma, 
major and minor morbidity were both 12% (two of 17 patients), overall morbidity was 
24% (four of 17 patients), and there were no deaths related to the index procedure. 
A comparison between patients in the primary anastomosis group with and without 
an ileostomy is given in the appendix (Table 9). In all but two patients, postoperative 
histopathology details were available, which showed a sigmoid carcinoma in two patients 
(one patient with Hinchey III diverticulitis and one with Hinchey IV diverticulitis).
44 (68%) of 65 patients with a stoma in the Hartmann’s procedure group underwent 
stoma reversal, compared with 38 (83%) of 46 patients with a stoma in the primary 
anastomosis group (p=0.085; Table 4). Hartmann’s procedure reversal was done 
laparoscopically in 20 (45%) of 44 patients. In 16 (25%) of 66 patients allocated to 
Hartmann’s procedure and one crossover patient from the primary anastomosis group, 
both the index procedure and Hartmann’s reversal procedure were done laparoscopically 
and without conversion.
For postoperative outcomes of stoma reversal, overall morbidity was significantly lower 
in the primary anastomosis group compared with the Hartmann’s procedure group (13 
[30%] of 66 patients vs three [8%] of 38 patients; p=0.023; Table 5). Furthermore, the 
median interval to reversal (113.5 days [IQR 80.0–155.0] vs 133.0 days [102.0–208.0]; 
p=0.021) and median postoperative stay (4.0 days [IQR 2.8–5.0] vs 5.0 days [4.0–6.0]; 
p=0.011) were significantly shorter for the primary anastomosis group. There were no 
deaths related to stoma reversal. One patient in the Hartmann’s procedure group had an 
anastomotic leakage after stoma reversal, for which an end colostomy was constructed. 
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For patients with Hinchey IV diverticulitis, there was no overall morbidity related to 
stoma reversal in the primary anastomosis group, compared with 30% (three of ten 
patients) in the Hartmann’s procedure group (p=0.21; appendix Table 10). Overall, no 
stoma reversal was done in 29 patients (appendix Table 11). 19 patients were alive with 
a stoma at 12-month follow-up, of whom six patients (all in the Hartmann’s procedure 
group) eventually underwent stoma reversal outside the follow-up period after a median 
total duration of 13.2 months (IQR 12.7–23.3).
Although not significantly different, overall morbidity for both the index procedure 
and any subsequent reversal was lower for primary anastomosis than for Hartmann’s 
procedure (25 [40%] of 63 patients vs 37 [56%] of 66 patients; p=0.078; Table 6). 
Furthermore, although not significantly different, the overall median postoperative stay 
was shorter for primary anastomosis than for Hartmann’s procedure (12.5 days [IQR 
9.0–16.8] vs 14.0 days [10.8–19.0]; p=0.054). Overall, two (3%) of 66 patients in the 
Hartmann’s group and four (6%) of 63 patients in the primary anastomosis group died. 
Overall, no postoperative urosepsis occurred. The median number of days alive and 
outside of the hospital was 348.0 (IQR 335.5–354.0) for Hartmann’s procedure and 
351.0 (342.3–358.0) for primary anastomosis (p=0.21). A midline incisional hernia 
was diagnosed in eight patients (five in the Hartmann’s procedure group and three in 
the primary anastomosis group), of which four were treated conservatively, whereas the 
remaining four underwent open repair (two patients), laparoscopic repair (one patient), 
or repair during Hartmann’s reversal (one patient). In two of these patients no stoma 
was constructed, in three the stoma was reversed before hernia occurrence, and in the 
remaining three the stoma was reversed after hernia occurrence. One patient with a 
midline incisional hernia also had a parastomal hernia without undergoing stoma 
reversal during follow-up. Ten patients in the Hartmann’s procedure group developed a 
parastomal hernia during follow-up, of which three were treated conservatively, and the 
remaining seven underwent Hartmann’s procedure reversal. After stoma reversal, stoma 
site incisional hernia was diagnosed in three patients (two in the Hartmann’s procedure 
group and one in the primary anastomosis group). Moreover, one patient in the primary 
anastomosis group developed a trocar site hernia.
Quality-of-life results and questionnaire response rates are given in the appendix (Tables 
12-13). After correction for multiple testing, no significant differences between the 
groups were found in any of the subscales and summarised scores.
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Discussion
This randomised trial, comparing Hartmann’s procedure to sigmoidectomy with 
primary anastomosis in patients with perforated diverticulitis and purulent or faecal 
peritonitis, showed significantly better 12-month stoma-free survival for patients in the 
primary anastomosis group, without significant differences in short-term morbidity 
and mortality. Furthermore, we found significantly lower short-term overall morbidity 
after stoma reversal for primary anastomosis, and a significantly shorter median time to 
reversal and postoperative stay after reversal.
Other randomised clinical trials comparing Hartmann’s procedure with primary 
anastomosis have shown similar outcomes regarding the difference in morbidity after 
the index and reversal procedures. In a study by Oberkofler and colleagues (23), which 
compared 30 patients who underwent Hartmann’s procedure with 32 patients who 
underwent primary anastomosis (with defunctioning ileostomy), no difference was 
found in the number of overall complications. Similarly, a trial by Binda and colleagues 
(24), did not find a difference in morbidity between Hartmann’s procedure and primary 
anastomosis. Bridoux and colleagues (25) also reported similar overall morbidity rates 
for Hartmann’s procedure and primary anastomosis. With the exception of a significant 
difference in overall morbidity after the stoma reversal procedure in favour of primary 
anastomosis, short-term outcomes after the index procedure were also similar in our 
study. Exact morbidity figures differ between studies, which might be due to a difference 
in definitions of morbidity. Although no significant differences were found in morbidity 
rates after the index procedure and both procedures combined in the present trial, 
the absolute number of events in each group was higher in the Hartmann’s procedure 
group than in the primary anastomosis group. Furthermore, mortality was twice as 
high after primary anastomosis than with Hartmann’s procedure, although the absolute 
difference was low (four patients in the primary anastomosis group vs two patients in 
the Hartmann’s procedure group). One of the four deceased patients in the primary 
anastomosis group crossed over to Hartmann’s procedure. When interpreting these 
results, it should be noted that the study was not powered to detect clinically significant 
differences in these secondary outcomes.
To our knowledge, this is the first trial to report on 12-month stoma-free survival. Our 
trial showed significantly better stoma-free survival for patients undergoing primary 
anastomosis compared with patients undergoing Hartmann’s procedure. This difference 
might be explained by the higher percentage of stoma reversals and the higher number 
of patients without a stoma in the primary anastomosis group, since the decision to 
construct a defunctioning ileostomy was left to the discretion of the surgeon. These 
results reflect the important benefit of potentially avoiding stoma construction in 
patients undergoing primary anastomosis, which is not possible in patients undergoing 
Hartmann’s procedure. Moreover, the significantly lower percentage of post-reversal 
overall morbidity associated with primary anastomosis, as well as the shorter interval 
until stoma reversal and postoperative stay after stoma reversal, further advocate the 
benefits of primary anastomosis. Results from a recent meta-analysis of experimental 
and observational studies (26) indicate decreased morbidity rates after stoma reversal 
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for primary anastomosis, whereas in a meta-analysis of three randomised studies (27), 
Hartmann’s procedure and primary anastomosis were not found to be different in 
terms of mortality or overall morbidity. Additionally, no difference in the number of 
permanent stoma was reported between the groups, despite the fact that two of three 
studies reported more stoma reversals after primary anastomosis than after Hartmann’s 
procedure (23, 25, 27).
Overall, baseline patient characteristics did not differ significantly between patients 
with Hinchey III and Hinchey IV diverticulitis. Additionally, the primary endpoint was 
found to be significantly better for patients undergoing primary anastomosis in both of 
these Hinchey grades. Moreover, from these analyses, morbidity and mortality in those 
with Hinchey IV disease appeared to be higher than for those with Hinchey III disease. 
Nevertheless, differences in secondary outcomes between Hartmann’s procedure and 
primary anastomosis in patients with Hinchey IV diverticulitis were not clearly shown 
in our study, although these results should be interpreted with caution because of the 
relatively small group size.
An important limitation of this trial is its premature termination and consequent non-
achievement of the planned sample size because of low accrual rates. Trials done in an 
emergency care setting are vulnerable to premature discontinuation because of slow 
patient recruitment (28). Moreover, surgical trials with invasive interventions tend to 
be more frequently discontinued because of slow recruitment (29). In patients with 
suspected perforated diverticulitis, the narrow time window in which decisions 
regarding trial participation had to be made by both patients and surgeons might have 
been an important limitation. Moreover, because of the emergency setting of our trial 
and the large number of participating hospitals, awareness among clinicians of the 
trial might not always have been optimal, despite efforts to increase this. Furthermore, 
treatment preferences of involved surgeons and subsequent refusal to randomly assign 
patients might have affected patient inclusion. Similar difficulties with slow patient 
recruitment and underlying reasons for these difficulties have been reported in three 
previously published trials (23-25). Early termination of trials for reasons of benefit 
potentially leads to overestimation of treatment effects (30). However, in the case of 
our study, termination was because of slow accrual, in which case the main concern is 
loss of study power. However, our primary endpoint was still statistically significant, 
which could partly be explained by the fact that the sample size calculation was based 
on 90% power (31).
Selection bias might have been introduced before randomisation due to surgeon or 
patient preferences. As a complete account of patients excluded before study enrolment 
could not be obtained in this trial, we cannot completely rule out the influence of 
selection bias. However, data on 235 non-included patients were available through an 
extensive medical chart review in many participating hospitals. Therefore, by contrast 
with previous trials, an important strength of the present study was the possibility to 
compare baseline characteristics of eligible non-included patients with included patients 
to assess potential selection bias and increase external validity (32). These results showed 
that included patients had slightly worse preoperative disease severity, although absolute 
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differences were small. The proportion of procedures for which a gastrointestinal surgeon 
was present was significantly lower in non-included patients than in included patients. 
Although speculative, this fact could be explained by increased trial awareness of the 
involved gastrointestinal surgeons and more willingness to enroll patients, leading to a 
higher percentage of patients operated on by gastrointestinal surgeons. A population-
based cohort study (33) found 24.3% mortality in a cohort with a mean age of 72 
years (range 30–95), both of which are higher values than in our study. Additionally, 
Gawlick and Nirula (34) reported mortality rates of 6.2% and 7.9% and mean ages of 
63.4 years (SD 15.8) and 63.0 years (15.0) for primary anastomosis and Hartmann’s 
procedure, respectively. These figures are more in line with the present study, as well as 
with the cumulative mortality in previously published trials (six [5.2%] of 116 patients 
for primary anastomosis) and 12 [8.7%] of 138 patients for Hartmann’s procedure) 
(27). Importantly, we did not find large differences in the mortality of included and 
non-included patients in the present study. Additionally, another strength of our trial is 
the multicentre setting, which increases the generalisability of the results and has made 
it possible to analyse, to our knowledge, the largest cohort of patients randomly assigned 
to Hartmann’s procedure or primary anastomosis to date. To our knowledge, the present 
study also included the largest subgroup of patients with Hinchey IV diverticulitis to 
date. Second, with regard to Hinchey III and Hinchey IV subgroups and preoperative 
disease classification, prediction of Hinchey classification by preoperative CT scanning 
is not very accurate (35). Previous trials have randomly assigned patients before the 
start of surgery, whereas in the present study, patients were randomised after diagnostic 
laparoscopy, thereby leading to a more accurate distinction between Hinchey grades. 
Hence, subgroup analyses for both Hinchey grades could also be done. We assumed 
centre-specific effects due to the multicentre setting to be small because of the low 
accrual rate per centre and the large number of hospitals. Finally, although we found 
no significant differences in quality-of-life scores between Hartmann’s procedure and 
primary anastomosis, to our knowledge, this is the first randomised study to evaluate 
and compare these patient-reported outcomes for both treatment strategies, which have 
previously be shown to be important in survivors of perforated diverticulitis, particularly 
with regard to the presence of a stoma (36).
In conclusion, to our knowledge, this is the largest randomised trial comparing 
Hartmann’s procedure with primary anastomosis in patients with perforated 
diverticulitis with purulent and faecal peritonitis. We found that primary anastomosis 
was superior to Hartmann’s procedure with regard to 12-month stoma-free survival 
and overall morbidity after stoma reversal, with no significant differences in short-term 
morbidity and mortality after the index procedure. Therefore, in haemodynamically 
stable, immunocompetent patients, primary anastomosis is preferable to Hartmann’s 
procedure for the treatment of perforated diverticulitis.
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Research in context
Evidence before this study
We did a systematic literature search in PubMed for articles published from inception to 
Jan 17, 2019, with the keywords “diverticulitis”, “peritonitis”, “Hartmann*”, “primary”, 
and “anastomosis”, without language restrictions. We specifically included randomised 
controlled trials that compared Hartmann’s procedure with sigmoidectomy with primary 
anastomosis for perforated diverticulitis with purulent or faecal peritonitis (Hinchey III 
or Hinchey IV); three of 127 articles identified by our search met this criterion. Quality 
assessment of these studies is given in the appendix (Figure 4). Overall, these trials 
randomly allocated 116 patients to primary anastomosis and 138 patients to Hartmann’s 
procedure, of whom 204 (80%) had Hinchey III diverticulitis. All three studies were 
prematurely terminated, either because of slow patient accrual (two studies) or for safety 
reasons (one study). No significant differences in mortality or overall morbidity were 
reported after the index procedure or reversal procedure. Two studies found a significant 
difference in stoma reversal rates in favour of primary anastomosis.
Added value of  this study
To our knowledge, the LADIES trial is the largest study to date on primary anastomosis 
in Hinchey III and Hinchey IV diverticulitis and has several methodological differences 
compared with previous randomised trials. First, to our knowledge, this is the first trial 
to report on stoma-free survival as a primary endpoint and to incorporate patient-
reported outcomes. Second, the decision to construct a defunctioning ileostomy was left 
to the discretion of the surgeon, whereas in previous studies, by design, a defunctioning 
ileostomy had to be constructed in all patients undergoing sigmoidectomy with primary 
anastomosis. However, in one previous trial, a third of patients underwent primary 
anastomosis without construction of an ileostomy, thereby deviating from the study 
protocol. Furthermore, patients in the present study were randomly assigned after 
diagnostic laparoscopy, allowing for a more accurate distinction between Hinchey 
III and Hinchey IV diverticulitis and, consequently, this is the first study to report 
on outcomes in Hinchey III and IV disease separately. Finally, although not all non-
included patients could be registered during the trial period, baseline demographics and 
preoperative disease severity data for 235 eligible non-included patients were available to 
compare with included patients. This comparison improves the external generalisability 
of our study.
Implications of  all the available evidence
The LADIES trial provides strong support in favour of sigmoidectomy with primary 
anastomosis as the most appropriate surgical treatment for diverticulitis with purulent or 
faecal peritonitis in patients who are haemodynamically stable and immunocompetent. 
This finding is important because, in combination with existing evidence, it has the 
potential to fundamentally change current practice and reduce both patient and 
socioeconomic burden.
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Tables
Table 1 Baseline patient and perioperative characteristics in the modified intention-to-treat population
Hartmann’s procedure 
group (n=66)
Primary anastomosis 
group (n=64)
Patient characteristics
Age (years) 61.7 (11.4) 62.4 (13.1)
Sex
Female 25 (38%) 23 (36%)
Male 41 (62%) 41 (64%)
Body-mass index (kg/m2) 28 (4.7) 26.3 (4.8)
American Society of Anesthesiologists score*
I–II 37 (63%) 45 (76%)
III–IV 22 (37%) 14 (24%)
Previous diverticulitis 12 (18%) 12 (19%)
Previous laparotomy† 3 (5%) 1 (2%)
CT diagnosis 61 (92%) 60 (94%)
Hinchey grade IV 20 (30%) 18 (28%)
Preoperative disease severity
Acute Physiology and Chronic Health Evaluation II score 8 (5–12) 7.5 (5–11)
POSSUM physiological score 20 (18–24) 20 (17–23)
POSSUM operative score 19 (19–20) 19 (19–20)
Portsmouth-POSSUM predicted mortality (%) 6 (4.4–15.0) 6.5 (3.8–11.2)
POSSUM predicted morbidity (%) 71.7 (64.1–86.6) 73 (61.1–82.1)
Mannheim peritonitis index 23 (17–27) 21 (17–26)
Interval from presentation to surgery (h) 8.0 (4.4–22.9) 9.4 (6.0–30.2)
C-reactive protein (mg/L)
≤10 4 (6%) 6 (9%)
11–100 15 (23%) 13 (20%)
101–200 13 (20%) 15 (23%)
201–300 19 (29%) 10 (16%)
301–400 8 (12%) 9 (14%)
401–500 4 (6%) 6 (9%)
>500 2 (3%) 3 (5%)
Missing 1 (2%) 2 (3%)
White blood cell count (cells per μL) 14 600 (10 200–20 600) 14 200 (9000–16 900)
Operative characteristics
Gastrointestinal surgeon present 57 (86%) 58 (91%)
Laparoscopic procedure 20 (30%) 17 (27%)
Operating time (min) 118.0 (95.5–135.3) 125.0 (110.0–154.0)
Drain placement‡ 21 (32%) 27 (44%)
Anastomotic construction
Manual 1 (2%) 11 (17%)
Stapler 0 43 (67%)
Missing 0 2 (3%)
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Hartmann’s procedure 
group (n=66)
Primary anastomosis 
group (n=64)
Anastomotic configuration
End-to-end 0 18 (28%)
End-to-side 0 3 (5%)
Side-to-side 1 (2%) 9 (14%)
Side-to-end 0 20 (31%)
Missing 0 6 (9%)
Blood loss (mL)
≤100 30 (45%) 31 (48%)
101–500 24 (36%) 20 (31%)
501–1000 3 (5%) 4 (6%)
>1000 0 1 (2%)
Missing 9 (14%) 8 (13%)
Data are mean (SD), n (%), or median (IQR). POSSUM=Physiological and operative severity score for the enumeration 
of mortality and morbidity.
*Missing in seven patients in the Hartmann’s procedure group and five patients in the primary anastomosis group.
†One patient missing (Hinchey III).
‡One patient missing in Hinchey III group and one patient in Hinchey IV group.
Table 2 Morbidity outcomes after the index procedure
Hartmann’s procedure group 
(n=66)
Primary anastomosis group 
(n=64)
p value
Patients Events Patients Events
Major morbidity 8 (12%) 16 9 (14%) 12 0.80
Surgical reintervention 4 (6%) 4 4 (6%) 5 ..
Abscess with drainage 2 (3%) 5 2 (3%) 2 ..
Fascial dehiscence 0 0 3 (5%) 3 ..
Myocardial infarction 1 (2%) 1 0 0 ..
Respiratory failure 4 (6%) 4 1 (2%) 1 ..
Renal failure 3 (5%) 3 1 (2%) 1 ..
Minor morbidity 26 (39%) 36 19 (30%) 21 0.27
Surgical site infection 8 (12%) 8 7 (11%) 7 ..
Postoperative ileus 6 (9%) 6 7 (11%) 7 ..
Pneumonia 5 (8%) 5 0 0 ..
Delirium 5 (8%) 5 3 (5%) 3 ..
Urinary tract infection or 
urine retention
2 (3%) 2 2 (3%) 2 ..
Abscess without drainage 5 (8%) 5 0 0 ..
Thrombosis 1 (2%) 1 0 0 ..
Cardiac complications 4 (6%) 4 2 (3%) 2 ..
Overall morbidity 29 (44%) 52 25 (39%) 33 0.60
Data are n (%). P values are for numbers of patients, not event numbers. Overall morbidity is major morbidity plus 
minor morbidity.
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Table 3 Short-term postoperative outcomes of the index procedure
Hartmann’s procedure group 
(n=66)
Primary anastomosis group 
(n=64)
p value
Postoperative admission to 0.53
Surgical ward 44 (67%) 40 (63%) ..
Post-anaesthesia care unit or 
medium care unit
4 (6%) 2 (3%) ..
ICU 18 (27%) 22 (34%) ..
Postoperative stay (days) 9.0 (7–15) 9.5 (7–13) 0.75
ICU stay (days) 2.0 (1–11) 1.5 (1–3) 0.18
Time until normal intake (days) 4.0 (1–6) 4.0 (2–6.8) 0.46
Data are n (%) or median (IQR). ICU=intensive care unit.
Table 4. Stoma outcomes
Hartmann’s procedure group 
(n=66)
Primary anastomosis group 
(n=63)
p value
Presence of stoma
Without stoma 1 (2%) 17 (27%) <0.0001
With stoma 65 (98%) 46 (73%) ..
Stoma reversal* 44 (68%) 38 (83%) 0.085
Ileostomy reversal 0 34 (89%) ..
Colostomy reversal (open) 24 (55%) 3 (8%) ..
Colostomy reversal (laparoscopic) 20 (45%) 1 (3%) ..
Data are n (%).
*One Hinchey III patient in the Hartmann’s procedure group had an anastomotic leakage after Hartmann’s reversal for 
which an end colostomy was constructed, which was not reversed before the end of the 12-month follow-up period. One 
Hinchey IV patient in the Hartmann’s procedure group underwent open end colostomy reversal, during which it was 
decided to construct a protective loop ileostomy, which was reversed outside the 12-month follow-up period.
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Figure 2 Kaplan-Meier graph of 12-month stoma-free survival
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Supplemental Figure 1 Trial design
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Supplemental Figure 2 Stoma-free survival (Hinchey III)
Supplemental Figure 3 Stoma-free survival (Hinchey IV)
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Supplemental Figure 4 Risk of Bias assessment
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Supplemental Table 1 Hinchey classification
Hinchey classification
I Pericolic abscess or phlegmon
II Pelvic, intra-abdominal, or retroperitoneal abscess
III Generalised purulent peritonitis
IV Generalised faecal peritonitis
Supplemental Table 2 Reasons for cross-over
Hartmann’s Procedure to Primary Anastomosis
Hinchey III
- Obese patient, ostomy not desirable (n = 1)
Hinchey IV
- None
Primary Anastomosis to Hartmann’s Procedure
Hinchey III
- Serosal layer rectum damaged (n = 2)
- Doubts on tissue quality (n = 3)
Hinchey IV
- Doubts on tissue quality (n = 1)
- Fear of blow-out (n = 1)
Primary Anastomosis to Laparoscopic Lavage
Hinchey III
- Recent knee replacement – not possible to be positioned in stirrups (n = 1)
Hinchey IV
- None
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Supplemental Table 3 Inclusion numbers per centre
Hartmann’s Procedure 
(n=66)
Primary Anastomosis 
(n=64)
Total 
(n=130)
Tergooi Hospital 5 (7·6) 8 (12·5) 13 (10)
Orbis Medical Centre* 5 (7·6) 7 (10·9) 12 (9·2)
University Medical Centre Amsterdam, AMC 6 (9·1) 5 (7·8) 11 (8·5)
Amphia Hospital 4 (6·1) 6 (9·4) 10 (7·7)
Atrium Medical Centre* 6 (9·1) 3 (4·7) 9 (6·9)
Catharina Hospital 3 (4·5) 6 (9·4) 9 (6·9)
Westfries Hospital** 5 (7·6) 3 (4·7) 8 (6·2)
Maggiore Hospital (Bologna, Italy) 4 (6·1) 3 (4·7) 7 (5·4)
OLVG 4 (6·1) 3 (4·7) 7 (5·4)
Kennemer Hospital† 3 (4·5) 3 (4·7) 6 (4·6)
Spaarne Hospital† 2 (3·0) 2 (3·1) 4 (3·1)
University Hospitals Leuven 1 (1·5) 3 (4·7) 4 (3·1)
Isala Hospital 2 (3·0) 1 (1·6) 3 (2·3)
Gelderse Vallei Hospital 2 (3·0) 1 (1·6) 3 (2·3)
Lucas Andreas Hospital§ 1 (1·5) 2 (3·1) 3 (2·3)
Meander Medical Centre 1 (1·5) 2 (3·1) 3 (2·3)
University Medical Centre Utrecht 2 (3·0) 1 (1·6) 3 (2·3)
Albert Schweitzer Hospital 1 (1·5) 1 (1·6) 2 (1·5)
Haga Hospital 1 (1·5) 1 (1·6) 2 (1·5)
Maggiore Hospital (Parma, Italy) 0 2 (3·1) 2 (1·5)
VieCuri Medical Centre 2 (3·0) 0 2 (1·5)
Elisabeth-TweeSteden Hospital 1 (1·5) 0 1 (0·8)
Erasmus University Medical Centre 1 (1·5) 0 1 (0·8)
Flevo Hospital 0 1 (1·6) 1 (0·8)
Maastricht University Medical Centre 1 (1·5) 0 1 (0·8)
Reinier de Graaf Hospital 1 (1·5) 0 1 (0·8)
Rode Kruis Hospital 1 (1·5) 0 1 (0·8)
St. Antonius Hospital 1 (1·5) 0 1 (0·8)
Data are n (%). 
*Now part of Zuyderland Medical Centre. 
**Now known as Dijklander Hospital. 
†Now part of Spaarne Gasthuis. 
§Now part of OLVG. 
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Supplemental Table 4 Baseline patient and perioperative characteristics for both Hinchey grades
Hinchey III (n=92) Hinchey IV (n=38) p value
Age (years) 61·8 (12·2) 62·8 (12·3) 0·663
Sex (male/female) 62/30 (67·4/32·6) 20/18 (52·6/47·4) 0·161
BMI (kg/m²) 27·1 (4·8) 27·3 (5·1) 0·820
ASA I-II
ASA III-IV
59 (70·2)
25 (29·8)
23 (67·6)
11 (32·4)
0·827
Previous diverticulitis 19 (20·7) 5 (13·2) 0·456
Previous laparotomy* 3 (3·3) 1 (2·6) 1·000
CT diagnosis 88 (95·7) 33 (86·8) 0·122
Preoperative disease severity
APACHE II 7·5 (5-11) 8 (5·8-11·3) 0·491
POSSUM PS 19 (17·3-23) 20 (17-25) 0·548
POSSUM OS 19 (19-20) 19 (19-20) 0·666
P-POSSUM predicted mortality (%) 6·1 (4·1-11·3) 7 (4·2-16·1) 0·585
POSSUM predicted morbidity (%) 71·4 (61·1-82·4) 74·3 (63·4-87·6) 0·510
Mannheim Peritonitis Index 21 (17-22) 27·5 (23-32) <0·001
Interval from presentation to surgery (hours) 9·4 (5·7-27) 7·2 (4·7-33·3) 0·440
C-reactive protein (mg/L)
  <10
  11-100
  101-200
  201-300
  301-400
  401-500
  >500
 Missing
5 (5·4)
20 (21·7)
20 (21·7)
23 (25)
13 (14·1)
7 (7·6)
3 (3·3)
1 (1·1)
5 (13·2)
8 (21·1)
9 (23·7)
6 (15·8)
4 (10·5)
3 (7·9)
2 (5·3)
1 (2·6)
0·700
White blood cell count (x109/L) 14·3 (9·6-18) 15·4 (9·7-20·1) 0·725
Operative characteristics
GI surgeon present 81 (88·0) 34 (89·5) 1·000
Laparoscopic procedure 30 (32·6) 7 (18·4) 0·135
Operating time (minutes) 120 (100-142) 126 (107-164) 0·346
Drain placement** 56 (61·5) 24 (64·9) 0·841
Blood loss (mL)
  <100
  101-500
  501-999
  >1000
  Missing
45 (48·9)
29 (31·5)
5 (5·4)
1 (1·1)
12 (13)
16 (42·1)
15 (39·5)
2 (5·3)
0
5 (13·2)
0·800
Postoperative care
Surgical ward
PACU or MCU
ICU
63 (68·5)
5 (5·4)
24 (26·1)
21 (55·3)
1 (2·6)
16 (42·1)
0·192
* One patient missing (Hinchey III)
** One patient missing in Hinchey III group and one patient in Hinchey IV group
Data are n (%), mean (SD), or median (IQR). ASA=American Society of Anesthesiologists score; APACHE II= 
Acute Physiology and Chronic Health Evaluation II; POSSUM PS/OS= Physiological and Operative Severity Score 
for the enUmeration of Mortality and morbidity; PACU=Post Anesthesia Care Unit; MCU=Medium Care Unit; 
ICU=Intensive Care unit.
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Supplemental Table 7 90-day Clavien-Dindo scores following the index procedure
Hartmann’s Procedure (n=66) Primary Anastomosis (n=63) p value
Clavien-Dindo
  No complications
  Grade I
  Grade II
  Grade IIIa
  Grade IIIb
  Grade IVa
  Grade IVb
  Grade V
25 (37·9)
7 (10·6)
19 (28·8)
3 (4·5)
7 (10·6)
1 (1·5)
2 (3)
2 (3)
26 (41·3)
13 (20·6)
11 (17·5)
4 (6·3)
5 (7·9)
 1 (1·6)
1 (1·6)
2 (3·2)
0·677
≥ Grade IIIb 12 (18·2) 9 (14·3) 0·636
Data are n (%).
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Supplemental Table 9 Characteristics and outcomes of patients allocated to primary anastomosis: primary 
anastomosis with ileostomy versus without ileostomy
No ileostomy (n=17) Ileostomy (n=40) p value
Age (years) 60·3 (3·2) 63·1 (2·1) 0·464
Sex (male/female) 12/5 (70.6·4/29·4) 24/16 (60/40) 0·555
BMI (kg/m²) 27·4 (1·2) 25·6 (0·8) 0·237
ASA I-II
ASA III-IV
13 (76·5)
4 (23·5)
19 (54·2)
16 (45·7)
0·143
Previous diverticulitis 1 (5·9) 9 (22·5) 0·253
Previous laparotomy 0 1 (2·5) 1·000
CT diagnosis 17 (100) 36 (90) 0·306
Preoperative disease severity
APACHE II 7 (4-8·5) 8 (6-11) 0·261
POSSUM PS 18 (16-23·5) 20 (18-23) 0·156
POSSUM OS 20 (19-20) 19 (19-20) 0·365
P-POSSUM predicted mortality (%) 4·4 (3·4-12·3) 7 (4·4-11·3) 0·299
POSSUM predicted morbidity (%) 64·1 (58·4-83·7) 74·3 (64·1-82·4) 0·407
Mannheim Peritonitis Index 18 (17-22) 22 (17-26) 0·172
Interval from presentation to surgery (hours) 9·4 (2·6-30·3) 9·3 (6·1-30) 0·919
C-reactive protein (mg/L)
  <10 
  11-100
  101-200
  201-300
  301-400
  401-500
  >500 
 Missing
3 (17·6)
2 (11·8)
6 (35·3)
1 (5·9)
4 (23·5)
1 (5·9)
0
0
3 (7·5)
11 (27·5)
9 (22·5)
7 (17·5)
4 (10)
3 (7·5)
2 (5)
1 (2·5)
0·382
White blood cell count (x109/L) 14·1 (12·1-16·3) 14·1 (8·9-17) 0·910
Operative characteristics
GI surgeon present 15 (88·2) 36 (90) 1·000
Laparoscopic procedure 4 (23·5) 12 (30) 0·753
Operating time (minutes) 120 (105-154) 126·5 (114-150) 0·428
Drain placement 12 (70·6) 18 (46·2) 0·145
Blood loss (mL)
  <100 
  101-500 
  501-999 
  >1000 
  Missing
7 (41·2)
7 (41·2)
1 (5·9)
1 (5·9)
1 (5·9)
21 (52·5)
11 (27·5)
2 (5)
0
6 (15)
0·345
Outcomes
Major morbidity 2 (11·8) 5 (12·5) 1·000
Minor morbidity 2 (11·8) 15 (37·5) 0·064
Overall morbidity 4 (23·5) 18 (45·0) 0·150
Mortality 0 3 (7·5) 0·547
Postoperative stay (days) 7 (11-14) 11 (7-14) 0·013
Data are n (%), mean (SD), or median (IQR). ASA=American Society of Anesthesiologists score; APACHE II= Acute 
Physiology and Chronic Health Evaluation II; POSSUM PS/OS= Physiological and Operative Severity Score for the 
enUmeration of Mortality and morbidity.
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Supplemental Table 11 Reasons for not reversing stoma within twelve-month follow-up period
Hartmann’s Procedure (n=21)
Hinchey III (n=11) 
- Preference of patient to keep stoma (n=1) 
- No approval of surgeon (n=1)
- Deceased before reversal (n=4) 
- Unknown reason (n=5)
Hinchey IV (n=10) 
- Preference of patient to keep stoma (n=1) 
- Patient not seen back (n=1)
- No approval cardiologist (n=1)
- Patient agreed to surgeon’s advice to not reverse (age) (n=1)
- Deceased before reversal (n=3)
- Unknown reason (n=3)
Primary Anastomosis (n=8)
Hinchey III (n=4) 
- Preference of patient to keep stoma (n=1) 
- Deceased before reversal (n=2) 
- Unknown reason (n=1)
Hinchey IV (n=4) 
- No approval of surgeon (n=1)
- Deceased before reversal (n=2) 
- Unknown reason (n=1)
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Supplemental Table 13 Questionnaire response rates
Group Observed Died Missing
SF-36v2
2 weeks HP (n=66) 42 (63·6) 1 (1·5) 23 (34·9)
PA (n=64) 40 (62·5) 3 (4·7) 21 (32·8)
4 weeks HP (n=66) 41 (62·1) 2 (3·0) 23 (34·9)
PA (n=64) 42 (65·6) 4 (6·3) 18 (28·1)
3 months HP (n=66) 39 (59·1) 2 (3·0) 25 (37·9)
PA (n=64) 40 (62·5) 5 (7·8) 19 (29·7)
6 months HP (n=66) 31 (47·0) 7 (10·6) 28 (42·4)
PA (n=64) 38 (59·4) 5 (7·8) 21 (32·8)
12 months HP (n=66) 13 (19·7) 7 (10·6) 46 (69·7)
PA (n=64) 8 (12·5) 5 (7·8) 51 (79·7)
GIQLI
2 weeks HP (n=66) 41 (62·1) 1 (1·5) 24 (36·4)
PA (n=64) 40 (62·5) 3 (4·7) 21 (32·8)
4 weeks HP (n=66) 41 (62·1) 2 (3·0) 23 (34·9)
PA (n=64) 42 (65·6) 4 (6·3) 18 (28·1)
3 months HP (n=66) 38 (57·6) 2 (3·0) 26 (39·4)
PA (n=64) 40 (62·5) 5 (7·8) 19 (29·7)
6 months HP (n=66) 31 (47) 7 (10·6) 28 (42·4)
PA (n=64) 38 (59·4) 5 (7·8) 21 (32·8)
12 months HP (n=66) 13 (19·7) 7 (10·6) 46 (69·7)
PA (n=64) 8 (12·5) 5 (7·8) 51 (79·7)
EQ-5D-3L
2 weeks HP (n=66) 42 (63·6) 1 (1·5) 23 (34·9)
PA (n=64) 40 (62·5) 3 (4·7) 21 (32·8)
4 weeks HP (n=66) 41 (62·1) 2 (3·0) 23 (34·9)
PA (n=64) 42 (65·6) 4 (6·3) 18 (28·1)
3 months HP (n=66) 39 (59·1) 2 (3·0) 25 (37·9)
PA (n=64) 39 (59·1) 5 (7·8) 20 (31·3)
6 months HP (n=66) 31 (47·0) 7 (10·6) 28 (42·4)
PA (n=64) 36 (56·3) 5 (7·8) 23 (35·9)
12 months HP (n=66) 13 (19·7) 7 (10·6) 46 (69·7)
PA (n=64) 8 (12·5) 5 (7·8) 51 (79·7)
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Abstract 
Introduction
Several studies have been published favouring sigmoidectomy with primary anastomosis 
(PA) over the Hartmann’s procedure (HP) for perforated diverticulitis with purulent 
or faecal peritonitis (Hinchey grade III or IV), but cost-related outcomes were scarcely 
reported. Therefore, the present study aimed to evaluate costs and cost-effectiveness 
within the DIVA arm of the Ladies trial.
Methods
A cost-effectiveness analysis of the DIVA arm of the multicentre, randomised Ladies 
trial, comparing PA and HP for Hinchey grade III or IV diverticulitis, was conducted. 
During 12-month follow-up, resource use, indirect costs (SF-HLQ), and quality of life 
(EQ-5D) were prospectively collected and analysed according to the modified intention-
to-treat principle. Main outcomes were incremental cost-effectiveness (ICER) and cost-
utility ratios (ICUR), expressed as the ratio of incremental costs and the incremental 
probability of being stoma-free or incremental quality-adjusted life-years, respectively.
Results
Overall, 130 patients were included, of which 64 were allocated to PA (Hinchey III/
IV: 46/20) and 66 to HP (Hinchey III/IV: 46/18). Overall mean costs per patient were 
lower for PA (€20 544 (95%CI 19 569 to 21 519) compared to HP (€28 670 (95%CI 
26 636 to 30 704)), with a mean difference of €-8 126 (95%CI -14 660 to -1 592). 
Moreover, an ICER of €-39 094 (95%BCaCI -1 213 to -116) was found, indicating PA 
to be more cost-effective. The ICUR was €-101 435 (95%BCaCI: -1 113 264 to 251 
840).
Conclusion
Primary anastomosis is more cost-effective than a Hartmann’s procedure for perforated 
diverticulitis with purulent or faecal peritonitis.
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Introduction
Acute diverticulitis is a common diagnosis in developed countries that is associated 
with considerable healthcare costs (1-5). The incidence of perforated diverticulitis with 
purulent or faecal peritonitis (Hinchey grade III or IV) is increasing, thereby emphasizing 
the need for cost-effective emergency surgical management (6, 7). 
In recent years, results have been published favouring sigmoidectomy with primary 
anastomosis (PA) over Hartmann’s procedure (HP) for the treatment of Hinchey III 
and IV diverticulitis (8). Benefits of PA comprise lower short‐term morbidity rates after 
index and reversal procedures, as well as a higher rate of stoma‐free survival, shorter time 
to stoma reversal and shorter postreversal hospital stay (8-11). Although these outcomes 
might reduce associated costs, studies comparing the two treatment strategies in terms 
of related costs and cost‐effectiveness are scarce. Therefore, a cost‐effectiveness analysis 
was undertaken comparing PA (with or without defunctioning ileostomy) with HP in 
patients treated in the DIVA arm of the Ladies trial (11, 12).
Methods
This cost‐effectiveness analysis was conducted within the DIVA arm of the Ladies 
trial. The study protocol, including details of cost analyses and clinical outcomes, has 
been reported previously (11, 12). In summary, the Ladies trial was an international, 
multicentre, parallel‐group, randomized, open‐label superiority trial of the surgical 
management of perforated diverticulitis. The aim of the DIVA arm was to compare HP 
and PA (with or without defunctioning ileostomy) as treatment for Hinchey III or IV 
diverticulitis. After diagnostic laparoscopy, patients were assigned randomly to HP or PA 
in a 1 : 1 ratio. Patients with dementia, a history of sigmoidectomy or pelvic radiotherapy, 
chronic steroid treatment (at least 20 mg daily) or preoperative shock requiring inotropic 
support were excluded. The primary endpoint of the DIVA arm was 12‐month stoma‐
free survival and secondary outcomes (such as morbidity and readmissions) were also 
recorded. The study was registered at trialregister.nl (NTR2037) and ClinicalTrials.
gov (NCT01317485), and designed in accordance with the Declaration of Helsinki 
and good clinical practice guidelines. The study protocol was approved by the ethical 
review board, and written informed consent was obtained from all patients before 
randomization. The CHEERS guideline and checklist (13) were used as guidance for 
the present cost‐effectiveness analysis.
Economic evaluation
The present analysis aimed to assess the cost‐effectiveness and cost–utility of HP 
compared with PA during the first 12 months after the index procedure, and included 
both direct and indirect costs (medical and non‐medical). The economic evaluation was 
performed from a societal perspective, and in accordance with the guidelines for health 
economic analyses published by the Dutch National Health Care Institute (14).
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Resource use
Data on resource use were collected prospectively through clinical record forms and 
study questionnaires completed 1, 3, 6, 9 and 12 months after the index procedure. 
Direct medical costs were those related to index and stoma reversal surgery and related 
admissions (such as ward and ICU stay), reinterventions (acute relaparotomy or 
percutaneous drainage), additional diagnostic imaging (X‐ray, ultrasound imaging, CT), 
readmissions, stoma care, emergency department visits, and outpatient consultation 
visits with the surgeon, gastroenterologist, general practitioner or company physician. 
Costs of the index procedure actually performed were used and did not include the 
cost of the study protocol‐based diagnostic laparoscopy. Costs associated with home 
and informal care and travel expenses were considered as direct non‐medical costs. 
Indirect non‐medical costs resulting from work absence or decreased productivity were 
determined by use of the Short Form Health and Labour Questionnaire (SF‐HLQ)(15). 
To estimate loss of productivity, the friction costs method was used with age‐adjusted 
mean daily wages derived from the Dutch National Health Care Institute guideline 
(14). Total costs per patient were calculated by multiplying resources used by associated 
unit costs.
Quality-adjusted life-years
Health‐related quality of life (QoL) and quality‐adjusted life‐years (QALYs) were derived 
from the EuroQol Five Dimensions three‐level questionnaire (EQ‐5D‐3 L™; EuroQol 
Group, Rotterdam, the Netherlands) at 2 and 4 weeks, 3, 6 and 12 months after the 
index procedure. Outcomes were scored from 0 to 1 according to the Dutch EQ‐5D™ 
tariff, where 1 is considered to represent optimal QoL.
Unit costs
Unit costs were calculated according to the methods described by Vennix and colleagues 
(16), and were estimated based on top‐down cost calculations from the hospital costs 
ledger of the Amsterdam University Medical Centre and Dutch guideline on unit costing 
in healthcare (17). Moreover, bottom‐up cost calculations for laparoscopic and open 
sigmoidectomy with and without PA were performed, including costs of instruments 
(reusable and disposable), and costs of personnel and overheads per time unit. As the 
index procedures and Hartmann’s reversal procedures could be open or laparoscopic, 
mean costs were calculated taking the ratio of these different possible procedures into 
account. Costs were calculated in euros, adjusted to 2018 by the Dutch consumer price 
index.
Statistical analysis
Depending on data distribution, continuous variables are presented as median (i.q.r.) or 
mean (s.d.). Categorical variables are shown as numbers with percentages. Patients were 
analysed according to the modified intention‐to‐treat principle, with costs calculated 
based on the index procedure actually performed. The intention‐to‐treat approach was 
deemed modified owing to the exclusion of three patients shortly after randomization 
who were found to have alternative diagnoses (11). The bias‐corrected and accelerated 
(BCa) bootstrapping method (1000 samples) was used to calculate 95 per cent confidence 
intervals (18). Missing data on EQ‐5D™ values and indirect costs were imputed by means 
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of multiple imputation, taking into account age, sex, Hinchey grade, randomization 
and direct costs. Imputed data were pooled according to Rubin’s rule (19). To determine 
the robustness of the calculated costs, sensitivity analyses were performed by varying 
unit costs of resources used (direct medical costs). Incremental cost‐effectiveness (ICER) 
and cost–utility (ICUR) ratios were calculated as the mean difference between treatment 
groups in total costs per patient divided by the mean difference in probability of being 
stoma‐free and mean difference in QALYs respectively. Cost‐effectiveness planes and 
acceptability curves were derived. Analyses were performed using SPSS® version 24.0 
(IBM, Armonk, New York, USA) and R version 3.6.1 (R Foundation for Statistical 
Computing, Vienna, Austria).
Results
Between 1 July 2010 and 22 February 2013, and between 9 June 2013 and 6 June 
2016, patients could be included in the DIVA arm of the Ladies trial. Trial inclusion 
was temporarily paused, owing to the early termination of the LOLA arm of the study. 
Eventually, a total of 130 patients were included according to a modified intention‐to‐
treat principle, of whom 66 were analysed in the HP group and 64 in the PA group. 
One patient in the PA group was lost to follow‐up after 30 days (Fig. S1 , supporting 
information). All patients were included in the present cost evaluation. Baseline and 
operative characteristics are summarized in Table 1. Full trial details and outcomes 
have been published previously (11). Response rates to the SF‐HLQ questionnaires are 
documented in Table S1 (supporting information).
Costs and resource use
A summary of unit costs of major resources is provided in Table 2, with full details in 
Table S2 (supporting information). Resource use and calculated costs are shown in Table 
3. Stoma‐related costs were significantly higher in the HP group (€8372, 95 per cent c.i. 
7316 to 9429) than in the PA group (€4382, 3481 to 5284), with a mean difference of 
€–3990 (–5370 to –2611). Overall total costs were €1 892 206 for the HP group and 
€1 314 798 for the PA group. Mean costs per patient were €28 670 (26 636 to 30 704) 
and €20 544 (19 569 to 21 519) respectively. This amounted to a mean difference in 
costs of €–8126 (–14 660 to –1592) in favour of PA.
Cost-effectiveness and cost-utility
The mean probability of being stoma‐free at end of the 12‐month follow‐up was 86 
(95 per cent c.i. 74 to 93) per cent for the PA group and 65 (53 to 75) for the HP 
group, with a significant mean difference of 21 (7 to 36) per cent. Fig. 1 shows a 
cost‐effectiveness plane, indicating the relationship between incremental costs and the 
incremental probability of being stoma‐free and alive. The ICER was €–39 094 (95 per 
cent BCa c.i. –1213 to –116), indicating that PA was more cost‐effective than HP. The 
associated willingness‐to‐pay curve is shown in Fig. S2 (supporting information).
The mean value of QALYs during the 12‐month follow‐up was 0·72 (95 per cent c.i. 
0·69 to 0·76) in the PA group, compared with 0·64 (0·60 to 0·68) in the HP group. 
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The mean difference in QALYs was 0·08 (–0·03 to 0·19), which was not statistically 
significant. The ICUR was €–101 435 (95 per cent BCa c.i. –1 113 264 to 251 840). 
A cost–utility plane and willingness‐to‐pay curve are shown in Fig. 2 and Fig. S3 
(supporting information) respectively.
Sensitivity analyses
Table 4 shows the results of sensitivity analyses, in which unit costs for specified cost 
groups were increased and decreased by 20 or 50 per cent, while those for other cost 
groups were not changed. Overall, these results demonstrated that PA was associated 
with lower costs, with cost differences ranging from €–7263 to €–8932.
Discussion
Admission rates for diverticulitis have increased over the past few decades (6, 20-23) 
and the incidence of perforated disease, for which surgery is often needed, has risen 
(24-26). In a retrospective study (27), overall expenses were between 74 and 229 per 
cent higher for HP than PA. More recently (28), in‐hospital costs within an RCT were 
found to be higher for HP, but this was not statistically significant. The present study 
differed from previous analyses by capturing all costs prospectively, including indirect 
non‐medical and other resource expenses (such as those related to readmissions or 
outpatient department visits) over the full 12‐month follow‐up. It showed that PA was 
more cost‐effective in the first postoperative year and in terms of the probability of being 
stoma‐free. Advantages of PA derive from a shorter time to, and less morbidity after, 
stoma reversal, and a shorter hospital stay, which are likely to reduce costs (11). Indeed, 
a large difference in absolute stoma‐related costs was identified in favour of PA. This is in 
line with a cost‐effectiveness analysis of the LOLA arm of the Ladies trial (16), in which 
stoma‐related costs were higher for resection than laparoscopic lavage for Hinchey 
III diverticulitis, and the economic analysis of the related DILALA (DIverticulitis – 
LAparoscopic LAvage versus resection (Hartmann’s procedure) for acute diverticulitis 
with peritonitis) study (29).
In terms of generalizability, some aspects are of importance to consider when interpreting 
the present outcomes. The majority of patients included in the Ladies trial were Dutch (11), 
and unit costs and subsequent calculations are based on that healthcare system. The 
results should be interpreted within the context of the inclusion and exclusion criteria that 
applied to the DIVA arm. Therefore, strictly speaking, the present outcomes apply only 
to haemodynamically stable, immunocompetent patients aged less than 85 years (11). 
Enrolment was terminated early because of slow accrual. Although not uncommon 
for RCTs in the emergency setting (30), early termination may limit the sample size 
and statistical power. The study was not specifically powered to show differences in 
cost‐associated or patient‐reported outcomes. Hence, it was decided not to differentiate 
between Hinchey III and IV diverticulitis in the present study, as this would have further 
reduced group sizes. In spite of the sample size, significant differences in overall mean 
costs per patient were identified, and their robustness was demonstrated in sensitivity 
analyses. Another limitation was the response rate to the questionnaires sent out during 
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follow‐up, which ranged from 47 to 64 per cent. Multiple imputation techniques were 
used to handle missing data and to decrease the influence of potential attrition bias.
This study has several strengths, including the setting of a multicentre randomized trial 
with cost data collected prospectively from a societal perspective, and indirect non‐
medical costs (such as absence from work and productivity losses) taken into account. 
These factors are relevant to consider as the disease is increasingly being seen in younger 
patients of working age (20, 21, 23). The assessment of unit costs came from the hospital 
ledger and Dutch costing manual (14), rather than being derived from diagnosis‐related 
group data, to better reflect clinical practice at a more individual level.
In general, the treatment of diverticulitis has shifted towards less aggressive approaches, 
which might also have beneficial effects on associated costs (31). The avoidance of 
antibiotics for uncomplicated diverticulitis has been proven to be safe in both the 
short and long term (32-35). The role of percutaneous drainage for diverticulitis with 
abscess formation has been debated (36, 37). Subsequently, follow‐up without elective 
colectomy after non‐operative treatment of an initial episode of diverticulitis with 
abscess formation or local extraluminal air seems justified (38, 39). Moreover, evidence 
shows that HP for perforated diverticulitis should be avoided if possible and that PA is 
preferred (9-11). The present cost‐effectiveness analysis has provided a health economic 
argument for use of PA over HP for perforated diverticulitis.
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Tables
Table 1 Summary of baseline and operative characteristics
Hartmann’s procedure (n=66) Primary anastomosis (n=64)
Patient characteristics
Age (years) 61.7 (11.4) 62.4 (13.1)
Sex (F/M) 25/41 (38/62) 23/41 (36/64)
BMI (kg/m2) 28 (4.7) 26.3 (4.8)
ASA score*
I-II
III-IV
37 (63)
22 (37)
45 (76)
14 (24)
Hinchey grade IV 20 (30) 18 (28)
Operative characteristics
Laparoscopic lavage 0 1 (1.6)
Hartmann’s procedure 65 (98) 7 (10.9)
Primary anastomosis 1 (2) 56 (87.5)
Without stoma 1 (2) 18 (28.1)
With stoma 65 (98) 46 (71.9)
Duration of surgery (minutes) 118 (95.5-135.3) 125 (110.0-154.0)
Laparoscopic procedure 20 (30) 17 (27)
Data are n (%), mean (SD), median (IQR). ASA = American Society of Anesthesiologists score, BMI = body mass 
index. *Missing in seven patients in the Hartmann’s procedure group and five patients in the primary anastomosis 
group.
Table 2 Major resources and unit costs
Costs (€) Unit
Hartmann’s procedure 3 247 Procedure
Primary anastomosis 3 914 Procedure
Laparoscopic lavage 2 346 Procedure
Ileostomy reversal 2 655 Procedure
Colostomy reversal 4 087 Procedure
Acute relaparotomy 3 476 Procedure
Percutaneous drainage 174 Procedure
Elective sigmoid resection 4 266 Procedure
Incisional hernia repair 1 305 Procedure
Surgical ward stay 419 Day
Intensive care unit stay 2 084 Day
Values are mean costs in €, as indexed for 2018.
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Table 3 Resource use and costs
Hartmann’s procedure (n=66) Primary anastomosis (n=64)
Unit Total units Total costs (€) Total units Total costs (€)
Index admission
Hartmann’s procedure Procedure 65 211 083 7 22 732
Primary anastomosis Procedure 1 3 914 56 219 181
Laparoscopic lavage Procedure 0 0 1 2 346
Surgical ward Day 733 307 076 591 247 588
Intensive care unit Day 197 410 611 87 181 336
Additional imaging Test 264 31 039 159 21 448
Subtotal 963 723 694 630
Mean subtotal per patient (95% CI) 14 602 (8 514 to 20 689) 10 854 (9 126 to 12 581)
Mean difference in subtotal (95% CI) -3 748 (-10 101 to 2 604)
Readmissions and reinterventions
Acute reinterventions Procedure 18 31 064 12 28 154
Elective reinterventions Procedure 4 5 218 1 1 305
Readmission surgical ward Day 172 72 056 142 59 488
Readmission intensive care unit Day 0 0 0 0
Subtotal 108 339 88 946
Mean subtotal per patient (95% CI) 1 641 (626 to 2 657) 1 390 (677 to 2 102)
Mean difference in subtotal (95% CI) -252 (-1 488 to 984)
Stoma-related costs
Stoma care Day 13 118 245 965 8288 104 737
Reversal surgery Procedure 45 183 915 38 106 612
Reversal admission (surgical 
ward + intensive care unit)
Day 277 122 705 165 69 123
Subtotal 552 584 280 473
Mean subtotal per patient (95% CI) 8 372 (7 316 to 9 429) 4 382 (3 481 to 5 284)
Mean difference in subtotal (95% CI) -3 990 (-5 370 to -2 611)
Other costs
Imaging Test 64 9 282 38 4 811
Consultations and travel 
expenses
Visit 349 30 038 295 26 423
Total direct medical costs 1 663 966 1 095 283
Indirect non-medical costs 228 240 219 515
Total costs (12 months) 1 892 206 1 314 798
Mean costs per patient (95% CI) 28 670
(26 636 to 30 704)
20 544
(19 569 to 21 519)
Mean difference in costs (95% CI) -8 126 (-14 660 to -1 592)
Values in parentheses are 95% confidence intervals. Smaller cost groups (e.g. hospital and general practitioner visits) 
are not shown, but are included in (sub)total costs.
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Table 4 Sensitivity analyses of medical costs
Hartmann’s procedure (€) Primary anastomosis (€) Cost difference (€)
Total medical costs 
(base analysis)
25 212 
(21 251 to 34 132)
17 114
(15 297 to 19 636)
-8 098 
(-17 016 to -3 550)
Index surgery
-50% 23 583 
(19 603 to 32 482)
15,206 
(13 398 to 17 789)
-8 377 
(-17 214 to -3 818)
+50% 26 840
(22 847 to 37 381)
19 022 
(16 978 to 21 455)
-7 818 
(-18 129 to -3 269)
Hospital stay (ward, intensive care unit)
-20% 23 036  
(19 258 to 30 896)
15 773 
(14 139 to 17 939)
-7 263 
(-14 878 to -2 910)
+20% 27 386
(22 398 to 39 156)
18 454
(16 284 to 21 358)
-8 932
(-19 534 to -3 261)
Stoma-associated costs
-20% 23 537 
(19 566 to 33 672)
16 237 
(14 598 to 18 812)
-7 300
(-16 843 to -2 507)
+20% 26 886 
(22 880 to 35 540)
17 990 
(16 064 to 20 586)
-8 896
(-17 734 to -4 320)
Acute or elective reintervention
-20% 25 102 
(21 174 to 35 659)
17 022
(15 370 to 19 443)
-8 079 
(-18 375 to -3 742)
+20% 25 321 
(21 399 to 36 105)
17 206 
(15 499 to 19 746)
-8 116
(-18 526 to -3 742)
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Figures
Figure 1 Cost-effectiveness plane
Black dot indicates the point estimate upon which the 1000 bootstrap samples are based.
Figure 2 Cost-utility plane
Black dot indicates the point estimate upon which the 1000 bootstrap samples are based. QALY, quality-adjusted life-
year.
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Supporting information
Table S1 Health and labour questionnaire response rates
Time point Group Observed Died Missing
1 month HP (n=66)
PA (n=64)
41 (62.1)
41 (64.1)
2 (3.0)
4 (6.3)
23 (34.8)
19 (29.7)
3 months HP (n=66)
PA (n=64)
39 (59.1)
40 (62.5)
2 (3.0)
5 (7.8)
25 (37.9)
19 (29.7)
6 months HP (n=66)
PA (n=64)
31 (47)
38 (59.4)
7 (10.6)
5 (7.8)
28 (42.4)
21 (32.8)
9 months HP (n=66)
PA (n=64)
31 (47)
36 (56.3)
7 (10.6)
5 (7.8)
28 (42.4)
23 (35.9)
12 months HP (n=66)
PA (n=64)
34 (51.5)
35 (54.7)
7 (10.6)
5 (7.8)
25 (37.9)
24 (37.5)
Data are presented as n (%).
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Table S2 Unit costs
Unit Costs (€) Valuation method/source Unit source
Index procedure
Hartmann’s procedure Procedure 3 247 Hospital ledger*/bottom-up CRF
Primary anastomosis Procedure 3 914 Hospital ledger/bottom-up CRF
Laparoscopic lavage Procedure 2 346 Hospital ledger/bottom-up CRF
Admission
Surgical ward Day 419 Dutch costing manual CRF
Intensive care Day 2 084 Dutch costing manual CRF
Stoma reversal
Ileostomy reversal Procedure 2 655 Hospital ledger/top-down CRF
Colostomy reversal Procedure 4 087 Hospital ledger/top-down CRF
Acute reintervention
Percutaneous drainage Procedure 174 Hospital ledger/top-down CRF
Relaparotomy Procedure 3 476 Hospital ledger/top-down CRF
Elective reintervention
Sigmoid resection Procedure 4 266 Hospital ledger/top-down CRF
Incisional hernia repair Procedure 1 305 Hospital ledger/top-down CRF
Stoma revision Procedure 1 690 Hospital ledger/top-down CRF
Diagnostic procedures
Chest/abdominal X-ray Procedure 71 Hospital ledger/top-down CRF
CT abdomen Procedure 203 Hospital ledger/top-down CRF
Ultrasonography abdomen Procedure 153 Hospital ledger/top-down CRF
Consultations
Emergency care Visit 268 Dutch costing manual Patient-reported
General practitioner Visit 34 Dutch costing manual Patient-reported
Company physician Visit 34 Dutch costing manual Patient-reported
Medical specialist Visit 76 Dutch costing manual Patient-reported
Stoma care
Ileostomy materials Day 16 Supplier/health insurance CRF
Colostomy materials Day 19 Supplier/health insurance CRF
Stoma nurse visits Year 66 Dutch costing manual CRF
Home care
Nursing Hour 52 Dutch costing manual Patient-reported
Informal care Hour 14 Dutch costing manual Patient-reported
Travel expenses
General practitioner visit Visit 4 Dutch costing manual Patient-reported
Hospital visit Visit 6 Dutch costing manual Patient-reported
Indirect non-medical costs Hour 36 Dutch costing manual Patient-reported
Values are mean costs in €, as indexed for 2018.  CRF, case record form; GP, general practitioner. *Hospital ledger: 
hospital ledger of 2012 from the University Medical Center Amsterdam (AMC), Amsterdam, The Netherlands.
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Fig. S2 Willingness-to-pay in relation to probability of cost-effectiveness
Figure S2 Willingness-to-pay in relation to probability of cost-eff ectiveness
Fig. S3 Willingness-to-pay in relation to probability of cost-utility
Figure S3 Willingness-to-pay in relation to probability of cost-utility
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Abstract
Background 
The optimal surgical approach for perforated diverticulitis with purulent or fecal 
peritonitis (Hinchey grade III or IV) remains debated. In recent years, accumulating 
evidence comparing sigmoid resection with primary anastomosis (PA) with the 
Hartmann’s procedure (HP) was presented. Therefore, the aim was to provide an 
updated and extensive synthesis of the available evidence.
Methods 
A systematic search in Embase, MEDLINE, Cochrane, and Web of Science databases 
was performed. Studies comparing PA to HP for adult patients with Hinchey III or 
IV diverticulitis were included. Data on mortality, morbidity, stoma reversal, patient-
reported and cost-related outcomes were extracted. Random-effects models were used to 
pool data and estimate odds ratios (OR).
Results 
From a total of 1560 articles, four randomized controlled trials and ten observational 
studies were identified, reporting on 1066 Hinchey III/IV patients. Based on trial 
outcomes, PA was found to be favorable over HP in terms of stoma reversal rates (OR 
2.62, 95%CI 1.29, 5.31) and reversal-related morbidity (OR 0.33, 95%CI 0.16, 0.69). 
No differences in mortality (OR 0.83, 95%CI 0.32, 2.19), morbidity (OR 0.99, 95%CI 
0.65, 1.51) and reintervention rates (OR 0.90, 95%CI 0.39, 2.11) after the index 
procedure were demonstrated. Data on patient-reported and cost-related outcomes were 
scarce, as well as outcomes in PA patients with or without ileostomy construction and 
Hinchey IV patients.
Conclusions 
Although between-study heterogeneity needs to be taken into account, the present results 
indicate that primary anastomosis seems to be the preferred option over Hartmann’s 
procedure in selected patients with Hinchey III or IV diverticulitis.
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Introduction
Up to 35% of patients with acute diverticulitis present with complicated disease, such 
as perforation with purulent or fecal peritonitis (Hinchey III or IV)(1-4). Treatment of 
perforated diverticulitis with peritonitis generally requires emergency surgical treatment 
(5). However, the optimal surgical treatment strategy remains a topic of debate.
Although the Hartmann’s procedure (HP) has been the favored approach for most 
surgeons, outcomes of sigmoidectomy with primary anastomosis (PA) have been reported 
to be comparable to those of HP (6, 7). Previous studies have found PA to be associated 
with higher stoma reversal rates and another important potential benefit of PA is the 
option to avoid a defunctioning ileostomy in selected cases (8-11). Moreover, restoration 
of intestinal continuity after HP is reported to be associated with higher morbidity and 
mortality rates (12, 13). Hence, PA has the potential benefit to decrease patient burden, 
lower associated healthcare costs, and improve patient-reported outcomes (14).
Particularly in the light of increased incidence and admission rates of perforated 
diverticulitis, a critical appraisal of treatment strategies and their outcomes is an 
important step towards consensus on its optimal surgical approach (15). Therefore, the 
aim of this systematic review and meta-analysis was to assess outcomes of HP and PA 
(with or without ileostomy) for perforated diverticulitis with purulent or fecal peritonitis.
Materials and methods
The study was conducted following the MOOSE and PRISMA guidelines (16, 17) 
and was registered in PROSPERO (CRD42019135333). Approval of the institutional 
review board and written consent were not required.
Study design 
Case reports, review articles, meta-analyses, letters, abstracts or comments were 
excluded. Randomized controlled trials (RCTs) and prospective or retrospective cohort 
studies were included if they met the following criteria: reporting on (1) patients ≥18 
years of age with acute left-sided perforated diverticulitis with peritonitis (Hinchey III 
or IV) and (2) a comparison of HP and PA (with or without defunctioning ileostomy). 
Exclusion criteria were: (1) studies reporting on Hinchey I or II diverticulitis, chronic 
diverticular complications (e.g. fistulae or obstruction), non-diverticular colorectal 
disease, or elective surgery, in which outcomes could not be assessed separately from 
Hinchey III and IV diverticulitis, (2) non-comparative studies, and (3) non-English 
studies.
Systematic literature search
A biomedical information specialist performed a systematic search in collaboration with 
one of the authors (DL). The Embase, MEDLINE, Cochrane, and Web of Science 
databases were searched on June 17, 2019. Publication date was not limited and the 
initial search was not restricted by language. Search syntaxes and results per database 
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are given in the Appendix. An additional search through reference lists was performed. 
Two researchers (DL and PE) independently reviewed the identified articles by title 
and abstract and, subsequently, by full-text using EndNote X9®. Differences in article 
selection were discussed and articles were in- or excluded after consensus was reached 
between reviewers.
Data collection
Two researchers (DL and PE) extracted data, which were checked by a third independent 
researcher (RB). Discrepancies were discussed until consensus was reached. In case of 
uncertainties with regard to reported outcomes, corresponding authors were contacted 
when possible. The following study details were collected: author, year, country/
countries, design, and length of follow-up, and -if applicable- sample size, inclusion 
period, number of screened and included patients, eligibility criteria, cross-overs, 
moment of randomization, primary endpoint, and trial accrual. Extracted baseline 
patient and operative characteristics were: sex, age, body mass index (BMI), American 
Society of Anesthesiologists (ASA) score, preoperative disease severity, Hinchey grade, 
previous diverticulitis and abdominal surgery, surgical expertise, time and duration 
of surgery, blood loss, approach (open/laparoscopic), anastomotic configuration and 
construction, drain placement and intraoperative lavage. Moreover, the following 
outcomes were collected: mortality, morbidity, hospital stay, intensive care unit (ICU) 
stay, (ongoing) sepsis, anastomotic leakage, intra-abdominal abscess occurrence 
and drainage, malignancies, surgical site infections (SSI), organ dysfunction, fascial 
dehiscence, stoma reversal rates, and hernia rates. Additionally, data on patient-reported 
outcomes and associated costs were extracted.
Risk of  bias and quality assessment
Study quality was assessed independently by two researchers (DL and PE) using the 
level of evidence (18), Newcastle-Ottawa Scale (NOS), and Methodological Index 
for Non-Randomized Studies (MINORS) criteria (19, 20). For RCTs, the Cochrane 
Collaboration’s risk-of-bias tool was used(21). Discrepancies in quality assessment 
outcomes were resolved by discussion.
Data synthesis and statistical analysis
To calculate pooled odds ratios (OR) with 95%CI, the Mantel-Haenszel random-effects 
model was used, which takes between-study and within-study variance into account. 
For continuous variables, inverse variance weighted random-effects models were used to 
calculate mean differences (MD) with 95%CI. Statistical heterogeneity was evaluated by 
calculating Q statistics and I2. In addition, risk differences (RD), risk ratios (RR), and 
numbers needed to treat (NNT) were calculated for outcomes that were significantly 
different between treatment groups. Analyses were performed using RevMan 5.3 
(Cochrane Centre, Copenhagen, Denmark).
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Results
Systematic literature search
Details of the study selection are provided in a PRISMA flow diagram (Fig. 1). After 
duplicate removal, 1560 of 2578 articles were further assessed. Eventually, 14 articles 
were included after title and abstract screening and full-text reading.
Study, patient and operative characteristics
Study characteristics are given in Table 1. Overall, four RCTs were included (22-25), as 
well as three prospective (26-28) and seven retrospective observational studies (29-35). 
Overall, data on a total of 1274 patients were available most of whom had Hinchey grade 
III/IV diverticulitis (1066/1274, 83.7%). Data were available on 731 and 536 patients 
who underwent or were allocated to HP or PA, respectively. Risk of bias assessment of 
the included RCTs is shown in Supplemental Fig. 1. For the non-randomized studies, the 
NOS and MINORS scores ranged between 6–9 and 13–18, respectively. An overview 
of patient baseline characteristics is given in Table 2. Moreover, Supplemental Tables 
1 and 2 provide details on the reported operative characteristics of index and reversal 
procedures. In Supplemental Table 3, summarized results of a quantitative analysis of 
baseline characteristics in the included observational studies are presented. As compared 
to HP, PA patients were more likely to undergo surgery for Hinchey III diverticulitis 
(OR 2.45, 95% CI 1.30, 4.63, p = 0.006) and to have a lower mean age (MD − 4.84, 
95% CI − 9.41, − 0.27, p = 0.04) and MPI score (MD − 3.58, 95% CI − 5.70, − 1.47, 
p = 0.0009).
Randomized controlled trials
Details of the four included RCTs are provided in Supplemental Table 4. Overall, 204 
HP and 180 PA patients were analyzed. Reported in- and exclusion criteria varied 
between trials, mainly in terms of exclusion criteria. The only trial to report reasons for 
not screening patients for eligibility and non-inclusion of screened patients was that by 
Oberkofler and colleagues (23). Overall, 53 patients were not assessed for participation 
due to disagreement of the surgeon (40% HP, 30% PA with diverting ileostomy, 22% 
PA without diverting ileostomy, 8% others). Moreover, the authors reported that 21 
patients were not included, because they declined to participate (n=7) or did not meet 
inclusion criteria (n=14). The Ladies trial(25) was the only study to be able to assess 
differences between the included patients and a cohort of 235 non-included but eligible 
patients, showing that in the latter group a GI surgeon was less often present (68.7% 
vs. 88.5%, p<0.001) and the median interval to surgery was longer (13.5 hours (6-
43.8) vs. 8.8 (5.3-29.3), p=0.02). However, no difference in in-hospital mortality was 
found for non-included (20/235, 8.5%) and included patients (6/130 (4.6%), p=0.21). 
Three of the four trials randomized preoperatively, whereas in the Ladies trial patients 
were randomized intraoperatively. All trials were terminated early due to recruitment 
difficulties. Oberkofler et al. (23) reported significant differences in relevant secondary 
endpoints to be an additional argument for early discontinuation, although they did not 
specify which endpoints. In total, 31.5% (384/1218) of the overall calculated sample 
sizes was reached.
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Index procedure: mortality
An overview of outcomes after the index procedure is given in Tables 3 and 4. Eleven 
of the included studies reported on mortality rates during follow-up for Hinchey III/IV 
patients. As shown in Fig. 2a, no difference was found in the occurrence of short-term 
mortality in a quantitative analysis of RCTs, with mortality occurring in 5% (9/180) 
of PA and 6.4% (13/204) of HP patients (OR 0.83 (95% CI 0.32, 2.19)). In addition, 
long-term mortality, defined as occurring within the trials’ full study period, showed no 
difference between PA and HP (9/179 (5%) vs. 17/204 (8.3%), OR 0.61, 95% CI 0.25, 
1.47) as shown in Fig. 2b. A separate quantitative analysis of data from observational 
studies (n = 7) showed a significant difference in overall mortality in favor of PA (18/146 
(12.3%)) as compared to HP (68/233 (29.2%)) with an OR of 0.39 (95% CI 0.18, 
0.85) (Fig. 2c).
Index procedure: morbidity
The overall morbidity rates in RCTs are provided in Fig. 3a, which shows no difference 
between both procedures with an OR of 0.99 (95% CI 0.65, 1.51; PA 91/180 (50.6%) 
vs. HP 101/204 (49.5%)). An additional analysis of short-term serious complications 
(Clavien-Dindo grade > IIIa) within the RCTs (Fig. 3b) also did not show a difference 
between PA and HP (30/145 (20.7%) vs. 31/148 (20.9%), OR 0.95, 95% CI 0.53, 
1.72). Additionally, morbidity could be assessed in four observational studies (Fig. 3c), 
which showed an OR of 1.01 (95% CI 0.21, 4.96; PA 28/62 (45.2%) vs. HP 85/176 
(48.3%)).
Reintervention rates after the index procedure, including surgical reinterventions 
and abscess drainage, were assessed within the RCTs (Supplemental Fig. 2a) and no 
differences were demonstrated between both procedures (PA 11/148 (7.4%) vs. HP 
13/174 (7.5%); OR 0.90, 95% CI 0.39, 2.11). A separate analysis of reoperation 
rates within these trial data also showed no differences (Supplemental Fig. 2b). From 
observational studies (n = 3), reintervention rates were 6.7% (6/90) and 16.3% (16/98) 
for PA and HP, respectively (OR 0.52, 95% CI 0.19, 1.46; see Supplemental Fig. 2c).
Nine studies provided anastomotic leakage rates after the index procedure, which showed 
the occurrence of 14 leakages in 226 PA patients (6.2%) and 3 leakages in 298 HP 
patients (1%). In the latter group, one patient had a rectal stump leakage (22), whereas 
two other patients were stated to have anastomotic leakage due to the presence of fistulas 
in the study by Regenet et al. [10]. Forest plots of surgical site infections, postoperative 
(ongoing) sepsis, and fascial dehiscence did not show significant differences between 
both treatment groups in experimental and observational studies (Supplemental Fig. 3a, 
b, c, d, e, and f ).
Stoma- and reversal-related outcomes
An overview of outcomes after the reversal procedure is given in Supplemental Tables 
6a and b. In Fig. 4a, reversal rates of constructed stomas were assessed within the 
included trials, showing a significant difference in favor of PA (118/147 (80.3%)) over 
HP (126/203 (62.1%); OR 2.62, 95% CI 1.29, 5.31), with an associated NNT of 
5 (Supplemental Table 5). From the assessment of the number of stoma-free patients 
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during trial follow-up, as provided in Fig. 4b, PA also showed favorable outcomes 
over HP (PA 150/179 (83.8%) vs. HP 127/204 (62.3%); OR 3.21, 95% CI 1.42, 
7.26; NNT 5). Reversal rates of the studies that could not be included are shown in 
Supplemental Table 6a.
Reasons for non-reversal were mentioned in the trial of Oberkofler et al.(23), including 
patient’s choice and the surgeon’s risk assessment, but related percentages were not 
presented. Bridoux and colleagues found that reasons for not undergoing stoma reversal 
in the HP group were patient’s choice (n=8/17) or if a patient was deemed unfit for 
surgery (n=9/17)(24). The latter was also the case in 2 of 16 PA patients, whereas 
the other 14 patients had no stoma constructed. In the Ladies trial, reasons were the 
surgeon’s disapproval (HP: n=3/21, PA: n=1/8), patient’s preferences (HP: n=2/21, PA; 
n=1/8), mortality before reversal (HP: 7/21, PA: n=4/8), or they were unknown (HP: 
n=8/21, PA: n=2/8)(25).
One case of reversal-related mortality was reported within the included studies, which 
was caused by mesenteric ischemia after atrial fibrillation (24). Postoperative morbidity 
related to the reversal procedure was assessed in four studies (Fig. 4c), being the four 
included trials, which showed a significant difference in favor of PA (PA 14/118 (11.9%) 
vs. HP 34/126 (27%); OR 0.33, 95% CI 0.16, 0.69; NNT 7). This difference was not 
found when serious complications were assessed in two of the four trials that reported 
these figures, as shown in Fig. 4d (PA 1/58 (1.7%) vs. HP 6/48 (12.5%); OR 0.18, 95% 
CI 0.03, 1.15).
Outcomes of  index and reversal procedure combined
An analysis of the short-term mortality of the index and reversal procedures combined 
(Supplemental Fig. 4a) did not show a significant difference, with an OR of 0.76 (PA 
9/179 (5%) vs. HP 14/204 (6.9%); 95% CI 0.29, 1.96). Additionally, short-term 
morbidity was assessed for the combined procedures (Supplemental Fig. 4b), which 
showed no difference between both treatment groups (PA 88/179 (49.2%) vs. HP 
120/204 (58.8%); OR 0.64, 95% CI 0.37, 1.13). The occurrence of anastomotic 
leakage after both the index and reversal procedure combined was assessed in the four 
RCTs, which did not show a difference between PA and HP (respectively, 6/179 (3.4%) 
vs. 6/204 (2.9%); OR 1.04, 95% CI 0.30, 3.52; see Supplemental Fig. 4c).
Outcomes in Hinchey IV patients
Four studies specifically reported on outcomes of Hinchey IV diverticulitis. Binda et 
al.(22) found the type of peritonitis (purulent or fecal) to be significantly related to 
morbidity (28/75 (37.3%) vs. 10/15 (66.7%), p=0.047) and mortality (3/75 (4%) 
vs. 4/15 (26.7%), p=0.014) in multivariate analysis. Outcomes of Hinchey III and IV 
patients were assessed separately in the Ladies trial(25), showing the 12-month stoma-
free survival after PA to be significantly better for both Hinchey grades (III: hazard 
ratio 2.35, 95%CI 1.49, 3.71; IV: hazard ratio 4.15, 95%CI 1.71, 10.1). Within the 
Hinchey IV group, no significant differences in short-term postoperative outcomes after 
the index procedure were demonstrated between HP and PA (mortality: 2/20 (10%) 
vs. 3/18 (16.7%); overall morbidity: 12/20 (60%) vs. 8/18 (44.4%), p=0.52). Also, no 
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differences in short-term post-reversal outcomes were found, with no mortality in both 
treatment groups and an overall morbidity of 30% in the HP group and 0% in the PA 
group (p=0.21). Trenti and colleagues(28) performed a logistic regression analysis with 
Hinchey grade (IV vs. III), Peritonitis Severity Score (≤9), ASA (III-IV vs. I-II), and 
treatment (HP vs. PA), but did not find Hinchey grade to be independently associated 
with post-operative mortality and morbidity, wound infection, or reoperation. Moreover, 
in the study by Vermeulen et al. (32), multivariate analyses adjusting for treatment, age, 
ASA, MPI, surgeon’s experience, and Hinchey grades showed Hinchey grade IV disease 
to be independently associated with the outcome as compared to the reference group 
of Hinchey I patients (postoperative mortality: OR 3.9, 95%CI 1.0, 13.8, p=0.03; 
reinterventions: OR 3.9, 95%CI 1.3, 12.7, p=0.02).
Outcomes of  primary anastomosis with or without ileostomy
Bridoux et al. (24) stated that no related mortality was found in the subgroup of selected 
PA patients without an ileostomy (n=15). Moreover, they reported overall morbidity 
and serious complication rates to be lower in PA patients without a stoma (respectively, 
0% vs. 27%, p=0.01, and 23% vs. 67%, p=0.042). In the Ladies trial (25), PA patients 
with (n=40) and without (n=17) an ileostomy were compared. No differences in overall 
morbidity (4/17 (23.5%) vs. 18/40 (45%), p=0.15) and mortality (0 vs. 3/40 (7.5%), 
p=0.55) were found, but patients without an ileostomy had a significantly shorter 
median postoperative stay (7 (11-14) days vs. 11 (7-14), p=0.01). In their overall 
cohort (including Hinchey I/II diverticulitis), Vermeulen and colleagues (32) found 
no difference in complication rates between PA patients with or without an ileostomy 
(respectively, 19% vs. 11%, p=0.42).
Patient-reported outcomes
Patient-reported outcomes were only identified within the Ladies trial(25). During the 
12-month follow-up period, questionnaires to measure health-related quality of life 
were sent out at weeks two and four, and months three, six, and twelve after the initial 
procedure. The questionnaires used were the EuroQol-5D-3-level, Short Form-36v2, 
and Gastrointestinal Quality of Life Index. Between treatment groups, no significant 
differences were found in summarized scores or subscales.
Cost-related outcomes
Two studies compared both procedures in terms of associated costs. Schilling et al. (30) 
compared costs (converted to U.S. dollars) associated with operative time, intensive care 
and hospital stay, and other resources (e.g. antibiotics, packed red blood cells, and fresh 
frozen plasma), demonstrating overall expenses to be 74 to 299 percent higher for HP 
with subsequent restoration of intestinal continuity as compared to PA. Oberkofler et 
al. (23) reported on in-hospital costs in U.S. dollars, but found no significant differences 
for the index and reversal procedure or both procedures combined. Mean (s.d.) costs 
associated with the combined procedures were 77.943±50.352 and 75.208±58.002 
(p=0.880) for HP and PA, respectively. A cost analysis of the DIVA arm of the Ladies 
trial is to be expected(25).
Sigmoid resection with primary anastomosis versus the Hartmann’s procedure for perforated diverticulitis
171
Ch
ap
te
r 7
Discussion
From this systematic review and meta-analysis of the available evidence on PA versus 
HP for perforated diverticulitis with purulent or fecal peritonitis, several arguments can 
be identified to support the choice of PA over HP. Firstly, no difference in mortality and 
morbidity after the index procedure were found between both procedures. Secondly, 
PA patients were more likely to have their stoma reversed and to be stoma free during 
follow-up, as compared to HP patients. In addition, the occurrence of reversal-related 
morbidity was less likely in the PA group.
Although in recent years other meta-analyses on this topic have been published, the 
present study included the recently published Ladies trial (25), which allowed for the 
analysis of a larger cohort of patients from randomized studies. Moreover, as compared 
to these previous review articles, a more extensive scope of outcomes (e.g. patient-
reported and cost-related) and results within subgroups of interest (e.g. PA patients with 
or without ileostomy and Hinchey IV patients) were assessed.
The present results are generally in line with those from previous meta-analyses. With 
regard to overall mortality from randomized and observational studies, Gachabayov et 
al.(36) and Shaban et al.(37) found PA to be favorable over HP, which was also the 
case in the present quantitative analysis of mortality within the included observational 
studies. However, in the subgroup analysis of randomized studies in the present study, 
no difference between treatment groups was demonstrated, which is comparable to the 
outcomes found by Acuna et al. (38). Furthermore, Acuna et al.(38) and Gachabayov 
et al. (36) both demonstrated PA patients to be more likely to undergo stoma reversal 
and be stoma free during follow-up, which is similar to the present results. Recently, 
two population-based analyses of patients who underwent emergency surgery for 
acute diverticulitis in the U.S. were published by Lee et al.(39) and Gawlick et al.(40). 
Although these studies were not included in this meta-analysis due to the lack of 
specification on Hinchey grades of included patients, their outcomes provide context to 
the present findings. The authors show favorable outcomes with regard to mortality after 
PA as compared to HP and did not find differences in complication rates. Interestingly, 
a third U.S. population-based study by Cauley et al.(41) concluded less favorable  on 
the role of PA. Most importantly, all three studies corrected for potential confounders 
by means of multivariable regression analyses incorporating factors such as age, BMI, 
ASA grade, and severity of sepsis. The importance of these potential confounders must 
be emphasized, as treatment outcomes might be subject to confounding by indication 
and, thereby, influence the generalizability and interpretation of the present results. 
Notably, from the quantitative synthesis of baseline characteristics within the included 
observational studies, this present study indeed found that PA patients were more likely 
to be younger and have less severe disease in terms of Hinchey grade and MPI scores.
In this review, results were only used for quantitative analyses if they could be assessed 
specifically for Hinchey III and IV diverticulitis. This strict inclusion and analysis 
approach was chosen in order to strengthen our conclusion, by avoiding the chance 
of overestimating true treatment effects through inclusion of patients with less severe 
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disease entities (e.g. Hinchey II diverticulitis). In addition, another strength of this study 
is the before mentioned broad scope of outcomes, including cost-related and patient-
reported outcomes. Diverticulitis is a costly disease and the incidence of perforated 
diverticulitis is increasing, therefore, insights into the treatment costs are of interest (15, 
42, 43). With benefits such as higher reversal rates and less reversal-related morbidity, 
PA has the potential to save both direct and indirect medical costs. However, despite its 
relevance, only two studies reported on the directly associated costs and, therefore, no 
robust conclusions could yet be drawn (23, 30). Especially, since cost-effectiveness and 
cost-utility analyses were not described. The presence of a stoma is known to negatively 
affect factors such as physical function and body image, and consequently, quality of 
life (44). In this regard, the stoma-related benefits of PA might be able to improve the 
overall quality of life. Nevertheless, patient-related outcomes could only be identified 
in the Ladies trial, which showed no differences in outcomes of general and gastro-
intestinal questionnaires (25). Novel and stronger evidence could be of importance, 
as the potential beneficial cost-related and patient-reported outcomes could likely be 
valuable additional arguments to opt for PA. Moreover, it could help with its wider 
implementation into clinical practice. Particularly, as it is suggested that HP still remains 
the most widely used procedure in past years (39).
A lack of evidence was identified with regard to the question whether or not it is safe 
to omit the construction of a defunctioning ileostomy in PA patients, and if so, under 
what circumstances. Results for PA patients without an ileostomy seemed comparable to 
those of patients with an ileostomy, albeit that groups were small and at risk for selection 
bias (25). Similarly, outcomes specifically reported for Hinchey IV patients were scarce 
and consisted of relatively small groups. It was demonstrated that PA had a significantly 
better 12-month stoma-free survival as compared to HP within Hinchey IV patients 
(25). Additionally, some authors found Hinchey IV to be independently associated 
with an increased morbidity risk, whereas others found no differences between Hinchey 
III and IV patients (22, 25, 28, 32). Nevertheless, despite the absence of results from 
larger cohorts of Hinchey IV, the majority of national and international guidelines still 
state the choice of PA with proximal diversion as a possible treatment option for these 
patients (5).
There are some limitations to the present study that are important to acknowledge. Most 
of the included studies consisted of small patient groups and were prone to selection bias 
due to their retrospective design. More importantly, there was substantial methodological 
heterogeneity between included studies, both for observational and randomized studies. 
For instance, differences in intraoperative details, follow-up duration, and definitions 
of morbidity were present. In order to reduce the effect of this heterogeneity, subgroup 
analyses of the included RCTs were performed, which for some outcomes showed 
differences with outcomes from observational studies. Nevertheless, even between these 
trials several methodological differences existed, such as the moment of randomization, 
outcome definitions, and follow-up duration. 
Interestingly, all four trials were terminated early for reasons of difficulties with patient 
accrual, which corresponds with the evidence that trials in the acute care setting are 
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notoriously difficult to conduct and more often lead to early discontinuation (45). 
However, more importantly, it should clearly be noted that these trial populations 
might still be a selected patient sample, as the decision to randomize an eligible 
patient might have been subject to surgeon’s preference. A comparison with eligible 
non-included patients could have helped objectify this potential bias and increase 
external generalizability, but was only reported in the Ladies trial. Additionally, the 
trial by Oberkofler and colleagues briefly reported on the numbers of patients that 
were not screened for eligibility or were not included after screening, but it did not 
compare patient and disease characteristics of these groups with those of the included 
patients (23). Furthermore, high-risk patients (e.g. hemodynamically unstable or 
immunocompromised) were not included or underrepresented in this systematic review. 
For example, two of the four trials specifically stated hemodynamic instability to be an 
exclusion criterion. Hence, even though the evidence identifies PA to be the preferred 
approach to HP, accurate patient selection still remains key. Indeed, in a recent evidence-
based EAES/SAGES consensus report it was stated that PA with proximal diversion 
should be considered over HP in the appropriate clinical setting, but that HP remains 
the preferred operation for hemodynamically unstable patients (46).
To overcome some of the mentioned methodological problems and to find evidence 
to fill in the identified gaps in current knowledge, future research might benefit from 
gathering data in the context of multi-center or (inter)national audit studies. Through 
multi-center collaboration and prospective (preferably long-term) data collection in a 
large sample of patients, such a study design has the ability to provide insights into 
current clinical practice and treatment trends, to analyze outcomes with adjustment 
for known confounders, as well as to assess outcomes in subgroups such as PA patients 
with or without ileostomy or Hinchey IV patients. Moreover, the role of emergency 
laparoscopic sigmoidectomy could potentially be further assessed in this context, as 
recent promising evidence found it to be superior in terms of postoperative morbidity 
and hospital stay and concluded it to be feasible in selected patients and performed by 
experienced hands (34, 47). The DAMASCUS study, a snapshot collaborative audit 
study on treatment of acute diverticulitis, is an example of such a design and its results 
are awaited with interest (48). Lastly, with regard to rates of stoma reversal, Hartmann’s 
reversals in particular, it can be hypothesized that restoration of continuity will take place 
either later or not at all in those patients that have an impaired clinical condition. This 
is already partly reflected in the reported reasons for non-reversal within the published 
trials, but is also of great value to assess within the long-term follow-up of existing or 
novel studies.
In conclusion, this updated systematic review and meta-analysis provides several 
arguments to prefer PA over HP for the treatment of perforated diverticulitis with 
purulent or fecal peritonitis. Importantly, between-study heterogeneity needs to be 
considered whilst interpreting the present results and, above all, the findings should 
be interpreted within the context of hemodynamically stable and immunocompetent 
patients. In addition, this study identified gaps in current knowledge that are of interest 
for future investigation and of which results might further aid accurate surgical decision-
making and optimal treatment within the setting of perforated diverticulitis.
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Figures
Figure 1 PRISMA flow diagram
Sigmoid resection with primary anastomosis versus the Hartmann’s procedure for perforated diverticulitis
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Figure 2 Quantitative analyses of a. short-term mortality rates in randomized controlled trials, b. long-term mortality 
rates in randomized controlled trials, and c. overall mortality rates during follow-up in observational studies.
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Figure 3 Quantitative analyses of a. overall morbidity rates in randomized controlled trials, b. short-term serious 
complications in randomized controlled trials, and c. overall morbidity rates in observational studies.
Sigmoid resection with primary anastomosis versus the Hartmann’s procedure for perforated diverticulitis
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Figure 4 Quantitative analyses of randomized controlled trials: a. reversal rates of constructed stomas, b. number of 
stoma-free patients, c. reversal-related morbidity, d. reversal-related serious complications.
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Appendix
Search syntaxes and results per database
embase.com 1211 1199
Medline Ovid 764 179
Web of science  569 176
Cochrane CENTRAL 34 6
Total 2578 1560
embase.com
(‘hartmann procedure’/de OR ‘hartmann operation’/de OR (hartman* OR ((non-restor* 
OR nonrestor*) NEAR/3 resect*)):ab,ti OR ((((‘diverticulitis’/exp OR diverticulosis/
exp) AND (‘perforation’/exp OR ‘acute disease’/de OR peritonitis/de)) OR ((diverticul* 
AND (perforat* OR complicat* OR acute OR peritonitis)) OR Hinchey*):ab,ti) AND 
(‘colostomy’/exp OR ‘colon stoma’/de OR (colostom* OR (colon* NEAR/3 stoma*) OR 
(staged NEAR/3 procedure*) OR two-stage* OR 2-stage*):ab,ti))) AND (‘anastomosis’/
de OR ‘ileostomy’/de OR (((primar* OR end-to-end OR end-to-side OR side-to-end 
OR side-to-side) NEAR/3 anastomos*) OR ileostom*):ab,ti)
Medline Ovid 
((hartman* OR ((non-restor* OR nonrestor*) ADJ3 resect*)).ab,ti. OR ((((exp 
Diverticulitis/ OR Diverticulum/ OR Diverticulosis, Colonic/) AND (exp Intestinal 
Perforation/ OR Acute Disease/ OR Peritonitis/)) OR ((diverticul* AND (perforat* 
OR complicat* OR acute OR peritonitis)) OR Hinchey*).ab,ti.) AND (colostomy/ OR 
(colostom* OR (colon* ADJ3 stoma*) OR (staged ADJ3 procedure*) OR two-stage* 
OR 2-stage*).ab,ti.))) AND (Anastomosis, Surgical/ OR Ileostomy/ OR (((primar* OR 
end-to-end OR end-to-side OR side-to-end OR side-to-side) ADJ3 anastomos*) OR 
ileostom*).ab,ti.)
Web of  science
TS=(((hartman* OR ((“non-restor*” OR nonrestor*) NEAR/2 resect*)) OR 
((((diverticul* AND (perforat* OR complicat* OR acute OR peritonitis)) OR 
Hinchey*)) AND ((colostom* OR (colon* NEAR/2 stoma*) OR (staged NEAR/2 
procedure*) OR two-stage* OR “2-stage*”)))) AND ((((primar*) NEAR/2 anastomos*) 
OR ileostom*)))
Cochrane CENTRAL
((hartman* OR ((non next restor* OR nonrestor*) NEAR/3 resect*)):ab,ti OR 
((((diverticul* AND (perforat* OR complicat* OR acute OR peritonitis)) OR 
Hinchey*):ab,ti) AND ((colostom* OR (colon* NEAR/3 stoma*) OR (staged NEAR/3 
procedure*) OR two next stage* OR 2 next stage*):ab,ti))) AND ((((primar*) NEAR/3 
anastomos*) OR ileostom*):ab,ti)
Sigmoid resection with primary anastomosis versus the Hartmann’s procedure for perforated diverticulitis
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Supplemental Figure 2 Quantitative analyses of: 
a. Reintervention rates in randomized controlled trials;
b. Reoperation rates in randomized controlled trials; 
c. Reintervention rates in observational studies.
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Supplemental Figure 3 Quantitative analyses of: 
a. Surgical site infections in randomized controlled trials; 
b. Surgical site infections in observational studies;
c. Postoperative (ongoing) sepsis in randomized controlled trials; 
d. Postoperative (ongoing) sepsis in randomized controlled trials; 
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e. Fascial dehiscence in randomized controlled trials; 
f. Fascial dehiscence in observational studies.
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Supplemental Figure 4 Quantitative analyses of outcomes after index and reversal procedures combined: 
a. Short-term mortality; 
b. Short-term morbidity; 
c. Anastomotic leakage.
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Abstract
Background 
Acute complicated diverticulitis (ACD) is an important and increasing issue in Western 
countries that leads to a significant impact and burden for patients, but also for the 
society due to its effects on hospital costs. In recent years, essential progression has 
been made regarding the research and implementation of novel or improved treatment 
strategies for the various disease entities of ACD. Much debated topics in the 
multidisciplinary approach of patients with ACD, such as the choice for nonoperative 
treatment options, the role of percutaneous drainage for diverticular abscesses, the role 
of laparoscopic lavage for perforated diverticulitis with purulent peritonitis and the role 
of sigmoidectomy with primary anastomosis for patients with perforated diverticulitis, 
require clinicians to attentively follow and participate in these discussions. 
Summary 
The aim of this review article is to provide clinicians with a structured overview of the 
recent literature on the multidisciplinary management of complicated diverticulitis by 
a panel of experts on the topic. By performing an extensive literature search in the 
online medical databases MEDLINE (Ovid) and Embase, insights into nonoperative 
treatment, percutaneous drainage, minimally invasive and open surgical treatment for 
ACD are provided. Furthermore, a comprehensive algorithm for the treatment of ACD 
has been developed.
Key messages 
Accurate patient evaluation and selection based on patient and disease characteristics is 
of paramount importance to determine the appropriate treatment strategy for patients 
with complicated diverticulitis. The presence of an experienced surgeon with advanced 
skills in laparoscopic emergency colorectal surgery is crucial for the treatment of patients 
with perforated diverticulitis in order to properly evaluate, select and treat patients 
suitable for nonoperative or operative treatment with an open or laparoscopic approach.
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Introduction
Epidemiology
Diverticulosis coli is a common condition in Western countries with prevalence rates of 
5% by the age of 40 years up to 65% when 85 years or older (1). An estimated 15-20% of 
individuals with diverticulosis coli will develop acute complicated diverticulitis (ACD) 
in their lifetime (2). The age group of patients with ACD below 50 years of age consists 
predominantly of men, whereas women seem to be the majority in the group between 
50-70 years (1). In recent years, a considerable increase in both uncomplicated and 
complicated diverticulitis rates have been found, as well as a significant rise in hospital 
admissions. This has led to a significant increase in associated hospital expenditure of up 
to 2.4 billion dollars of direct costs annually in the United States (3, 4).
Terminology
The terminology used in the literature regarding diverticulosis coli and diverticular 
disease is heterogeneous, so uniformity is required in order to correctly interpret and 
compare results between studies. The general term ‘diverticular disease’ indicates 
that diverticulosis has risen to the level of illness (4). In the majority of national and 
international guidelines acute diverticulitis is further divided into complicated and 
uncomplicated disease (5). Uncomplicated acute diverticulitis is defined as localized 
diverticular inflammation without any phlegmon, abscess, perforation, or fistula, 
whereas acute complicated diverticulitis (ACD) is defined as acute inflamed diverticula 
giving rise to phlegmon, abscess, fistula or perforation (6). Moreover, recurrent episodes 
of ACD can lead to late complications such as stenosis or fistula (5).
Classifications of  ACD
After Hinchey et al. (7) presented their classification for ACD, various modifications 
and novel classifications have been proposed to grade the different entities of diverticular 
disease and ACD in particular (Table 1). The Hansen/Stock clinical classification 
comprises diverticulosis, as well as uncomplicated and complicated diverticulitis (8). 
Likewise, Köhler et al. (9) introduced a classification including uncomplicated and 
recurrent ACD. Both these classifications were based on the clinical severity of the disease, 
whereas the Hinchey classification was based on operative findings. However, as a result 
of the increasing role of computed tomography (CT) as diagnostic tool, subcategories 
could be defined and modified Hinchey classifications were introduced, as well as CT-
based classifications, as those by Ambrosetti et al. and Kaiser et al. (10, 11). Modified 
Hinchey classifications have been introduced by Sher et al. (12) and Wasvary et al. (13), 
of which the latter is the most widely adopted, focusing not only on perforated disease, 
but also on mild clinical disease. The number of classifications and the fact that they 
are based on different clinical, radiological or operative findings has led to discordance 
in the literature. However, as Klarenbeek et al. (14) stated, a proper classification is 
necessary to improve communication between doctors, support clinical decision-
making, and provide help in prediction of outcomes. Subsequently, they designed a 
comprehensive grading system that combined existing classifications and differentiates 
three stages of diverticular disease: uncomplicated, chronic complicated, and acute 
complicated. For each of these stages clinical characteristics, radiological findings, and 
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treatment modalities are given (14). More recently, Sartelli et al. (15) have proposed a 
CT-based classification, with suggested management options, to drive decision-making 
in nonoperative and operative treatment of ACD. Nevertheless, currently, the modified 
Hinchey classification (Fig. 1) remains the most widely used classification and is used in 
several guidelines, and will be further referred to in this review (5, 13). 
Diagnosis
In the clinical work-up of ACD it is of paramount importance to diagnose and 
differentiate patients timely and correctly in order to initiate appropriate management. 
Moreover, accurate staging of the disease has become increasingly important, since 
treatment approaches have become less aggressive and more tailored to the stage of 
diverticulitis (16). The clinical diagnosis of ACD seems to be correct in 43-68% of 
patients, when only based on symptoms, physical examination and laboratory results 
(1). External validation of a clinical decision rule has shown that isolated tenderness in 
the left lower quadrant, C-reactive protein level of >50 mg/L, and absence of vomiting 
might have predictive value in patients with suspected acute diverticulitis. However, it 
must be acknowledged that these criteria only identified up to 24% of patients and, 
therefore, clinical assessment still remains insufficiently precise (17). It is suggested that in 
these patients imaging might be omitted, but in general, the clinical diagnosis of ACD is 
not sufficiently accurate and all guidelines recommend radiological evidence to support 
clinical diagnosis (1, 5). Diagnostic techniques that have been assessed are double-
contrast barium enemas, magnetic resonance imaging (MRI), colonoscopy, ultrasound 
(US), and CT scan. However, double-contrast barium enema is contraindicated in 
the setting of suspected ACD, due to its low accuracy, high radiation exposure and 
low patient acceptability (18). MRI has the advantage that contrast is not needed and 
does not expose the patient to ionizing radiation, but sufficient evidence and accuracy 
data are still lacking (19). Furthermore, in many hospitals, availability of MRI in the 
emergency department is limited (18). Colonoscopy is not recommended in the acute 
phase, because of potential difficulties, such as incomplete bowel preparation, bowel 
stenosis, and the risk of perforation and bleeding (18, 20). US and CT are comparable 
in diagnosing diverticulitis and superior to other modalities, with a sensitivity of 92% 
vs. 94% and specificity of 90% vs. 99%, respectively (19, 21). Nowadays, CT is the 
established method of choice when compared to US and most guidelines agree on the 
high accuracy and other advantages of CT (5, 22). Andeweg et al. (19) published a 
step-up approach in which CT is performed after an inconclusive or negative graded 
compression US. Nevertheless, CT is recommended for severe peritonitis, since it is 
superior to US in providing an alternative diagnosis and detecting complicated disease 
(5, 16).
Nonoperative treatment
In past decades, ACD management has moved towards a more nonoperative approach, 
by virtue of significant progression in critical care medicine, interventional radiological 
techniques, antibiotic treatment, parenteral nutrition, and diagnostic accuracy of CT 
(23). Results of the DIABOLO trial by Daniels et al. (24) indicate that observational 
treatment without antibiotics did not prolong recovery and can be considered appropriate 
in Hinchey Ia and Ib patients. Moreover, Stam et al. (25) concluded that an unrestricted 
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diet is safe in this patient population. Nowadays, the goal of surgical care for ACD, is to 
convert an emergent surgical situation into an elective situation, by means of aggressive, 
supportive medical care (23, 26). Despite this important change in treatment strategy, 
literature on this topic is scarce, especially with concern to more complex cases of ACD. 
Consequently, optimal treatment strategies remain controversial, notably in patients 
presenting with extraluminal air (27). A considerable overall success rate of 91% for a 
nonoperative approach in patients with extraluminal air was reported by Dharmajaran 
et al. (23), who managed patients in a monitored setting, with intravenous (IV) fluids, 
broad-spectrum IV antibiotics, and bowel rest, according to local protocol. If possible, 
percutaneous drainage (PCD) was advised in patients with an abscess larger than 4 
cm, indicating the importance of a multidisciplinary management with involvement of 
interventional radiologists. Sallinen et al. (27) reported a 62% success rate in patients 
with distant intraperitoneal air, although this rate increased to 86% when patients with 
abundant distant intraperitoneal air or fluid in the recto-vesical or recto-uterine pouch 
were excluded. In the World Society of Emergency Surgery (WSES) guidelines (28) it 
is stated that patients with CT findings of pericolic air or small fluid collection should 
be managed by antimicrobial therapy. Furthermore, it is articulated that nonoperative 
treatment might be an option in selected patients with distant air, but without diffuse 
fluid on CT. However, clearly, surgery is still indicated in case of failure of this approach. 
Initial choice of antibiotic regimen should be empirical and therefore partly depends on 
presumable pathogens involved, as well as local resistance profiles and other risk factors 
for resistance patterns (29). Additional CT imaging is advised in patients with persistent 
signs of intra-abdominal infection after 4-6 days, or in case of recurrent evidence of 
infection (15). Although the reported results seem to indicate that nonoperative 
management is a viable option, even in patients with extraluminal air, a careful case-
by-case decision should still be made, with attention to the patient’s clinical state (30, 
31). Evidently, nonoperative management is contraindicated in case of hemodynamic 
instability, generalized peritonitis, diffuse free air and fluid on CT, immunosuppression, 
or comorbidities that hinder the resolution of sepsis (23).
Percutaneous drainage
An important group of patients with ACD that can initially be treated non-surgically 
are patients with diverticular abscess formation (Hinchey IIa and IIb). This peri- or 
paracolic abscess formation occurs in 15-40% of ACD cases and is caused by bacteria 
and inflammatory cells spreading into the mesocolon and peritoneal cavity (32). 
Treatment choice in the acute setting depends on clinical presentation, size and 
location of the abscess, as well as the amenability for PCD (32). At present, no definite 
consensus has been reached on the optimal approach for this patient group, due to the 
lack of high-quality research (1). Definitions of a large abscess vary from 2 to 5 cm 
throughout literature, but the cut-off value of >4-5 cm is generally used in publications 
and guidelines (1, 5, 28, 32). However, as supported by several international guidelines, 
small mesocolic abscesses can be treated with antibiotics alone, whereas larger mesocolic 
or pelvic abscesses require PCD (5). In case of small abscesses (<4-5cm) bowel rest, 
pain control and IV antibiotics are advised. In the absence of clinical trials comparing 
antibiotic regimens, recommendations on specific agents or treatment duration cannot 
be made (33). Nevertheless, broad-spectrum, IV antibiotics, covering anaerobic and 
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gram-negative bacteria, are considered as essential component of successful nonoperative 
treatment (33, 34). In choice of imaging modality, ultrasound (US) guided drainage has 
the benefit of easy handling, low costs and avoidance of ionizing radiation. However, 
despite these benefits, the US-guided method might be predominantly convenient in 
superficial abscesses, partly because the air acoustic barrier of bowel loops can limit the 
abdominal approach (35). CT-guided PCD is considered to be the preferred and the 
most effective method for detection and interventional guidance of abscesses drainage 
in the abdomen and pelvis, because of the anatomic detail and localization related to 
nearby vital structures (35, 36). Several access routes for interventional radiological 
drainage exist such as the transabdominal approach (anterior or lateral) and transgluteal 
approach. The latter approach can be considered as option for deep pelvic abscesses and 
requires CT-guidance (35, 36). Furthermore, endocavitary (e.g. transrectal) approaches 
might be suitable for more complex, deep pelvic collections (35, 36). Endoscopic 
transluminal abscess drainage has been proposed as a treatment option for diverticular 
abscesses, however no strong evidence exists on this topic (37-40).
Both the direct trocar technique and the Seldinger technique can be used during the 
procedure, from which the trocar technique seems faster and better suited for large 
fluid collections, whereas the Seldinger technique is more time-consuming and suitable 
for complex pelvic collections (35, 36). Size of the catheter depends on the viscosity 
of the fluid and should not be too small to avoid kinking and clogging. Moreover, 
daily flushing of the catheter is recommended to maintain effective drainage (35, 
36). Timing of catheter removal can be based on clinical and imaging criteria (35). If 
resolution of the abscess is not reached and the patient has no clinical improvement, 
repeated CT and further drainage or catheter repositioning might be indicated, and 
eventually necessitate surgery (28, 35, 41). Laparoscopic drainage has a limited role in 
the treatment of diverticular abscesses, but may be considered in case of a large abscess 
that is not amenable for PCD (42). 
In their systematic review, Gregersen et al. (32) found that nonoperative treatment 
failure rate, regardless of treatment choice, was 19-21% for both PCD and antibiotic 
treatment, with failure defined as emergency surgery, readmission or mortality within 
30 days from initial treatment, residual abscess, or persistent symptoms. However, these 
results need to be carefully interpreted, because treatment groups may primarily reflect 
disease severity (indication/selection bias), since antibiotics were mainly used for smaller 
and primarily Hinchey Ib abscesses, and PCD for larger, Hinchey II abscesses. Several 
reasons for treatment failure of PCD have been identified, such as a multiloculated 
or pelvic abscess occurrence, or patients with significant comorbidities (32, 41). 
Jalouta et al. (43) found a 77% recurrence-free survival after nonoperative treatment. 
Overall, a pooled recurrence rate of 25.5% is observed in the nonoperative treatment 
group, consisting of patients treated with antibiotics and/or PCD, whereas PCD and 
antibiotics alone have a pooled average recurrence rate of 15.9% and 22.2% respectively 
(32). However, the overall recurrence can get as high as 68%, especially in risk groups 
of patients with abscesses larger than >5 cm or at pelvic or distant locations (32, 34). 
Moreover, Gregersen et al. (32) found a weighted average of 4.8% (median 1.3%, range 
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0-18.2%) of acute or urgent surgery due to recurrence following successful nonoperative 
treatment. 
No clear consensus exists on follow-up after the nonoperative treatment of diverticular 
abscesses, although the WSES guideline advises early colonoscopic evaluation (4-6 
weeks) (28). More importantly, the role and necessity of elective surgery is still debated. 
Although no strong evidence exists, from their systematic review, Lamb et al. (34) have 
concluded that abscess formation is associated with a high probability of resectional 
surgery at follow-up, whilst nonoperative management may evidently result in recurrent 
diverticular disease. Therefore, the choice for elective surgery should be made on a case-
by-case basis, until future research clarifies how to select patients for whom elective 
surgery might be indicated (5, 34).
Operative treatment
Minimally invasive operative treatment
Although the open approach is still the most common in operative treatment of ACD, 
encouraging data on the feasibility and advantages of laparoscopic treatment have been 
published and the minimally invasive approach in the management of ACD has been 
included in the EAES, Dutch, and WSES guidelines (5, 28, 44).
Patients needing operative treatment of ACD are commonly critical and their clinical 
status might be severely impaired by sepsis. In these patients, laparotomy often leads to 
high morbidity rates (e.g. wound infection, pneumonia, renal failure, adhesions, and 
incisional hernias). Therefore, especially in these acute patients, the minimally invasive 
surgical treatment might significantly decrease postoperative complication rates and 
allow a faster recovery, as compared to the open approach. However, to proceed to 
a laparoscopic treatment of ACD, it is of paramount importance that the patient is 
hemodynamically stable and has no absolute contraindications to pneumoperitoneum. 
Either severely inflamed tissues in perforated ACD, or severe bowel distention in 
obstructing ACD, make the surgical procedure technically demanding and the presence 
of an acute care surgeon with advanced laparoscopic colorectal skills is recommended. 
According to the patient’s status, available surgical expertise and extent and severity 
of underlying disease, the surgical treatment of ACD can be either non-resectional or 
resectional. 
Laparoscopic non-resectional treatment
Laparoscopic lavage (LL) has first been described in 1996, as a minimally invasive 
technique to avoid resection in perforated diverticulitis with purulent peritonitis 
(45, 46). Since then, the technique has not gained a wide acceptance and, up to date, 
three randomized controlled trials (RCT) comparing LL to sigmoidectomy have been 
published (47-49). Interestingly, their conclusions did not agree and the strong debate 
raised from these conflicting results led seven meta-analyses to be published over the 
last two years (50-56). Some authors claimed selection biases in the RCTs (57) or 
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methodological flaws in the meta-analyses, since opposite conclusions on the 30-day and 
90-day reoperation risk were reported in the meta-analyses(58). Despite its increased 
incidence of postoperative abscesses and PCD, LL still appears to be faster and leading 
to a faster recovery. No indisputable differences in terms of postoperative short- and 
long-term mortality, morbidity and stoma presence at 12 months seem to be present 
(50-56). LL might, however, be more cost-effective as compared to resection (59, 60). 
The main factor related to failure or success of LL is the grade of experience of the 
operator (61). The intra-operative distinction between Hinchey III and IV is not always 
obvious and experience and technical skill are essential features for effective irrigation, 
drainage and, most importantly, reliably ruling out free perforation or perforated cancer 
(61). An experienced surgeon is better able to distinguish between purulent and fecal 
peritonitis and is more likely to be able to identify the perforation, which mostly is 
on the mesenteric side of the sigmoid, surrounded by dense inflammatory tissue, and 
therefore not easily accessible or visible. Intraoperative endoscopy or insufflation of CO2 
in the rectum might be helpful to discriminate between a sealed or open perforation. 
Furthermore, since purulent peritonitis is the consequence of transient peritoneal 
contamination, with a sealed perforation at the time of the operation, the main aim of 
LL might not be to control the source of infection, but to clean the peritoneal cavity, 
reduce microbial contamination and the consequent release of inflammatory factors, 
in order to improve sepsis treatment. In this view, the peritoneal washout must be as 
complete and careful as possible, including thorough cleaning of all four quadrants’ 
recesses and placement of abdominal drains deep in the Douglas’ and Morison’s pouches. 
Inexperienced surgeons might be less competent to correctly perform these procedural 
steps, potentially leading to an increased rate of persistent sepsis or intra-abdominal 
collections. LL may represent a valuable option for the management of perforated 
diverticulitis with purulent peritonitis, however, the risk of failure, early reintervention, 
perforated carcinoma and diverticulitis recurrence need to be balanced against the risk 
of sigmoidectomy, and potential stoma formation and closure (49, 62). Therefore, 
correct patient evaluation, performed by an experienced surgeon, with advanced skills 
in laparoscopic emergency colorectal surgery, is crucial for the selection and treatment 
of stable, young and fit patients, without an overt perforation. 
Laparoscopic resectional treatment
The literature on emergency laparoscopic Hartmann’s procedure (HP) or sigmoidectomy 
with primary anastomosis (PA) for ACD is still scant. Several small retrospective cohort 
studies and case series have been published, but no RCTs comparing the laparoscopic 
and open approach in the acute setting exist (63), mostly because of concerns about 
the clinical characteristics of ACD that, potentially, negatively affects outcomes of the 
laparoscopic approach. In the acute setting, the distended bowel, inflammatory dense 
adhesions, and the contamination of the abdominal cavity caused by perforated ACD 
often raise concerns on the safety and feasibility of the approach. Moreover, the severely 
inflamed tissues make the procedure remarkably more challenging if compared to the 
elective sigmoid colectomy (Fig. 2), with loss of anatomical planes and consequent 
increased risk of bleeding and ureteric injuries. Because of these technical demands, it is 
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therefore advisable to consider these procedures only in the presence of an experienced 
surgeon, who is highly skilled in emergency laparoscopic colorectal surgery.
Small retrospective series have demonstrated emergency laparoscopic sigmoidectomy 
in ACD to be safe and feasible, with significant advantages in terms of low conversion, 
reintervention, morbidity, and mortality rates, as well as faster recovery, and higher 
stoma reversal rates (64). Although the published studies are limited by their small size, 
heterogeneity of participants and outcome variables, obvious selection bias, and lack of 
open control group, it is still stated that the approach is feasible in selected patients and 
experienced hands (64), as was also concluded in a recent propensity-score matched 
analysis (65). Furthermore, the benefit of laparoscopic HP might be a decrease in 
abdominal wall complications, such as incisional hernias (65). Subsequently, this might 
lead to higher rates of stoma reversal in the follow-up of these patients. 
In selected cases, it can be decided to perform a sigmoidectomy with PA, with or 
without defunctioning loop-ileostomy, depending on patient’s age, comorbidities and 
clinical condition. Furthermore, the intraoperative quality of colonic tissue and edges is 
of importance (e.g. not ischemic), and it is important that these can be joined without 
tension, making routine splenic flexure mobilization highly recommendable. The role 
of defunctioning loop-ileostomy can be debated in emergency procedures since the 
colon has not been prepared, even though an intraoperative colonic anterograde enema 
through the appendicular orifice may be performed after the resection and PA have been 
performed. The largest reported series of emergency laparoscopic anterior resection and 
PA for complicated diverticular disease is the one by Titu et al. (66) including 50 cases, 
with an anastomotic leak rate of 8%. The retrospective comparative cohort study by 
Letarte et al. (67) included 103 emergency colonic resections and primary anastomosis 
(37 laparoscopic vs. 66 open) for acute complicated diverticulitis, with no significant 
difference in the anastomotic leak rate. Overall, no mortality and significantly better 
postoperative outcomes were found in the laparoscopic group, in terms of less frequent 
prolonged ileus (12.8% vs 32%), shorter time to oral intake (3 vs. 6 days) and shorter 
LOS (5 vs. 8 days) (67). Moreover, Vennix et al. (63) performed a systematic review 
of four case series and one cohort study, in which a total of 104 patients underwent 
emergency laparoscopic resection for perforated diverticulitis (84 Hartmann, 20 primary 
anastomoses). Mean operating time varied between 115 and 200 minutes, conversion 
rate varied from zero up to 19%, mean hospital stay ranged between 6-16 days, surgical 
reintervention was necessary in two patients, no anastomotic leak was reported, and 
three patients died postoperatively. In highly selected and fit patients, the presence of 
fecal gross contamination, with peritonitis lasting less than 12-24 hours, might not be an 
absolute contraindication to laparoscopic resection and PA, although data on this topic 
are limited (68). Accordingly, the essential aspects of laparoscopic resectional treatment 
are accurate patient evaluation, selection and treatment by experienced laparoscopic 
colorectal surgeons.
Before embarking in challenging laparoscopic emergency colorectal procedures, 
expertise in acute care, emergency and colorectal surgery, as well as minimally invasive 
expertise (e.g. having completed a laparoscopic fellowship) are required. In absence 
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of an experienced emergency colorectal laparoscopic surgeon, advanced laparoscopic 
procedures should not be performed and open procedures are advised outside centers of 
excellence (61, 69-72). 
Open operative treatment
Although laparoscopic resectional treatment has gained increasing attention and 
promising results have been published, general peritonitis is often still regarded as a 
contraindication for the laparoscopic approach, especially when fecal. Moreover, 
concerns have been raised on the risk of damage to the vulnerable and distended small 
bowel, as well as the hypothetical risk of increased bacteraemia and hypercapnia, caused 
by pneumoperitoneum (63, 65). Despite the fact that there is no strong evidence proving 
or disproving these concerns, laparotomy and HP are still the most commonly used 
procedures (28, 63). The role of sigmoid resection with PA vs. HP has been discussed 
in several studies (73, 74). Potentially, PA, with or without construction of a temporary 
loop ileostomy, has the major benefit of avoiding an end colostomy, and the significant 
risks associated with Hartmann’s reversal. In their systematic review, Constantinides et 
al. (73) found favorable results regarding mortality for PA as compared to HP, however, 
they correctly indicated the considerable risk of selection bias in the studies under 
review, due to their retrospective design. To reduce this bias, introduced by performing 
PA in more favorable subjects, prospective randomized studies were soon designed and 
conducted. As stated by the authors, from the prematurely terminated trial by Binda et 
al. (75) no conclusions could be drawn on treatment preference, although they included 
a total of 90 patients (15% of calculated sample size) of which 15 patients (16.7%) had 
Hinchey IV. Furthermore, Oberkofler et al. (76) published results favoring PA with 
diverting ileostomy over HP in a total of 62 patients (30 HP vs. 32 PA). In the HP and 
PA group, respectively, postoperative outcomes were not significantly different (mortality 
13% vs 9% and morbidity 67% vs 75%). Nevertheless, the stoma reversal rate was 
higher and operating time, hospital stay, and in-hospital costs were significantly reduced 
in patients who underwent PA. Currently, results of the DIVA-arm of the LADIES trial 
are awaited, in order to further elucidate this important and much discussed surgical 
topic (77). Despite the absence of strong evidence, HP is advised for critically ill patients 
or patients with multiple comorbidities, whereas PA, with or without a diverting loop-
ileostomy, is considered safe or even preferable for hemodynamically stable patients 
with Hinchey III and IV diverticulitis or after failed nonoperative treatment of ACD 
(Hinchey I-III) (1, 5, 28).
Conclusions
Diverticulitis is an important and increasing problem in Western countries, leading to 
an increase in hospital admissions and expenditure. Therefore, the use of uniform and 
comprehensive terminology and disease classification is necessary in order to improve 
diagnostics, subsequent treatment choices, and future research related to ACD. Contrast 
CT scan is the gold standard for the diagnosis of ACD. Due to advances in critical care 
medicine and interventional radiological techniques nonoperative treatment strategies 
might be viable even in highly selected patients with extraluminal air. In case of abscess 
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formation, size and location of abscess should, apart from patient characteristics, be 
taken into consideration before performing PCD. In selected cases and in presence 
of an experienced emergency colorectal laparoscopic surgeon, minimally-invasive 
operative management of ACD is feasible and has multiple advantages. Benefits and 
risks of LL should, evidently, be balanced with those of resectional treatment. HP 
(open or laparoscopic) is the most common resectional treatment in case of ACD with 
peritonitis, failed nonoperative management of ACD or acute large bowel obstruction 
resulting from diverticular disease. A benefit of laparoscopic HP might be a decrease 
in abdominal wall complications, such as incisional hernias, with a subsequently 
higher rate of stoma reversal. In case of resectional treatment (open or laparoscopic), 
a PA can be performed, with or without defunctioning loop-ileostomy, depending on 
patient’s age, comorbidities and clinical condition, as well as intraoperative findings and 
quality of colonic tissue. According to the modified Hinchey classification of ACD, a 
comprehensive algorithm for the management of ACD has been developed (Fig. 3).
In conclusion, accurate patient evaluation based on clinical and disease characteristics 
is of paramount importance to determine the appropriate treatment strategy of ACD. 
Future research should aim to provide data supporting accurate case-by-case evaluation 
and decision-making in order to improve the various mentioned aspects of the 
multidisciplinary treatment of complicated diverticulitis.
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Figures
Figure 1 Radiological and clinical images of the modified Hinchey classification. Hinchey Ib: CT image of pericolic 
abscess (a); Hinchey II: CT image of pelvic abscess (b); Hinchey III: intraoperative image of purulent peritonitis (c); 
Hinchey IV: intraoperative image of fecal peritonitis (d). Pictures provided by Dr. Salomone Di Saverio, MD, FACS, 
FRCS; patients gave permission to publish.
Chapter 8
232
Figure 2 Operative steps of laparoscopic HP for ACD. After the inflamed and thickened sigmoid mesocolon is dissected 
(a), the sigmoid colon is mobilized and the distal intracorporeal stapled resection is performed (b). The specimen is 
extracted through the colostomy site avoiding any laparotomy (c) and therefore reducing the risk of wound infection 
and incisional hernia. Operative pictures provided by Dr. Salomone Di Saverio, MD, FACS, FRCS; the patient gave 
permission to publish.
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Figure 3 Proposed algorithm for the multidisciplinary management of ACD. PCD, percutaneous drainage; HP, 
Hartmann’s procedure; PA, primary anastomosis. a According to Waswary et al. [13] and Sher et al. [12]. b Broad-
spectrum IV antibiotics and bowel rest. c Immunosuppressed, diabetes, chemotherapy, multiple comorbidities.
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Abstract
Aim
The goal of this European Society of Coloproctology (ESCP) guideline project is to 
give an overview of the existing evidence on the management of diverticular disease, 
primarily as a guidance to surgeons.
Methods
The guideline was developed during several working phases including three voting 
rounds and one consensus meeting. The two project leads (JKS and EA) appointed by 
the ESCP guideline committee together with one member of the guideline committee 
(WB) agreed on the methodology, decided on six themes for working groups (WGs) 
and drafted a list of research questions. Senior WG members, mostly colorectal surgeons 
within the ESCP, were invited based on publication records and geographical aspects. 
Other specialties were included in the WGs where relevant. In addition, one trainee 
or PhD fellow was invited in each WG. All six WGs revised the research questions if 
necessary, did a literature search, created evidence tables where feasible, and drafted 
supporting text to each research question and statement. The text and statement 
proposals from each WG were arranged as one document by the first and last authors 
before online voting by all authors in two rounds. For the second voting ESCP national 
representatives were also invited. More than 90% agreement was considered a consensus. 
The final phrasing of the statements with < 90% agreement was discussed in a consensus 
meeting at the ESCP annual meeting in Vienna in September 2019. Thereafter, the 
first and the last author drafted the final text of the guideline and circulated it for final 
approval and for a third and final online voting of rephrased statements.
Results
This guideline contains 38 evidence based consensus statements on the management of 
diverticular disease.
Conclusion
This international, multidisciplinary guideline provides an up to date summary of the 
current knowledge of the management of diverticular disease as a guidance for clinicians 
and patients.
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Introduction
There are currently several national guidelines available from member countries of the 
European Society of Coloproctology (ESCP) on the management of diverticular disease, 
some of which are not updated (1-7). The guidelines committee of the ESCP decided in 
2017 to develop a pan‐European guideline for the management of diverticular disease, 
acknowledging that it will be a compromise of different national guidelines and different 
accessibilities to healthcare and medical procedures in different healthcare systems.
Method
Two project leads (JKS and EA) were appointed by the guideline committee at the 
annual ESCP meeting in 2017. Together with a representative from the ESCP 
guidelines committee (WB), they assembled a team of ESCP and United European 
Gastroenterology members divided into six work groups (WGs). All WGs comprised a 
group leader, up to three researchers and a surgical resident who were invited personally 
to participate by the project leaders. Senior group members were specialists in colorectal 
surgery, gastroenterology or radiology and were considered based on their scientific 
contribution in the field. Consideration was taken to ascertain that there was a balanced 
contribution of the different nationalities within each WG. The groups covered six 
topics: WG I, Aetiology, follow‐up including risk for cancer; WG II, Imaging, indication 
and classifications, initial evaluation of diverticulitis and imaging; WG III, Nonsurgical 
management of diverticulitis and dietary recommendations; WG IV, Emergency 
surgery for acute diverticulitis; WG V, Elective surgery for diverticulitis; WG VI, 
Technical considerations, special considerations. For all six WGs, research questions 
were formulated and subsequently revised until all members of the WGs agreed. 
Each WG conducted their literature research and drafted statements and supporting 
documentation to their research questions.
Search methods and manuscript selection
Based on the research questions a literature search was performed by the individual 
WGs. The literature searches were performed using MEDLINE/PubMed/ISI/Scopus 
and the Cochrane database between July and September of 2018.
Study inclusion criteria were systematic reviews, randomized clinical trials, cohort studies 
and case series on the subject of colonic diverticulosis and diverticulitis. The trainee or 
PhD candidate in each research group performed an evaluation of the quality of evidence 
and created evidence tables with structured summaries for each relevant included article 
(supplements 1–6; available online). The level of evidence for each recommendation was 
graded according to the levels of evidence published by the Oxford Centre for Evidence‐
Based Medicine 2011(8).
The drafting of  supporting text and statements
All statements and the initial supporting text were presented at a face to face meeting of 
the entire team at the ESCP annual meeting in Nice in September 2018. The content 
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and the strength of each statement and recommendation were reviewed. All statements 
were then revised to meet the changes requested. A first voting round with all WG 
members was conducted online in February 2019. After the voting, all statements and 
the supporting text were revised by the WGs taking into account both the strength of 
the supporting evidence and the expert comments from the voting round. The results 
of this revision were then arranged into one document by the first and last authors. 
During the summer of 2019, all WG members and all country representatives of the 
ESCP were invited to participate in a second online voting round on all the statements. 
Based on these surveys, all statements that reached an agreement of more than 90% were 
considered to be in agreement unless there were important reasoned objections by single 
voters. All other statements were revised and discussed at a meeting during the ESCP 
annual meeting in Vienna in September 2019. Following this meeting, all statements 
and the supporting text were edited by the first and last authors before the paper was 
sent for final revision and approval by all the authors combined with a third voting on 
revised statements.
WG I: Aetiology, follow-up including risk for cancer – statement of  the problem 
and epidemiology
1.1 How is diverticular disease defined and how should it be classified?
The evolution of new diagnostic pathways and novel treatments has led to a diversity 
of terms such as asymptomatic and symptomatic diverticulosis, diverticular disease, 
acute and chronic diverticulitis and some other subgroup definitions. Unfortunately, 
this variety causes confusion. To establish clear definitions is important in the area of 
diverticula‐related clinical and scientific communication.
Numerous classifications and modifications describe the various stages of diverticular 
disease (7, 9). The first widely used classification by Hinchey (10) was intended as 
an intra‐operative stratification of perforated diverticulitis with abscess or peritonitis 
enabling surgeons to adjust the surgical approach. It was later modified to preoperative 
use, incorporating CT findings (11). The German guidelines suggest a new classification 
that is currently under validation. It was developed on the basis of Hinchey/Wasvary 
and Hansen and Stock, and adapted to current diagnostic and therapeutic aspects 
(5, 12). The ESCP guideline committee has decided neither to create yet another 
classification nor to quote one of the existing ones. All the existing classifications lack 
reliable validation and none of them is generally accepted. The guideline committee has 
therefore used definitions based on evidence as far as possible with some overlap with 
existing classifications. Figure 1 displays terms used in this guideline project.
Diverticulosis vs diverticular disease
Diverticulosis of the colon (existence of false diverticula – outpouchings of mucosa and 
serosa through openings in the muscular layer of the bowel) develops in the majority of 
individuals in western countries with increasing age and usually remains asymptomatic 
(13, 14). Diverticulosis per se should not therefore be considered a disease. The term 
diverticular disease implies that there are symptoms related to the diverticula.
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Symptomatic uncomplicated diverticular disease (SUDD)
Whether diverticula can lead to symptoms in the absence of inflammation or bleeding 
is controversial (15-17). The term symptomatic uncomplicated diverticular disease 
(SUDD) is used in some countries for patients with diverticula who experience 
abdominal symptoms (e.g. abdominal pain and bloating) and changes in bowel habit 
(e.g. diarrhoea, constipation or alternating bowel habit) in the absence of inflammation 
(3, 18). However, the term has not found general acceptance and a uniform definition 
does not exist (15). A major difficulty is the differential diagnosis between irritable bowel 
syndrome (IBS) and SUDD as there is an overlap between the two (18). Epidemiological 
studies have shown that IBS‐like symptoms may develop after a bout of acute diverticulitis 
(19). A comparative study between SUDD and IBS found significantly different pain 
characteristics (20) with abdominal pain lasting > 24 h occurring more frequently in 
SUDD, but a recent large cohort study including individuals in a colonoscopy screening 
programme found no association between diverticulosis and abdominal pain (15). 
Currently, there is little evidence on how to manage SUDD.
Figure 1 List of terms and stages used in the guideline. The flowchart shows the different stages of diverticulosis and 
diverticular disease. Note that although diverticulosis is a conditio sine qua non for the other stages, the different stages 
are not part of a continuous development and may appear independently in individual cases. *The term SUDD is 
controversial, as it remains unclear whether this is a disease of its own or whether it represents the coexistence of irritable 
bowel syndrome and diverticulosis.
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Diverticulitis
The term diverticulitis describes a peridiverticular inflammation of the bowel wall 
and usually the surrounding tissue. The theory that the inflammation is a result of 
translocation of intestinal bacteria through the mucosa of the diverticulum on the basis 
of a weak barrier has lately been challenged (21) and the true aetiology is unclear.
Diverticulitis can be acute or chronic and complicated or uncomplicated with possible 
complications including abscess, perforation, fistulas, obstruction and bleeding (3). The 
severity of acute diverticulitis, mainly determined by cross‐sectional imaging (CT scan, 
ultrasound) and laboratory tests (C‐reactive protein), is decisive and guides management 
and treatment. In general, uncomplicated acute diverticulitis is differentiated from 
complicated acute diverticulitis. The cut‐off is poorly defined but depends on the degree 
of inflammation.
Acute uncomplicated diverticulitis
Acute uncomplicated diverticulitis is inflammation in a diverticula‐bearing bowel 
segment and the surrounding tissue without signs of perforation (extraluminal air) or 
abscess formation.
Acute complicated diverticulitis
Typical complications of acute diverticulitis occur if the inflammatory process extends 
beyond the colonic wall. However, peridiverticulitis alone is not considered complicated 
disease. A covered perforation with air bubbles in proximity to the bowel, intra‐abdominal 
abscess adjacent to the inflamed segment (Hinchey Ib, according to Wasvary) or distant 
(Hinchey II) and free perforations with purulent or faecal peritonitis (Hinchey III and 
IV) represent the major manifestations of acute complicated diverticulitis (11).
Chronic diverticulitis
If an acute diverticulitis does not resolve completely, chronic diverticulitis can develop. 
Wall thickening or chronic mucosal inflammation in the absence of stenosis is called 
chronic uncomplicated diverticulitis. Complicated chronic diverticulitis includes both 
stenotic disease, which may lead to acute bowel obstruction, and fistulation most 
commonly to the urinary tract.
Diverticular bleeding
Diverticular bleeding is reported to account for about 35% of painless lower 
gastrointestinal bleeding and occurs in up to 50% of elderly patients with diverticulosis (5). 
The exact incidence is difficult to estimate, however. Frequently, the bleeding site cannot 
be identified, and coexisting diverticula may then falsely be reported as the bleeding 
cause.
Diverticular bleeding is arterial and occurs from rupture of the intramural branches of 
the marginal artery at the dome or neck of the diverticulum. Trauma from mechanical or 
chemical causes within the lumen of the diverticulum leads to injury to the penetrating 
vessels and bleeding. Histopathological examination of diverticular bleeding sites has 
shown absence of diverticulitis (22), but bleeding may occur during inflammation as 
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well. If surgery is required, precise localization of the bleeding site is crucial for any 
surgical procedure. Colonic resections in patients with diverticular bleeding and an 
unclear localization have shown a postoperative mortality of 43% in comparison to 
7% in patients with defined bleeding localization (23). There are separate guidelines for 
the management of lower gastrointestinal bleeding which is therefore not part of this 
guideline.
The following statements are definitions by agreement of the guideline group.
Statements
1.1.1 Diverticulosis means an asymptomatic presence of  diverticula and is per 
se not a disease.
Agreement 97% (second voting)
1.1.2 Diverticular disease is defined as diverticulosis with related symptoms or 
complications.
Agreement 100% (consensus meeting)
1.1.3 Clinical and scientific communication on diverticular disease must use 
accepted definitions.
Agreement 100% (second voting)
1.1.4 It is unclear whether SUDD – as defined by abdominal symptoms without 
proven inflammation or bleeding – can be considered a disease of  its own or 
whether it represents the coexistence of  IBS and diverticulosis.
Evidence level 4. Agreement 100% (consensus meeting)
1.1.5 Diverticulitis should be associated with symptoms and signs of  
peridiverticular inflammation proven by cross‐sectional imaging and laboratory 
tests. Diagnosis should differentiate between uncomplicated and complicated 
as well as acute and chronic diverticulitis.
Evidence level 4. Agreement 97% (second voting)
1.1.6 Diverticular bleeding, very probably caused by a mechanical disruption of  
a vessel, occurs mostly painlessly without preceding diverticulitis. Patients with 
possible diverticular bleeding often need hospitalization with multidisciplinary 
treatment options and an urgent or semi-urgent endoscopic evaluation.
Evidence level 4. Agreement 93% (second voting)
1.2 What is the prevalence of  diverticulosis?
By far the majority of individuals with diverticulosis remain asymptomatic throughout 
life (12). Therefore, the incidence of diverticulosis is difficult to estimate. Most 
data come from autopsy studies. A prospective study from Taiwan in asymptomatic 
subjects undergoing colonoscopy for a health screening revealed a frequency of colonic 
diverticulosis of 256 out of 1899 asymptomatic subjects (13.5%) ranging from 4.9% 
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in young adults (< 39 years) to 74.4% in the group > 70 years of age. There was a 
clear preponderance of men (24). In western countries with a predominant Caucasian 
population, the prevalence is higher (14, 15). Estimated rates of diverticulitis in patients 
with known diverticulosis are as low as 1%–4% or 1.5–6.0 per 1000 patient‐years (25). 
Diverticulosis and associated clinical problems are most likely to occur in older age 
groups. However, although diverticula still are most frequent in elderly individuals, 
evidence is emerging that the condition has increased particularly in younger subjects 
under 45 years of age (26).
1.3 What is the incidence of  uncomplicated and complicated diverticulitis and what 
are the annual healthcare costs for diverticulitis in Europe?
Although there is quite a variability of frequency rates for diverticulitis in the literature, 
there is some evidence that the incidence of diverticulitis has risen over the last years 
particularly in younger adults and women. There are almost no population‐based data. 
Nearly all studies refer to the number of hospital admissions. A recent Italian study 
found an overall rate of 48 hospital admissions for acute diverticular disease per 100 
000 inhabitants in 2015, and a yearly increase of over 3% from 2008. Interestingly, the 
age‐specific rate was constant for older ages and there was only a slight increase for the 
younger age groups; thus some of the increase of the overall rate might be attributed 
to the aging population. The overall rate of hospital admissions for acute diverticular 
disease per 100 000 hospitalizations was 248 with an annual increase of 7.5% from 190 
in 2008 to 310 in 2015 (27). From the USA, a prevalence of 92/100 000 persons with 
a preponderance of women has been reported (28). In the Netherlands, approximately 
22 000 patients per year are referred to secondary care with diverticulitis. Ten per cent of 
these patients will develop complications such as abscess or perforation and will require 
further treatment in the form of close observation, antibiotics, percutaneous drainage 
or surgery (29). Due to uncertainties about the incidence, it is difficult to estimate the 
health economic burden of diverticulitis and there are no reliable calculations
1.4 What are the risk factors for diverticulosis, diverticulitis and its complications?
The formation of diverticula and the pathogenesis of diverticular disease is multifactorial 
and as yet not completely understood. Traditionally, the factors are thought to include 
older age, environment (diet, physical activity) and intestinal motility. Obesity is 
a major risk factor with a linear relationship and a relative risk for each 5‐unit body 
mass index increase of 1.28 (95% CI 1.18–1.40) for diverticular disease, 1.31 (95% CI 
1.09–1.56) for diverticulitis and 1.20 (95% CI 1.04–1.40) for complicated diverticular 
disease (defined as bleeding, abscess or perforation)(30). Recent research has identified 
other factors, such as genetic patterns, altered tissue composition and malfunction as 
associated with neuro‐gastrointestinal disturbances (21). Colonic diverticula may occur 
in all segments of the colon but mostly in the sigmoid colon, with the second most 
common site in the right colon (31).
For practical reasons, risk factors for the development, appearance and outcome of acute 
diverticulitis are split into noncontrollable factors (age, sex and genetics) and factors that 
can be influenced.
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Twin studies have demonstrated that a genetic component is present in the development 
of diverticulosis (32, 33). Few genetic studies have identified the actual genes that are 
susceptible culprits. Genetic connective tissue disorders like Ehlers–Danlos and Marfans 
syndrome have been linked to the development of diverticulosis in young age (34, 
35). Some studies indicated that genes involved in immunity, extracellular matrix, cell 
adhesion, membrane transport and intestinal motility may be related to diverticular 
disease (36-38). However, the exact mechanisms remain to be shown.
Food and lifestyle are among the commonly discussed controllable risk factors, 
particularly dietary fibre. Epidemiological studies indicate that dietary fibre has a 
protective effect against development of diverticulosis and diverticulitis (39, 40). In 
addition, nuts, grains, corn and popcorn have been shown in big cohort studies to be 
protective against the development of diverticulitis (41). Red meat and smoking are 
possible risk factors (21).
Obesity is a risk factor for developing diverticulosis, diverticulitis and diverticular 
bleeding while physical activity is protective (42-45). 
Commonly used drugs, such as nonsteroidal anti‐inflammatory drugs, aspirin, 
acetaminophen, corticosteroids and opioids increase the risk of diverticular disease, 
particularly complicated diverticulitis (46).
In Denmark, 12%–17% of all hospitalizations for diverticulitis are for complicated 
diverticulitis with a marked increase of 43% in absolute numbers between 2000 and 
2012 (47). Similar trends have been reported from Scotland (48).
Acute complicated diverticulitis comes with considerable mortality. In the largest series 
of Hinchey Ib‐II diverticulitis (n  = 3148, nationwide Danish registry), 8.7% of patients 
died within 30 days from admission, and 2.5% of those discharged alive died within 
30 days from discharge; age and use of glucocorticoids were the main independent risk 
factors for death in multivariate analysis (49). Following an episode of acute diverticulitis 
with abscess formation, there is a marked risk for recurrence. The nationwide Danish 
registry data show recurrence rates of 9%–24%. Most recurrences and recurrence‐related 
mortality occurred within the first year (50).
Mortality risk increases even more in the case of free perforations with peritonitis. A 
Dutch series from 1990 to 2005 found it to be as high as 26.5% during initial hospital 
stay with an overall 5‐year survival of just 53%, mainly caused by the poor general 
health of the patients (51).
Both the risk of a subsequent free perforation and the risk of death decrease with the 
number of previous episodes (49, 52). The first episode of complicated diverticulitis is 
by far the most dangerous.
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Statements
1.4.1 The development of  diverticulosis is multifactorial and risk factors 
include age, genetic predisposition and obesity. The pathogenesis from 
diverticulosis to diverticulitis and its complications can be influenced by 
lifestyle and medications.
Evidence level 2. Agreement 100% (consensus meeting)
1.4.2 Acute complicated diverticulitis is associated with considerable short-
term and long-term mortality. The risk of  severe complications is highest at 
the first episode of  diverticulitis and decreases with the number of  recurrences.
Evidence level 2. Agreement 100% (second voting)
1.5 How should patients be followed-up after an episode of  uncomplicated and 
complicated diverticulitis?
Due to the generally benign course of diverticulitis a routine follow‐up of the disease itself 
seems only justified in unresolved complicated cases. However, although the widespread 
use of abdominal CT in the acute setting has made the diagnostics more accurate, the 
differentiation between diverticulitis and colorectal cancer (CRC) is still difficult in some 
cases. Most previous guidelines recommended routine colonoscopy some weeks after an 
episode of acute diverticulitis (6). The rationale was that early detection of CRC in 
misdiagnosed patients could reduce the chance of dissemination. No randomized trials 
to investigate the usefulness of this practice (by comparing cancer‐specific survival with 
and without endoscopy) exist. Many primarily retrospective studies have investigated 
detection rates for CRC with colonoscopy after acute diverticulitis. However, meta‐
analyses of data have been troubled by the heterogeneity of the studies, the lack of a 
valid reference population, inconsistent reporting of CT verification of the diverticulitis 
episode, inconsistent definitions of uncomplicated and complicated diverticulitis and 
the lack of information about ongoing symptoms in the included patients (53-57). 
Routine colonoscopy after an episode of conservatively treated complicated diverticulitis 
is generally accepted, as the prevalence of CRC is between 7.9% and 10.8% in this 
group (53, 55, 56).
For patients with CT verified uncomplicated diverticulitis, the two most recent meta‐
analyses have calculated a prevalence of CRC of 0.5% and 1.2% respectively due to 
the inclusion of different studies (55, 56). Furthermore, in the meta‐analyses different 
reference populations are used leading to different conclusions. Meyer et al. calculated 
the prevalence of CRC after uncomplicated diverticulitis to be higher than that in the rest 
of the population whereas Rottier et al . found these prevalences to be similar. It should 
be noted that the prevalence of undiagnosed CRC in the asymptomatic background 
population can only be estimated. Detection rates of CRC in screening programmes 
vary between 0.1%(58) and 1%(59) (mostly around 0.5%(60)), depending on the 
age and risk profile of the included population. Screening probably overestimates the 
prevalence of CRC in asymptomatic patients, as participation rates are usually far below 
50% and symptomatic and high‐risk patients probably are more likely to attend. Also, 
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incidence rates for CRC have been used to estimate the prevalence of undiagnosed CRC 
in the population (55, 61), which has the weakness that it is uncertain how long the 
CRC existed before diagnosis.
After a CT verified uncomplicated diverticulitis, colonoscopy is usually part of the 
normal work‐up of symptomatic patients (bleeding, changed bowel habits or ongoing 
pain). Controversy exists whether asymptomatic patients need endoscopic follow‐up.
Statement
1.5.1 Endoscopic follow-up: for patients with symptom-free recovery after a 
single episode of  CT verified uncomplicated diverticulitis endoscopic follow-
up remains controversial and may not be necessary. All other patients treated 
without resection for acute diverticulitis should be followed up with an 
examination of  the colon at least 6 weeks after the acute episode, if  not done 
within the last 3 years.
Evidence level 3. Agreement 100% (third voting)
WG II: Imaging, indication and classifications – initial evaluation of  diverticulitis 
and imaging
2.1 How can clinical findings be correlated to the severity of  the disease?
Before the introduction of current imaging modalities, acute diverticulitis was a 
diagnostic challenge (62). A diagnosis of acute diverticulitis based solely on clinical 
findings is incorrect in more than 50% of cases (63). Together with other clinical 
findings, laboratory tests may be helpful to guide the clinician in the diagnosis (64). 
Several studies indicate that C‐reactive protein levels are correlated to the severity of 
disease and recurrence rates; however, certain discrimination between the stages of the 
disease is not possible (65-68). Existing studies investigating the correlation between 
clinical findings and staging at imaging are very heterogeneous and generally not of 
high quality (29). Clinical findings may lead the clinician, however, when deciding the 
urgency of imaging and intervention.
Statement
2.1.1 There is a poor correlation between clinical findings and severity of  the 
disease.
Evidence level 2. Consensus 100% (consensus meeting)
2.2 When should imaging be obtained on index and successive presentations of  
disease? (Which cases can be treated in primary care without imaging?)
Due to the low diagnostic accuracy of a clinical evaluation, imaging is generally required 
to confirm the clinical suspicion of acute diverticulitis in primary and secondary care, 
especially in patients with no previous diagnosis of diverticulitis (64, 69, 70). Even 
successive presentation of diverticulitis may require imaging to confirm the diagnosis. 
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However, as the course of acute uncomplicated diverticulitis even with small abscesses 
is benign (71), and severe complications are rare with low C‐reactive protein levels, 
an observational strategy without imaging may be adequate in mild cases, especially 
in frequent recurrent disease (69). If no imaging is obtained, elective endoscopic 
examination, if not recently done, may be helpful for differential diagnosis.
Statement
2.2.1 Imaging is required to confirm the diagnosis of  acute diverticulitis if  
there is no prior diagnostic information.
Evidence level 2, Strong recommendation. Consensus 100% (consensus meeting)
2.3 What is the most appropriate imaging tool to diagnose acute diverticulitis?
CT, ultrasound and MRI are possible imaging modalities that have been studied as tools 
to identify and classify diverticulitis. CT has a high sensitivity and specificity in the 
diagnosis of acute diverticulitis (72). Although abdominal ultrasound in expert hands 
has a high diagnostic accuracy, it has not gained widespread popularity (73). Ultrasound 
has the advantages of avoiding ionizing radiation and easy repetition if needed and it 
can be useful in pregnancy (72, 74). However, it is less accurate for abscess identification 
and exclusion of other gastrointestinal issues. A modified Hinchey classification cannot 
be assessed by ultrasound evaluation (75, 76). MRI is highly sensitive and specific in 
the differential diagnostics of diverticulitis (77). However, as it is time consuming and 
less available than CT it has not found wide acceptance. MRI is an alternative when 
ultrasound is inconclusive in pregnant women as well as after the acute phase to assist 
in differential diagnoses.
Statement
2.3.1 CT is recommended as the first-line investigation in suspected 
diverticulitis. Ultrasound and MRI are alternatives.
Evidence level 2, Strong recommendation. Consensus 100% (consensus meeting)
2.4 Which CT classification is appropriate?
There are many classifications in the literature but most of the published papers use 
either the Hinchey classification or a modified version of it. However, the Hinchey 
classification was originally a classification of intra‐operative findings in patients with 
perforated diverticulitis and included only patients with abscesses or free perforations. 
One should be aware that the most frequently used modification by Wasvary also 
includes mild phlegmonous disease in the absence of complications (11, 78-83). It is 
useful for classifying both acute uncomplicated and complicated diverticulitis although 
there is little validation.
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Statement
2.4.1 No CT classification is superior to others as a diagnostic tool for acute 
diverticulitis. Each centre should choose their preferred classification in 
communication with available radiologists.
Evidence level 5, Conditional recommendation. Consensus 100% (third voting)
WG III: Nonsurgical management of  diverticulitis and dietary recommendations
3.1 Should uncomplicated diverticulitis be treated with antibiotics?
Two randomized clinical trials (AVOD(84, 85) and DIABOLO(71, 86)) were performed 
comparing antibiotic and nonantibiotic treatment in immunocompetent and nonseptic 
patients with uncomplicated acute diverticulitis. No differences in time to recovery 
from the initial episode or in hospital stay were seen in the two trials. Furthermore, no 
differences were observed in the two trials regarding rates of complicated diverticulitis 
and the need for sigmoid resection after the initial diverticulitis episode and on long term 
(up to 11 years), in rates of recurrent diverticulitis, and in the need for sigmoid resection 
during the initial diverticulitis episode. Slightly but nonsignificantly more (elective) 
sigmoid resections were performed in the nonantibiotic group at 24 months (DIABOLO 
trial). This may have been caused by a lower threshold for surgery in the nonantibiotic 
group as they may have felt undertreated for their initial episode. Antibiotic‐related 
morbidity occurred in 8.3% of patients in the antibiotic group from the DIABOLO 
trial. Two recent meta‐analyses of the two randomized trials concluded that patients can 
be treated safely without antibiotics (87, 88). Cross‐sectional imaging to confirm the 
diagnosis of uncomplicated diverticulitis was performed in both randomized trials and 
is encouraged in this guideline (Statement 2.2.1). However, if imaging in mild cases is 
not obtained, an observational strategy without antibiotic treatment seems justified as 
there is no evidence whatsoever for a positive effect of antibiotics in this situation.
Statement
3.1.1 Patients with acute uncomplicated diverticulitis do not require antibiotics 
routinely. Antibiotic treatment should be reserved for immunocompromised 
patients and patients with sepsis.
Evidence level 1, Strong recommendation. Consensus 100%, consensus meeting
3.2 What is the role of  antibiotics in complicated diverticulitis?
Little evidence exists about antibiotic treatment in patients with complicated 
diverticulitis. Many patients with complicated diverticulitis are critically ill and it 
seems unethical to investigate the role of antibiotics in these patients. Patients who 
might be eligible for nonantibiotic treatment are those with small abscesses or small 
air bubbles around the sigmoid. In the above‐mentioned AVOD study (84), patients 
with radiological signs of complications were excluded. The Dutch DIABOLO trial did 
include patients with small abscesses on CT (71). However, the number of patients in 
this category was very small and no final conclusions can be drawn. There are several 
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cohort studies investigating patients with pericolic air, showing that they have the same 
prognosis as patients with uncomplicated diverticulitis (89-91). However, in nearly all 
of these studies patients were treated with antibiotics (92).
Statement
3.2.1 Patients with radiological signs of  complicated diverticulitis should 
normally be treated with antibiotics.
Evidence level 3, Conditional recommendation. Consensus 100%, consensus 
meeting
3.3 Which group of  diverticulitis patients can safely be treated as outpatients?
Two recent systematic reviews (93, 94) have studied the evidence. One included 21 
and the other 19 studies including one randomized trial (95) comparing inpatient and 
outpatient treatment for patients with uncomplicated diverticulitis, and comparable 
rates of readmission were found. The 19 studies combined showed a pooled readmission 
rate of 7%, very low rates of surgical or percutaneous interventions (0.2%) and potential 
healthcare cost savings up to 82%. Most studies only selected patients as outpatient 
treatment candidates based on patient characteristics (such as absence of comorbidities or 
immunosuppressed state), clinical condition (such as having uncomplicated diverticulitis 
and ability to tolerate oral intake) and patients’ social environment (adequate family and 
social network). The second review published in 2019 included 21 studies and found a 
failure rate of 4.3% but highlighted that there were no criteria of failure, which makes 
patient selection difficult.
Statement
3.2.2 For patients with an adequate social network tolerating oral intake, 
outpatient treatment of  uncomplicated diverticulitis seems to be safe in the 
absence of  sepsis, significant comorbidity and immunosuppression.
Evidence level 2, Conditional recommendation. Consensus 97% , consensus 
meeting
3.4 Which supportive measures should be recommended in the acute stage of  
diverticulitis?
Although dietary restrictions and bed rest have been suggested as part of the treatment 
of acute diverticulitis, no benefit has ever been proven in studies. Many surgeons have 
traditionally recommended a low residue diet, but there is little evidence to support 
this practice. Two observational studies showed that an unrestricted diet is not 
associated with an increase in the rate of diverticular complications. A retrospective 
study showed no increase in complications in a group of patients with a solid food diet 
compared to several types of dietary restrictions (96). A prospective single‐arm study 
with an unrestricted diet found an 8.1% complication rate after 6 months, which is 
comparable to rates in the literature on uncomplicated diverticulitis (97). Additionally, 
a randomized trial found no increased pain scores, no increased length of hospital stay 
and no treatment failures in patients with an unrestricted oral regimen compared to 
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an intravenous regimen including a minimum 24 h of fasting (98). Notably, this trial 
primarily compared oral and intravenous antibiotics which may have affected its results. 
Bed rest has not been studied at all. In addition, all patients with acute uncomplicated 
diverticulitis included in studies regarding outpatient management with or without 
antibiotics have had oral antibiotics with comparable outcomes as in the literature.
Statements
3.4.1 There is no evidence to support dietary restrictions. An unrestricted diet 
(when tolerated) is preferable.
Evidence level 3, Conditional recommendation. Consensus 93% (second voting)
3.4.2. Any evidence regarding bed rest is lacking and, since imposed physical 
inactivity may impair the patients’ general condition, bed rest is not recommended.
Evidence level 4, Conditional recommendation. Consensus 100% (second voting)
3.5 Are medical agents (mesalazine, rifaximin, probiotics) useful to prevent 
recurrences or persistent symptoms after an episode of  acute diverticulitis?
Several medical agents have been studied for their ability to prevent recurrent 
diverticulitis or persistent symptoms after an episode of acute diverticulitis: mesalazine 
(anti‐inflammatory agent), rifaximin (nonsystemic, broad‐spectrum nonabsorbable 
antibiotic) and probiotics. Mesalazine has been studied most thoroughly. A recent 
systematic review including seven randomized trials showed a pooled risk ratio for 
recurrent diverticulitis of 0.90 (95% CI 0.61–1.33) for mesalazine treatment compared 
to no treatment or placebo (99). Mesalazine may reduce global symptom scores. This 
has only been investigated by two trials including few patients (77 mesalazine and 76 
control patients)(100, 101). The effect of 7–10 days per month rifaximin was assessed 
in one proof‐of‐concept randomized clinical trial (102) (rifaximin vs placebo) and two 
observational studies (103, 104) (rifaximin vs mesalazine). The randomized clinical 
trial found no difference in recurrent diverticulitis rates at 48 weeks in the intention‐
to‐treat analysis, although some benefit of rifaximin was seen in additional analyses 
that were adjusted for several confounders. However, the number needed to treat is 
high and it is hence not clinically useful. The two observational studies comparing 
rifaximin and mesalazine found opposite results – one was in favour of rifaximin and 
the other in favour of mesalazine. Probiotics have been the topic of two randomized 
trials demonstrating conflicting results. One trial compared a combination of probiotics 
and mesalazine with mesalazine monotherapy (101). The probiotics/mesalazine group 
yielded the highest rate of recurrent diverticulitis and gastrointestinal complaints. The 
other trial found lower rates of recurrent diverticulitis in the probiotics group compared 
to the control (no treatment) group, but this trial included only 43 and 40 patients per 
group respectively and followed patients for only 3 months (105).
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Statement
3.5.1. From the available medical agents, neither mesalazine, rifaximin nor 
probiotics can be recommended to prevent recurrent diverticulitis or persistent 
complaints after an episode of  acute diverticulitis.
Evidence level 3, Conditional recommendation. Consensus 96% (second voting)
3.6 Should a high-fibre diet be recommended following an episode of  acute 
diverticulitis?
A recent systematic review identified only two randomized studies assessing the effect of 
fibre modifications following an episode of acute diverticulitis (106). Both studies were 
conducted over 30 years ago and included only 20 and 56 patients, respectively. A three‐
arm randomized cross‐over intervention study showed a higher proportion of patients 
being symptom free after 1 month of fibre supplements compared to a high‐fibre diet. A 
retrospective cohort study demonstrated a lower recurrence rate in patients adhering to a 
high‐fibre diet compared to patients not adhering to this diet (107). This is in line with 
large epidemiological cohort studies concluding that a high‐fibre diet is associated with 
a lower risk of diverticular disease (39, 40, 108). Although this evidence suggests that a 
high‐fibre diet may be beneficial in the prevention of diverticulitis and its recurrence or 
persistent symptoms, no final conclusions can be drawn due to the limitations of these 
studies.
Statement
3.6.1 Although a high-fibre diet may be recommendable for general health 
purposes, there is little evidence that it can prevent recurrent episodes or 
persistent symptoms in patients with acute diverticulitis.
Evidence level 3, Conditional recommendation. Consensus 93% (second voting)
3.7 What is the appropriate treatment strategy for patients with a diverticular 
abscess in the acute setting?
The management of acute diverticulitis with abscess formation consists of two different 
topics: how to manage these abscesses in the acute stage of disease and whether to 
perform an elective resection due to the complicated nature of this initial episode (see 
Statement 5.2.1). Diverticular abscesses can initially be treated with antibiotics and/or 
percutaneous drainage and/or surgery. A great number of studies have assessed the risk of 
treatment failure in one or more of these treatment strategies. However, no randomized 
data are available, and the observational studies suffer from high risk of selection bias. 
In almost all studies abscesses are larger and patients more severely ill in percutaneous 
drainage groups compared to the antibiotic groups, and in the surgical groups compared 
to nonsurgical groups, hampering the comparison of outcomes between these groups. 
A recent systematic review including 42 studies found comparable rates of treatment 
failure for antibiotics (19.9%), percutaneous abscess drainage (20.8%) and nonoperative 
management (20.6%)(109). Mortality rates increased with increasing invasiveness of 
treatment: 0.6% for antibiotics, 1.1% for nonoperative, 1.6% for percutaneous drainage 
and 12.1% for surgery. A recent large multicentre observational study including 447 
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patients demonstrates a significantly higher rate of treatment failure in the percutaneous 
drainage group compared to antibiotic treatment group (36% vs 24%, P  = 0.013) and 
more complications in a subgroup of patients with a large or distant abscess (Hinchey 
II) when undergoing percutaneous drainage compared to antibiotics (12% vs 4%, P 
= 0.032), although these results were probably affected by selection bias as previously 
mentioned (110). In an attempt to eliminate this selection bias as much as possible in 
observational data, a multivariate analysis has been performed showing that percutaneous 
drainage was not independently associated with treatment failure (OR 1.47, 95% CI 
0.81–2.68). In addition to earlier studies indicating 3 cm as the best cut‐off above which 
treatment failure is more likely, multivariate analysis in this study showed an abscess 
cut‐off size of 3 cm as the best predictor for treatment failure and 5 cm for the need for 
emergency surgery. However, in subgroups of patients with abscesses larger than 3 and 
5 cm, respectively, percutaneous drainage was not able to decrease the rates of treatment 
failure. In summary, the risk of adverse outcomes increases with abscess size, but the role 
of percutaneous drainage remains unclear.
Statement
3.7.1 Although the role of  percutaneous drainage of  abscesses in acute 
diverticulitis is not completely clear, it may be considered in patients with an 
abscess larger than 3 cm. Emergency surgery should be kept as last resort for 
patients failing other nonsurgical treatments.
Evidence level 3, Conditional recommendation. Consensus 100% (consensus 
meeting)
WG IV: Emergency surgery for acute diverticulitis
4.1 What are the indications for abdominal exploration in patients with acute 
diverticulitis?
Clinical evaluation alone is very subjective and has not been assessed in many studies. 
Traditionally, clinical signs of sepsis in combination with generalized peritonitis were 
considered an indication for surgery. This practice is based on experience rather than 
evidence. Radiologically detected extraluminal air has usually been considered as a sign 
of perforation with indication for surgery. There is little evidence, however, whether 
pericolic or free air alone is an indication for exploration or not. If extraluminal air is 
used as a surrogate marker for abdominal exploration, there are five retrospective and 
three prospective cohort studies with a total of 1470 patients (89-91, 111-115). Most of 
the studies are of poor quality with a low number of patients. Between 0% and 10% of 
all patients required a surgical procedure.
Free fluid has been suggested to be another surrogate marker, but it is frequently found 
in uncomplicated diverticulitis as well, rendering the use as a surrogate marker for 
complicated disease difficult (84).
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Statement
4.1.1 It seems fairly safe to observe immunocompetent haemodynamically stable 
patients even if  there are radiological signs of  extraluminal air. Immediate 
surgery should be considered in haemodynamically unstable or septic patients.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
4.2 Which surgical approach is appropriate in patients with faecal peritonitis (overt 
perforation)?
There are no randomized trials that involve nonsurgical or nonresectional treatment for 
faecal peritonitis (116-119). Some patient series have investigated laparoscopic closure 
of a perforation combined with laparoscopic lavage but there is little evidence to support 
this practice (120). There are some studies suggesting damage control with a second 
look within a couple of days (116, 121). Neither are established techniques. There 
are no randomized trials comparing the laparoscopic vs the open technique for faecal 
peritonitis and existing nonrandomized trials are heavily influenced by selection bias.
Statement
4.2.1 The surgical approach in patients with faecal peritonitis should be 
related to the experience of  the surgeon; there is no evidence supporting 
laparoscopic or open surgery. Resection is the treatment of  choice.
Evidence level 4, Strong recommendation. Consensus 97% (second voting)
4.3 Which surgical approach is appropriate in patients with purulent peritonitis?
There are three recently published randomized trials comparing laparoscopic lavage 
to open surgery with sigmoid resection with or without primary anastomosis. In 
the three studies, a total of 358 Hinchey III patients were included of whom 185 
underwent laparoscopic lavage (122-124). Several meta‐analyses have been performed 
with somewhat different results (125-133). There are several noncomparative cohorts 
showing that laparoscopic lavage is feasible in selected patients (134).
Laparoscopic lavage reduces the risk for colostomy at 1‐ and 2‐year follow‐up but may 
in the short term result in intra‐abdominal abscesses and overlooked free perforations 
or tumour perforations requiring reintervention (drainage or reoperation)(135, 136). 
Laparoscopic lavage is cheaper than resection and colostomy (Hartmann’s procedure)
(137-139).
Statement
4.3.1 Laparoscopic lavage is feasible in selected patients with Hinchey III 
peritonitis. Alternatively, resection is recommended.
Evidence level 2, Conditional recommendation. Consensus 93% (second voting)
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4.4 What is the role of  restoration of  intestinal continuity with or without proximal 
faecal diversion in the management of  acute diverticulitis?
Several studies have addressed the intestinal continuity during surgical treatment for 
acute diverticulitis. There are three cohort studies and four randomized trials (116-119, 
140-142). The randomized clinical trials all include a diverting loop ileostomy in the 
primary anastomosis arm. None of the randomized clinical trials found a difference 
in morbidity or mortality between primary anastomosis and sigmoid resection with 
colostomy. Primary anastomosis will result in a lower stoma rate but may also increase 
the risk for complications. Many studies have used a diverting loop ileostomy. The 
DIVA arm of the LADIES trial has indicated that primary anastomosis is a safe option 
for Hinchey III and Hinchey IV patients compared to resection and a stoma (142). The 
larger cohort studies included both Hinchey III and Hinchey IV and one of the cohort 
studies included 67 721 patients (141). This study found a higher risk for complications 
in patients with anastomosis and diversion compared to colostomy.
Statement
4.4.1 Primary anastomosis with or without diverting ileostomy can be performed 
in haemodynamically stable and immunocompetent patients with Hinchey III 
or IV diverticulitis.
Evidence level 2, Conditional recommendation. Consensus 97% (second voting)
WG V: Elective surgery for diverticulitis
5.1 When should elective sigmoid colectomy be considered after recovery from 
uncomplicated acute diverticulitis?
Previously elective colon resection after the second episode of uncomplicated diverticulitis 
in order to prevent severe attacks was widely recommended (79, 143, 144). While 
sigmoid resection is effective to reduce the risk of recurrent attacks of diverticulitis, 
several cohort studies have shown that complications are most likely to occur at the first 
episode and prophylactic surgery to prevent complications is not indicated (52, 145). 
The only justifiable reason to operate on patients with recurrent disease or with ongoing 
symptoms after uncomplicated diverticulitis is to improve their quality of life (QoL). 
There are numerous retrospective cohort studies on elective surgery (146-151), some 
of them addressing QoL(150, 151). These studies are very heterogeneous and of low 
quality, with a high probability of selection bias and inconsistent findings (152).
Recently the short‐ and long‐term results of the DIRECT trial have been published. This 
is the only randomized trial comparing elective surgery vs conservative management of 
patients with frequently recurrent diverticulitis or ongoing symptoms after an episode 
of diverticulitis (153, 154). The QoL after 6 month and after 5 years was significantly 
better for patients in the surgical group. However, the trial had several limitations. It 
was prematurely aborted, had a relatively small sample size and the observed difference 
in QoL between the groups was quite small. Furthermore, the inclusion criteria were 
very strict, only patients with frequent recurrences (more than two within 2 years) or 
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patients with ongoing symptoms and radiologically or endoscopically proven ongoing 
inflammation were eligible. The complication rate in the operative group was high (15% 
anastomotic leakages).
Statements
5.1.1 Elective surgery to prevent complicated disease is not justified, irrespective 
of  the number of  previous attacks.
Evidence level 2, Strong recommendation, Consensus: 97% (second voting)
5.1.2 There is no evidence to support resection in symptomatic patients without 
radiological or endoscopic signs of  ongoing inflammation, stenosis or fistula.
Evidence level 3, Strong recommendation. Consensus 97% (second voting)
5.1.3 The goal of  elective surgery after one or more episodes of  diverticulitis 
is to improve QoL. The indication should be individualized and based on the 
frequency of  recurrences, duration and severity of  symptoms after the attacks 
and the comorbidity of  the patient.
Evidence level 3, Strong recommendation. Consensus 97% (second voting)
5.2 Should elective colectomy typically be offered/considered after recovery from a 
conservatively managed episode of  acute complicated diverticulitis?
Traditionally most patients with acute complicated diverticulitis were treated with 
emergency surgery, which before the era of cross‐sectional imaging was the only way 
to diagnose complicated disease with certainty (10). The introduction of CT and 
transcutaneous treatment of abscesses has revolutionized the treatment of abscesses and 
acute surgery is rarely required in these patients. It is quite likely that the frequent use of 
CT has also led to a stage migration, as the detection of small amounts of extraluminal 
air and small abscesses is much easier with up to date multidetector CT scanning. 
Many patients with covered perforations or even with distant free air are now initially 
treated conservatively with antibiotics alone. Several previous guidelines recommend 
elective resection after a complicated attack but there is little evidence to support 
this practice. Some retrospective cohort studies have reported higher recurrence rates 
after acute complicated diverticulitis (up to> 60%) compared to acute uncomplicated 
diverticulitis (15%–23%) whereas others report similar recurrence rates in both groups 
(84, 86, 155-157). A systematic review shows a recurrence rate of 25.5% in 7653 
patients with diverticular abscesses (109). Other studies that are published later show 
mostly comparable rates of 25%–30% but ranging from 9% to 61%(50, 110, 158-
162). Several studies included in the systematic review do not show an increased risk for 
complications in recurrent episodes; others (160) report a 63% complicated recurrence 
rate and the previously discussed large observational study (110) shows 43% of 
recurrences being complicated. It should be noted that a substantial number of patients 
can be treated nonoperatively again and the risk of recurrence requiring acute operation 
following conservative management of acute complicated diverticulitis is relatively low 
(159, 160). There is only one small trial which randomized patients with extraluminal 
air and/or abscesses to either elective surgery (n  = 26) or observation (n  = 81). The 
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majority of patients in the observation group did not require elective surgery. However, 
QoL was not evaluated in this trial (163).
Statement
5.2.1 The decision to operate on patients after a conservatively managed episode 
of  acute complicated diverticulitis should follow the same principles as for patients 
with uncomplicated diverticulitis, resection is not recommended routinely.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
5.3 How should surgery of  persisting abscesses and fistulas be performed and is there 
a role for nonsurgical treatment?
There are few high‐quality studies investigating the management of persistent abscesses 
and fistulas due to diverticulitis. Some descriptive case series, focusing either on the 
open or the laparoscopic approach, supported resection with primary anastomosis 
when possible and contextual bladder resection if needed (164-172). Only one small 
retrospective cohort study investigated laparoscopic vs open surgery, demonstrating 
similar results (173). Although limited by the poor quality of included studies, two 
meta‐analyses by the same first author reported no clear advantage of the laparoscopic 
approach(174, 175). Furthermore, the authors highlighted that the laparoscopic 
approach may be challenging and consequently should be performed by experienced 
laparoscopic surgeons. There is only scarce evidence for the use of a robotic approach 
(176, 177). The conservative management of fistulas is documented only in two older 
retrospective studies(178, 179). Although limited by several sources of bias, the results 
of these studies were in favour of surgical management when the patient’s general 
condition allows it, as the conservative treatment is related to a high mortality rate and 
poor QoL. There is no evidence concerning oncological vs nononcological resection.
Statement
5.3.1 Fistulas or persistent abscesses should normally be treated with laparoscopic 
or open resection of  the diseased bowel with or without anastomosis.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
5.4 Which surgical approach is most appropriate in elective surgery for diverticulitis 
(open/laparoscopic)?
Laparoscopic sigmoid resection for the treatment of diverticular disease is feasible in an 
elective setting (180-185). Three randomized controlled trials comparing laparoscopic 
to open sigmoid resection have been published (186-188). However, they were all 
underpowered, included different stages of the disease and reported inconsistent 
results. Only two of these conclude with better short‐term outcomes with laparoscopic 
resection (187, 188) and none of the three demonstrated convincing superiority of the 
laparoscopic over an open approach in long‐term results. Three meta‐analyses about the 
role of mini‐invasive surgery for elective surgery for diverticulitis have been published 
(189-191), two of which included nonrandomized studies (189, 190). The Cochrane 
review by Abraha et al.(191) analysed only the three existing randomized clinical trials. 
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They find it uncertain whether laparoscopic sigmoid resection has any substantial 
advantage over open sigmoid resection in diverticular disease. However, laparoscopic 
surgery has evolved since these trials were conducted and it is likely that laparoscopic 
resection has the same short‐term advantages in diverticular disease as demonstrated for 
other diagnoses.
Statement
5.4.1 Elective colon resection for diverticulitis should preferably be performed 
laparoscopically when feasible.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
5.5 Should immunocompromised and young patients be treated differently?
In immunosuppressed patients, complicated diverticulitis appears to be more aggressive, 
with more frequent free peritoneal perforation and worse outcomes (192, 193). The 
incidence of complicated diverticulitis in patients after organ transplant is approximately 
1% higher than in immunocompetent patients (194). Nonoperative management of 
renal transplant patients with uncomplicated diverticulitis is safe, with outcomes similar 
to immunocompetent patients. However, the optimal management of renal transplant 
patients with complicated diverticulitis remains unclear as both treatment choices 
and complication rates differed from immunocompetent patients (195). Comparison 
of elective colectomy in transplant patients after one episode vs multiple attacks of 
diverticulitis showed no differences in complication rates and mortality. Colectomy 
after a single attack of diverticulitis in transplant patients is not justified as the operative 
risk is higher in these patients (196).
Among immunocompromised patients, chronic corticosteroid users have the highest risk 
of emergency surgery and of recurrence, especially in the first year after a diverticulitis 
attack. There should be a low threshold for abdominal CT in their follow‐up, to search 
for persistent fluid collections or pericolic inflammation, in which case elective surgery 
may be indicated (197).
In young patients elective surgery after one episode of acute diverticulitis has been 
suggested due to the supposedly higher risk of recurrences and a more aggressive 
presentation (198). In a systematic review including 4751 patients younger and 18 328 
older than 50 years of age, patients younger than 50 years substantially differ from 
patients older than 50 years only in the risk for recurrent disease. Although the relative 
risk for requiring urgent surgery for recurrent disease may be higher in younger patients, 
the absolute risk difference was relatively small (7.3% vs 4.9%)(199). Nevertheless, 
controversy persists about whether younger patients have more aggressive attacks, 
and the effect of the disease on their QoL. However, recommendation of more liberal 
resection in younger patients is not supported by the evidence (200).
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Statement
5.5.1 The decision for elective resection after an acute episode of  diverticulitis 
in immunocompromised and younger patients should follow the same principles 
as in other patients and is not recommended routinely.
Evidence level 3, Conditional recommendation. Consensus 100% (consensus 
meeting)
WG VI: Technical considerations – special considerations
6.1 What is the role of  leak tests in surgery for diverticular disease?
The literature search did not show studies assessing intra‐operative leak tests during 
surgery for diverticulitis. However, a systematic review and meta‐analysis of 20 studies 
assessing intra‐operative air leak test (ALT) during colorectal surgery concluded that 
evidence suggests that ALT is necessary to identify patients with a higher risk of colorectal 
anastomotic leakage (201). In addition, another systematic review assessed ALT and 
recommended intra‐operative ALT, since it is relatively simple, inexpensive and allows 
for intra‐operative revision of the anastomosis (202). This is further supported by the 
results of the largest randomized trial so far, comparing ALT to no ALT in 145 colorectal 
surgery patients, that demonstrated that ALT significantly reduces the incidence of 
postoperative clinical and radiological leaks (203). We suggest that, in the case of a 
doubtful air leak, the test should be repeated. Moreover, after a positive ALT, a test with 
methylene blue might be used to examine the extent and location of the leak.
Statement
6.1.1. An ALT of  the colorectal anastomosis during surgery for sigmoid 
diverticulitis is recommended.
Evidence level 2, Conditional recommendation. Consensus 93% (second voting)
6.2 Which extent of  resection is appropriate in an emergency setting?
Most literature regarding the extent of resection is based on retrospective data of elective 
surgery for diverticular disease (204-209). A recent case–control study did not show 
histological inflammation or diverticula at the resection margins to be correlated with 
the occurrence of anastomotic stenosis (206). Extending margins in the case of extensive 
diverticulosis seems unnecessary to prevent recurrent diverticulitis (209). However, with 
regard to the construction of an anastomosis, it seems important to resect the grossly 
inflamed bowel segment both proximally and distally. Limited data are available on 
the proximal resection margin, whereas more data are available on the distal margin. 
Evidence from studies comparing colo‐sigmoid and colorectal anastomoses suggests that 
the latter has a lower frequency of recurrent disease (204). 
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Statements
6.2.1 In the emergency setting, the focus is to control sepsis and resect the 
perforated segment.
Evidence level 4, Conditional recommendation. Consensus 100% (consensus 
meeting)
6.2.2 In the case of  resection and primary anastomosis, sigmoid resection down 
to the rectum with colorectal anastomosis should be done, with the proximal 
margin in as healthy colon as possible.
Evidence level 3, Strong recommendation. Consensus 100% (consensus meeting)
6.3 What is the preferred vascular approach in surgery for diverticular disease?
A meta‐analysis, published in 2012, indicates no significant difference in anastomotic 
leak rate between preservation or ligation of the inferior mesenteric artery (IMA)(210). 
Results from a randomized, controlled trial comparing IMA preservation and ligation 
in patients undergoing surgery for diverticulitis (note that Hinchey III/IV were not 
included) show an improvement in intestinal function through a reduction in neo‐
sigmoid denervation (211). Results from a comparable randomized trial show clinical and 
radiological leakage rates to be lower in the IMA preservation group (212). More recent 
evidence, from both retrospective and prospective cohort studies, was either in favour of 
IMA preservation or inconclusive on its effect compared to IMA ligation (213-217). A 
recent review and meta‐analysis failed to demonstrate a statistically significant difference 
in the anastomotic leakage rate comparing IMA preservation with IMA ligation (218). 
The authors conclude that, to date, there is insufficient evidence to recommend the 
IMA‐preserving technique as mandatory in resection for left‐sided colonic diverticular 
disease and the decision remains at the discretion of the operating surgeon. High ligation 
seems warranted in cases with diagnostic uncertainty or when cancer cannot be excluded 
(inconclusive CT, MRI or endoscopy), whereas IMA preservation might be beneficial in 
cases where the diagnosis is clear.
Statement
6.3.1 In cases where there is no suspicion of  cancer, IMA-preserving surgery 
can be performed to optimize preservation of  the vascularization and the 
autonomic nerves.
Evidence level 2, Strong recommendation. Consensus 97% (second voting)
6.4 What is the role of  ureteral stents in elective resection for diverticular disease?
No results from prospective, randomized trials were available (219-221). Results from 
large population‐based studies performed in the USA have shown that, after adjustment 
for other patient and clinical factors, ureteral stenting in surgery for diverticular disease 
is significantly associated with a longer operative time, as well as a longer length of 
stay and higher costs (219, 220, 222). Despite this, the benefits of ureteral stent use 
remain unclear, since the available literature indicates that selective stent use might have 
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led to confounding by indication. Evidence identifying patient populations that most 
probably benefit from ureteral stenting is not available yet.
Statement
6.4.1 Ureteral stenting is not recommended as a routine, due to increased costs and 
operative time, but may be appropriate in selected cases with severe complicated 
disease.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
6.5 Should the splenic flexure routinely be mobilized?
One retrospective study was identified that compared routine splenic flexure mobilization 
with no splenic flexure mobilization in elective surgery for diverticular disease (223). Data 
were derived from a population‐based cohort, with innate risk of selection bias, and showed 
splenic flexure mobilization to be safe and feasible. Despite a trend towards an increased 
minor morbidity rate (defined as superficial or deep surgical site infection, pneumonia, 
unplanned intubation, urinary tract infection or deep vein thrombosis) after splenic flexure 
mobilization, no difference was found in major adverse events. One other retrospective 
study showed from univariate analysis that splenic flexure mobilization did not seem to 
contribute to the complication rate (224). From the literature, it is suggested that splenic 
flexure mobilization is performed on an individual basis, depending on the anatomy, disease 
extent, and the potential for the creation of a tension‐free anastomosis (223).
Statement
6.5.1 Partial or full mobilization of  the splenic flexure might facilitate the 
anastomosis being made of  soft and compliant descending colon, by being brought 
down to the pelvic brim and anastomosed with the rectum without tension. It is up 
to the judgement of  the surgeon whether this is necessary.
Evidence level 3, Conditional recommendation. Consensus 100% (second voting)
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Abstract
Aim
Parastomal hernia is the most common complication following stoma construction. 
Surgical treatment is usually chosen over non-operative treatment, but a clear rationale 
for the choice of management is often lacking. This study aims to investigate reasons for 
non-operative treatment, cross-over rates and postoperative complications.
Method
A multicentre, retrospective cohort study was conducted. Patients diagnosed with a 
parastomal hernia between January 2007 and December 2012. Data on baseline 
characteristics, primary surgery and hernias were collected. For non-operative treatment 
patients, reasons for this treatment and cross-over rates were evaluated. For all patients 
undergoing surgery (surgical treatment and cross-overs), complication and recurrence 
rates were analyzed.
Results
Of the 80 patients included, 42 (53%) were in the surgical treatment group and 
38 (48%) in the non-operative treatment group. Median follow-up was 46 months 
(interquartile range 24-72). The reasons for non-operative treatment were absence of 
symptoms in 12 patients (32%), comorbidities in nine (24%) and patient preference in 
three (7.9%). In 14 patients (37%) reasons were not documented. Eight patients (21%) 
crossed over from non-operative treatment to surgical treatment, of whom one needed 
emergency surgery. In 23 patients (55%), parastomal hernia recurred after original 
surgical treatment, of whom 21 (91%) underwent additional repair.
Conclusion
Parastomal hernia repair is associated with high recurrence and additional repair rates. 
Non-operative treatment has a relatively low cross-over and emergency surgery rate. 
Given these data, non-operative treatment might be a better choice for patients without 
complaints or with comorbidities.
What does this paper add to the literature?
Parastomal hernia is the most common complication after stoma construction. To date, 
no data exist on non-operative treatment as a treatment option. This paper analyses non-
operative treatment and compares it with surgical treatment. By doing so, it provides a 
first step towards patient-centered treatment of parastomal hernia.
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Introduction
Parastomal hernia is the most common complication following stoma construction, 
especially after end colostomy(1, 2). Incidence numbers depend on the type of stoma, 
with ileostomy leading to 0-6.0% herniation and colostomy to 3.0-39% herniation(2-4). 
Over 120,000 colostomies are created each year in the USA alone(5), potentially 
resulting in 3,600-46,800 parastomal hernias. 
Preventative strategies such as prophylactic mesh placement or extraperitoneal colostomy 
have lowered these numbers, but they remain high(6-8). 
Parastomal hernia commonly occurs within the first year after stoma formation, but the 
incidence increases over time(1). Parastomal hernias can be asymptomatic. However, when 
parastomal hernias become symptomatic, complaints can be discomfort, pain, bowel 
obstruction, problems with stoma appliance handling, leakage and incarceration(3). 
The majority of patients with parastomal hernia are managed primarily by hospital 
stoma care nurses (SCN), who therefore play an important role in the provision of care 
for patients with parastomal hernia(9). However, surgery remains the most common 
treatment of parastomal hernias. Surgical treatment can be performed both open and 
laparoscopically and with or without mesh augmentation, but there is no consensus. 
Recent research has focused mainly on surgical repair with mesh augmentation(10). 
However, mesh repair still results in recurrence rates of 6.9-17%(11). 
Apart from surgery, non-operative treatment (NT) potentially is an appropriate 
alternative. The obvious benefit of this strategy is the absence of the risk of complications 
following surgical repair. On the other hand, the potential risk is emergency surgery for 
incarceration or strangulation, which is associated with higher complication rates than 
elective surgery(12, 13). 
For inguinal hernia treatment, the NT strategy is generally accepted after being proven 
to be safe and cost effective(14-16). More recently, Verhelst et al. (17) found that non-
operative treatment in patients with incisional hernia leads to a one-third cross-over 
rate with high rates of postoperative complications. However, whether this strategy 
could be useful for parastomal hernia has not yet been properly investigated. Only one 
study from 1984 describes the possibility of non-operative treatment(18). The study by 
Cevese et al.(18) was characterized by a number of methodological flaws: only 27% of 
all patients having a colostomy were examined, a variety of different surgical approaches 
for colostomy were included, and there was no definition of outcome. For these reasons, 
no robust conclusions could be drawn. 
Therefore, the aim of this retrospective study was to identify the rationale for choosing 
NT or surgical treatment (ST) for parastomal hernia and to compare outcomes of both 
strategies in terms of complications, hernia recurrences and cross-over rates.
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Method
A multicentre, retrospective study was performed. The study was approved by 
all participating hospitals’ Institutional Review Boards. Informed consent was 
waived for participation in this study, because it was a retrospective records review. 
STROBE (Strengthening the Reporting of Observational studies in Epidemiology) 
recommendations for the reporting of observational studies were used(19).
All patients diagnosed with a parastomal hernia between January 2007 and December 
2012 were included from the databases of the Erasmus University Medical Center 
Rotterdam, Academic Medical Center Amsterdam, Havenziekenhuis Rotterdam, and 
IJsselland Hospital Capelle aan den IJssel. Colostomies (end and loop), ileostomies 
(end and loop), and ileal conduits were included. The diagnosis of parastomal hernia 
could be made by the stoma care nurse or the surgeon and could be made clinically or 
radiologically. In all participating hospitals, experienced hernia surgeons were involved 
and both ST and NT were treatment strategies used for parastomal hernia. Since no 
international guidelines exist on this topic, the decision to choose either treatment 
was made in agreement between surgeons and patients. Patients were divided into two 
groups based on initial treatment strategy chosen directly after diagnosis: ST and NT. 
Only patients who were diagnosed with parastomal hernia in an elective setting were 
included. Patients with first presentation of parastomal hernia in an emergency situation 
were excluded, since NT is seldom a therapeutic option in these patients. Patient records 
and the electronic hospital database systems were reviewed. Patients were identified 
searching for DBC codes (‘Diagnose Behandel Combinatie’; Diagnosis Related Groups) 
and ICD-9 codes (International Statistical Classification of Diseases and Related Health 
Problems). To minimize the risk of missing eligible patients, all codes regarding any 
abdominal wall hernia were searched for in the medical records of patients with a stoma.
Data collection
General patient characteristics, comorbidities, medical history, American Society 
of Anesthesiologists (ASA) grade, and information regarding primary surgery were 
recorded. Symptoms at first presentation were categorized into groups: pain, appliance 
leakages, aesthetic complaints, and bowel obstruction. Parastomal hernia size (defect of 
the abdominal wall fascia, as measured with ultrasound or axial CT imaging) and the 
presence of a concomitant incisional hernia were noted for European Hernia Society 
(EHS) classification (class I, size <5cm without a concomitant incisional hernia; class 
II, size <5cm with a concomitant incisional hernia; class III, size >5cm without a 
concomitant incisional hernia; and class IV, size >5cm with a concomitant incisional 
hernia)(20).
For patients in the ST group and cross-over patients from the NT group, reasons for ST 
and type of repair were noted and postoperative complications (infection, postoperative 
ileus, perforation, obstruction) were scored. In general, patients visited stoma nurses or 
surgeons on a regular basis. Data on recurrence and, if needed, additional surgical repair 
were collected. For patients in NT group, the reason of NT (absence of symptoms, 
comorbidity, obesity, patient preference) was noted. 
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Statistical analysis
Statistical analyses were performed with the SPSS Software Package (IBM SPSS Statistics 
for Windows, Version 21.0. Armonk, New York, USA). To test normal distribution 
of continuous variables, Levene’s test for equality of variances was used. Continuous 
variables are presented as medians with interquartile ranges or as means with standard 
deviations, depending on the normality of data distribution. Categorical variables are 
presented as numbers with percentages (%). Differences between groups were compared 
using Mann-Whitney U test (continuous data) or chi-squared test (categorical data). In 
case of small groups (n<5), Fisher’s exact test was used. P values <0.05 were considered 
statistically significant.
Results
A total of 80 patients were included from the hospital databases. Of these 80 patients, 42 
patients (53%) were scheduled for ST. NT was chosen in 38 patients (48%). Reasons for 
NT were absence of symptoms in 12 patients (32%), comorbidities in nine (24%) and 
patient preference in three (7.9%). In 14 patients (37%) reasons were not documented. 
Eight patients (21%) of the 38 NT patients crossed over to ST. Of these eight patients, 
one patient had to undergo emergency surgery (2.63% of the total NT group). Median 
follow-up duration of all patients was 46 months (interquartile range was 24-72) and 
did not differ between the ST and NT group [respectively, 43.5 months (20.3-72.0) and 
47.1 (28.5-96.2), P = 0.823].
Patient characteristics 
Baseline characteristics of both groups are given in Table 1. Mean age in the ST group 
was 51 ± 15 years and 63 ± 12 in the NT group (P < 0.001). There were less patients 
with COPD in the ST group than in the NT group (n=0 (0%) vs n=4 (11%), P = 
0.047). Ten patients (24%) in the ST group were operated for a malignancy compared 
to 23 patients (62%) in the NT group (P < 0.001). Consequently, more patients in the 
ST were operated for other reasons (n=16 (39%) vs n=5 (14%), P = 0.020). All other 
characteristics (baseline characteristics, stoma types, and complications after primary 
surgery) were not statistically significantly different between the ST and NT groups.
Parastomal hernia characteristics
Parastomal hernia characteristics are listed in Table 2. The mean hernia size was 3.59 ± 
1.96 cm in the ST group and 3.43 ± 1.37 cm in the NT group (P = 0.762). Size details 
were not available for 18 patients (43%) of the ST group and 18 patients (47%) of 
the NT group because of the absence of ultrasound or CT images. There were fewer 
asymptomatic patients in the ST group compared with the NT group (n=1 (2.7%) vs 
n=9 (27%), P = 0.005), but more patients with pain as their presenting symptom (n=24 
(65%) vs n=6 (18%), P < 0.001). Other symptoms were not significantly different. 
Presenting symptoms are presented in Table 2 and Figure 1. There was no difference 
between groups in the time between initial surgery and parastomal hernia diagnosis, or 
in EHS Classification(20).
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Type of  hernia repair and complications after hernia repair
Table 3 shows the different types of procedures performed for hernia repair. The vast 
majority of patients (72% in total) underwent open mesh repair. For two patients (25%) 
in the NT group, no specific records were available on the type of procedure. This was 
the only significant difference between the two groups.
An overview of the surgical complications is listed in Table 4. There were no statistically 
significant differences between the two groups; complication rates were 45% for ST and 
50% for NT cross-overs (P = 1.000). Parastomal hernia recurrence occurred in 48% of 
all operated patients: in 23 (55%) ST patients and one (13%) NT cross-over patient 
(P = 0.05). Recurrences led to additional repair in 21 (50%) ST patients but in none 
of the NT patients (P = 0.015). Emergency surgery was needed for incarceration of the 
parastomal hernia in three patients (7.1%) in the ST group and one patient (13%) in 
the NT group. Detailed results regarding only those patients with end colostomy can be 
found in Supporting Information Tables S1 and S2. 
Discussion
In this retrospective study of 80 patients with a parastomal hernia, the main reason for 
choosing NT over ST was absence of complaints (32%) and presence of comorbidities 
(24%). For 14 patients (37%), the reason for NT was not documented in the medical 
records. Although not documented, based on the baseline characteristics it could 
be that the initial oncologic surgery was a reason for NT in some of these patients. 
During a median follow-up of 46 months, eight patients (21%) crossed over from NT 
to ST. Cross-over, however, did not result in higher emergency surgery, postoperative 
complications or recurrence rates.
To date, few published data exist on outcomes of NT for parastomal hernia. There is one 
study from which no conclusions can be drawn because of its methodological flaws(18). 
However, data on NT for inguinal and incisional hernia are available(14-17). The data 
on inguinal hernia suggest that NT can be safe, whereas for incisional hernia cross-over 
to ST was associated with higher rates (29% vs 17%) of postoperative complications(17). 
Our study found higher postoperative complication rates in both groups (45% for ST 
and 50.0% for NT cross-overs). These figures are in accordance with literature data on 
parastomal hernia repair(21). 
Apart from complications, the cumulated recurrence rate of both groups was 48%. 
Similar rates (6.9%-69.4%) are found in the literature(10). This demonstrates that 
parastomal hernia surgery is still not very successful. As long as these numbers remain 
this high, NT seems to be a feasible treatment option.
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Limitations
The main limitation of this study is its retrospective design, which could potentially 
have introduced selection bias. NT strategy could have been chosen more often in 
patients with a worse general condition. This might be reflected in some of the baseline 
characteristics displayed in Table 1. However, it does not affect the results after hernia 
repair surgery in those patients who crossed over (Table 4). 
It is possible that patients have visited other hospitals for ST (both elective and emergency 
surgery). Additionally, hernia characteristics and patients’ complaints were not recorded 
systematically by surgeons or stoma nurses.
Secondly, we found a relatively small number of patients with parastomal hernia, given 
the study period and the number of participating hospitals. In our opinion, two possible 
explanations exist for this finding: (i) many patients with an asymptomatic parastomal 
hernia would not be referred to a hospital for this reason only and (ii) many parastomal 
hernias would not be diagnosed or registered during regular follow-up for patients’ 
underlying disease. For these reasons, we can conclude that any missed patients were 
more likely to be treated conservatively. Moreover, patients who have surgery are more 
likely to have been identified because of that documentation in the patient records. 
Therefore, the NT group might in fact be larger and consequently cross-over rates might 
be lower than reported in this study. Finally, one important limitation in hernia research 
in general is the lack of data on patient-reported outcomes, such as quality of life and 
body image. Although they were reported as reasons for treatment choice, no patient-
reported data were available on complaints after surgery and reasons for NT were 
missing in 37% of those cases. Therefore, the only outcome measures used to compare 
the two groups were parastomal hernia recurrence, postoperative complications, and 
emergency surgery rates.
To get more insight into the effects of different treatment options on patient-reported 
outcomes, prospective studies or registries should include these as outcome measures. 
Widely used generic quality of life questionnaires might not be able to distinguish 
between the effect of the underlying disease and the parastomal hernia itself. Therefore, 
disease-specific quality of life questionnaires concentrating on stoma-specific symptoms 
should preferably be used. Recently, an attempt has been made to develop such a 
questionnaire, which might be useful for future research (22). Furthermore, prospective 
research might be able to study more, possibly asymptomatic, patients with parastomal 
hernias, who are otherwise missed in retrospective reviews. Data from these future 
studies could support treatment recommendations for asymptomatic and symptomatic 
patients with a parastomal hernia.
In conclusion, despite the above mentioned limitations, this study is the first to provide 
insight into reasons, complications, and cross-over rates for NT compared to ST in 
patients with parastomal hernias. Based on the results, NT might be the better choice in 
patients without complaints or with comorbidities, since there is more potential for risk 
than benefit of ST in these patients.
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Tables
Table 1 Baseline patient characteristics
Characteristic Surgical treatment
(n=42)
Non-operative treatment
(n=38)
P value
Age (SD) 51(15) 63 (12) <0.001
Male (%) 17 (41) 22 (58) 0.179
BMI (SD) 27.65 (4.82) 26.02 (3.62) 0.101
Smoking (%) 10 (24) 7 (20) 0.786
COPD (%) 0 (0) 4 (11) 0.047
Corticosteroid use (%) 4 (9.5) 3 (7.9) 1.000
ASA Class (%) 0.169
I-II 37 (90) 20 (77)
III-IV 4 (9.8) 6 (23)
Indication of initial surgery (%)
Malignancy 10 (24) 23 (62) 0.001
IBD 15 (37) 9 (24) 0.327
Other 16 (39) 5 (14) 0.020
Emergency surgery 11 (26) 10 (26) 1.000
ICU admission 6 (17) 7 (22) 0.760
Type of ostomy (%)
End colostomy 23 (55) 26 (68) 0.254
Loop colostomy 2 (4.8) 0 (0) 0.495
End ileostomy 11 (26) 9 (24) 1.000
Loop ileostomy 2 (4.8) 1 (2.6) 1.000
Ileal conduit 4 (9.5) 2 (5.3) 0.678
Complications* (%)
Surgical site infection 1 (2.9) 4 (12) 0.191
Abscess 2 (5.7) 5 (15) 0.259
Fistula 1 (2.9) 1 (3.0) 1.00
Ileus 4 (11) 2 (6.1) 0.675
Pneumonia 2 (5.6) 3 (9.1) 0.665
Other complications 7 (17) 4 (11)
Follow-up time in months (IQR) 43.5 (20.3-72.0) 47.1 (28.5-96.2) 0.823
BMI, body mass index; COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiologists; 
IBD, inflammatory bowel disease; ICU, intensive care unit; IQR, interquartile range. *Complications after initial surgery. 
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Table 2 Hernia characteristics
Characteristic Surgical treatment
(n=42)
Non-operative treatment
(n=38)
P value
Size in cm (SD) 3.59 (1.96) 3.43 (1.37) 0.762
EHS Classification (%)
I 17 (71) 12 (60) 0.532
II 4 (17) 6 (30) 0.472
III 1 (4.2) 2 (10) 0.583
IV 2 (8.3) 0 (0) 0.493
Time to diagnosis in months (IQR) 16.69 (5.67-38.05) 15.49 (4.90-31.63) 0.907
Presenting symptoms (%)
No symptoms 1 (2.4) 9 (23.7) 0.011
Pain 24 (57) 6 (15.8) <0.001
Appliance leakages 6 (14.3) 9 (23.7) 0.391
Bowel obstruction 4 (9.5) 6 (15.8) 0.505
Aesthetic complaints 1 (2.4) 2 (5.3) 0.602
Incarceration 1 (2.4) 1 (2.6) 1.000
Unknown 5 (12) 5 (13) 1.000
EHS, European Hernia Society; IQR, interquartile range
Chapter 10
290
Table 3 Type of parastomal hernia surgery
Type of repair Surgical treatment (n=42) Non-operative treatment* (n=8) P value
Open repair with mesh (%) 30 (72) 6 (75) 0.837
Open suture repair (%) 5 (12) 0 (0) 0.577
Restoration of continuity (%) 4 (9.5) 0 (0) 1.000
Stoma relocation (%) 3 (7.1) 0 (0) 1.000
Unknown (%) 0 (0.0) 2 (25) 0.023
*Cross-overs from non-operative treatment to surgical treatment.
Table 4 Complications after hernia repair
Complication Surgical treatment (n=42) Non-operative treatment† (n=8) P value
Overall morbidity* (%) 19 (45) 4 (50) 1.000
SSI (%) 9 (21) 1 (13) 1.000
Seroma (%) 2 (4.8) 1 (13) 0.414
Obstruction (%) 2 (4.8) 0 (0) 1.000
Ileus (%) 3 (7.1) 1 (13) 0.514
Recurrence (%) 23 (55) 1 (13) 0.050
Additional repair (%) 21 (50) 0 (0) 0.015
Emergency surgery (%) 3 (7.1) 1 (13) 0.514
Follow-up time, in months (IQR) 43.5 (20.3-72.0) 55.0 (34.5-74.0) 0.700
SSI, surgical site infection; IQR, interquartile range.
*Number of patients with at least one complication.
†Cross-overs from non-operative treatment to surgical treatment
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Figures
Figure 1 Parastomal hernia symptoms
The outer circle represents the non-operative treatment (NT) group, the inner circle represents the surgical treatment 
(ST) group.
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Supporting Information
Supplemental Table 1 Hernia characteristics in end colostomy patients
Characteristic Surgical treatment (n=23) Non-surgical treatment (n=26) P-value
Size in cm (SD) 3.48 (1.84) 3.10 (1.26) 0.537
EHS Classification (%)
I 9 (64.3) 7 (58.3) 0.756
II 4 (28.6) 4 (33.3) 1.000
III 0 (0) 1 (8.3) 0.462
IV 1 (7.1) 0 (0) 1.000
Time to diagnosis in months (IQR) 12.50 (3.92-26.32) 13.47 (4.35-27.03) 0.772
Presenting symptoms (%)
No symptoms 1 (4.8) 6 (28.6) 0.093
Pain 16 (76.2) 5 (23.8) 0.001
Appliance leakages 2 (9.5) 6 (28.6) 0.238
Bowel obstruction 2 (9.5) 3 (14.3) 1.000
Aesthetic complaints 0 (0) 1 (4.8) 1.000
Incarceration 0 (0) 0 (0) NA
SD, standard deviation; EHS, European Hernia Society; IQR, interquartile range
Supplemental Table 2 Complications after hernia repair in end colostomy patients
Complication Surgical treatment (n=23) Non-surgical treatment (n=5) P-value
Overall morbidity (%) 10 (43.5) 2 (40.0) 1.000
SSI (%) 5 (21.7) 0 (0) 0.550
Seroma (%) 0 (0) 1 (20.0) 0.179
Obstruction (%) 2 (8.7) 0 (0) 1.000
Ileus (%) 2 (8.7) 1 (20.0) 0.459
Recurrence (%) 14 (60.9) 0 (0) 0.041
Additional repair (%) 13 (56.5) 0 (0) 0.044
Emergency surgery (%) 1 (4.3) 1 (20.0) 0.331
Follow-up time in months (IQR) 41.00 (24.00-61.00) 60.00 (47.50-86.87) 0.041
SSI, surgical site infection; IQR, interquartile range
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Abstract 
Purpose
Parastomal hernia (PSH) is a common complication following stoma formation. The 
incidence of PSH varies widely due to several factors including differences in diagnostic 
modality, observer, definition and classification used for diagnosing PSH. The aim of 
this systematic review was to evaluate the diagnostic accuracy of the modalities used to 
identify PSH.
Methods
Embase, MEDLINE, Cochrane, Web of Science and Google Scholar databases were 
searched. Studies reporting PSH incidence rates detected by two or more different 
diagnostic modalities or inter-observer variation on one diagnostic modality were 
included. Article selection and assessment of study quality were conducted independently 
by two researchers using Cochrane Collaboration’s tool for assessing risk of bias. 
PROSPERO registration: CRD42018112732.
Results
Twenty-nine studies (n = 2514 patients) were included. Nineteen studies compared CT 
to clinical examination with relative difference in incidence rates ranging from 0.64 to 
3.0 (n = 1369). Overall, 79% of studies found an increase in incidence rate when using 
CT. Disagreement between CT and clinical examination ranged between 0 and 37.3% 
with pooled inter-modality agreement Kappa value of 0.64 (95% CI 0.52–0.77). Four 
studies investigated the diagnostic accuracy of ultrasonography (n = 103). Compared 
with peroperative diagnosis, CT and ultrasonography both seemed accurate imaging 
modalities with a sensitivity of 83%.
Conclusion 
CT is an accurate diagnostic modality for PSH diagnosis and increases PSH detection 
rates, as compared to clinical examination. Studies that specially focus on the diagnostic 
accuracy are needed and should aim to take patient-reported outcomes into account. 
A detailed description of the diagnostic approach, modality, definition, and involved 
observers is prerequisite for future PSH research.
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Introduction 
Parastomal hernia (PSH) is a common complication following stoma formation and 
can cause discomfort, pain, strangulation, and incarceration of intestines, as well as 
difficulties with stoma care (1). The exact incidence of PSH remains unclear, but most 
studies report high rates of over 30%, especially in case of colostomy (1, 2). Still, reported 
rates vary widely in the literature, ranging from 0-86% (1, 3, 4). This variability depends 
on several factors such as the length of follow-up, patient and surgical characteristics 
including type of stoma, method of stoma construction, but also on definition of PSH 
(5-8). 
Moreover, several different diagnostic modalities can be used for the diagnosis of PSH, 
making it a factor affecting the incidence rate. In practice, clinical examination is the first 
method to assess the presence or absence of a PSH. In case of doubt about the diagnosis 
or to help plan for the surgical approach and management, an imaging modality can be 
chosen, such as ultrasonography (US), computed tomography (CT) scan, or magnetic 
resonance imaging (MRI) scan.
In addition, the lack of a clear definition and the use of several different classifications of 
PSH is a significant problem in PSH research (9). Some studies use imaging to confirm 
the diagnosis of PSH, whereas others only use imaging in clinically unconvincing cases 
(10, 11). Due to these differences, protocols often deviate between clinical practice and 
the research setting, as well as between clinical studies.
In 2014, the European Hernia Society (EHS) proposed a classification depending on 
the defect size and the presence of a concomitant incisional hernia (9, 12). With the 
ability to correctly compare different studies and thus to provide a uniform research 
reporting, this classification is recommended by the EHS to use in PSH research (9). 
However, these guidelines also emphasize the uncertainties on the accuracy of clinical 
and imaging diagnoses of PSH.
Therefore, the aim of this systematic review is to evaluate the accuracy of the different 
modalities used to identify PSH after stoma construction or after PSH repair. The 
secondary objective is to assess the inter-observer variation, correlations between (a)
symptomatic PSH and imaging or surgical findings, and identify different definitions 
and classifications used for diagnosis of PSH.
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Methods 
The study protocol was registered in PROSPERO (CRD42018112732; International 
Prospective Register of Systematic Reviews). The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA) statement 
was followed (13). Moreover, the article by Wille-Jørgensen et al. on systematic reviews 
and meta-analyses in coloproctology was used for methodological guidance (14).
Systematic literature search 
A systematic search was performed by a biomedical information specialist instructed by 
first author (G.S.). Embase, MEDLINE, Cochrane, Web of Science and Google Scholar 
databases were searched on March 5th, 2019. Full search strategies and results per 
database are presented in Appendix 1. There was no limit on date of publication. After 
duplicate removal, studies were reviewed independently by two researchers (D.L. and 
G.S.) on title and abstract, followed by full-text review using EndNote X9®. Differences 
in article selection were discussed and articles were included or excluded after consensus 
was reached.
Inclusion and exclusion criteria 
Studies were included if they met the following criteria: (1) Inclusion of patients that 
underwent stoma construction (ileal conduit, ileo- or colostomy) or PSH repair surgery; 
(2) Studies assessing the performance of a diagnostic modality (clinical examination, 
CT, US, MRI or diagnosis at surgery) used for the diagnosis of PSH. Only (non)
randomized controlled trials, prospective, or retrospective cohort or case-control studies 
were included. Excluded were: Studies reporting on pediatric patients (< 18 years of 
age), studies reporting only on gastro-/oesophago- or duodenostomies, studies in which 
no data on diagnostic modalities were described, and studies with unclear diagnostic 
work-up, so that diagnostic data could not be extracted. Studies not written in English, 
case reports, letters, comments, abstracts or posters were also excluded.
Data extraction 
Data from included studies were extracted by one researcher (G.S.) and were 
checked independently by another researcher (S.H.) using standard forms covering 
study characteristics (year, journal, study design, level of evidence and risk of bias), 
patient characteristics (number of patients, sex, age, body-mass index and follow-
up), surgical characteristics (indication for surgery, acute or elective, laparoscopic or 
open abdominal surgery, reoperation, stoma type, use of mesh, location of mesh), and 
outcome characteristics (definition and classification of PSH, diagnostic modalities 
and corresponding incidence of PSH and inter-observer variation). Since there is 
no gold standard modality for diagnosing a PSH, the detection rates of the different 
diagnostic modalities are compared within each study. The available absolute data and 
incidence rates of modalities are presented and compared in contingency tables. Intra-
class correlation coefficient and Kappa values for inter-observer variation were extracted 
and presented. Inter-modality agreements were expressed as Cohen’s Kappa values for 
each study if possible. Statistical level of agreement per Cohen’s Kappa value range is 
presented in Supplemental table 1. The pooled Cohen’s Kappa value was calculated in a 
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random effects model using inverse variance method, using meta-package for R version 
3.5.1. (R Foundation for Statistical Computing, Vienna, Austria).
Study quality assessment 
Two researchers (S.H. and G.S.) independently assessed the quality of included studies 
by assessing the level of evidence according to the Oxford Centre for Evidence-based 
Medicine Levels of Evidence (15) and the possible risk of bias using the Cochrane 
Collaboration’s tool for assessing risk of bias (16) and the QUADAS-2 tool (17) with 
RevMan 5.3 (Cochrane Centre, Denmark). 
Results 
Search and study characteristics 
A PRISMA flow diagram of the complete search results is shown in Figure 1. After 
removal of duplicates, 1,495 articles were screened on title and abstract of which 192 
articles were selected for full-text reading. Finally, 29 articles were judged eligible and 
were included.
An overview of study characteristics is shown in Table 1. The methodological quality 
of all included studies per outcome measure is summarized in Figure 2. Overall, a high 
risk of bias was present in the included studies (Figure 3). Applicability concerns were 
present in 10-20% of the review sample (Figure 3). Specific methodological concerns 
per included study are outlined in Appendix 2.
Definition and classification of  PSH 
The definition of PSH was reported in eighteen (62%) of the included studies (2, 11, 18-
32). Some studies used two different definitions for clinical and radiologic examination 
(19, 20, 23, 25). Therefore, a total of nineteen different definitions were used 
(Appendix 3). For the definitions used in clinical examination, most studies included 
a combination of the terms ‘bulge’ or ‘protrusion’ and ‘around’ or ‘in the vicinity of ’ 
the stoma. Also, some studies added the position of the patient’s body (supine or/and 
erect) during examination and the use of the Valsalva maneuver. For the definitions 
used in radiological examination, the terms ‘defect,’ ‘fascia’ and ‘hernia sac’ were often 
incorporated in the definition. Five studies did not describe the definition of PSH or 
diagnostic approach (33-37).
The classification of PSH was reported in thirteen (45%) of the included studies (2, 10, 
21, 26, 28, 31, 32, 38-43). Two classifications were used. One developed and introduced 
by the European Hernia Society (12) and one by Moreno-Matias (26) (Appendix 4). 
Inter-observer variation 
Three of the included studies reported on inter-observer variation (22, 25, 30). Each 
study investigated different modalities examined by different observers. An overview 
of the methods and results of these studies is summarized in Table 2. Gurmu et al. 
reported a low inter-observer reliability when diagnosing PSH by clinical examination 
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with disagreement rates of 35 and 54% between three surgeons and 18% between two 
surgeons (22). Jänes et al. reported a strong agreement between three surgeons after 
diagnosing PSH by clinical examination with a Kappa value of 0.85 (25). Also, the 
inter-observer reliability was higher amongst radiologists when patients underwent a 
CT in prone position as compared to patients in supine position with Kappa values 
of 0.85 and 0.82, respectively (25). Strigård et al. investigated inter-observer reliability 
and learning curve of three-dimensional ultrasonography (3D US) in 40 patients. They 
found an overall inter-observer agreement of 72% with a Kappa value of 0.59, which 
is classified as ‘weak’. The learning curve reached its top at around 30 patients with an 
inter-observer agreement of 80% for the last ten examined patients (30).
CT versus clinical examination 
The incidence rates of PSH after CT and clinical examination were reported in nineteen 
studies including a total of 1,369 patients (2, 18-20, 23, 24, 27, 28, 31-33, 37-41, 43). 
PSH incidence rates, disagreement percentages, and Kappa values are presented in Table 
3. Study quality and clinico-radiological concordance are presented in Supplemental 
table 2. Fifteen studies (79%) reported a higher incidence rate and two studies (11%) 
reported lower incidence rate when diagnosing PSH using CT as compared to clinical 
diagnoses. When comparing CT to clinical examination, the relative difference in 
incidence rates ranged from 0.64 to 3.0. Disagreement between diagnoses by using 
CT versus clinical examination could be obtained in fifteen studies and ranged from 
0 to 37.3%. The pooled inter-modality agreement Kappa value for all fourteen studies 
with contingency tables was 0.64 (95% CI 0.52-0.77) which is classified as ‘substantial 
agreement’.
Ultrasonography versus clinical examination 
The incidence rates of PSH after US and clinical examination were reported in one 
study, which included 43 patients with peristomal bulging (Table 4, Supplemental table 
3) (29). Sjödahl et al. reported a lower incidence rate by US for diagnosing PSH with 
relative difference of 0.58 when compared to clinical examination. The disagreement 
between these modalities was 53.5%.
CT versus ultrasonography 
Studies comparing PSH incidence of CT to regular US were not identified. One study 
by Näsvall et al. (36), investigated intrastomal 3D US as an alternative to CT and 
included twenty patients that were indicated for surgical revision due to stoma-related 
symptoms. The PSH incidence was higher when using CT (80%) as compared to 3D 
US (75%) (Table 5, Supplemental table 4). 
Peroperative diagnosis 
Näsvall et al. compared 3D US and CT to findings at surgery in twenty patients (36). 
For both imaging modalities a high sensitivity of 83% was found. A positive predictive 
value (PPV) of 94% and a negative predicted value (NPV) of 75% were reported for 
diagnosis with CT. For diagnosis with 3D US, a PPV of 100% and a NPV of 60% 
were reported. Also, Fleshman et al. reported peroperative findings in thirteen patients 
who were diagnosed with PSH at clinical examination of which eleven were confirmed 
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by CT and two were confirmed operatively (34). Study quality, PSH incidence rates 
and surgico-radiological concordance of the two studies are presented in Table 6 and 
Supplemental table 5.
Imaging versus clinical examination 
Two studies reported on clinical examination, CT and MRI for the diagnosis of PSH. 
These studies did not subdivide the incidence rate per type of imaging modality (11, 
21). Study quality, PSH incidence rates and clinico-radiological concordance of the 
studies are presented in Table 7 and Supplemental table 6. Donahue et al. reported a 
higher incidence rate when using imaging with a relative increase of 1.47 and found no 
patients with clinical detected but radiological occult PSH (21). Hansson et al. found 
three symptomatic PSHs in 60 patients that were clinically examined. A CT or MRI 
was performed in 27 of the 60 patients of whom nineteen patients had a asymptomatic 
hernia. Hotouras et al. reported 25 (58%) PSHs diagnosed with CT. Eleven (44%) of 
these 25 patients with radiological confirmed PSH were symptomatic as reported by the 
patients.
Imaging after clinical suspicion of  parastomal hernia 
Brandsma et al. and Fleshman et al. used only a CT when there was clinical suspicion 
of PSH. In the study of Brandsma et al. (10), sixteen out of nineteen clinical PSHs 
(14.3%) were confirmed by CT, two by MRI and one by US. Fleshman  et al. found 
thirteen (13%) clinical PSHs of which eleven (11%) were confirmed by CT and two 
peroperatively. Hansson et al. performed a CT or MRI when there were doubts about the 
diagnosis of PSH during clinical examination (11). One participating center performed 
imaging routinely (Table 7). The incidence after clinical examination was 5% (3/60) 
and after imaging 7% (4/61).
Discussion 
Today, in both clinical practice and research there is no gold standard modality to 
examine patients for the presence of PSH. The literature on this subject is diverse and 
inconclusive. Facilitating comparison between studies on PSH remains challenging, 
due to, amongst others, the number of existing definitions, imaging modalities, and 
classifications. Indeed, this systematic review shows a great variance in detection rates of 
PSH between different diagnostic modalities.
Most included studies compared CT to clinical examination. The majority of these 
studies found higher incidence rates by using CT (2, 18-20, 24, 26-28, 32, 33, 38, 40-
43). However, some studies showed contradictory results in favor of clinical examination 
(23, 34, 39). This discrepancy between studies could be explained by the technical 
differences in examination of the patients’ abdominal wall, bearing in mind that a 
patients’ body position and the use of Valsalva maneuver during examination might 
affect detection rates (25). It is possible to use Valsalva maneuver in case of patients 
undergoing CT imaging. However, this is rarely reported in studies. 
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Gurmu et al. found a low inter-observer reliability when patients were clinically examined 
by surgeons, indicating that PSH is difficult to diagnose by clinical examination (22). 
This was also stated by Sjödahl et al. who found poor correlation between US and 
findings at clinical examination (29). If these examinations are performed correctly, 
the use of dynamic modalities such as US and clinical examination may have some 
advantages compared to the more static and expensive CT or MRI. However, the inter-
observer variation and diagnostic accuracy of US have not been investigated thoroughly. 
In contrast, more evidence is available on the diagnostic performance of clinical 
examination and CT. For research purposes, the combined use of these two modalities 
might be recommended since multiple studies found significant disagreements in 
detection rates between both modalities (23, 26, 32).
This is the first review to date that provides a complete overview of the research of the 
available literature on different diagnostic modalities for PSH diagnosis. Nevertheless, it 
is important to note that this systematic review covers studies that investigate the PSH 
incidence rates in the setting of a research protocol that might not always fully reflect 
standard clinical practice. Also, the minority of included studies has the accuracy of the 
used diagnostic modality as primary outcome (19, 22, 25, 26, 29, 30, 33, 36). In clinical 
practice the main goal is to identify symptomatic PSHs that might require treatment 
and for asymptomatic patients it seems unnecessary to follow a full diagnostic workup. 
Therefore, the clinical approach might differ from that in a research setting. In general, 
patients with stoma problems such as pain, appliance leakage, bowel obstruction or 
symptoms of incarceration, first undergo clinical examination by a stoma nurse and/or 
clinician. When PSH is identified clinically or the diagnosis is inconclusive the clinician 
can consider an imaging modality to confirm the diagnosis, taking into account patient 
safety, patient comfort, availability and costs. Whereas for research purposes, factors 
as costs and availability might play a less important role in the decision on imaging 
modality.
Intrastomal 3D US is a relatively new imaging modality for diagnosing PSH or other 
stoma-related pathology (44). 3D US seems to be an accurate imaging modality with 
a sensitivity of 83% when compared to peroperative diagnosis (36). With this imaging 
modality it is possible to examine patients in erect position and without the use of 
radiation, providing potential advantages over CT. There is, however, too little available 
evidence for this technique to consider this as standard imaging modality for the 
diagnosing of PSH. 
In contrast to diagnosing incisional hernia, traditional two-dimensional ultrasonography 
(2D US) is not often used for diagnosing PSH in both research and in clinical setting. 
However, 2D US is the most patient-friendly, inexpensive and practical modality of all 
imaging modalities. This systematic review included only one study comparing 2D US 
to clinical examination for diagnosing PSH. However, to make any recommendations 
on 2D US, it would be interesting to compare ultrasonography with other imaging 
modalities in the future. 
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Another important aspect of clinical practice with regard to the use of diagnostic 
modalities is that many stoma patients have a stoma created after oncological resection 
and for these patients a CT is routinely made during follow-up to detect potential 
cancer recurrence. Although some PSHs occur many years after stoma construction, 
most PSHs develop within the first years after stoma construction and are thus likely to 
be identified with follow-up CT (5). This is one of the main reasons why most included 
studies used CT instead of MRI or US. However, with the patient in supine position 
a CT is not a reliable tool for diagnosing PSH and a CT with the patient in prone 
position is associated with higher inter-observer agreement and an increase in sensitivity 
(25). By using CT routinely for cancer follow-up, asymptomatic PSHs will appear more 
frequently. Although not entirely insignificant, studies do not often distinguish between 
symptomatic and asymptomatic when reporting PSH  incidence rates.  
Evidently, patient-reported outcomes are of paramount importance in the context of 
stoma-related complications. Patients know their own bodies in a way no physician 
possibly can, and have to take care of the stoma several times a day, whereas the 
physician examines the patients’ stoma once or maybe twice. Any physical differences 
of the stoma will be noticed by the patient, which probably makes it more reliable 
than the studied modalities on the existence of bulging at some time point during 
follow-up. Currently, prospective cohort studies, such as the PROPHER and CIPHER 
studies (ISRCTN17573805; ISRCTN registry), are assessing the value of subjective 
and objective outcomes after stoma construction or for parastomal hernia treatment, 
respectively.
Despite the increased interest in PSH care and research in recent decades, there is still 
no consensus regarding the definition of PSH or a gold standard for diagnosis (9). 
Although many definitions consisted of similar terms and contexts, some definitions 
differ considerably which can lead to discrepancies in detection rates. Moreover, the fact 
that five included studies have not even described the definition of PSH, emphasizes 
the need for uniform reporting in studies regarding PSH (33-37). This heterogeneity in 
diagnostic procedures makes it difficult to compare studies and to determine an accurate 
incidence of PSH. Therefore, a clear and standard definition and diagnosis of PSH 
is of paramount importance. The European Hernia Society (EHS) acknowledged this 
problem and proposed to use the definition of PSH introduced by Muysoms et al. 
(45): “An incisional hernia through the abdominal wall defect created during placement 
of a colostomy, ileostomy or ileal conduit stoma”. Furthermore, the EHS proposed a 
new classification for PSH, which might help to facilitate more uniform reporting of 
outcomes in PSH research (Appendix 4) (12). 
Limitations 
This systematic review has some limitations. Firstly, the low level of evidence of included 
studies is an important limitation. Eleven studies have a retrospective study design, 
which is prone for selection and information bias. Also, most studies presented small 
study populations. Nevertheless, to give a complete overview of diagnostic accuracy and 
variation of the different modalities, studies of low quality or studies with small samples 
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were not excluded and a comprehensive overview of study characteristics and study 
quality assessment was provided. 
Secondly, significant heterogeneity between studies was demonstrated, as operation and 
stoma types, use of mesh reinforcement, patient characteristics (e.g. age and BMI), and 
follow-up duration differed between included studies. Besides the choice of diagnostic 
modality, all these factors also influence the PSH incidence rates. Although it was not 
possible to account for this, these factors would be of less importance for the within-
study diagnostic performance, since diagnostic modalities were only compared within 
each study. However, some studies did not investigate the PSH incidence rate or the 
accuracy of the diagnostic modalities as primary objective. As a result, the incidence 
could easily be underestimated. Accordingly, the results of diagnostic performance may 
also be affected.
Conclusion 
In conclusion, this review shows great variance in accuracy of different modalities for the 
detection of PSH. The use of CT increases the PSH detection rate, indicating that this 
is a more accurate modality compared to clinical examination. However, the evidence 
on the accuracy of the other imaging modalities, also within patient-reported outcome 
measures, is scarce and warrants further investigation. There are significant differences 
in diagnostic methods between clinical practice and in the setting of research protocols, 
as well as between clinical studies. In order to compare studies correctly and increase 
transparency among studies, a more detailed report of the diagnostic method and a 
detailed and preferably uniform definition are required in future research. It might be of 
added value to develop a standard and validated protocol in which self-report, clinical 
examination and imaging are combined.  
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Table 4 Ultrasonography versus clinical examination.
Study N Incidence 
US vs CE (%)
Relative increase 
with US
Disagreement 
CE vs US (%)
Kappa value Standard Error 
Sjödahl 43 US: 35%, CE: 61% 0.58 53.5% -0,01 0,94
CE, clinical examination; US, ultrasonography.
Table 5 CT versus ultrasonography.
Study N Incidence CT vs 3D US (%) Relative increase with US Disagreement CT vs US (%)
Nasväll 20 CT: 80%, US: 75% ~ ~
CT, computed tomography scan; US, ultrasonography.
Table 6 Peroperative diagnosis.
Study N Incidence CT vs surgery (%) Incidence US vs surgery (%) Disagreement imaging 
vs surgery (%)
Nasväll 20 CT: 80%, surgery: 90% ~ 20%
Fleshman ~ CT: 11%, surgery: 13% ~ ~
Nasväll 20 ~ US: 75%, surgery: 90% 15%
CT, computed tomography scan; US, ultrasonography.
Table 7 Imaging versus clinical examination.
Study N Incidence imaging 
vs CE (%)
Relative increase 
with imaging
Disagreement 
imaging vs CE (%)
Kappa 
value
Standard 
Error 
Donahue 386 Imaging: 36%, CE: 24% 1.47 15 0.73 0,04
CE, clinical examination
Comparison of different modalities for the diagnosis of parastomal hernia: a systematic review
313
Ch
ap
te
r 1
1
Figures
Figure 1 Preferred items for reporting of systematic reviews and meta-analyses (PRISMA) flow diagram.
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Figure 2 Risk of bias and applicability concerns summary
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Figure 3 Overall risk of bias and applicability concerns
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Supporting information
Supplemental Table 1
Statistical level of agreement with Fleiss’ Kappa Values
Kappa value Statistical level of agreement 
<0 Poor
0.01-0.20 Slight agreement
0.21-0.40 Fair agreement
0.41-0.60 Moderate agreement
0.61-0.80 Substantial agreement
0.81-1.00 Almost perfect agreement
Supplemental Table 2 CT versus clinical examination, contingency tables.
Aslam Risk of bias ++ 4 x 4 Table    
Level of evidence 2b CE + CE - Total
Incidence CE 18% CT + 3 0 3
Incidence CT 18% CT - 0 14 14
Relative increase 1.0 Total 3 14 17
Canda Risk of bias + 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 22% CT + 15 4 19
Incidence CT 28% CT - 0 48 48
Relative increase 1.27 Total 15 52 67
Cingi Risk of bias + 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 52% CT + 12 6 18
Incidence CT 86% CT - 0 3 3
Relative increase 1.5 Total 12 9 21
Conde-Muino Risk of bias ++++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 3% CT + 1 1 2
Incidence CT 7% CT - 0 29 29
Relative increase 2.0 Total 1 30 31
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Etherington Risk of bias +++ 4 x 4 Table
Level of evidence 4 CE + CE - Total
Incidence CE 29% CT + 8 2 10
Incidence CT 36% CT - 0 18 18
Relative increase 1.25 Total 8 20 28
Hauters Risk of bias ++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 3% CT + 1 1 2
Incidence CT 7% CT - 0 27 27
Relative increase 2.0 Total 1 28 29
Hino Risk of bias +++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 20% CT + 16 10 26
Incidence CT 17% CT - 12 21 33
Relative increase 0.93 Total 28 31 59
Hong Risk of bias ++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 27% CT + 29 7 36
Incidence CT 33% CT - 0 72 72
Relative increase 1.24 Total 29 79 108
Köhler Risk of bias - 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 1% CT + 1 2 3
Incidence CT 4% CT - 0 48 48
Relative increase 3.0 Total 1 50 51
Lambrecht Risk of bias ++++ 4 x 4 Table
Level of evidence 1b CE + CE - Total
Incidence CE 24% CT + 10 9 19
Incidence CT 33% CT - 4 35 39
Relative increase 1.36 Total 14 44 58
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Moreno-Matias Risk of bias ++++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 44% CT + 23 12 35
Incidence CT 47% CT - 10 30 40
Relative increase 1.06 Total 33 42 75
Näsvall 2017 Risk of bias - 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 22% CT + 5 2 7
Incidence CT 15% CT - 6 34 40
Relative increase 0.64 Total 11 36 47
Seo Risk of bias ++ 4 x 4 Table
Level of evidence 2b CE + CE - Total
Incidence CE 24% CT + 20 4 24
Incidence CT 29% CT - 0 59 59
Relative increase 1.2 Total 20 63 83
Serra-Aracil Risk of bias +++ 4 x 4 Table
Level of evidence 1b CE + CE - Total
Incidence CE 28% CT + 15 3 18
Incidence CT 33% CT - 0 36 36
Relative increase 1.2 Total 15 39 54
Veirimaa Risk of bias +++ 4 x 4 Table
Level of evidence 1b CE + CE - Total
Incidence CE 25% CT + 17 16 33
Incidence CT 49% CT - 0 34 34
Relative increase 1.94 Total 17 50 67
Fleshmana Risk of bias -
Level of evidence 1b
Incidence CE 13%
Incidence CT 11%
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Ihnát Risk of bias +++
Level of evidence 2b
Incidence CE 48%
Incidence CT 53%
Nikberg Risk of bias -
Level of evidence 2b 
Incidence CE 25%
Incidence CT 53% 141 CT of 187 patients
Odensten Risk of bias ++
Level of evidence 1b
Incidence CE 29%
Incidence CT 35% 198 CT of 211 patients
Timmermans Risk of bias -
Level of evidence 2b
Incidence CE 53%
  Incidence CT 53% 87 CT of 150 patients
CE, clinical examination; CT, computed tomography scan.
a CT if there was clinical suspicion that a hernia was present.
Supplemental Table 3 Ultrasonography versus clinical examination, contingency table.
Sjödahl Risk of bias ++++ 4 x 4 Table    
Level of evidence 2b CE + CE - Total
Incidence CE 61% US + 9 6 15
Incidence US 35% US - 17 11 28
  Relative increase 0.58 Total 26 17 43a 
CE, clinical examination; US, ultrasonography.
a All patients with peristomal bulging.
Supplemental Table 4 CT versus ultrasonography.
Näsvall 2014 Risk of bias ++
Level of evidence 2b
Incidence CT 80%
Incidence 3D US 75%
  Relative increase ~
CT, computed tomography scan; US, ultrasonography.
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Supplemental Table 5 Peroperative diagnosis, contingency tables.
Näsvall 2014 Risk of bias ++++ 4 x 4 Table    
Level of evidence 2b CT + CT - Total
Incidence CT 80% Surgery + 15 3 18
Incidence surgery 90% Surgery - 1 1 2
Total 16 4 20
Näsvall 2014 Risk of bias ++++ 4 x 4 Table
Level of evidence 2b 3D US + 3D US - Total
Incidence 3D US 75% Surgery + 15 3 18
Incidence surgery 90% Surgery - 0 2 2
Total 15 5 20
Fleshman Risk of bias -
Level of evidence 1b
Incidence CE 13%
Incidence CT 11%
  Incidence surgery 13%        
CT, computed tomography scan; US, ultrasonography.
Supplemental Table 6 Imaging versus clinical examination, contingency tables.
Donahuea Risk of bias + 4 x 4 Table    
Level of evidence 2b CE + CE- Total
Incidence CE 24% Imaging + 93 44 137
Incidence imaging 36% Imaging - 0 249 249
Relative increase 1.47 Total 93 293 386
Hansson Risk of bias +
Level of evidence 2b
Incidence CE 5%
Incidence imaging 7% Imaging: CT or MRI when in doubt
27 patients had a CT or MRI  
CE, clinical examination; CT, computed tomography scan; MRI, magnetic resonance imaging.
a Imaging = CT or MRI.
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Appendix 1 Literature search syntax.
Embase.com
(‘parastomal hernia’/exp OR ((stoma/exp OR ‘enterostomy’/exp) AND (‘abdominal 
wall hernia’/de OR hernia/de OR hernioplasty/de OR ‘herniorrhaphy’/de)) OR 
(((parastoma* OR stoma OR stomal OR colostom* OR ileostom* OR jejunostom* 
OR parajejunostom* OR cecostom* OR paracecostom* OR duodenostom* OR 
paraduodenostom* OR urostom* OR paracolostom* OR paraileostom* OR 
paraurostom*) NEAR/6 (hernia* OR hernioplast*  OR herniorrha*))):ab,ti) NOT 
([Conference Abstract]/lim OR [Letter]/lim OR [Note]/lim OR [Editorial]/lim) AND 
[english]/lim
Medline Ovid 
(((exp Surgical Stomas/ OR exp Enterostomy/) AND (Hernia, Ventral/ OR Hernia, 
Abdominal/ OR Hernia/ OR Herniorrhaphy/)) OR (((parastoma* OR stoma OR stomal 
OR colostom* OR ileostom* OR jejunostom*  OR parajejunostom* OR cecostom* 
OR paracecostom* OR duodenostom*  OR paraduodenostom* OR urostom* OR 
paracolostom* OR paraileostom*  OR paraurostom*) ADJ6 (hernia* OR hernioplast* 
OR herniorrha*))).ab,ti.) NOT (letter OR news OR comment OR editorial OR 
congresses OR abstracts).pt. AND english.la.
Cochrane CENTRAL
((((parastoma* OR stoma OR stomal OR colostom* OR ileostom* OR jejunostom* 
OR parajejunostom* OR cecostom* OR paracecostom* OR duodenostom* OR 
paraduodenostom* OR urostom* OR paracolostom* OR paraileostom* OR 
paraurostom*) NEAR/6 (hernia* OR hernioplast* OR herniorrha*))):ab,ti) 
Web of  Science 
TS=(((((parastoma* OR stoma OR stomal OR colostom* OR ileostom* OR jejunostom* 
OR parajejunostom* OR cecostom* OR paracecostom* OR duodenostom* OR 
paraduodenostom* OR urostom* OR paracolostom* OR paraileostom* OR 
paraurostom*) NEAR/5 (hernia* OR hernioplast*  OR herniorrha*))))) AND 
LA=(english) AND DT=(article)
Google scholar 
“parastomal|stomal|stoma|colostomal|ileostomal|jejunostomal|parajejunostomal|cecos-
tomal|paracecostomal|duodenostomal|paraduodenostomal|urostomal|paracolosto-
mal|paraileostomal|paraurostomal hernia”
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Appendix 2 Methodological concerns.
Inter-observer variation
Gurmu Selection of patients depending on different hospitals (selection bias); No definition 
used for clinical examination (reporting bias)
Jänes No major methodological concerns
Strigård One experienced physicians and two with short training
CT-scan vs. clinical examination
Brandsma Only a CT-scan was performed when there was a clinical suspicion of a PSH (selection 
bias)
Canda Patients with no postoperative available CT-scan were excluded (selection bias); No 
definition used for clinical examination (reporting bias)
Cingi Unclear whether comparison was blinded (reporting bias)
Conde-Muino No major methodological concerns 
Etherington No definition used for imaging (reporting bias)
Fleshman Only a CT-scan was performed when there was a clinical suspicion of a PSH (selection 
bias); no definition used (reporting bias)
Hauters No definition used for clinical examination (reporting bias)
Hino Unclear whether comparison was blinded (reporting bias)
Hong Unclear whether comparison was blinded (reporting bias); no definition used for 
clinical examination (reporting bias)
Köhler Not all included patients underwent a CT-scan (selection bias); No definition used for 
clinical examination (reporting bias)
Lambrecht No major methodological concerns 
Moreno-Matias No major methodological concerns 
Näsvall 2017 Part of included patient did not underwent imaging (selection bias); Unclear whether 
comparison was blinded (reporting bias)
Nikberg Part of included patient did not underwent imaging (selection bias); Unclear whether 
comparison was blinded (reporting bias)
Odensten Part of included patient did not underwent imaging (selection bias)
Seo Interval between CT-scan and clinical examination unclear 
Serra-Aracil No definition used for clinical examination (reporting bias)
Timmermans Part of included patient did not underwent imaging (selection bias); Interval between 
CT-scan and clinical examination unclear 
Veirimaa Unclear whether comparison was blinded (reporting bias)
Ultrasonography vs. clinical examination
Sjödahl No major methodological concerns 
CT-scan vs. ultrasonography
Näsvall 2014 No definition used (reporting bias)
Comparison of different modalities for the diagnosis of parastomal hernia: a systematic review
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Imaging vs. clinical examination
Donahue No definition used for clinical examination (reporting bias); Unclear whether all 
patients underwent clinical examination (reporting bias)
Hansson Only in clinical unconvincing cases a CT-scan or a MRI was performed (selection 
bias); in one of the participating center a CT-scan or MRI was performed routinely 
(selection bias)
Hotouras Patients with no postoperative available CT-scan were excluded (selection bias); only 
symptomatic or asymptomatic PSHs were reported. No clinical examination was 
reported (reporting bias)
Peroperative diagnosis  
Fleshman No definition used (reporting bias)
Näsvall 2014 No major methodological concerns 
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Appendix 3 Definitions of  parastomal hernia.
Study Definition of parastomal hernia
Strigård ‘Defect of the fascia with a protruding hernia sac at the passage of the stoma 
intestine through the abdominal wall’
Veirimaa ‘Clinically significant parastomal hernia was defined here as parastomal hernia 
associated with stoma appliance dysfunction and leakage not responsive to 
conservative measures, peristomal skin breakdown related to sheer injury or 
ischemia from pressure on the thinned peristomal skin, and recurrent partial 
bowel obstruction’
Definition clinical examination
Cingi ‘Bulging during the Valsalva maneuver and palpation of the fascial defect’
Conde-Muino ‘Any noticeable bulge, in the vicinity of the ostomy with the patient erect, 
supine, and performing the Valsalva maneuver’
Hansson ‘Recurrent or persistent bulge when the patient is standing during a Valsalva 
maneuver, or palpation of the fascial defect with the patient in the supine 
position’
Hino ‘Any protrusion around the stoma observed during physical examination’
Jänes ‘Any protrusion in the vicinity of the stoma with the patient straining in a supine 
and an erect position’
Lambrecht ‘Bulge associated with the stoma’
Seo ‘Any protrusion in the vicinity of the stoma’
Sjödahl ‘A wide opening (more than two fingers) presenting as a manifest parastomal 
hernia with a palpable bowel segment or omentum passing through the 
abdominal opening together with the stoma bowel’
Timmermans ‘Any palpable defect or bulge adjacent to the stoma when the patient was supine 
with their elevated legs or erect and coughing or straining’
Comparison of different modalities for the diagnosis of parastomal hernia: a systematic review
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Definition imaging
Canda, Conde-Muino, Jänes ‘Any intraabdominal content protruding beyond the peritoneum or the presence 
of a hernia sac’ 
Donahue, Moreno-Matias ‘The protrusion of abdominal contents through the abdominal wall defect 
created by forming the stoma’
Cingi ‘A loop of intestine or any abdominal organ, as well as preperitoneal fat, 
protruding through the defect alongside the ostomy was considered as 
parastomal hernia’
Gurmu ‘A defect in the fascia through which intraabdominal contents such as omentum 
or bowel could be extruded out’
Hino ‘(1) Herniation of a loop of intestine other than the distal colon , (2) sliding 
and winding of the distal colon, or (3) herniation of any structures such as the 
omentum and a winder defect of the parastomal abdominall wall fascia’
Hong ‘Any intraabdominal content protruding beyond the fascia or the presence of a 
hernia sac’
Näsvall 2017 ‘A peritoneal sac protruding through the fascia beside the stoma bowel’
Nikberg ‘Any intra-abdominal content protruding beyond the peritoneum or the presence 
of a hernia sac at least 1 year after operation’
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Appendix 4 Classification of  parastomal hernia.
Study Developed by Description classification
Brandsma, Köhler, 
Lambrecht, Näsvall 
2017, Timmermans, 
Vierimaa 
European Hernia Society Primary
Recurrence
Type 1 <5 cm
Type 2 <5 cm, concomitant incisional hernia
Type 3 >5 cm
Type 4 >5 cm, concomitant incisional hernia
Brandsma, Donahue, 
Hauters, Köhler, 
Lambrecht, Moreno-
Matias, Odensten, Seo, 
Serra-Aracil 
Moreno-Matias Type 0 Peritoneum follows the wall of the bowel forming 
the stoma, with no formation of a sac
Type 1a Bowel forming the colostomy with a sac <5 cm
Type 1b Bowel forming the colostomy with a sac >5 cm
Type 2 Sac containing omentum
Type 3 Intestinal loop other than the bowel forming the 
stoma
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Abstract
Aim
Stoma reversal might lead to a stoma site incisional hernia. Recently, prophylactic mesh 
reinforcement of the stoma site has gained increased attention, supporting the need for 
accurate data on the incidence of and risk factors for stoma site incisional hernia and to 
identify high‐risk patients. The aim of this study was to assess incidence, risk factors and 
prevention of stoma site incisional hernias.
Method
Embase, MEDLINE, Web of Science, Cochrane and Google Scholar databases were 
searched. Studies reporting the incidence of stoma site incisional hernia after stoma 
reversal were included. Study quality was assessed with the Newcastle–Ottawa Scale 
and Cochrane risk of bias tool. Data on incidence, risk factors and prophylactic mesh 
reinforcement were extracted.
Results
Of 1440 articles found, 33 studies comprising 4679 reversals were included. The overall 
incidence of incisional hernia was 6.5% [range 0%–38%, median follow‐up 27.5 
(17.54–36) months]. Eleven studies assessed stoma site incisional hernia as the primary 
end‐point, showing an incidence of 17.7% [range 1.7%–36.1%, median follow‐up 
28 (15.25–51.70) months]. Body mass index, diabetes and surgery for malignant 
disease were found to be independent risk factors, as derived from eight studies. Two 
retrospective comparative cohort studies showed significantly lower rates of stoma 
site incisional hernia with prophylactic mesh reinforcement compared with nonmesh 
controls [6.4% vs 36.1% (P = 0.001); 3% vs 19% (P = 0.04)].
Conclusion
Stoma site incisional hernia should not be underestimated as a long‐term problem. Body 
mass index, diabetes and malignancy seem to be potential risk factors. Currently, limited 
data are available on the outcomes of prophylactic mesh reinforcement to prevent stoma 
site incisional hernia.
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Introduction
Temporary stomas are frequently constructed to defunction a low colorectal anastomosis 
and during surgery for acute complicated diverticulitis, inflammatory bowel disease and 
traumatic intestinal injury (1-8). Subsequent stoma reversal is associated with surgical 
site infection (SSI), anastomotic leakage, postoperative ileus and development of stoma 
site or midline incisional hernia (MIH) (9-13). Stoma site incisional hernia (SSIH) can 
cause pain, disfiguration, incarceration and strangulation (14, 15). 
Recent research has shown that prophylactic mesh reinforcement (PMR) in midline 
laparotomies in high‐risk patients significantly decreases the incidence of MIH (16, 17), 
and PMR at the stoma site during permanent stoma construction has been considered 
to reduce rates of parastomal hernia (18-21). Considering the largely comparable 
pathophysiology, PMR during temporary ostomy takedown to prevent SSIH could also 
be beneficial by potentially obviating complications and re‐operations, and has gained 
increased attention amongst surgeons (17). Accurate data on incidence and risk factors 
for the development of SSIH are of importance to correctly assess the clinical value of 
PMR to prevent SSIH, to facilitate selection of high‐risk patients and to aid clinical and 
shared decision‐making (22). 
Therefore, the aims of this study were to systematically investigate the literature regarding 
the incidence of SSIH after stoma reversal, to evaluate potential risk factors for SSIH 
and to assess the effectiveness of PMR in preventing SSIH.
Methods
The protocol of this study was registered in PROSPERO (CRD42016053347). This 
study was conducted following the MOOSE guidelines and PRISMA statement(23, 
24). Furthermore, decisions on the content were based on items proposed by Wille-
Jørgensen et al.(25).
Study design and participants
Randomized controlled trials (RCTs) and prospective or retrospective cohort or case–
control studies providing data on the incidence of SSIH were included. Case reports, 
reviews, letters, abstracts or comments were excluded. Studies were included if they met 
the following criteria: (1) patients ≥ 16 years of age, (2) participants underwent stoma 
reversal via laparotomy, laparoscopy or local surgery, (3) study outcome included data 
on the occurrence of SSIH and (4) follow‐up duration. Studies reporting on > 10% of 
patients with abdominal wall trauma; only reporting on duodeno‐/gastro‐/oesophago‐ 
or urostomies; and only including stoma revisions or re‐siting were excluded.
Systematic literature search
A systematic search was performed by a biomedical information specialist. On 4 July 
2017, the Embase, MEDLINE, Cochrane, Web of Science and Google Scholar databases 
were searched. Full search syntaxes and results per database are shown in Appendix S1 in 
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the online Supporting Information. There was no limit on publication date. Identified 
articles were reviewed independently by two reviewers (GS and DL) after duplicates 
were removed on title and abstract, followed by full‐text review using EndNote X7®. 
Differences in article selection were discussed and inclusion or exclusion was performed 
after consensus was reached between reviewers.
Data extraction
Data extraction was performed by two researchers (GS and DL) and checked by a third 
independent researcher (RB). Discrepancies were discussed amongst all three researchers, 
and decisions were made when consensus was reached. In case of uncertainties on 
reported study results, corresponding authors were contacted if possible. Two researchers 
(GS and DL) independently assessed the quality of included studies by assessing level 
of evidence (26), Newcastle-Ottawa Scale (NOS) criteria (nonrandomized studies)(27), 
and risk of bias (RCTs)(28).
Primary and secondary outcomes
The following outcome variables were extracted: study characteristics (author, year, 
design, level of evidence, risk of bias, NOS, SSIH detection methods), baseline 
characteristics [number of patients, gender, age, body mass index (BMI), smoking status, 
chemotherapy, surgical type and approach, indication, follow‐up duration], stoma 
characteristics [numbers constructed and closed, stoma type (loop colostomy (LC) or 
ileostomy (LI) and end colostomy (EC) or end ileostomy (EI)), time to closure, closure 
method and surgical site infection (SSI) after closure] and SSIH characteristics (number 
of SSIH, SSIH per stoma type and SSIH repairs). Median follow‐up for reported 
cumulative SSI and SSIH rates was calculated based on available follow‐up data.
Data synthesis
A Mantel-Haenszel random-effects model was used to calculate pooled odds ratios 
(ORs), while A Mantel–Haenszel random‐effects model was used to calculate pooled 
odds ratios (ORs), while taking between‐study variance and within‐study variance into 
account. ORs with 95% CIs were calculated to assess outcome differences after ileostomy 
or colostomy reversal. Q statistics and I2 were calculated to evaluate heterogeneity. All 
analyses were performed with RevMan 5.3 (Cochrane Centre, Denmark), except for the 
cumulative meta‐analysis, which was performed using R (version 3.4.1.).
Results
Search
A PRISMA flow diagram of the full search results is shown in Fig. 1. After fulfilling the 
search, a total of 2458 articles were identified, of which 1440 remained after removal 
of duplicates. After screening on title and abstract and full‐text reading, 33 articles were 
included for qualitative and quantitative analyses (3-8, 29-55). Four articles provided data 
on outcomes after PMR for prevention of SSIH (45, 46, 56, 57), of which two had a 
nonmesh control group and could therefore be included in quantitative synthesis (45, 46).
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Study characteristics
Study characteristics are shown in Table 1. Two articles were RCTs, 7 were prospective, 
23 were retrospective cohort studies and 1 study was case‐matched. A total of 6594 
nonmesh and 77 mesh patients were available. The majority of studies (20/33) did 
not specify the SSIH detection method. Two studies specifically mentioned the use of 
clinical examination and 11 reported on imaging [ultrasound (US), CT or MRI].
Stoma characteristics 
An overview of stoma characteristics is shown in Table 2. Overall, 5289 stomas were 
constructed, of which 4679 (88.5%) were closed. In three studies, the type of colostomy 
or ileostomy was not clearly described and was therefore reported as total number of 
colostomies or ileostomies. In all other studies, LI was the most investigated stoma type 
(28/30), followed by LC (8/30), EC (6/30) and EI (5/30).
Hernia rates
Table  3  provides data on the number of closures, SSIH, SSI and SSIH repairs in 
individual studies for different stoma types. The rate of SSI after stoma closure ranged 
from 0% to 18.3% [median follow‐up 28 (21.08–36) months]. SSIH rates per stoma 
type are given in Table 4. The total SSIH rate was 6.5%, with a range from 0% to 38.5% 
[median follow‐up 27.5 (17.54–36) months]. Eleven studies assessed SSIH rate as the 
primary outcome, whereas the other studies recorded SSIH as a secondary outcome. 
The SSIH rate of all 11 studies with SSIH rate as the primary outcome was 17.7% 
[172/970; range 1.7%–36.1%, median follow‐up 28 (15.25–51.70) months]. Of these 
studies, nine used imaging to detect hernias, also leading to a 17.7% rate (139/786; 
range 1.7%–36.1%). From the 22 studies which did not have SSIH as the primary 
outcome, an overall rate of 3.6% [129/3622; range 0%–38.5%, median follow‐up 
27 (16.56–36) months] was found. As calculated from 11 studies (11/33) that used 
imaging to detect hernias, the SSIH rate was 15.3% [173/1134; range 1.2%–36.1%, 
median follow‐up 28 (15.25–51.7) months]. In contrast, an incidence rate of 3.7% for 
SSIH [128/3458; range 0%–38.5%, median follow‐up 27 (16.56–36) months] was 
derived from all studies (22/31) that did not use or did not mention the use of imaging 
for detection of SSIH.
Figure 2 shows a forest plot of seven studies from which data could be used to compare 
SSIH rates after ileostomy and colostomy reversal. No difference in SSIH risk was found 
(OR 0.82, 95%CI 0.40–1.69,  I2 0%). Publication bias seemed unlikely, because the 
study distribution was justifiably symmetrical in an additional funnel plot (Fig. 3). In 
addition, no differences were found in cumulative meta‐analysis (cumulative OR 0.87, 
95%CI 0.44–1.75), as shown in Figure S2.
SSIH operation rates
SSIH operation data are shown in Table S1. No data on SSIH operations were available 
for LC and EI. Of all patients undergoing stoma closure, 6.1% (0%–38.4%) needed 
an operation for SSIH. Of the patients with SSIH, 51.4% (0%–100%) were operated. 
In the total ileostomy group, these percentages were 5.6% (0%–12.5%) and 56.4% 
(0%–100%), respectively, as derived from 10 studies.
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Risk factors
Eight studies reported on risk factors for development of SSIH (Table  S2)(3-5, 30-
32, 45, 52). In univariate analysis, Brook et al.(5) found a significantly higher BMI in 
patients who developed SSIH compared with patients without SSIH (mean 28.4 kg/
m² vs 24.7 kg/m²). Moreover, they found a significantly higher percentage of clinically 
obese patients (BMI ≥ 30 kg/m²) in the SSIH group (42.3% vs 15%, P < 0.001). From 
a logistic regression model, an OR of 1.2 was found for BMI. Furthermore, from a 
nonparametric correlation test of Stage 1 hypertension (≥ 140/90 mmHg), a Spearman›s 
rho of 0.183 was found (P  = 0.01). In addition, malignant disease was found to be 
associated with a higher likelihood of hernia in logistic regression analysis (OR 18, P = 
0.009) and, albeit in univariate analysis, postoperative complication rates were higher in 
patients with SSIH (27% vs 22%, P < 0.001).
Liu et al.(45) investigated the influence of PMR versus no mesh in ileostomy closures 
and assessed potential risk factors. From univariate analyses, the following significant 
factors were found: age > 60 years, malignant disease, diabetes, hypertension, chronic 
steroid usage and chronic kidney injury. A multivariate analysis was performed and 
showed malignancy (OR 21.93, 95% CI 1.58–303.95, P  = 0.02) and diabetes (OR 
20.98, 95% CI 3.23–136.31, P = 0.001) to be independent risk factors for SSIH.
Bhangu et al.(30) found no significant differences in age or gender for patients with SSIH 
versus no SSIH. Moreover, no difference in MIH between patients with and without 
SSIH was found (50% vs 41%, P = 0.51). Age, SSI, stoma type, gender, BMI and time 
to closure did not significantly increase the risk of SSIH in the study by Cingi et al. (31). 
However, patients with a MIH had an increased risk (OR 4.4) of SSIH.
De Keersmaecker et al.(32) assessed a number of potential patient‐ and surgery‐related 
risk factors but did not find any significant differences in univariate analysis.
Oriel et al.(4) showed that myofascial release was performed more often in the SSIH 
group (18.2% vs 2.9%, P = 0.02) and more SSIH patients had superficial incisional 
SSI (27.3% vs 5.8%, P = 0.01). From univariate analyses, Saha et al.(3) found the 
development of SSIH to be significantly associated with reoperation after LI reversal 
(3% vs 25%, P < 0.001) and emergency surgery (4% vs 13%, P = 0.01).
Lastly, Schreinemacher et al.(52) performed a multivariate analysis for risk factors, 
which only showed that BMI (≥ 30 kg/m2 vs < 25 kg/m2) was a significant risk factor 
(OR 5.53, 95% CI 1.72–17.80), whereas a time to closure of < 6 months did not appear 
as risk factor (OR 2.38, 95% CI 0.96–5.99, P = 0.06).
Prophylactic mesh reinforcement
Four studies provided data on PMR outcomes, of which details are given in Table 5. 
Bhangu et al.(56) used biological mesh (StratticeTM) and intraperitoneal onlay mesh 
(IPOM) placement in a case series of seven patients. During 30‐day follow‐up, only one 
adverse event was seen (a SSI with subsequent superficial wound breakdown) while the 
mesh was still in situ (on US). 
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In the case series by Van Barneveld et al. (57), 10 patients received a Parietex Composite 
Parastomal® mesh during creation of a temporary stoma for parastomal hernia prophylaxis 
(IPOM placement). At stoma reversal, mesh continuity was restored to serve as SSIH 
prophylaxis. No serious mesh‐related or other serious complications were observed 
during 12 month’ follow‐up. After a median follow‐up of 26 months [interquartile 
range (IQR) 14–29), no SSIH was found during physical and US examination in nine 
patients.
Two other studies, by Liu et al. and Maggiori et al., were comparative cohort studies, 
including 83 and 94 patients, respectively (45, 46). In the retrospective study by Liu et 
al. (45), consecutive patients undergoing ileostomy closure were included, of whom 
47 (56.6%) had PMR with polypropylene mesh (Ultrapro, Ethicon Inc.) placed in an 
onlay position by the same surgeon in all patients. During median follow‐up of 18.2 
months (IQR 11.7–30.8), three SSIHs (6.4%) were detected in mesh patients, whereas 
13 SSIHs (36.1%) were found in control patients (OR 8.29, 95% CI 2.14–32.08, P = 
0.001). SSIH in the mesh group was small and asymptomatic, and did not require 
repair, compared with 23% SSIH repairs in control patients. In the matched case–
control study by Maggiori et al.(46), 30 consecutive patients were individually matched 
to patients from a prospective database. In these patients, a biological mesh (noncross‐
linked collagen, porcine dermal matrix; Meccellis BioTech, France) was placed in a 
retromuscular position. At 1‐year CT follow‐up, SSIH incidence was lower in mesh 
patients than the control group (3% vs 19%, P = 0.04), while postoperative morbidity 
was similar in both groups (17% vs 11%, P = 0.51). SSIH repair was needed in eight 
control patients (13% vs 0%, P = 0.05).
Discussion
This study shows an overall incidence of SSIH of 6.5% [range 0%–38.5%, median 
follow‐up 27.5 (17.54–36) months], which is in accordance with the review by 
Bhangu et al. (58) , who reported an overall hernia rate of 7% (range 0%–48%, median 
follow‐up 36 months). However, this study was based on a smaller number of patients 
(n = 2698) than the present study (n = 4602). Both previous studies, by Bhangu et al. 
and Nguyen et al., reported on significant heterogeneity between studies and difficulties 
in interpretation and combining study results (58, 59). To reduce this heterogeneity, 
several inclusion and exclusion criteria were used during our systematic literature search 
(Fig. 1). Most importantly, to be included, studies had to mention follow‐up duration, 
since hernia rates increase over time and might vary between different durations. 
Furthermore, studies with > 10% of patients with abdominal trauma were excluded, as 
earlier reports showed these patients to be more prone to hernia development (60, 61). 
To compare the SSIH rate between ileostomy and colostomy reversal, seven studies 
were eligible for analysis. Whereas the previous review of Bhangu et al.(58) showed a 
significantly different lower SSIH rate after ileostomy (OR 0.28, 95% CI 0.12–0.65), 
this review found no significant difference in the risk of SSIH between ileostomy and 
Chapter 12
336
colostomy (OR 0.82, 95% CI 0.40–1.69), which was also not found in an additional 
cumulative meta‐analysis (cumulative OR 0.87, 95% CI 0.44–1.75). 
In this study, only one‐third (11/33) of included studies assessed SSIH incidence as the 
primary outcome. Twenty studies did not mention detection methods and, therefore, 
it seems likely to assume that imaging was not used in these studies. To investigate 
potential underestimation, the overall incidence of SSIH from the 11 studies with 
SSIH as the primary outcome was calculated (17.7%, range 1.7%–36.1%) (4, 5, 30-
32, 37, 45, 46, 48, 51, 52). These rates indeed support the hypothesis that the overall 
incidence of hernia from all included studies (6.5%), as from those only reporting on 
SSIH as a secondary outcome (3.6%), is an underestimation. The potential risk of 
underestimation by not using imaging for detection of SSIH is further supported by 
the higher incidence in studies that used imaging, compared with studies that did not 
use, or did not mention the use of imaging as a detection method (15.3% vs 3.7%, 
respectively). Indeed, from the literature on incisional hernias it is known that prevalence 
rates vary substantially, through differences in diagnostic modalities, observer, definition 
and diagnostic protocol (62). The use of imaging, which led to higher SSIH rates, might 
have identified asymptomatic or occult hernias. Therefore, the overall SSIH rate of 6.5% 
seems to be lower but more clinically relevant, and thus it remains debatable if PMR 
might even be necessary at all. Hence, it is important to identify high‐risk patients, in 
whom PMR might still be of added value and if in these patients its risks outweigh its 
benefits.
Eight studies were identified that reported on potential risk factors for development of 
SSIH. Three studies (5, 45, 52) performed a multivariate analysis, from which BMI, 
primary surgery for malignant disease and diabetes mellitus were identified as potential 
risk factors. BMI is known to affect midline incisional and parastomal hernia rates(16, 
63-66), which might be explained by higher intra‐abdominal pressure and consequent 
higher abdominal wall tension (16, 67). Additionally, obesity and diabetes are associated 
with wound healing complications due to local hypoxia, caused by a decreased 
vascularization of adipose tissue and other microvascular changes, impairing collagen 
synthesis and having a negative effect on the overall healing process (16, 68). Smoking 
has a comparable negative effect on wound healing and is considered a risk factor for 
incisional hernia (69). However, none of the included studies has shown a significant 
effect on occurrence of SSIH. Moreover, with regard to primary surgery for malignant 
disease, factors as malnutrition, poor general health and immunosuppressive effects of 
chemotherapy are thought to negatively affect the normal healing process (45, 68, 70). 
Wound infections are known to increase the risk of hernia formation (63, 71),  however, 
in the present literature review SSIs were not found to be independently associated 
with an increased risk of SSIH. Overall, the study by Oriel et al. (4) was the only study 
to identify superficial SSI as a factor contributing to future SSIH formation. The data 
on risk factors in this review might help with the selection of high‐risk patients and 
therefore help guide clinical decision‐making, potentially involving PMR. Moreover, 
since factors such as obesity and smoking can potentially be minimized, it might be of 
interest to focus not only on PMR but also on lifestyle interventions such as preoperative 
weight loss, smoking cessation and nutritional optimization for the prevention of SSIHs. 
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However, to date no evidence is available on the efficacy or effectiveness of these lifestyle 
interventions with regard to incidence of SSIH.
Four studies reported on PMR for SSIH prevention (45, 46, 56, 57). These studies 
had several methodological limitations that made it difficult to draw conclusions 
about the potential added value of PMR. Two of the studies reported on a very limited 
number of patients (n  < 10), decreasing their generalizability (56, 57). urthermore, 
these studies had no control (nonmesh) group. Two other studies on PMR were of 
better quality because they included larger numbers of patients and as well as control 
patients (45, 46). Liu et al.(45) stated that mesh placement significantly reduced the 
incidence of SSIH following ileostomy closure, without an increase in complications. 
Maggiori et al.(46) reported a significant difference in SSIH on 1‐year follow‐up CT in 
favour of PMR. Nevertheless, all four studies recognized the need for RCTs to further 
evaluate the beneficial effects, safety and (cost‐) effectiveness of PMR. Efforts have 
already been made by several research groups, and further trial results are awaited. A 
feasibility study by the Reinforcement of Closure of Stoma Site (ROCSS) Collaborative 
has recently been published and reported their study protocol to be feasible, without 
early safety concerns (72). Based on their data, progression towards their ROCCS trial 
(ClinicalTrials.gov identifier NCT02238964) has continued (72, 73). Several other trials 
have been initiated, such as the MEMBO trial (NCT02576184), the ILEOCLOSE trial 
(NCT02226887) and the LISTO‐trial (NCT02669992). Next to ileostomy closure, 
only the ROCCS trial also includes patients undergoing colostomy closure, and none 
of these trials focuses on a specific risk group, such as obese patients. However, since 
obesity seems to increase the risk of SSIH after stoma closure, this group of patients 
might potentially benefit more from PMR, although, paradoxically, these patients, 
especially in case of diabetes, might at the same time also be at higher risk of developing 
mesh‐related complications (74, 75). Therefore, it would be interesting to see the results 
of PMR in these patients specifically. With regard to the efficacy and (cost‐)effectiveness 
of PMR, it is still debatable as to what would be a clinically significant reduction in 
SSIH rates. In the case of the ROCCS trial, sample size calculation of the full Phase 
III study was based on a 40% reduction (25% to 15%) in the 2‐year clinical hernia 
rate (72). In the study by Maggiori et al. (46),  a 16% difference was found (19% vs 
3%, P  = 0.043), which might have been used for the sample size calculation of the 
MEMBO trial. However, further data on sample size calculations and risk reduction 
were not available. Unfortunately, robust conclusions cannot yet be drawn on its risks 
and benefits from the available literature on PMR. If PMR is proven to be beneficial 
in these studies, further implications for practice should be made sufficiently clear (e.g. 
patient selection) in order to overcome the barriers of implementing these findings (76). 
The low level of evidence and the vast heterogeneity of the included studies are two 
important limitations of this study. Nevertheless, inclusion of these studies was still 
deemed necessary as they allowed a more comprehensive overview of potential risk factors, 
as well as more detailed analyses of SSIH and repair rates. The lack of a predefined time 
period from which studies could be included might also have been a limitation of this 
review, because important changes in operative and perioperative care of patients have 
been introduced in recent decades (e.g. laparoscopy). However, this effect is presumably 
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largely negligible since the majority of included studies were published in the previous 
decade (Table 1).
In conclusion, this review shows an overall incidence of SSIH of 6.5% (range 0%–
38.5%), as well as an incidence of 17.7% (range 1.7%–36.1%) from 11 studies assessing 
SSIH as the primary outcome. Furthermore, potential risk factors have been identified, 
of which BMI, malignant disease and diabetes were considered to be the most important. 
Lastly, early results from four studies on PMR were identified, but no robust conclusions 
could be drawn. Results of ongoing trials are awaited.
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Table 4 Hernia rates (subdivided by stoma type)
Stoma group Studies Number of 
stomas closed
Number of 
SSIH detected
Percentage SSIH 
detected (%)
Range (%)* Median
follow-up (IQR)†
Loop 
colostomy
3 54 9 16.7 6.7-37.5 36 (36–36)
Loop ileostomy 21 2837 150 5.3 0-50 23.75 (14.92–43.75)
End colostomy 5 131 13 9.9 0-40 12.35 (10–12.35)
End ileostomy 1 3 0 0 - -
Colostomy 9 302 48 15.9 0-40 28 (12.35–52.20)
Ileostomy 26 3776 175 4.6 0-36.1 27 (18.53–51.50)
Total 33 4602 301 6.5 0-38.5 27.5 (17.54–36)
Only control patients were included, patients with prophylactic mesh placement were excluded.
SSIH, stoma site incisional hernia; IQR, interquartile range.
*Range of SSIH percentages reported in studies.
†Median (IQR) of available information on reported median study follow-up since closure (months).
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Table 5 Overview of studies reporting on prophylactic mesh placement for the prevention of SSIH
Author Year Design Mesh or 
control
Method of closure Control 
group
Outcome 
measure
SSIH 
detection 
method
Mesh type Mesh 
placement
Bhangu 2014 CS Mesh Biological 
(StratticeTM)
IPOM None 30-day 
outcomes
~
Liu 2013 R Mesh Polypropylene 
(Ethicon 
Ultrapro®)
Onlay ~ Rate of SSIH C and/or 
CT
Control ~ ~ Skin 
defect 
open
Maggiori 2015 CM Mesh Bioprosthetic, 
non-cross linked 
collagen, porcine 
dermal matrix 
(Meccellis, 
Biotech)
Sublay, 
retromuscular
~ 1-year rate of 
SSIH
CT
Control ~ ~ Primary 
closure
van 
Barneveld
2013 CS Mesh ParietexTM 
Composite 
Parastomal 
mesh + 
AbsorbaTackTM 
(Covidien/
Medtronic)
IPOM None SSIH 
and mesh 
complications
C and US
Continuous data are mean (standard deviation), mean (standard deviation, range), or median (interquartile range). C, 
clinical diagnosis; CT, computed tomography diagnosis; CS, case series; EI, end ileostomy; LC, loop colostomy; LI, 
loop ileostomy; m, months; R, retrospective; CM, case matched; IPOM, intraperitoneal onlay mesh; SSI, surgical site 
infection; SSIH, stoma site incisional hernia; US, ultrasound.
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Table 5 continued
Patients Follow-up details Number 
of 
stomas
closed
Type of 
stomas
Number 
of SSIH 
(%)
Number 
of SSI 
(%)
Number Males 
(%)
Age BMI 
(kg/
m²)
Total Time to 
closure
Time 
since 
closure
7 ~ ~ ~ 30 days ~ 30 days 7 LI, EI 0 1 (14.3)
47 63.8 69.6 
(57.9-
76.0)
>30, 
n=9
18.2m
(11.7-30.8)
9.2m
(4.1-
15.0)
~ 47 LI 3 (6.4) 2 (4.3)
36 58.3 65.0 
(57.8-
70.5)
>30, 
n=12
18.2m(11.7-
30.8)
8.6m
(4.1-
15.1)
~ 36 LI 13 (36.1) 1 (2.8)
30 60 61 (13, 
25-79)
26 (4, 
19-
36) 
16.8m(3.3, 
11.4-23.9)
11 weeks 
(5, 5-26)
30 LI 1 (3.3) 2 (6.7)
64 62 61 (13, 
28-84)
25 (4, 
18-
38)
39.2m(16.9, 
14.9-79.7)
11 weeks 
(5, 2-27)
64 LI 12 (18.8) 1 (1.5)
10 40 66 (58-
77)
25 
(20-
28)
~ 6m
(2–15)
10 LI, LC 0 1 (10)
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Figures
Figure 1 Preferred items for reporting of systematic reviews and meta-analyses (PRISMA) flow diagram.
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Figure 2 Forest plot of SSIH rates. M-H, random, Mantel–Haenszel random-effects model; df, degrees of freedom.
Figure 3 Funnel plot of the included studies
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Appendix S1 Details of the search strategy
Search syntax per database:
Embase.com
(‘incisional hernia’/de OR ‘hernia’/de OR ‘abdominal wall hernia’/de OR ‘complication’/
mj OR ‘postoperative complication’/mj OR (herni*):ab,ti OR complication*:ti) AND 
(‘enterostomy’/exp OR (stoma OR stomal OR stomas OR enterostom* OR ileostom* 
OR colostom* OR jejunostom* OR duodenostom* OR cecostom* OR ostomy ):ab,ti) 
AND (‘abdominal wall closure’/de OR ‘wound closure’/de OR (revers* OR close OR 
closed OR closing OR closure* OR ‘take down’ OR takedown OR ((former OR site) 
NEAR/3 stoma)):ab,ti)
Medline Ovid 
(“Incisional Hernia”/ OR “hernia”/ OR “Hernia, Abdominal”/ OR *”Postoperative 
Complications”/mj OR (herni*).ab,ti. OR complication*.ti.) AND (exp “Enterostomy”/ 
OR (stoma OR stomal OR stomas OR enterostom* OR ileostom* OR colostom* OR 
jejunostom* OR duodenostom* OR cecostom* OR ostomy ).ab,ti.) AND (exp “Wound 
Closure Techniques”/ OR (revers* OR close OR closed OR closing OR closure* OR 
“take down” OR takedown OR ((former OR site) ADJ3 stoma)).ab,ti.)
Cochrane 
((herni*):ab,ti OR complication*:ti) AND ((stoma OR stomal OR stomas OR 
enterostom* OR ileostom* OR colostom* OR jejunostom* OR duodenostom* OR 
cecostom* OR ostomy ):ab,ti) AND ((revers* OR close OR closed OR closing OR 
closure* OR ‘take down’ OR takedown OR ((former OR site) NEAR/3 stoma)):ab,ti)
Web of  science 
((TS=(herni*) OR TI=complication*) AND TS=(((stoma OR stomal OR stomas OR 
enterostom* OR ileostom* OR colostom* OR jejunostom* OR duodenostom* OR 
cecostom* OR ostomy )) AND ((revers* OR close OR closed OR closing OR closure* 
OR “take down” OR takedown OR ((former OR site) NEAR/2 stoma)))))
Google scholar 
Hernia| Herniation|Hernias stoma|stomal|stomas|enterostomy|ileostomy|colostomy|je-
junostomy|duodenostomy|cecostomy|ostomy reversal|close|closed|closing|closure|”take 
down”|takedown|”former stoma”|”stoma site”
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Overview of number of articles per database before and after removal of duplicate 
articles:
Embase.com 1138 1112
Medline Ovid 649 150
Web of science 448 61
Cochrane 23 1
Google scholar 200 116
Total 2458 1440
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Supporting information
Supplemental Table 1 SSIH repair rates (subdivided by stoma type)
Stoma 
group
Studies Number 
of stomas 
closed
Number 
of SSIH 
detected
Number 
of SSIH 
repairs
Percentage 
of stoma 
closures 
needing SSIH 
repair
Range 
(%)*
Percentage of 
SSIH needing 
repair
Range (%)*
Loop 
colostomy
0 ~ ~ ~ ~ ~ ~ ~
Loop 
ileostomy
9 865 90 51 5.9 0-12.5 56.7 0-100
End 
colostomy
2 42 4 3 7.14 0-15 75 0-100
End 
ileostomy
0 ~ ~ ~ ~ ~ ~ ~
Colostomy 2 42 4 3 7.14 0-15 75 0-100
Ileostomy 10 945 94 53 5.6 0-12.5 56.4 0-100
Total 16 1152 138 71 6.1 0-38.4 51.4 0-100
Only control patients were included, patients with prophylactic mesh placement were excluded. SSIH = stoma site 
incisional hernia. *Range of SSIH percentages reported in studies.
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Supplemental Table 2 Risk factors for SSIH 
Author Year Risk factor(s) from 
univariate analysis
Risk factor(s) from 
multivariate analysis
Non-significant risk factors
Bhangu(30) 2012 ~ ~ - Age
- Gender
- Presence of MIH
Brook(5) 2016 - BMI
- Hypertension (Stage 
1; ≥140/90 mmHg)
- Overall incidence 
of postoperative 
complications
- BMI
- Primary surgery for 
malignant disease
- ASA score
- Time to ileostomy closure
- Surgical approach (open or 
laparoscopic)
- Urgency of primary surgery 
(emergency or elective
- Seniority of surgical supervision
- Suture choice for rectal sheath 
defect (PDS or polypropylene)
- Use of absorbable skin suture
Cingi(31) 2008 - Presence of MIH ~ - Age
- Gender
- BMI
- SSI
- Stoma type
- Time to stoma closure
De 
Keersmaecker(32) 
2016 ~ ~ - Age (<65 versus ≥65 years of age)
- Gender
- Diabetes mellitus
- COPD
- Heart failure
- Surgical approach (open or 
laparoscopic)
- Postoperative chemotherapy
- Previous malignancy
- Previous ventral abdominal 
hernia repair
- Previous laparotomy
- Previous inguinal hernia repair
Liu(45) 2013 - Age >60 years
- Primary surgery for 
malignant disease
- Diabetes mellitus
- Chronic steroid usage
- Chronic kidney injury
- Primary surgery for 
malignant disease
- Diabetes mellitus
- Mesh reinforcement 
(protective effect)
~
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Author Year Risk factor(s) from 
univariate analysis
Risk factor(s) from 
multivariate analysis
Non-significant risk factors
Oriel(4) 2017 - Myofascial release at 
midline
- Superficial incisional 
SSI
~ - COPD
- Smoking
- Diverticulitis
- Time to stoma closure
- Midline surgical approach
- Presence of MIH at time of 
stoma reversal
- Absorbable suture for trephine 
wound
- Primary trephine wound closure
- Presence of drain at trephine 
wound closure
- Trephine fascial closure 
technique (interrupted or 
running)
- Return to operating room
- Systemic sepsis
Saha(3) 2009 - Reoperation after 
closure
- Emergency primary 
surgery
~ ~
Schreinemacher(52) 2011 ~ - BMI (≥30 versus 
<25 kg/m2)
- Age
- Gender
- COPD
- Smoking
- Corticosteroid use
- Diabetes mellitus
- Underlying disease
- Stoma type
- Peritonitis at time of stoma 
creation
- Time to stoma closure (<6 
months)
- Suture material for closure of 
fascia
- Open skin
- Length of hospital stay after 
stoma closure
- Number of prior laparotomies
- History of hernia (parastomal, 
other, or combined)
- Wound infection
- Reoperation after stoma closure
ASA = American Society of Anesthesiologists; BMI = body mass index; COPD = chronic obstructive pulmonary 
disease; MIH = midline incisional hernia; SSI = surgical site infection.
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Supplemental Figure 1 Risk of bias assessment
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Supplemental Figure 2 Cumulative meta-analysis of studies reporting on SSIH rates of ileostomies and colostomies
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Prevention of postoperative ileus
Part V
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Nicotine chewing gum for the 
prevention of postoperative ileus 
after colorectal surgery – 
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Abstract
Purpose
When postoperative ileus is not resolved after 5 days or recurs after resolution, 
prolonged POI (PPOI) is diagnosed. PPOI increases discomfort, morbidity and 
hospitalisation length, and is mainly caused by an inflammatory response following 
intestinal manipulation. This response can be weakened by targeting the cholinergic 
anti-inflammatory pathway, with nicotine as essential regulator. Chewing gum, 
already known to stimulate gastrointestinal motility itself, combined with nicotine is 
hypothesised to improve gastrointestinal recovery and prevent PPOI. This pilot study is 
the first to assess efficacy and safety of nicotine gum in colorectal surgery.
Methods
Patients undergoing elective oncological colorectal surgery were enrolled in this double-
blind, parallel-group, controlled trial and randomly assigned to a treatment protocol 
with normal or nicotine gum (2 mg). Patient reported outcomes (PROMS), clinical 
characteristics and blood samples were collected. Primary endpoint was defined as time 
to first passage of faeces and toleration of solid food for at least 24 h.
Results
In total, 40 patients were enrolled (20 vs. 20). In both groups, six patients developed 
PPOI. Time to primary endpoint (4.50 [3.00–7.25] vs. 3.50 days [3.00–4.25], 
p = 0.398) and length of stay (5.50 [4.00–8.50] vs. 4.50 days [4.00–6.00], p = 0.738) 
did not differ significantly between normal and nicotine gum. There were no differences 
in PROMS, inflammatory parameters and postoperative complications.
Conclusions
We proved nicotine gum to be safe but ineffective in improving gastrointestinal recovery 
and prevention of PPOI after colorectal surgery. Other dosages and administration 
routes of nicotine should be tested in future research.
Nicotine chewing gum for the prevention of postoperative ileus after colorectal surgery
369
Ch
ap
te
r 1
3
Introduction
Postoperative ileus (POI) is a temporary inhibition of gastrointestinal motility after 
abdominal surgery and is usually associated with nausea, vomiting, abdominal distension 
and lack of flatus and defaecation (1, 2). In more than 50% of cases, POI is not fully 
resolved in 4 days after the operation and when it does not resolve after 5 days or recurs 
after an apparent resolution, prolonged POI (PPOI) is diagnosed (3, 4). PPOI causes an 
increase in patient discomfort, morbidity, hospital-acquired infections, hospitalisation 
days and healthcare costs (5). The aetiology of POI is complex, with multiple factors 
contributing to its pathogenesis (6). Opioid use for postoperative analgesia is known 
to inhibit gastrointestinal transit and prolong POI (7, 8). However, the development 
of POI after abdominal surgery is mainly caused by intestinal manipulation during the 
surgical procedure, thereby triggering an inflammatory response and causing a sustained 
and generalised gastrointestinal hypomotility (7, 9, 10). Targeting this inflammatory 
response is of clinical relevance, but effective strategies are not yet available in clinical 
practice (8). The cholinergic anti-inflammatory pathway (CAIP) is one of the mechanisms 
that can be targeted for the prevention of POI. Experimental studies have shown that 
mediation of CAIP by vagus nerve stimulation can increase bowel motility and control 
inflammatory cell recruitment, by that preventing pathological changes important in the 
development of POI (1, 8, 11). Moreover, nicotinic acetylcholine receptors (nAChR) 
play an important role in mediation of CAIP, making nicotine an essential regulator of 
the pathway (11-13). Additionally, the α7-nAChR also plays a role in nicotine-induced 
analgesia (14) and clinical evidence shows that preoperative transdermal and intranasal 
administration of nicotine significantly reduced postoperative opioid use (15, 16), while 
reducing opioids is an important strategy of shortening POI (1, 8, 17). Gum chewing 
is another important strategy, which has already been proven to be beneficial for 
gastrointestinal recovery after surgery. Several systematic reviews and meta-analyses have 
been published, supporting postoperative gum chewing in abdominal surgery (18-23). 
As a form of sham feeding, it mimics the cephalic phase of digestion and stimulates the 
gastrointestinal motility via neurohormonal and vagal pathways (18, 24). Combining 
perioperative gum chewing with the potential beneficial effects of nicotine leads to 
the hypothesis that nicotine gum chewing can reduce POI and improve postoperative 
outcomes (e.g. less morbidity and shorter length of stay) as well as reduce medical costs 
(25). The commercially available and inexpensive nicotine chewing gum may have a 
wide clinical application in POI prevention, by both stimulating the cephalic-vagal 
reflex and activating CAIP (Fig. 1). Therefore, we performed a multicenter, randomised, 
double-blind, controlled pilot study, comparing perioperative use of nicotine chewing 
gum with normal chewing gum, to assess the clinical efficacy and safety in patients 
undergoing colorectal surgery.
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Methods
Study design and participants
This is a prospective, parallel-group, double-blind, randomised, controlled pilot study, 
conducted in the Havenziekenhuis, Rotterdam and the Sint Franciscus Gasthuis, 
Rotterdam. Adult patients who underwent an elective oncologic colorectal resection and 
gave written consent were included. Exclusion criteria were severe chronic cardiovascular 
disease or acute cardiovascular disease, severe liver- or kidney disease, oral or pharyngeal 
infection, esophagitis, hypersensitivity to any component of the nicotine gum, previous 
colorectal surgery, pregnancy, breast feeding, having an elevated risk of choking or being 
unable to chew gum for any reason.
Study procedures
Patients received either normal chewing gum or Nicorette® 2-mg chewing gum (2 mg/
gum). This nicotine chewing gum is normally used as nicotine replacement therapy to 
help control craving for cigarettes and contains a low dose of nicotine. Patients had to 
chew the allocated chewing gum 2 h preoperatively and three times a day postoperatively, 
for half an hour at a time, until the first passage of faeces and tolerance of solid food for 
more than 24 h. Patients were asked to fill out a questionnaire before surgery and daily 
after surgery, until postoperative day (POD) 6. This patient diary contained questions 
regarding chewing gum use, oral intake, bowel movements, defaecation, gastrointestinal 
symptoms and visual analogue scale (VAS) pain score. Surgeons or surgical residents 
were asked to fill out case record forms (CRF) with information regarding both patient 
and surgical characteristics, such as age, gender, body mass index (BMI), American 
Society of Anesthesiologists (ASA) score, medication use, smoking, operative procedure, 
postoperative course and postoperative complications (e.g. anastomotic leakage (AL), 
surgical site infection (SSI), fascial dehiscence, urinary tract infection (UTI) and 
pneumonia).
Blood sample analysis
Peripheral blood samples was drawn from patients prior to the surgical procedure, and 
in the morning on POD1 and POD3. Measurements of plasma white blood cell count 
(WBC) and C-reactive protein (CRP) were performed by the hospital’s laboratory 
at these same time points. Blood samples were centrifuged and plasma was stored at 
−80 °C. Enzyme-linked immunosorbent assays (ELISAs) were performed according to 
instructions of the manufacturer (PeproTech Inc., Rocky Hill, USA) to quantify the 
concentration of the systemic inflammatory marker interleukin-6 (IL-6).
A ratio of samples was calculated, through dividing the values of POD3 samples by 
those of the preoperative samples. 
Outcome parameters
The primary study parameter was the time from surgery until the resolution of 
POI, defined as passage of faeces and toleration of solid food for at least 24 h (26). 
Secondary endpoints included time to first flatus, hospitalisation length, postoperative 
(infectious) complications, postoperative mortality, postoperative opioid use, patient 
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reported outcomes (e.g. pain score, nausea, regurgitations, vomiting, chewing gum use), 
inflammatory parameters (e.g. CRP, WBC and IL-6), blood pressure, body temperature 
and heart rate. PPOI was defined as POI that was not resolved after POD5 or recurrent 
POI after an apparent resolution of POI. Diagnosis of PPOI was not made directly by 
the participating surgeons, but via retrospective review of the patient diary and medical 
record, to ensure objectiveness of the primary endpoint.
Sample size calculation
According to Asao’s gum chewing experiment (24) and Flood’s nicotine trial (16) , a 
sample size calculation was made, based on a mean POI time of 4.0 days in the chewing 
gum groups and an assumption of 2.6 days in the nicotine chewing gum group with a 
standard deviation of 1.5 days in both groups. In order to obtain a power of 80%, with 
an α level of 0.05, a number of 16 patients were needed in each group. As a dropout 
rate of 20% was expected, a total number of 40 patients (20 patients per group) were 
needed.
Patient allocation
Randomisation was done with Microsoft Excel 2010 (Microsoft Corporation, Redmond, 
WA, USA) and results were placed and concealed in sequentially numbered, sealed, 
opaque envelopes by a person who was not connected to the trial. Patients were asked 
to participate by surgeons or specialised nurses who were involved in the trial. Patients 
were preoperatively randomised in a 1:1 design to either treatment with normal chewing 
gum or nicotine chewing gum. The allocated treatment was given to the patients by the 
nursing staff. Both patients and investigators were blinded for treatment allocation.
Statistical analysis
Only patients who completed the full study period were analysed. Data analysis was 
carried out using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, 
USA, version 21.0 for Windows). Demographic data were presented in n (%) and median 
(interquartile range [IQR]). Categorical variables were compared using the Fisher’s exact 
test. Continuous variables were compared using the Mann-Whitney U test.
Results
In Fig. 2, the CONSORT flow diagram of the study is shown. Between January 29, 
2015 and July 14, 2016, 62 patients were assessed for eligibility. Of these patients, 53 
were randomly assigned to the normal chewing gum group or the nicotine chewing gum 
group. Two patients in each group withdrew from participation, because of disliking the 
chewing gum. One patient in the normal gum group was unable to continue treatment 
protocol, because of postoperative complications and ICU admission. The other patients 
withdrew for other reasons than disliking or being unable to chew the allocated gum. In 
total, 40 patients were included for data analysis.
Baseline patient and surgical characteristics were distributed evenly between both 
groups, without significant differences (Table 1). Urinary catheterisation failed in one 
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patient in the normal gum group and one patient in the nicotine gum group required 
vasopressors for hemodynamic support during surgery. All patients who were admitted 
to the intensive care unit (ICU) directly after surgery were transferred to the surgical 
ward after 1 day.
The time to primary endpoint (as defined earlier) as well as the time to first passage of 
faeces and flatus and length of stay (LOS) are given in Table 2. No statistically significant 
differences were found between groups. In both groups, six patients (30%) suffered 
from PPOI on or after POD6. Furthermore, there was no significant difference in the 
percentage of resolution of POI on POD1 to 5 (Table 3 and Supporting Information 
Fig.  S1). In a subgroup analysis in which all four open procedures were excluded, 
the time to primary endpoint in the nicotine gum group was shorter, but also not 
significantly different from the normal gum group (3.00  days [3.00–4.50] vs. 4.50 
[3.00–7.25], p = 0.249).
Six patients in the normal gum group and six in the nicotine group required a nasogastric 
tube during their postoperative stay. Three patients in the normal gum group and four 
in the nicotine gum group required total parental nutrition (TPN). Postoperative 
complications, reinterventions, readmissions and mortality during the first 30 days after 
surgery are given in Table 4. No differences were found between both treatment groups. 
Only one patient in the nicotine gum group had a short period of atrial fibrillation 
and overall, no myocardial infarction was seen. One patient in each treatment group 
required blood transfusion. One patient was readmitted because of anastomotic 
leakage and drainage of an intra-abdominal abscess, one patient was readmitted for 
adhesion ileus and one for observation of fever of unknown origin. One patient died 
during primary hospital stay, due to severe small bowel ischemia, caused by venous 
mesenteric thrombosis. Subgroup analysis for cases without intra-abdominal infectious 
complications during primary stay showed a time to primary endpoint of 4.00 days 
(3.00–5.50) vs. 4.50 (4.00–6.00) (p = 0.339) and LOS of 5.00 days (4.00–8.00) vs. 4.50 
(4.00–6.00) (p = 0.673), for the normal gum and nicotine gum groups, respectively.
Postoperative opioid use
Fourteen patients in the normal gum group used oral opioids postoperatively, compared 
to 11 in the nicotine gum group (p = 0.514). Respectively, epidural opioids were used 
in 16 and 14 patients and a combination of oral and epidural opioids was used in 12 
and 9 patients (p = 0.527). One patient in the normal group used a PCA pump and 
five patients in the nicotine gum group (p = 0.091). Patients in the nicotine gum group 
used epidural opioids for a significantly longer time (3.00 days [2.00–4.25] vs. 2.00 
[1.00–.00], p = 0.006), but duration of oral opioid use did not differ between groups 
(1.00 day [0–3.50] vs. 1.00 [0–3.00], p = 0.740).
Patient reported outcomes
Fifteen patients who received normal gum filled out their diary, as compared to 16 patients 
who received nicotine chewing gum (p  =  1.000). Pain scores (VAS) were significantly 
lower in the nicotine gum group on POD3 (1.40 [0.50-] vs. 2.70 [1.50-], p = 0.007), 
but did not differ on the other postoperative days (Supporting Information Fig. S2). No 
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differences were found in patient reported nausea, vomiting, regurgitations, abdominal 
distension and appetite (Supporting Information Fig. S3). Treatment compliance, as based 
on patient reported chewing gum use, is given in Supporting Information Table S1.
Inflammatory parameters
No significant differences were observed in IL-6 levels and white blood cell counts in 
preoperative samples and POD1 and three samples (Supporting Information Fig. S4). 
CRP levels differed on POD1 in the normal and nicotine gum groups, respectively 
(71.50  mg/L [35.00–92.75] vs. 94.50  mg/L [58.50–128.25],  p  =  0.017), but no 
differences were found in preoperative and POD3 samples (Supporting Information 
Fig. S4b). None of the calculated ratios showed differences between both groups (Table 
5). On none of the postoperative days, a statistically significant difference was found in 
systolic and diastolic blood pressure, and heart rate (Supporting Information Fig. S5).
Discussion
This study was the first to investigate the role of nicotine chewing gum for the 
prevention of postoperative ileus by assessing its clinical efficacy and safety in patients 
undergoing elective colorectal surgery. By performing this parallel-group, double-blind, 
randomised, controlled pilot study, it was not possible to prove the beneficial effect of 
nicotine chewing gum, as compared to normal chewing gum. We hypothesised that 
the combination of perioperative gum chewing, with the potential beneficial effects 
of nicotine, could improve the resolution of POI, but although the median time to 
primary endpoint seemed shorter in the nicotine gum group (3.50 days vs. 4.50), the 
difference was not statistically significant. Moreover, an equal number of patients (n = 6) 
in each group suffered from PPOI and LOS did not differ significantly between both 
groups. Open procedures are known to worsen POI outcomes in colorectal surgery as 
compared to the laparoscopic approach (27). ince all four open procedures in this study 
were in the nicotine gum group, a subgroup analysis was performed in which these four 
procedures were excluded. This showed an improvement in median time to primary 
endpoint (3.50 vs. 3.00 days) and length of stay (4.50 vs. 4.00 days) in the nicotine 
gum group, but although these open procedures influenced the outcomes, they did not 
provide a complete explanation for the lack of efficacy, since a significant difference 
between both groups was still not found.
A limitation of this study might be the relatively small sample size of 40 patients in 
total. However, our sample size calculation was based on the results of Asao et al. (24) 
who showed significant effects of chewing gum in a total of 19 patients. With a larger 
sample size than we initially calculated, we might have had more power to make a better 
distinguishment between the effects of sham feeding with normal chewing gum and the 
hypothesised additional effects of sham feeding with nicotine chewing gum.
Experimental studies have shown that a specific α7-nAChR agonist (AR-R17779) 
ameliorates POI in rats and that stimulation of the α7-nAChR improves survival of 
sepsis in rats (11, 28). Nevertheless, as clinical results of nicotine use for POI after 
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colorectal surgery were still lacking, the second aim of this pilot study was to evaluate the 
safety of nicotine chewing gum for the purpose of preventing POI. Because of concerns 
of systemic effects induced by nicotine administration, particularly cardiovascular 
complications (29), we decided to use Nicorette® 2 mg. This relatively low dose might 
have potentially been another reason for the lack of efficacy of the nicotine chewing gum 
in this study. However, the use of Nicorette® 2 mg in a perioperative setting of elective 
colorectal surgery, which has not been described in the literature before, seems to be safe.
No myocardial infarctions were registered in this study and only one patient had one 
short period of atrial fibrillation. This patient did receive nicotine chewing gum, but was 
known to have had previous episodes of paroxysmal atrial fibrillation. These findings 
are consistent with a previously published Cochrane Review, concluding that there is 
no evidence that nicotine replacement therapy increases the risk of heart attacks (30). 
Moreover, apart from cardiovascular complications, no differences were found in major 
and minor postoperative complications, reinterventions, readmissions and mortality 
between the normal and nicotine chewing gum groups. Overall, only one patient—
enrolled in the nicotine chewing gum group—died during primary hospital stay on 
the 15th postoperative day. We did not consider usage of the nicotine chewing gum 
related to the cause of death, which was a result of intestinal ischemia caused by venous 
mesenteric thrombosis.
To combine the potential benefits of sham feeding with chewing gum and nicotine, 
we chose to use nicotine chewing gum in this pilot study. The reason being that this 
facilitated the possibility for a simple blinded comparison with normal chewing gum. 
However, a limitation of nicotine administration through chewing gum is that a sufficient 
release of nicotine is dependent on treatment compliance of the patient. All patients in 
this study were asked to report their use of chewing gum in the patient diary and it can 
be concluded that compliance to chewing the allocated gum is decreasing in the first 
three postoperative days. Conceivably, a more constant way of nicotine administration, 
such as the nicotine patches which Habib et al. (15) used in their study, might have 
given a more continuous release of nicotine.
If indeed the effective dose of nicotine would be too low in some patients, either due to 
low administered dose, insufficient exposure to the nicotine chewing gum or both, this 
might account for the absence of significant differences between the measured clinical 
and inflammatory parameters in both groups.
Il-6 and CRP levels, as well as WBC, were analysed in venous blood samples, as markers 
of the immune response, because it was hypothesised that this response would be less 
pronounced in patients in the nicotine chewing gum group. Overall lower levels of any 
of the three inflammatory parameters (IL-6, CRP and WBC) were not seen in this group 
and no differences were found, when compared to the normal chewing gum group, 
except for a significant difference of CRP levels on POD1. Sparreboom et al. (31) have 
concluded in their meta-analysis that levels of pro-inflammatory cytokines, such as IL-6, 
were higher in peritoneal samples as compared to serum samples after colorectal surgery, 
which might also explain why significant changes and differences were not detected in 
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our serum samples. Moreover, postoperative infectious complications, such as surgical 
site infections and pneumonia, could have affected the levels of these inflammatory 
parameters in both groups.
No differences in patient reported outcomes, such as nausea, vomiting, regurgitations, 
abdominal distension and appetite, were found. However, patient reported pain scores 
were significantly lower in the nicotine gum group as compared to the normal gum 
group on POD3 (1.40 [0.50-] vs. 2.70 [1.50-], p = 0.007). Although promising, this 
difference could partially be explained by the fact that patients in this group received 
epidural opioids for a significantly longer period of time (3.00  days [2.00–4.25] vs. 
2.00 [1.00–.00], p  =  0.006). However, the exact reason for a longer use of epidural 
opioids remains uncertain, since the decision to stop epidural anaesthesia in this study 
was made by the anaesthesiologist, who was blinded for patient allocation, with the aim 
to stop as early as possible, and preferably on or before POD2–3. These decisions were 
not registered prospectively. Furthermore, no significant differences in patient outcomes 
were found between both groups which might explain the extended requirement for 
epidural opioids in the nicotine gum group.
In conclusion, this study is the first to evaluate the potential beneficial role of nicotine 
chewing gum for another purpose than NRT in a randomised and double-blind clinical 
setting. Although the hypothesised potential benefits of nicotine chewing gum, as a 
cheap and readily available treatment option, seemed promising, no evident beneficial 
effects were found. This might be attributed to the sample size, the dose of the nicotine 
chewing gum and insufficient patient compliance to the allocated chewing gum. People 
in the nicotine chewing gum group seemed to experience less pain in the first three 
postoperative days, but a difference could only be proven on POD3. Therefore, more 
data on the effects of nicotine gum on bowel recovery after surgery are awaited (32). 
Furthermore, this study provides positive new insights on the safety of nicotine chewing 
in the setting of patients undergoing elective colorectal surgery. Future research should 
focus on other means of nicotine administration to patients undergoing colorectal 
surgery (e.g. patches), whether or not combined with normal chewing gum, and in 
higher doses, to further assess its effects on gastrointestinal recovery after colorectal 
surgery.
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Tables
Table 1 Baseline patient and surgical characteristics in treatment groups
Normal gum group
(n=20)
Nicotine gum group 
(n=20)
Patient characteristics
Sex 
   Male 
   Female
 
13 (65) 
7 (35)
 
14 (70) 
6 (30)
Age (years) 67.50 [60.75-74.75] 69.00 [62.50-70.00]
BMI (kg/m2) 26.91 [23.77-31.61] 25.02 [23.15-27.67]
Smoking 2 (10) 4 (20)
Diabetes mellitus 1 (5) 4 (20)
COPD 2 (10) 3 (15)
Cardiovascular disease 9 (45) 5 (25)
Corticosteroid use 3 (15) 1 (5)
Statin use 4 (20) 5 (25)
Neoadjuvant radiotherapy 1 (5) 0
Neoadjuvant chemoradiotherapy 1 (5) 0
Previous abdominal surgery 3 (15) 3 (15)
ASA Classification 
   ASA I 
   ASA II 
   ASA III 
   ASA IV
 
4 (20) 
13 (65) 
3 (15) 
0
 
3 (15) 
14 (70) 
2 (10) 
0
Surgical characteristics
Type of procedure
   Low anterior resection 
   Left hemicolectomy
   Right hemicolectomy
   Sigmoidectomy
   Subtotal colectomy
   Transverse colon resection
 
3 (15) 
3 (15) 
8 (40) 
5 (25) 
1 (5) 
0
3 (15) 
2 (10) 
6 (30) 
6 (30) 
0 
3 (15)
Laparoscopic approach 20 (100) 16 (80)
Anastomotic technique 
   End-to-end
   End-to-side
   Side-to-end
   Side-to-side
 
4 (20) 
1 (5) 
5 (25) 
10 (50)
2 (10)
1 (5)
5 (25)
11 (55)
Anastomotic configuration 
   Stapled
   Sutured
12 (60) 
8 (40)
 
13 (65) 
8 (40)
Protective ileostomy 2 (10) 2 (10)
Nasogastric tube 12 (60) 13 (65)
Intraoperative complications 1 (5) 1 (5)
>50 mL blood loss 5 (25) 9 (45)
Duration of surgery (minutes) 133 [101-176] 117 [109-150]
Postoperative ICU admission 1 (5) 2 (10)
Data are median [IQR] or n (%). 
BMI body mass index, ASA American Society of Anesthesiologists classification, ICU intensive care unit
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Table 2 Time to primary endpoint, time to first passage of faeces and flatus, length of stay in days.
Normal gum group
(n=20)
Nicotine gum group 
(n=20)
p value
Time to primary endpoint (days) 4.50 [3.00-7.25] 3.50 [3.00-4.25] 0.398
Time to first passage of faeces (days) 3.00 [1.75-5.00] 3.00 [1.75-4.00] 0.414
Time to first passage of flatus (days) 1.00 [1.00-2.25] 1.00 [1.00-1.00] 0.454
Length of stay (days) 5.50 [4.00-8.50] 4.50 [4.00-6.00] 0.738
Data are median [IQR].
Table 3 Resolution of POI
Normal gum group
(n=20)
Nicotine gum group 
(n=20)
p value
Resolution of POI 
   POD1 
   POD2 
   POD3 
   POD4 
   POD5 
   POD6 or later
0 
0
6 (30) 
11 (55) 
14 (70) 
20 (100)
0 
2 (10) 
9 (45) 
13 (65) 
14 (70) 
20 (100)
-
0.487
0.515
0.748
1.000
1.000
Data are n (%).
Table 4 Postoperative complications, reinterventions (surgical and/or radiological), readmissions and mortality (≤30 days)
Normal gum group
(n=20)
Nicotine gum group 
(n=20)
p value
Atrial fibrillation 0 1 (5) 1.000
Fascial dehiscence 0 0 -
Colorectal anastomotic leakage 2 (10) 0 0.487
Intra-abdominal abscess 1 (5) 0 1.000
Myocardial infarction 0 0 -
Pneumonia 1 (5) 0 1.000
Surgical site infection 4 (20) 2 (10) 0.661
Urinary retention 0 1 (5) 1.000
Urinary tract infection 2 (10) 1 (5) 1.000
Reinterventions (<30 days) 4 (20) 2 (10) 0.661
Readmissions (<30 days) 3 (15) 0 0.231
Mortality (<30 days) 0 1 (5) 1.000
Data are n (%).
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Table 5 Inflammatory parameters (Interleukin-6 (IL-6), C-reactive protein (CRP) and white blood cell (WBC) count)
Normal gum group
(n=20)
Nicotine gum group 
(n=20)
p value
IL-6 (pg/mL)
   Preoperative 
   POD1 
   POD3
1088.95 [529.65-1680.70]  
881.80 [516.90-2138.70]  
959.00 [648.90-2043.60]
1108.40 [547.18-1732.38] 
1047.65 [752.53-1930.10] 
987.40 [518.38-2139.75]
0.663 
0.883 
0.940
   Ratio 1.13 [0.99-1.54] 1.12 [0.89-1.24] 0.517
CRP (mg/L) 
   Preoperative 
   POD1 
   POD3
 
2.60 [1.00-4.75] 
71.50 [35.00-92.75] 
99.50 [76.25-179.50]
3.70 [2.25-23.38] 
94.50 [58.50-128.25] 
151.00 [101.75-188.50]
0.089
0.017
0.180
   Ratio 45.83 [19.70-83.68] 33.92 [6.59-79.10] 0.180
WBC count (x 109/L) 
   Preoperative 
   POD1 
   POD3
7.10 [3.90-9.60]
12.30 [7.65-15.45]
8.50 [4.95-10.60]
6.60 [6.25-9.10]
12.30 [10.85-13.85] 
9.00 [7.15-11.85]
0.477
0.865
0.583
   Ratio 1.08 [0.95-1.59] 1.15 [0.99-1.77] 0.734
Data are median [IQR]
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Figures
Figure 1 Simplified scheme of hypothesised effect mechanism of nicotine chewing gum
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Figure 2 CONSORT flow diagram
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Supporting Information
Normal gum = ● (dots), nicotine gum = ■ (squares)
Supplemental Figure 1 Resolution of POI (A, B)
Supplemental Figure 2 Postoperative patient reported pain scores (Visual Analogue Scale)
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Supplemental Figure 3 Postoperative patient reported outcomes: (A) Nausea, (B) Vomiting, (C) Regurgitations, (D) 
Abdominal distension, (E) Appetite
Supplemental Figure 4 Inflammatory parameters (A) Interleukin-6 (IL-6) levels, (B) C-reactive protein (CRP) levels, 
(C) white blood cell count
Supplemental Figure 5 Postoperative outcomes: (A) Systolic blood pressure, (B) Diastolic blood pressure, (C) Heart rate
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Supplemental Table 1 Patient reported compliance to chewing gum
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General Discussion
Over past decades, the treatment of complicated diverticulitis has gradually shifted 
towards a more conservative approach. This shift necessitates a tailored and evidence-
based clinical assessment in order to choose the right treatment for the right patient. 
For this reason, the treatment of the different stages of complicated diverticulitis still 
remains a topic that is much debated. In this thesis, novel evidence was presented on 
both the non-resectional and resectional treatment of complicated diverticulitis with 
the aim to help elucidate some of these debated topics. In addition, this thesis also 
focused on complications related to the construction of a stoma, which might be the 
case during surgery for complicated diverticulitis, but, evidently, also for other benign 
or malignant colorectal disease. On the long term, the presence of a stoma puts patients 
at risk for the development of a parastomal hernia, or in case of stoma reversal, for a 
stoma site incisional hernia. Hence, the aim of this thesis was to contribute new insights 
on the incidence, diagnostics, and management of these stoma-related complications. 
Moreover, focus was put on the prevention of (prolonged) postoperative ileus, which is 
a potential short-term complication of colorectal surgery.
Part I Non-resectional treatment of complicated diverticulitis
Several options for the treatment of diverticular abscesses are at hand, such as surgery, 
abscess drainage, and antibiotics. Although treatment strategies have shifted from 
emergency surgery to non-surgical and non-resectional management, no clear consensus 
on their role yet exists (1). Importantly, conservative management might put patients at 
risk for adverse outcomes, both on the short and long term (2).
In Chapter 2, these short- and long-term outcomes, such as treatment failure, disease 
recurrence, and (emergency) surgery rates, were investigated in a retrospective, 
multicentre, cohort study of patients with CT-proven Hinchey Ib or II diverticulitis. 
Whereas previous studies were limited by sample size, short follow-up duration, single-
institutional setting, or the lack of patient and disease characteristics, the present study 
tried to overcome these limitations (3-7). A total of 447 patients (Hinchey Ib 215; 
Hinchey II 232) were included and, after initial non-surgical management (antibiotics 
with (n=115) or without (n=332) percutaneous drainage), follow-up was available for 
a median period of 72 (interquartile range 55-93) months. From univariable analyses 
stratified by Hinchey grade, no differences were found between patients who were 
treated with or without drainage, in terms of short-term treatment failure, readmissions, 
emergency surgery, and mortality. In contrast, the short-term complication and long-
term resection rates were higher for percutaneous drainage in Hinchey II patients. Even 
though they were stratified by Hinchey grade, these results might still partly be biased 
due to confounding by indication. Interestingly, however, multivariable analyses showed 
that the choice of treatment was not independently associated with short- and long-
term adverse outcomes. Similarly, a more recent study from Finland also found that, 
despite adjustment for confounding, drainage did not seem to be superior to antibiotics 
alone (8). These potential confounders (e.g. patient and abscess characteristics) are of 
importance to consider, as these are factors that typically shape clinical decision-making. 
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In terms of these characteristics, another interesting finding was the fact that abscess sizes 
of ≥3 and ≥5 centimeter were demonstrated to be independent risk factors for short-term 
treatment failure and emergency surgery, respectively. Hence, in conclusion, it seems 
that abscesses of <3 centimeter can be treated with antibiotics alone, on the premise 
that drainage can still be considered if there is no apparent clinical improvement. For 
patients with abscesses of ≥3 centimeter, close monitoring seems warranted and some 
restraint in the choice to drain seems justified.
In past decades, the role of non-resectional treatment by means of laparoscopic lavage 
for perforated diverticulitis with purulent peritonitis (Hinchey III) has increasingly been 
investigated (9-11). Similar to the conservative management of patients with diverticular 
abscesses, the sigmoid colon remains in situ and, hence, these patients are at risk for 
short-term treatment failure, as well as long-term disease recurrence, readmission, and 
surgery. In contrast to the potential risks, long-term benefits of laparoscopic lavage 
might be the avoidance of stoma construction and the subsequent risk of stoma-related 
and reversal-related complications. Although these long-term outcomes of laparoscopic 
lavage are an important factor in the debate on its added value to clinical practice, results 
were scarce and mostly limited to a 12-month follow-up (12-16).
The results presented in Chapter 3 add novel evidence on the long-term consequences 
of laparoscopic lavage. Retrospective follow-up was conducted over a median period of 
46 (interquartile range 7-77) months within a cohort of 38 patients who were initially 
treated with laparoscopic lavage. During this period, a total of 12 patients (32%) 
required additional surgery. Of the 32 patients who were alive and did not undergo a 
sigmoidectomy by the end of short-term (90-day) follow-up, seven (22%) eventually did 
undergo a sigmoidectomy. Also, in 31 patients who initially were successfully treated, 
recurrent diverticulitis or other complications occurred in 12 (31%). Although mostly 
descriptive and assessed in a relatively small cohort of patients, these results indicate 
that long-term consequences should not be underestimated. Of the three published 
randomized trials comparing laparoscopic lavage to sigmoid resection, only the DILALA 
has published results of a two-year follow-up period (13, 15-17). Within this period, it 
was found that lavage patients had a reduced risk of undergoing one or more reoperations 
as compared to the Hartmann’s group (relative risk 0.55, 95%CI 0.36, 0.84)(17). These 
promising results might be strengthened by the long-term results of the SCANDIV trial 
and LOLA arm of the Ladies trial, which are awaited with interest (13, 15).
The long-term findings presented in this thesis and a wide range of other available 
evidence on laparoscopic lavage for the treatment of perforated diverticulitis were 
further discussed in Chapter 4, in which the question was posed ‘when, how and if ’ 
laparoscopic lavage should be performed. One of the arguments against laparoscopic 
lavage is its higher risk for short-term adverse outcomes. However, it can be argued that 
these short-term risks are outweighed by potential benefits such as lower stoma and 
operation rates during further follow-up. Hence, minimizing short-term treatment risks 
is an important step towards the wider acceptance of lavage as a treatment option. In 
order to do so, accurate patient selection becomes even more crucial. An important step 
to improve this selection might be the optimization of pre- and intraoperative diagnostic 
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strategies to rule out diagnoses such as Hinchey IV disease or perforated colorectal cancer, 
such as CT imaging with rectal contrast or intraoperative sigmoidoscopy. Moreover, 
preoperative risk factors should be determined to distinguish between patients that 
might benefit most and patients at risk of treatment failure.
Part II Resectional treatment of complicated diverticulitis 
In Chapter 5, the results of the DIVA arm of the international, multicentre, parallel-
group, randomized, open-label, superiority Ladies trial were presented, in which the 
outcomes of sigmoid resection with primary anastomosis (with or without ileostomy) 
were compared to those of the Hartmann’s procedure for patients with purulent or fecal 
peritonitis (Hinchey III or IV). Overall, 66 patients were included in the Hartmann’s 
procedure group (Hinchey III 46, Hinchey IV 20) and 64 in the primary anastomosis 
group (Hinchey III 46, Hinchey IV 18). It showed the primary endpoint of 12-month 
stoma-free survival to be higher for primary anastomosis patients (94.6% [95% CI 
88.7, 100] vs 71.7% [95% CI 60.1, 83.3], hazard ratio 2.79 [95% CI 1.86, 4.18]; log-
rank p<0.0001). No differences were found in the short-term morbidity and mortality 
rates, whereas results showed that primary anastomosis was favorable in terms of short-
term reversal-related morbidity, as well as the time to stoma reversal and postoperative 
stay after reversal. Therefore, it was concluded that primary anastomosis is preferable 
to the Hartmann’s procedure for hemodynamically stable, immunocompetent patients 
younger than 85 years with Hinchey III or IV diverticular disease. 
Although this was not the first published trial to compare both procedures for this 
indication, it did have the largest sample size and several methodological advantages. 
Firstly, patients were randomized intraoperatively after diagnostic laparoscopy as opposed 
to the preoperative randomization in the other three trials (18-20). This allowed for a 
more accurate distinction between Hinchey grades, as this distinction is notoriously 
difficult to make based on CT imaging alone (21).
Secondly, even though no clear differences were identified, this trial was the first to 
assess patient-reported outcomes, in terms of general and gastrointestinal quality of life 
scores. Also, the present trial was the first to compare a sample of non-included patients 
with the included patient cohort. This is of importance, because despite the randomized 
study design, results might still have been biased by the exclusion of potentially eligible 
patients due to treatment preferences of both the surgeon or patient involved. Lastly, 
another methodological difference was the ability for surgeons to decide whether or not 
to construct a defunctioning ileostomy during the primary anastomosis procedure, which 
is an important benefit of this procedure as compared to the Hartmann’s procedure.
As part of its design, the study did not only aim to assess patient-related outcomes, 
but also aimed to provide insights into the cost-effectiveness and cost-utility of both 
treatment groups. In Chapter 6, the results of the cost evaluation of the study were 
presented. The results showed that primary anastomosis was associated with significantly 
lower costs as compared to the Hartmann’s procedure, with a mean difference in overall 
(direct and indirect) costs of €-8126 (95% CI -14660 to -1592). Moreover, primary 
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anastomosis was shown to be cost-effective in terms of the probability of being stoma-
free and alive after 12 months (incremental cost-effect effectiveness ratio was €-39,094 
(95% BCaCI –1,213 to –116). As the rates of acute diverticulitis and related admissions 
have been found to have increased over the course of the past decades, logically, the 
associated financial burden also increases (22, 23). Favorable cost-related outcomes, as 
demonstrated in the present cost evaluation, might serve as an additional argument 
to opt for primary anastomosis and might, as a consequence, help with its wider 
implementation in clinical practice. 
In Chapter 7, a systematic review and meta-analysis of observational and randomized 
studies on the comparison of both procedures were presented. Based on these trial 
outcomes it provided arguments to prefer sigmoid resection with primary anastomosis 
over the Hartmann’s procedure, such as favorable outcomes in terms of stoma reversal rates 
(OR 2.62, 95%CI 1.29, 5.31) and reversal-related morbidity (OR 0.33, 95%CI 0.16, 
0.69), without a difference in mortality (OR 0.83, 95%CI 0.32, 2.19). Some authors 
stated that it seems to be the end of the Hartmann’s era for perforated diverticulitis in 
light of all the accumulated evidence (24). However, it is of importance to acknowledge 
that this still might not apply to all patients with perforated diverticulitis and is in 
fact only true for selected patients. Indeed, the need for careful interpretation of the 
conclusions provided in the included studies and their application to the appropriate 
clinical setting were emphasized in the presented systematic review. In case of the 
included observational studies it should be noted that favorable outcomes of primary 
anastomosis might have been the result of confounding by indication. With regard to 
the randomized studies, it should be mentioned that the generalizability of their results 
largely depends on the applied in- and exclusion criteria, which - for example - led to the 
exclusion of hemodynamically unstable patients. Moreover, as stated before, these trial 
populations might also be subject to bias due to the non-inclusion of eligible patients. In 
addition to these results and notions, some of the knowledge gaps related to the surgical 
treatment of Hinchey III or IV disease were also identified in this chapter. Results from 
specific subgroups, such as patients undergoing primary anastomosis without ileostomy 
construction or Hinchey IV patients, were limited. Also, patient-reported and cost-
related outcomes were scarcely reported, despite the fact that they might aid the further 
implementation of primary anastomosis into clinical practice.
Part III Treatment of (complicated) diverticulitis: appraisal of the evidence
In Chapter 8, a narrative review on the multidisciplinary management of complicated 
diverticulitis was presented. As the evidence on the various aspects of complicated 
diverticulitis and its management has progressed over recent years, the aim was to 
help guide clinicians by means of an extensive overview of the available literature on 
these aspects. The review discussed the several different treatment options and their 
indications and also focused on the epidemiology, classification, and diagnostics. These 
latter aspects have become increasingly important as they are paramount to facilitate 
accurate patient selection and, thus, to recognize the correct tailored approach for each 
individual patient. 
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In addition to evidence on the management of complicated diverticulitis, the guidelines 
of the European Society of Coloproctology that are presented in Chapter 9 also focus on 
uncomplicated diverticular disease. These guidelines were the product of an international 
collaboration of surgical residents, PhD students, as well as expert clinicians from the 
fields of colorectal surgery, gastroenterology, and radiology. The multidisciplinary and 
evidence-based approach aided the development of guidance and recommendations on 
various topics related to all entities of diverticular disease, ranging from their etiology, 
diagnosis and follow-up to their (non-)surgical treatment and surgery-related technical 
considerations. Additionally, the development process helped to identify some of the 
remaining knowledge gaps and topics that can potentially be further elucidated in future 
research.
Part IV Stoma-related complications
Within the retrospective cohort study presented in Chapter 10, outcomes of the 
non-operative ‘watchful waiting’ strategy for parastomal hernia were compared to 
surgical treatment. It was found that 8 of the 38 patients (21%) who were treated non-
operatively eventually underwent surgical treatment, of whom only one patient (2.6%) 
needed emergency surgery. Moreover, 23 of the 42 surgically treated patients (55%) had 
a recurrence over a median follow-up period of 46 months (i.q.r. 24-72), of whom 21 
(91%) underwent an additional repair procedure. Given the relatively low cross-over 
and emergency surgery rate of non-operative treatment, it seems justified to opt for a 
non-operative treatment in patients with comorbidities and in those patients who are 
free of parastomal hernia symptoms, certainly within the light of the high recurrence rate 
after surgical treatment. The presented data facilitate the counseling of patients about 
the risks and benefits of both treatment strategies and, thus, support shared decision 
making. Evidently, the most important aim within the context of parastomal hernias 
is to optimize the prevention of occurrence. Consequently, a wide range of studies 
focusing on topics such as stoma construction and prophylactic mesh reinforcement 
have been published (25-28).
In the field of parastomal hernia research, it is of paramount importance to realize that 
several factors might affect reported incidence rates and that, therefore, these factors 
need to be acknowledged during the interpretation of these results and their potential 
translation into clinical practice. These factors include patient and stoma characteristics, 
length of follow-up, definition of parastomal hernia, as well as the choice of diagnostic 
modality (e.g. clinical examination, ultrasound, and CT imaging).
In Chapter 11, a systematic review was presented with the aim to compare these different 
modalities, as well as to assess and identify the different classifications and definitions 
used for parastomal hernias. Although the literature on this topic was heterogeneous and 
relatively scarce, a wide variance in the accuracy of the different modalities was found. 
Also, a large number of different definitions was identified, as well as studies in which a 
definition of parastomal hernia was not mentioned at all. Hence, the findings presented 
in this systematic review provide arguments to strive towards more consistency in the 
conduct and report of research on parastomal hernia. To improve the possibility of 
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comparing outcomes between clinical studies, the identification of a uniform parastomal 
hernia definition, such as the one proposed by the European Hernia Society (26, 29), 
might be required, in addition to the optimization of the report of diagnostic protocols 
within these studies. Evidently, the detection of parastomal hernia within the setting of 
research protocols might differ significantly from that in the everyday clinical context. 
Particularly, as in the latter context, symptomatic hernias and patient-reported outcomes 
play a much more important role.
Chapter 12 described the findings of a systematic review and meta-analysis on the 
incidence, risk factors, and prevention of stoma site incisional hernias. As for parastomal 
and incisional hernias, prophylactic mesh reinforcement has gained increased interest 
with regard to the prevention of stoma site incisional hernia. Results of the use of mesh 
during stoma reversal have been reported to reduce hernia rates (30). However, to further 
evaluate the potential beneficial role of prophylactic mesh, it is of importance to gain 
insights into the incidence of stoma site incisional hernia, as well as to identify patients 
that are at higher risk of developing such a hernia. The presented meta-analysis showed 
an overall rate of 6.5% (range 0%–38%, median follow-up 27.5 (17.54–36) months), 
which was 17.7% (range 1.7%–36.1%, median follow-up 28 (15.25–51.70) months) 
in the eleven studies that reported stoma site incisional hernias as primary endpoint. 
These figures also indicate the importance of reporting on outcomes assessment and 
its subsequent effect on incidence rates in the field of hernia research. In addition 
to the incidence rates, risk factors for stoma site incisional hernias were identified, 
which included diabetes, body mass index, and surgery for malignancy. The latter two 
factors were also found to be a risk factor in the cohort study by Amelung et al. (31), 
which identified stoma prolapse, parastomal hernia, and hypertension as additional 
independent risk factors.
Part V The prevention of postoperative ileus
In Chapter 13, the results of a randomized, double-blind pilot study comparing nicotine 
chewing gum with regular chewing gum for the prevention of (prolonged) postoperative 
ileus after colorectal surgery were presented. No clear differences were demonstrated 
in terms of prolonged postoperative ileus rates, postoperative and patient-reported 
outcomes, as well as inflammatory parameters. Hence, it was concluded that nicotine 
chewing gum seems to be safe but ineffective as preventative measure. Still, it might 
be worth exploring options such as sham feeding combined with nicotine patches, as 
these might improve compliance and provide a more constant nicotine administration. 
Nevertheless, due to the multifactorial etiology of postoperative ileus, several other 
measures that aim to prevent this common adverse outcome have been studied or are 
currently being investigated (32). Interestingly, reports of transcutaneous vagus or tibial 
nerve stimulation in humans have recently been reported to be feasible, although it 
should be acknowledged that these results are preliminary and require further evaluation 
(33, 34). As the burden of prolonged postoperative ileus is significant, research into 
improved or novel methods to reduce it should be supported and their results will 
hopefully help to further optimize existing enhanced recovery protocols.
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Future Perspectives
Complicated diverticulitis
Throughout this thesis, the term ‘patient selection’ has been used several times. As the 
management of the different stages of complicated diverticulitis is shifting towards the 
use of less invasive and less extensive treatment options, this term becomes more and 
more important. Accurate assessment of both patient and disease characteristics is of 
paramount importance to be able to correctly identify the best treatment approach 
tailored for each individual patient.
To help facilitate patient selection, novel data on potential selection criteria and risk 
factors are needed. However, research into the emergency surgical setting and complicated 
diverticulitis is known to have some inherent difficulties to it. Firstly, the conduct of 
randomized controlled trials in critical and emergency care is known to be difficult (35, 
36). In a relatively limited time span both patients and surgeons need to decide if they 
are willing to participate in the trial, which might subsequently lead to selection bias. 
In addition, trial awareness might in general also be limited in the emergency setting. 
Moreover, when interpreting results from prospective trials, the outcomes should only 
be interpreted within the context of the in- and exclusion criteria that were applied. 
At that point, population-based studies might be more useful, as they assess treatment 
outcomes from a broader perspective. Nevertheless, these studies are often limited by 
a short follow-up period, the lack of details on patient and disease characteristics, the 
absence of patient-reported outcomes, or a combination of these factors.
Thus, the challenge of future research is to find ways to overcome these methodological 
limitations. Ideally, new data should be gathered in the setting of a national or 
international, multicenter, prospective, observational design. Within this design, 
extensive details on patient and disease characteristics, as well as short- and long-term 
and patient-related outcomes should be gathered. This will enable both the identification 
of risk factors, with the possibility to adjust for potential confounders, but will also 
provide a reflection of treatment decisions and current clinical practice. Additionally, 
some of the remaining knowledge gaps – as identified in the meta-analysis presented 
in Chapter 7 – can be further elucidated, such as outcomes in perforated diverticulitis 
patients who undergo primary anastomosis without the construction of an ileostomy. 
Student- and trainee-led collaborative networks or collaborative study groups, such as 
the EuroSurg Collaborative and the Right Iliac Fossa Pain Treatment (RIFT) Study 
Group, are relevant examples of ways to conduct these types of studies (37, 38). In fact, 
efforts to assess the treatment and outcomes of complicated diverticulitis have recently 
been made by means of the DAMASCUS study, which is an international collaborative 
snapshot audit study (39). 
In addition, the increasing centralization of colorectal surgery might have a beneficial 
effect on the ability to conduct research in the field of emergency colorectal surgery. 
The increase in clinical expertise, subsequent to centralization, might also lead to more 
engagement in the field of colorectal research. Hence, these centers of expertise will 
likely be more dedicated to the aid the conduct of clinical trials and cohort studies, 
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thereby increasing trial involvement and rates of patient enrollment, even in the setting 
of emergency surgical care. Moreover, in the future, the emerging role of the ‘emergency 
(general) surgeon’ might also come to positively influence both outcomes and research 
within the acute care setting (40-43).
Next to these novel studies and potential future research initiatives, new evidence can 
also be sought within existing trial designs and data. Examples include the long-term 
follow-up of studies such as the SCANDIV trial and the LOLA and DIVA arm of the 
Ladies trial. Moreover, combining individual data from trials might lead to new insights 
through post-hoc analysis of a larger sample of included patients. Indeed, an effort to 
combine data from the SCANDIV trial and LOLA arm of the Ladies trial is currently 
being undertaken and hopefully its results will provide useful evidence on the outcomes 
of laparoscopic lavage and risk factors for its potential failure.
Within the light of the published trials that compared primary anastomosis with the 
Hartmann’s procedure for perforated diverticulitis, it should be noted that the majority 
of patients underwent open procedures. However, several studies have demonstrated that 
laparoscopic procedures also seem to be feasible in the setting of surgery for perforated 
diverticulitis and it has been suggested that laparoscopic emergency sigmoidectomy might 
even be superior in terms of less postoperative morbidity and a shorter hospital stay (44-
46). Nevertheless, these studies should be interpreted with caution, as their conclusions 
might only apply to selected patients and require the need of experienced surgeons and 
optimal perioperative care (47, 48). Therefore, another future research direction might 
be to further investigate the role of laparoscopic emergency sigmoidectomy and, more 
specifically, the laparoscopic Hartmann’s procedure. The latter procedure could be of 
interest for selected patients, as it might avoid some of the disadvantages of the open 
procedure and might facilitate a less complex (laparoscopic) reversal procedure.
However, importantly, future research should not only focus on the treatment of 
diverticulitis, but also on its prevention. In this regard, the increasingly investigated role 
of gut microbiota as part of the pathogenesis of diverticular disease might potentially be 
of clinical value (49). Although the existing evidence on this topic currently is relatively 
scarce, more studies seem to point towards a plausible role of the gut microbiome in 
relation to diverticulosis and diverticulitis (50). An increased understanding of the role 
of the microbiome in the pathogenesis of diverticular disease and disease progression will 
likely open up the way for less aggressive and patient tailored prevention and treatment 
approaches (51, 52).
Stoma-related complications
As stated in the general discussion of this thesis, within the literature on parastomal 
hernia increased attention has been put on the prevention of its occurrence, as well as 
patient-reported outcomes, which have rightfully come to play a more important role in 
research on stomas and stoma-related complications. Similarly to the before mentioned 
research initiatives, the CIPHER and PROPHER studies are two examples of research 
that focuses on these aspects (53, 54). The aims of the CIPHER study, a prospective 
observational cohort study conducted in the United Kingdom, are to investigate the 
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incidence of parastomal hernias during the follow-up after stoma construction, as well 
as to assess other complications and resource use. In addition, it also aims to assess the 
generic health status of included patients up to 24 months after index surgery. The 
PROPHER study, an international, prospective, observational cohort study, will be 
conducted to investigate outcomes of operative and non-operative parastomal hernia 
treatment in terms of patient-reported outcomes, such as quality of life, satisfaction, and 
decisional regret (54, 55). These research initiatives are awaited with great interest and 
will likely produce valuable results that are helpful for tailored prevention and treatment 
strategies, as well as shared decision-making.
Efforts have been made to come up with novel strategies to lower the occurrence 
and burden of colorectal anastomotic leakage. Consequently, these strategies might 
potentially decrease the need for protective ileostomy construction and might therefore 
help to decrease the rate of stoma-related and reversal-related morbidity. One such 
strategy is the use of intraluminal stents or sheaths, which has already been studied in 
a clinical setting (56). Within this context, investigators of the REPAIR research group 
(Department of Surgery, Erasmus University Medical Center) are currently setting up 
novel experimental models and studies to further investigate the effectiveness and safety 
of these measures.
Finally, with regard to the topic of stoma site incisional hernia, several trials have been 
designed to assess the effect of prophylactic mesh reinforcement to prevent hernia 
occurrence. One of these randomised trials, conducted by the Reinforcement of Closure 
of Stoma Site (ROCCS) Collaborative and West Midlands Research Collaborative, has 
shown that reinforcement of the abdominal wall with a biological mesh at the time 
of stoma closure reduced the rate of clinically detectable incisional hernia within 24 
months after surgery (57). Additional data from other ongoing trials are also expected 
to provide novel evidence. The MEMBO, ILEOCLOSE, and LISTO trial all focus on 
ileostomy closure, whereas the ROCCS also included patients who undergo colostomy 
reversal (58-62). Certainly, within the light of future evidence, important factors such 
as quality of life and symptomatic hernias, the identification of specific risk groups, and 
economic implications should be investigated and taken into account (63).
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In this thesis, several aspects of the non-resectional and resectional treatment of 
complicated diverticulitis were assessed. Moreover, focus was put on the management and 
incidence of stoma-related complications, as well as on the prevention of postoperative 
ileus. A general introduction on these topics was provided in Chapter 1.
Part I describes the non-resectional treatment of complicated diverticulitis.
In Chapter 2, a multicentre, retrospective cohort study was presented, in which a total 
of 447 patients with a first episode of CT-diagnosed diverticular abscess (Hinchey Ib or 
II) were included in ten Dutch hospitals. Within this patient cohort, both short- and 
long-term outcomes of initial non-surgical management (antibiotics with percutaneous 
drainage (n=115, 25.7%) or without (n=332, 74.3%)) and risk factors for adverse 
outcomes were assessed. As stratified by Hinchey grade Ib or II, no differences in short-
term treatment failure (Hinchey Ib: 22.3 vs. 33%, p=0.359; Hinchey II: 25.9 vs. 36%, 
p=0.149) and emergency surgery (Hinchey Ib: 5.1 vs. 6%, p=0.639; Hinchey II: 10.4 
vs. 15%, p=0.117) were found between treatment groups, although Hinchey II patients 
undergoing percutaneous drainage had significantly more complications (12 vs. 3.7%, 
p=0.032). From multivariable regression analyses, it was derived that the treatment 
choice was not independently associated with short-term treatment failure (odds ratio 
(OR) 1.47, 95%CI 0.81-2.68), emergency surgery (OR 1.29, 95%CI 0.56-2.99), and 
long-term need for surgery (hazard ratio 1.08, 95%CI 0.69-1.69). Interestingly, it was 
found that an abscess size of ≥3 centimeter was associated with short-term treatment 
failure (OR 2.05, 9%CI 1.09-3.86) and of ≥5 centimeter with emergency surgery (OR 
2.96, 95%CI 1.03-8.13). Hence, although these results did not show treatment choice 
to influence outcomes, they did seem to acknowledge that abscesses of ≥3 centimeter are 
at higher risk of adverse outcomes and warrant close monitoring.
In Chapter 3, long-term results of laparoscopic lavage as treatment for perforated 
diverticulitis were reported within a cohort of 38 patients who were included in ten Dutch 
hospitals. Follow-up was conducted over a median period of 46 months (interquartile 
range 7-77), in which recurrent uncomplicated and complicated diverticulitis, presence 
of a stoma, as well as (re)operations were assessed. It was found that in 12 patients, a total 
of 17 episodes of recurrent diverticulitis occurred, of which seven were complicated. A 
stoma could be avoided in 76% of all patients and in those patients with a stoma, it 
could be reversed in 78%. Also, 29 subsequent surgical procedures were reported in 
12 patients, of which seven patients had at least undergone one emergency procedure. 
Interestingly, relevant events occurred up to six years after the lavage procedure.
In Chapter 4, an evidence-based answer to the questions ‘when, how, and if ’ 
laparoscopic lavage should be performed was provided. After an introduction on 
complicated diverticulitis and a short overview of the history of surgical treatment for 
perforated diverticulitis, it describes the several technical perspectives, outcomes of 
randomized controlled trials, considerations on patient selection, and the conclusions 
and contradictions from the abundance of meta-analyses of studies reporting results of 
laparoscopic lavage in comparison to resectional treatment.
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Part II covers the resectional treatment of complicated diverticulitis.
In Chapter 5, results of the DIVA arm of the Ladies trial, a multicenter, randomized, open-
label, superiority trial on the surgical treatment of perforated diverticulitis with purulent 
or fecal peritonitis, were reported. The Hartmann’s procedure and sigmoidectomy with 
primary anastomosis (with or without ileostomy) were compared in terms of 12-month 
stoma-free survival, morbidity and mortality after the index and reversal procedures, as 
well as quality of life. Eventually, outcomes of 66 patients in the Hartmann’s procedure 
group and 64 in the primary anastomosis group were analyzed according to a modified 
intention-to-treat principle. The primary endpoint, 12-month stoma-free survival, 
showed to be significantly better for patients in the primary anastomosis group (94.6% 
[95% CI 88.7-100] vs. 71.7% [95% CI 60.1-83.3], hazard ratio 2.79 [95% CI 1.86-
4.18]; log-rank p<0.0001). In addition, no significant differences in short-term mortality 
(3% vs. 6%, p=0.44) and overall morbidity (44% vs. 39%, p=0·60) were found between 
Hartmann’s procedure and primary anastomosis, respectively, whereas it was found 
that the short-term overall morbidity after stoma reversal was significantly lower for 
primary anastomosis (30% vs. 8%, p=0.023). Therefore, it was concluded that primary 
anastomosis is preferable to Hartmann’s procedure for the treatment of patients with 
perforated diverticulitis with purulent or fecal peritonitis, who are hemodynamically 
stable, immunocompetent, and younger than 85 years.
Chapter 6 described the results of the cost evaluation that was conducted within the 
DIVA arm of the Ladies trial. The overall total costs, including both direct and indirect 
costs, were €1,892,206 for the Hartmann’s procedure group and €1,314,798 for the 
primary anastomosis group. For Hartmann’s and primary anastomosis patients, the 
mean costs were €28,670 (95% CI 26,636 to 30,704) and €20,544 (95% CI 19,569 to 
21,519), respectively. Subsequently, a difference in mean costs of €-8126 (95% CI -14660 
to -1592) between both treatment groups was found, indicating primary anastomosis to 
be associated with significantly lower costs as compared to the Hartmann’s procedure. 
In terms of the probability to be stoma-free and alive at the end of the 12 month follow-
up, the incremental cost-effect effectiveness ratio was €-39,094 (95% BCaCI -1,213 
to -116), demonstrating primary anastomosis to be cost-effective in comparison to the 
Hartmann’s procedure.
In Chapter 7, a systematic review and meta-analysis of studies comparing the Hartmann’s 
procedure to sigmoidectomy with primary anastomosis for patients with purulent or 
fecal peritonitis was presented. After an extensive systematic literature search of 1560 
articles, a total of ten observational and four randomized studies were included. From 
the quantitative analyses of these studies, it could be derived that primary anastomosis 
was in terms of stoma reversal rates (OR 2.62, 95%CI 1.29, 5.31) and reversal-related 
morbidity (OR 0.33, 95%CI 0.16, 0.69), without a difference in mortality (OR 0.83, 
95%CI 0.32, 2.19). These outcomes provide arguments to favor primary anastomosis 
over Hartmann’s procedure in selected patients. Furthermore, a scarcity of evidence with 
regard to the cost-effectiveness and patient-reported outcomes of both procedures was 
identified, which are relevant outcomes to be addressed in future research.
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Part III focuses on the synthesis of the available evidence on the treatment of diverticulitis.
Chapter 8 addressed the multidisciplinary treatment of complicated diverticulitis and 
provides a structured overview of the recent literature on a range of - often much debated 
– topics, such as nonoperative treatment options, the role of percutaneous drainage and 
laparoscopic lavage, as well as the resectional treatment of complicated diverticulitis. 
Moreover, an algorithm to help guide clinical decision-making was introduced.
Chapter 9 consists of the guidelines on diverticular disease as composed by the European 
Society of Coloproctology’s (ESCP) guideline committee. Six working groups, consisting 
of clinical specialists (e.g. colorectal surgeons, gastroenterologists, and radiologists), 
residents and PhD students, were established and had the task to identify and assess 
the available evidence on a range of relevant topics. These general work group topics 
included the etiology of diverticular disease and its follow-up; imaging, indication, 
and classification; non-surgical management and dietary recommendations; emergency 
surgery; elective surgery; as well as technical considerations. Through several voting 
rounds, by members of the working groups and national representatives of all countries 
in the ESCP, proposed statements and recommendations were finalized.
Part IV consists of chapters that assessed stoma-related complications.
In Chapter 10, the nonoperative treatment of patients with a parastomal hernia was 
examined and compared to surgical treatment in a multicentre, retrospective cohort 
study in four Dutch hospitals. A total of 80 patients was included, of which 38 (48%) 
were treated nonoperatively and 42 (52%) underwent surgical treatment. The reasons for 
nonoperative treatment were assessed and were known in 24 patients (63%), being the 
absence of symptoms (n=12, 32%), comorbidities (n=9, 24%), and patient preference 
(n=3, 7.9%). During an overall median follow-up of 46 months (interquartile range 
24-72), eight patients (21%) crossed over from nonoperative treatment to surgical 
treatment, of which one patient required emergency surgery. In the surgical treatment 
group, recurrence of parastomal hernia occurred in 23 patients (55%) and 21 of these 
patients (91%) underwent additional surgery. As the cross-over and emergency surgery 
rates of nonoperative treatment are relatively low, and the recurrence and re-repair 
rates of surgical treatment are high, it seems that patients without symptoms or with 
comorbidities might benefit most from the nonoperative ‘watchful waiting’ strategy.
In Chapter 11, a systematic review on the different modalities for the diagnosis of 
parastomal hernia was presented. In a total of 29 included studies, diagnostic modalities 
such as ultrasound, CT scan, but also clinical examination were assessed and compared. 
In 19 studies, CT could be compared with clinical examination, which showed a 
relative difference in parastomal hernia incidence rates of 0.64 to 3.0 and, overall, 79% 
of the studies identified an increased incidence as compared to clinical assessment. 
Additionally, this review identified a wide range of definitions used throughout the 
literature. The results further emphasize the need for an accurate description of the 
diagnostic approach, definition, and classification in future research, as these might all 
affect the incidence of parastomal hernia.
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In Chapter 12, the incidence, risk factors, and prevention of stoma site incisional hernias 
were assessed through the conduct of a systematic review and meta-analysis. From a total 
of 1440 identified articles, eventually, 33 studies were included that reported on the 
incidence of stoma site incisional hernias after stoma reversal. Eleven of the included 
studies assessed stoma site incisional hernia as primary endpoint and from these studies 
an incidence of 17.7% (range 1.7%–36.1%, median follow-up 28 (15.25–51.70) 
months) was derived. As extracted from all included studies, the incidence was 6.5% 
(range 0%–38%, median follow-up 27.5 (17.54–36) months). This indicates that the 
long-term complication of stoma site incisional hernia should not be underestimated. 
Furthermore, eight studies reported on risk factors, of which body mass index, diabetes 
and surgery for malignant disease were identified as independent risk factors. In 
addition, although two retrospective studies showed promising results for prophylactic 
mesh reinforcement as preventative method, data were limited and strong conclusions 
on its role could not be drawn.
Part V focuses on the prevention of postoperative ileus.
In Chapter 13, the results of a randomized, double-blind, pilot study on the efficacy 
and safety of nicotine chewing gum as compared to regular chewing gum for the 
prevention of postoperative ileus were described. In two Dutch centers, a total of 53 
patients undergoing elective oncological colorectal surgery were enrolled. Eventually, 
outcomes were analyzed in 20 patients in both the nicotine chewing gum group, as 
well as the regular chewing gum group. No difference in primary endpoint, defined as 
time to first passage of feces and toleration of solid food for at least 24 hours, could be 
identified between both groups. For nicotine and regular chewing gum the median time 
to primary endpoint was 4.5 days (interquartile range, 3.0–7.25) vs. 3.5 days (3.0–4.25; 
p = 0.398), respectively. Similarly, no differences were found with regard to inflammatory 
parameters (C-reactive protein, white blood cell count, and interleukin-6) and patient-
reported outcomes (e.g. pain scores and gastrointestinal symptoms). In addition, 
postoperative complications, reinterventions, and readmissions did not differ between 
both treatment groups. These results led to the conclusion that, within this pilot study, 
nicotine chewing gum seemed safe but ineffective in preventing postoperative ileus and 
improving gastrointestinal recovery.
In Chapter 14 the findings of the presented studies were discussed and future perspectives 
were described.
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Nederlandse samenvatting
In dit proefschrift kwamen verscheidene aspecten van de niet-resectionele en resectionele 
behandeling van gecompliceerde diverticulitis aan bod. Tevens werd aandacht besteed 
aan de incidentie van en het beleid bij stomagerelateerde complicaties, als ook aan de 
preventie van postoperatieve ileus. Een algemene introductie over deze onderwerpen 
werd beschreven in Hoofdstuk 1.
In Deel I werd de niet-resectionele behandeling van gecompliceerde diverticulitis 
onderzocht.
In Hoofdstuk 2 werd een multicentrische, retrospectieve cohortstudie gepresenteerd, 
waarin een totaal van 447 patiënten met een eerste episode van CT-gediagnosticeerde 
diverticulitis met abcesvorming (Hinchey Ib of II) werd geïncludeerd in tien 
Nederlandse ziekenhuizen. In dit cohort van patiënten werden zowel de korte- als 
langetermijnuitkomsten van de initiële niet-chirurgische behandeling (antibiotica met 
(n=115, 25.7%) of zonder (n=332, 74.3%) percutane drainage) als ook de risicofactoren 
voor ongewenste uitkomsten onderzocht. Na stratificatie voor Hinchey klasse Ib of 
II, werden geen verschillen gevonden in falen van de behandeling (Hinchey Ib: 22.3 
vs. 33%, p=0.359; Hinchey II: 25.9 vs. 36%, p=0.149) en spoedchirurgie (Hinchey 
Ib: 5.1 vs. 6%, p=0.639; Hinchey II: 10.4 vs. 15%, p=0.117) op de korte termijn. 
Echter, Hinchey II patiënten die werden behandeld met percutane drainage hadden 
wel significant meer complicaties (12 vs. 3.7%, p=0.032). Uit een multivariabele 
regressie analyse kon worden afgeleid dat de keuze van behandeling niet onafhankelijk 
geassocieerd was met korte termijns behandelfalen (odds ratio (OR) 1.47, 95%CI 0.81-
2.68) en spoedchirurgie (OR 1.29, 95%CI 0.56-2.99), en bovendien ook niet met 
chirurgische procedures op de lange termijn (hazard ratio 1.08, 95%CI 0.69-1.69). 
Daarentegen kon wel worden vastgesteld dat een grootte van het abces van ≥3 en ≥5 
centimeter geassocieerd was met, respectievelijk, korte termijn behandelfalen (OR 2.05, 
9%CI 1.09-3.86) en spoedchirurgie (OR 2.96, 95%CI 1.03-8.13). Ondanks dat in 
deze studie de keuze van behandeling de uitkomsten niet leek te beïnvloeden, leken de 
studieresultaten wel te bevestigen dat patiënten met een abces groter dan 3 centimeter 
een hoger risico op negatieve uitkomsten lopen en hun ziektebeloop dus nauwlettend 
dient te worden gevolgd.
In Hoofdstuk 3 werden de lange termijn resultaten van laparoscopische lavage 
als behandeling voor geperforeerde diverticulitis weergegeven, zoals deze werden 
gevonden in een cohort van 38 patiënten die werden geïncludeerd in tien Nederlandse 
ziekenhuizen. De follow-up werd uitgevoerd over een mediane periode van 46 
maanden (interkwartielafstand 7-77), waarin het aantal episodes van recidiverende 
ongecompliceerde en gecompliceerde diverticulitis, als ook de aanwezigheid van een 
stoma en (her)operaties werden vastgesteld. Bij 12 patiënten traden in totaal 17 episodes 
van recidiverende diverticulitis op, waarvan er zeven gecompliceerd waren. In 76% 
van de patiënten kon een stoma worden vermeden. Bij de patiënten bij wie toch een 
stoma moest worden aangelegd, werd het stoma in 78% van de patiënten later alsnog 
opgeheven. Voorts werden 29 chirurgische procedures geregistreerd bij een totaal van 
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12 patiënten, van wie zeven patiënten tenminste één spoedprocedure ondergingen. 
Relevante gerelateerde uitkomsten werden tot zes jaar na de lavage procedure nog 
gerapporteerd.
In Hoofdstuk 4 werd een ‘evidence-based’ antwoord gegeven op de vragen ‘wanneer, 
hoe en of ’ laparoscopische lavage uitgevoerd dient te worden. Na een introductie 
over gecompliceerde diverticulitis en een korte verhandeling over de historie van de 
chirurgische behandeling van geperforeerde diverticulitis, beschrijft het de verschillende 
technische perspectieven, uitkomsten van gerandomiseerde studies, overwegingen met 
betrekking tot patiëntselectie, als ook de conclusies en tegenstellingen zoals gevonden 
in de overvloed aan meta-analyses van de resultaten van studies die de resultaten van 
laparoscopische lavage hebben vergeleken met resectionele procedures.
In Deel II werd de resectionele behandeling van gecompliceerde diverticulitis onderzocht.
In Hoofdstuk 5 werden de resultaten van de DIVA arm van de multicentrische, 
gerandomiseerde, open-label, superioriteitsstudie (Ladies) gepresenteerd, waarin de 
chirurgische behandeling van geperforeerde diverticulitis met purulente of fecale 
peritonitis werd onderzocht. De Hartmann procedure en sigmoïdresectie met primaire 
anastomose (met of zonder constructie van een ontlastend ileostoma) werden vergeleken 
in uitkomsten als de 12-maanden stomavrije overleving, morbiditeit en mortaliteit na 
de index- en ophefprocedure, als ook in termen van kwaliteit van leven. De uitkomsten 
van 66 patiënten in de Hartmann groep en 64 patiënten in de primaire anastomose 
groep werden vergeleken volgens het ‘modified intention-to-treat’ principe. Het 
primaire eindpunt, de 12-maanden stomavrije overleving, was significant beter voor 
patiënten in de primaire anastomose groep (94.6% [95% CI 88.7-100] vs. 71.7% [95% 
CI 60.1-83.3], hazard ratio 2.79 [95% CI 1.86-4.18]; log-rank p<0.0001). Daarnaast 
werd geen verschil aangetoond in korte termijn mortaliteit (3% vs. 6%, p=0.44) en 
totale morbiditeit (44% vs. 39%, p=0·60) tussen respectievelijk de Hartmann procedure 
en primaire anastomose. Op de korte termijn na de ophefprocedure werd een significant 
lagere totale morbiditeit gevonden ten faveure van de primaire anastomose (30% vs. 
8%, p=0.023). Concluderend, werd dus gesteld dat de primaire anastomose de voorkeur 
verdient boven de Hartmann procedure voor de behandeling van hemodynamisch 
stabiele, immunocompetente patiënten van jonger dan 85 jaar, waarbij sprake is van 
geperforeerde diverticulitis met purulente of fecale peritonitis.
De resultaten van de kostenevaluatie van de DIVA-arm van de Ladies trial werden 
beschreven in Hoofdstuk 6. De totale kosten, bestaande uit zowel directe als indirecte 
kosten, waren €1,892,206 in de Hartmann groep en €1,314,798 in de primaire 
anastomose groep. Voor de Hartmann procedure en primaire anastomose waren de 
gemiddelde kosten per patiënt respectievelijk €28,670 (95% CI 26,636 tot 30,704) 
en €20,544 (95% CI 19,569 tot 21,519). Dit resulteerde in een gemiddeld verschil in 
kosten van €-8,126 (95% CI -14,660 tot -1,592) tussen beide behandelgroepen, waarbij 
sigmoïdresectie met primaire anastomose aldus significant met lagere kosten geassocieerd 
was. Voorts werd aangetoond dat, met betrekking tot de kans om stomavrij en in leven 
te zijn aan het einde van de 12-maanden follow-up, sigmoïdresectie met primaire 
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anastomose ook kosten-effectiever was, gezien een incrementele kosteneffectiviteitsratio 
van €-39,094 (95% BCaCI -1,213 tot -116).
In Hoofdstuk 7 werden een systematische review en meta-analyse beschreven, 
waarin eveneens de vergelijking gemaakt werd tussen de Hartmann procedure en 
sigmoïdresectie met primaire anastomose voor patiënten met geperforeerde diverticulitis 
met purulente of fecale peritonitis. Na een uitgebreide systematische evaluatie van de 
literatuur werden, uit een totaal van 1560 gevonden artikelen, tien observationele en 
vier gerandomiseerde studies geïncludeerd. Op basis van een kwantitatieve analyse van 
deze studies kon worden afgeleid dat de resultaten van een sigmoïdresectie met primaire 
anastomose beter zijn in het opzicht van het aantal opgeheven stoma’s (OR 2.62, 95%CI 
1.29, 5.31) en morbiditeit gerelateerd aan de ophefprocedure (OR 0.33, 95%CI 0.16, 
0.69), zonder verschillen in mortaliteit (OR 0.83, 95%CI 0.32, 2.19). Deze uitkomsten 
bieden argumenten ten faveure van de primaire anastomose in geselecteerde patiënten. 
Eveneens werd er een lacune aan resultaten op het gebied van kosteneffectiviteit en 
patiënt-gerapporteerde uitkomstmaten geduid in de literatuur, hetgeen daarom relevante 
uitkomstmaten zijn voor toekomstig onderzoek.
In Deel III werd de nadruk gelegd op de samenvatting van het beschikbare 
wetenschappelijke bewijs over de behandelingsmogelijkheden voor diverticulitis.
Hoofdstuk 8 adresseerde de multidisciplinaire behandeling van gecompliceerde 
diverticulitis en biedt daarvoor een gestructureerd overzicht van de recente literatuur 
op een verscheidenheid van – vaak nog veel bediscussieerde – onderwerpen, zoals niet-
operatieve behandelopties, de rol van percutane drainage en laparoscopische lavage, als 
ook de resectionele behandeling van gecompliceerde diverticulitis. Bovendien werd een 
algoritme voorgesteld ter ondersteuning van de klinische besluitvorming.
Hoofdstuk 9 bestaat uit de richtlijnen over diverticulitis, zoals deze zijn opgesteld door de 
richtlijncommissie van de European Society of Coloproctology (ESCP). Zes werkgroepen, 
bestaande uit medisch specialisten (e.g. colorectale chirurgen, radiologen en maag-, 
darm-, leverartsen) en onderzoekers op dit gebied, werden opgezet en kregen de taak 
toebedeeld om het beschikbare wetenschappelijke bewijs te beoordelen en een antwoord 
te geven op enkele vooraf gestelde onderzoeksvragen. De overkoepelende thema’s van de 
werkgroepen waren: etiologie en follow-up van diverticulitis; beeldvorming, indicaties, en 
classificaties; niet-chirurgische behandeling en voedingsaanbevelingen; spoedchirurgie; 
electieve chirurgie; en technische overwegingen. Na meerdere stemrondes, met daarin 
de betrokkenheid van werkgroepleden en nationale vertegenwoordigers van alle landen 
betrokken bij de ESCP, werden de voorgestelde conclusies en aanbevelingen afgerond.
In Deel IV werd aandacht besteed aan stomagerelateerde complicaties.
In Hoofdstuk 10 werd de non-operatieve behandeling van patiënten met een parastomale 
hernia onderzocht en vergeleken met de chirurgische behandeling door middel van een 
multicentrische, retrospectieve cohortstudie die werd uitgevoerd in vier Nederlandse 
ziekenhuizen. In totaal werden 80 patiënten geïncludeerd, van wie er 38 (48%) non-
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operatief en 42 (52%) chirurgisch werden behandeld. De redenen om te kiezen voor 
een non-operatieve behandeling werden bestudeerd en waren voor 24 patiënten (63%) 
bekend, te weten: afwezigheid van symptomen (n=12, 32%), co-morbiditeit (n=9, 
24%) en een voorkeur van de patiënt (n=3, 7.9%). Gedurende een mediane follow-up 
periode van 46 maanden (interkwartielafstand 24-72) was er sprake van ‘cross-over’ van 
non-operatieve naar chirurgische behandeling in acht patiënten (21%), bij wie er in één 
geval sprake was van een spoedprocedure. In de chirurgisch behandelde groep was er 
sprake van een recidief parastomale hernia bij 23 patiënten (55%), van wie 21 patiënten 
(91%) nogmaals een chirurgische procedure ondergingen. Gezien het relatief lage aantal 
‘cross-overs’ en spoedoperaties in de non-operatieve groep en juist de hoge percentages 
recidieven en re-operaties, lijkt een non-operatieve ‘watchful waiting’ strategie voor 
patiënten zonder klachten of met co-morbiditeit acceptabel te zijn.
In Hoofdstuk 11 werd een systematische review over de verschillende diagnostische 
modaliteiten voor de diagnosestelling van parastomale hernia’s beschreven. Voor een 
totaal van 29 studies werden modaliteiten zoals echografie, CT-scan, als ook lichamelijk 
onderzoek geduid en vergeleken. Diagnostiek door middel van CT-scan kon in 19 studies 
worden vergeleken met lichamelijk onderzoek, waarbij een relatief verschil in de detectie 
van parastomale hernia’s werd gevonden variërend van 0.64 tot 3.0 en tevens was er 
sprake van een toegenomen detectie ten opzichte van lichamelijk onderzoek in 79% van 
deze studies. In aanvulling hierop werd ook een groot aantal verschillende definities van 
parastomale hernia’s in de geïncludeerde studies geconstateerd. De beschreven resultaten 
benadrukken de noodzaak van een eenduidige beschrijving van de diagnostische 
benadering, definitie, en classificatie van parastomale hernia’s in toekomstig onderzoek, 
aangezien al deze factoren de incidentie kunnen beïnvloeden.
In Hoofdstuk 12 werden de incidentie, risicofactoren en preventie van 
stomalittekenbreuken – zijnde littekenbreuken op de plek van een reeds opgeheven 
stoma – onderzocht door middel van een systematische review en meta-analyse. Vanuit 
een totaal van 1440 geïdentificeerde studies werden 33 studies geïncludeerd die de 
incidentie van stomalittekenbreuken beschreven. In elf van de geïncludeerde studies 
was de incidentie van stomalittekenbreuken daadwerkelijk het primaire eindpunt 
en op basis van deze studies werd een incidentie van 17.7% (range 1.7%–36.1%, 
mediane follow-up 28 (15.25–51.70) maanden) gevonden. Tevens kon een incidentie 
van 6.5% (range 0%–38%, mediane follow-up 27.5 (17.54–36) maanden) worden 
afgeleid uit alle geïncludeerde studies. Deze percentages geven aan dat het probleem 
van stomalittekenbreuken op de lange termijn niet onderschat dient te worden. In 
aanvulling op deze resultaten, konden uit acht studies ook risicofactoren worden afgeleid, 
waarbij BMI, diabetes en chirurgie voor een maligniteit als onafhankelijke risicofactoren 
werden geïdentificeerd. In twee retrospectieve studies werden veelbelovende uitkomsten 
gevonden van profylactische meshversterking ter preventie van een stomalittekenbreuk, 
echter deze resultaten waren gelimiteerd en boden daarom nog weinig ruimte voor 
stevige conclusies over de rol en toegevoegde waarde van meshversterking.
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In Deel V werd de preventie van postoperatieve ileus beschreven.
In Hoofdstuk 13 werden de resultaten van een gerandomiseerde, dubbelblinde 
pilotstudie gepresenteerd, waarin de effectiviteit en veiligheid van nicotine kauwgum 
werden vergeleken met normale kauwgum ter preventie van postoperatieve ileus. In 
twee Nederlandse ziekenhuizen werd een totaal van 53 patiënten geïncludeerd die een 
electieve oncologische colorectale resectie ondergingen. Uiteindelijk konden in beide 
behandelgroepen 20 patiënten worden geanalyseerd. Het primaire eindpunt werd 
gedefinieerd als de combinatie van de eerste passage van feces en het 24 uur tolereren van 
vast voedsel, maar er werd geen verschil tussen beide groepen gevonden. Voor nicotine 
en normale kauwgum was de mediane tijd tot het primaire eindpunt respectievelijk 
4.5 dagen (interkwartielafstand, 3.0–7.25) vs. 3.5 dagen (3.0–4.25; p = 0.398). 
Vergelijkbaar met de primaire uitkomst, werden er ook geen verschillen gevonden in 
inflammatoire parameters (C-reactief eiwit, leukocyten en interleukine-6) en patiënt-
gerapporteerde uitkomstmaten (e.g. pijnscores en gastro-intestinale symptomen). 
Het aantal postoperatieve complicaties, re-interventies en heropnames verschilde ook 
niet tussen beide methoden. Op basis van deze resultaten werd geconcludeerd dat in 
deze pilotstudie, nicotine kauwgum veilig maar ineffectief bleek voor de preventie van 
postoperatieve ileus en het bevorderen van het gastro-intestinale herstel.
In Hoofdstuk 14 werden de studies in dit proefschrift bediscussieerd en werden 
verschillende toekomstperspectieven benoemd.
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Dankwoord
Dit proefschrift had niet tot stand kunnen komen zonder de hulp van velen.
Allereerst wil ik mijn bijzondere dank uiten aan de betrokken patiënten die zich, op 
een kwetsbaar moment, toch bereid toonden om deel te nemen aan wetenschappelijk 
onderzoek.
Mijn promotor, professor Lange, ik ben u veel dank verschuldigd voor het vertrouwen 
dat u in mij stelde als student en voor de ruimte die u mij heeft geboden om mijzelf 
onder uw supervisie te ontwikkelen als onderzoeker. Niet alleen uw sturing bij de 
lopende projecten hebben mij veel geholpen, maar juist ook de vrijheid en steun bij het 
uitwerken van eigen onderzoeksvoorstellen waren erg waardevol. Uiteraard kijk ik ook 
met veel plezier terug op de culturele intermezzo’s tijdens de REPAIR-vergaderingen.
Mijn tweede promotor, professor Bemelman, ook u ben ik veel dank verschuldigd voor 
het feit dat ik, met net pas mijn Bachelor op zak, de kans en het vertrouwen kreeg om 
coördinator van de Ladies trial te worden. Daarmee werd daadwerkelijk de kiem gelegd 
voor dit uiteindelijke proefschrift. Onze gesprekken hielpen mij altijd om de nodige 
knopen door te hakken én zorgden ervoor dat ik weer extra motivatie en nieuwe ideeën 
vond.
Professor Bouvy, professor van Eijck en professor Verhoef, geachte leden van de 
leescommissie, veel dank voor uw moeite om zitting te nemen in de leescommissie. Ook 
de overige leden wil ik hartelijk danken voor hun bereidheid om als opponent plaats te 
nemen in mijn grote commissie. Ik kijk er naar uit om met u van gedachten te wisselen 
tijdens de verdediging.
Professor Kleinrensink, beste prof. Als groentje mocht ik ooit starten in het Snijzaalteam, 
waarmee het ‘academische balletje’ ging rollen. Als Snijzaalteamlijert, EARP-bestuur 
en, uiteindelijk, promovendus: op vele manieren heb ik met u samen mogen werken 
en heeft u mij gestimuleerd mijzelf te ontplooien in al die verschillende rollen. Altijd 
was er tijd voor een goed gesprek, luisterend oor en een straffe bak koffie op de 14e 
verdieping. Ik heb veel bewondering voor uw tomeloze energie en positieve kijk op het 
leven. Quaestionem orturam iam solvimus!
Professor Jeekel, uw passie voor chirurgisch onderzoek is bewonderenswaardig en heeft 
mij vaak gemotiveerd. Uw nieuwsgierigheid is een voorbeeld voor alle onderzoekers.
Beste dr. Menon, beste Anand. Veel dank voor je begeleiding gedurende de uitvoering 
van mijn onderzoeken en de nuttige feedback op mijn manuscripten. 
Beste Annelies, veel dank voor jouw waardevolle hulp bij de laatste (organisatorische) 
loodjes van mijn promotietraject.
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Beste Susan, enorm bedankt voor je hulp bij het uitvoeren van een deel van de analyses 
in dit proefschrift.
Voorts mijn grote dank aan alle lokale hoofdonderzoekers, chirurgen, arts-assistenten, 
verpleegkundigen en secretaresses die betrokken waren bij de Ladies trial: jullie inzet en 
hulp waren onmisbaar!
Dan uiteraard een woord van dank aan mijn voorgangers op de Ladies trial: Hilko, 
Irene, Gijs en Sandra, als ook grondlegger Jefrey Vermeulen. Met dank aan jullie eerdere 
inspanningen en harde werk heb ik de kans gekregen deze uitdagende studie tot een 
goed einde te kunnen brengen.
Beste leden van de Dutch Diverticular Disease (3D) werkgroep: prof. dr. Boermeester, 
prof. dr. Consten en dr. Draaisma. Het was inspirerend om deel uit te maken van dit 
onderzoekscollectief en te zien hoe de samenwerking heeft geleid tot het verder invullen 
van de hiaten binnen het diverticulitis onderzoeksveld. Hendrike, jij in het bijzonder 
ook bedankt voor de goede samenwerking!
Labcollegae, dank voor de onvergetelijke tijden in de kelder. Het epicentrum van 
de faculteit heeft veel mensen aan zich voorbij zien trekken, maar enkelen wil ik in 
het bijzonder bedanken. Cloë, al vanaf de eerste summer school samen opgetrokken 
en nu allebei een proefschrift: wie had dat gedacht!? Altijd tijd voor overleg met een 
‘snackerelletje’, nooit te beroerd voor een fout uurtje. Leonard, dank voor de vele 
roestige gaten die je in mijn manuscripten hebt geschoten. Je hebt het reaguren tot een 
kunst weten te verheffen. Michael, altijd kon ik rekenen op jouw galmende kopstem 
om de ruimte mee te vullen. Vugt, wij Brabanders weten: a worstenbroodje a day, keeps 
the doctor away. Yagmur, dank dat ik keer op keer welkom was in jouw hoekie van 
het lab, voor goed advies en/of een koffiecupje. Stefan, vele onvergetelijke uren samen 
doorgebracht in de krochten van het ‘Ee’, heel gaaf. Dank voor alle momenten van bege- 
en (eigenlijk voornamelijk) afleiding. Tot slot, Ron, mag jij - als pater laboratoriae - niet 
ontbreken in dit rijtje. Ik blijf uiteraard graag op de hoogte van je schildpadden(congres)
verhalen.
Alle andere heelkunde-onderzoekers in Rotterdam en Amsterdam met wie ik paden heb 
gekruist in de afgelopen jaren: dank voor alle mooie momenten!
Chirurgen en assistenten uit het Maasstad Ziekenhuis: dank voor de mooie en leerzame 
tijd tot nu toe! 
Roosendalers, ook zoveel jaren nadat we het Gertrudis achter ons hebben gelaten, zijn 
we elkaar nog niet uit het oog verloren. Over het land uitgewaaierd, maar altijd genoeg 
reden om samen te komen voor een Bourgondische borrel. De Derde Kerstdag staat 
alvast weer gereserveerd.
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Huize Volmarijn, lieve Tho, Jeff, Daaf, Lien, Yv en Saar. Ik had me geen betere 
huisgenoten kunnen wensen. De herinneringen zijn schitterend en ontelbaar. Het is 
mooi om te zien hoe jullie allemaal jullie eigen doelen en dromen nastreven.
Boris, goede vriend. Altijd bomvol mooie verhalen. Het is goed om te weten altijd 
het leven met je te kunnen bespiegelen (in aanwezigheid van een goed glas). Sjoerd, 
buurman, wanneer gaan we varen? Galjart, monsieur, binnenkort dan maar weer eens 
met het Moksi-peloton op pad.
Mijn paranimfen, Ruben en Gijs. Niet alleen wetenschappelijk zijn wij een succesvol 
team gebleken, maar ook als belangrijke sfeermakers in Vakje E hebben wij onze strepen 
ruimschoots verdiend. Het is een bijzonder genoegen dat jullie aan mijn zijde staan 
tijdens mijn verdediging. 
Lieve Rob, Birgit, John, Jeffrey, Kim, Bobbi en Mikkie. Dank voor jullie warmte en 
interesse. Ik kan me geen fijnere schoonfamilie bedenken.
Dear JoAnne, although often from distant places around the globe, thank you for your 
support and interest.
Lieve oma, wellicht vind ik ooit nog die wonderpil voor je uit. In de tussentijd is dit toch 
ook al een aardige pil geworden.
Lieve Claire, grote zus, ik ben onwijs trots op je.
Lieve mam, lieve pap, voor altijd ben ik jullie dankbaar voor jullie onvoorwaardelijke 
steun en liefde.
Lieve Isabel, lief, dank voor alles. Ik kan niet wachten om de wereld met je te ontdekken.
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Graag nodig ik u uit voor de 
openbare verdediging van 
mijn proefschrift
Novel Insights into the 
Treatment of Complicated 
Diverticulitis
De verdediging vindt plaats 
op woensdag 28 oktober 
om 13.30 uur in de Professor 
Andries Queridozaal, 
Onderwijscentrum Erasmus 
MC, Wytemaweg 80, 
Rotterdam.
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contact op te nemen over 
de mogelijkheden voor het 
bijwonen/volgen van de 
plechtigheid.
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